(function(){const c=document.createElement("link").relList;if(c&&c.supports&&c.supports("modulepreload"))return;for(const m of document.querySelectorAll('link[rel="modulepreload"]'))u(m);new MutationObserver(m=>{for(const h of m)if(h.type==="childList")for(const v of h.addedNodes)v.tagName==="LINK"&&v.rel==="modulepreload"&&u(v)}).observe(document,{childList:!0,subtree:!0});function l(m){const h={};return m.integrity&&(h.integrity=m.integrity),m.referrerPolicy&&(h.referrerPolicy=m.referrerPolicy),m.crossOrigin==="use-credentials"?h.credentials="include":m.crossOrigin==="anonymous"?h.credentials="omit":h.credentials="same-origin",h}function u(m){if(m.ep)return;m.ep=!0;const h=l(m);fetch(m.href,h)}})();var Ur={exports:{}},En={},Kr={exports:{}},Z={};var nd;function Lp(){if(nd)return Z;nd=1;var r=Symbol.for("react.element"),c=Symbol.for("react.portal"),l=Symbol.for("react.fragment"),u=Symbol.for("react.strict_mode"),m=Symbol.for("react.profiler"),h=Symbol.for("react.provider"),v=Symbol.for("react.context"),k=Symbol.for("react.forward_ref"),w=Symbol.for("react.suspense"),T=Symbol.for("react.memo"),q=Symbol.for("react.lazy"),C=Symbol.iterator;function R(g){return g===null||typeof g!="object"?null:(g=C&&g[C]||g["@@iterator"],typeof g=="function"?g:null)}var V={isMounted:function(){return!1},enqueueForceUpdate:function(){},enqueueReplaceState:function(){},enqueueSetState:function(){}},U=Object.assign,B={};function z(g,S,Y){this.props=g,this.context=S,this.refs=B,this.updater=Y||V}z.prototype.isReactComponent={},z.prototype.setState=function(g,S){if(typeof g!="object"&&typeof g!="function"&&g!=null)throw Error("setState(...): takes an object of state variables to update or a function which returns an object of state variables.");this.updater.enqueueSetState(this,g,S,"setState")},z.prototype.forceUpdate=function(g){this.updater.enqueueForceUpdate(this,g,"forceUpdate")};function G(){}G.prototype=z.prototype;function _(g,S,Y){this.props=g,this.context=S,this.refs=B,this.updater=Y||V}var X=_.prototype=new G;X.constructor=_,U(X,z.prototype),X.isPureReactComponent=!0;var oe=Array.isArray,pe=Object.prototype.hasOwnProperty,xe={current:null},fe={key:!0,ref:!0,__self:!0,__source:!0};function ze(g,S,Y){var ee,ie={},ne=null,le=null;if(S!=null)for(ee in S.ref!==void 0&&(le=S.ref),S.key!==void 0&&(ne=""+S.key),S)pe.call(S,ee)&&!fe.hasOwnProperty(ee)&&(ie[ee]=S[ee]);var re=arguments.length-2;if(re===1)ie.children=Y;else if(1<re){for(var he=Array(re),Je=0;Je<re;Je++)he[Je]=arguments[Je+2];ie.children=he}if(g&&g.defaultProps)for(ee in re=g.defaultProps,re)ie[ee]===void 0&&(ie[ee]=re[ee]);return{$$typeof:r,type:g,key:ne,ref:le,props:ie,_owner:xe.current}}function We(g,S){return{$$typeof:r,type:g.type,key:S,ref:g.ref,props:g.props,_owner:g._owner}}function Te(g){return typeof g=="object"&&g!==null&&g.$$typeof===r}function tt(g){var S={"=":"=0",":":"=2"};return"$"+g.replace(/[=:]/g,function(Y){return S[Y]})}var $e=/\/+/g;function Qe(g,S){return typeof g=="object"&&g!==null&&g.key!=null?tt(""+g.key):S.toString(36)}function lt(g,S,Y,ee,ie){var ne=typeof g;(ne==="undefined"||ne==="boolean")&&(g=null);var le=!1;if(g===null)le=!0;else switch(ne){case"string":case"number":le=!0;break;case"object":switch(g.$$typeof){case r:case c:le=!0}}if(le)return le=g,ie=ie(le),g=ee===""?"."+Qe(le,0):ee,oe(ie)?(Y="",g!=null&&(Y=g.replace($e,"$&/")+"/"),lt(ie,S,Y,"",function(Je){return Je})):ie!=null&&(Te(ie)&&(ie=We(ie,Y+(!ie.key||le&&le.key===ie.key?"":(""+ie.key).replace($e,"$&/")+"/")+g)),S.push(ie)),1;if(le=0,ee=ee===""?".":ee+":",oe(g))for(var re=0;re<g.length;re++){ne=g[re];var he=ee+Qe(ne,re);le+=lt(ne,S,Y,he,ie)}else if(he=R(g),typeof he=="function")for(g=he.call(g),re=0;!(ne=g.next()).done;)ne=ne.value,he=ee+Qe(ne,re++),le+=lt(ne,S,Y,he,ie);else if(ne==="object")throw S=String(g),Error("Objects are not valid as a React child (found: "+(S==="[object Object]"?"object with keys {"+Object.keys(g).join(", ")+"}":S)+"). If you meant to render a collection of children, use an array instead.");return le}function vt(g,S,Y){if(g==null)return g;var ee=[],ie=0;return lt(g,ee,"","",function(ne){return S.call(Y,ne,ie++)}),ee}function je(g){if(g._status===-1){var S=g._result;S=S(),S.then(function(Y){(g._status===0||g._status===-1)&&(g._status=1,g._result=Y)},function(Y){(g._status===0||g._status===-1)&&(g._status=2,g._result=Y)}),g._status===-1&&(g._status=0,g._result=S)}if(g._status===1)return g._result.default;throw g._result}var Ie={current:null},N={transition:null},Q={ReactCurrentDispatcher:Ie,ReactCurrentBatchConfig:N,ReactCurrentOwner:xe};function F(){throw Error("act(...) is not supported in production builds of React.")}return Z.Children={map:vt,forEach:function(g,S,Y){vt(g,function(){S.apply(this,arguments)},Y)},count:function(g){var S=0;return vt(g,function(){S++}),S},toArray:function(g){return vt(g,function(S){return S})||[]},only:function(g){if(!Te(g))throw Error("React.Children.only expected to receive a single React element child.");return g}},Z.Component=z,Z.Fragment=l,Z.Profiler=m,Z.PureComponent=_,Z.StrictMode=u,Z.Suspense=w,Z.__SECRET_INTERNALS_DO_NOT_USE_OR_YOU_WILL_BE_FIRED=Q,Z.act=F,Z.cloneElement=function(g,S,Y){if(g==null)throw Error("React.cloneElement(...): The argument must be a React element, but you passed "+g+".");var ee=U({},g.props),ie=g.key,ne=g.ref,le=g._owner;if(S!=null){if(S.ref!==void 0&&(ne=S.ref,le=xe.current),S.key!==void 0&&(ie=""+S.key),g.type&&g.type.defaultProps)var re=g.type.defaultProps;for(he in S)pe.call(S,he)&&!fe.hasOwnProperty(he)&&(ee[he]=S[he]===void 0&&re!==void 0?re[he]:S[he])}var he=arguments.length-2;if(he===1)ee.children=Y;else if(1<he){re=Array(he);for(var Je=0;Je<he;Je++)re[Je]=arguments[Je+2];ee.children=re}return{$$typeof:r,type:g.type,key:ie,ref:ne,props:ee,_owner:le}},Z.createContext=function(g){return g={$$typeof:v,_currentValue:g,_currentValue2:g,_threadCount:0,Provider:null,Consumer:null,_defaultValue:null,_globalName:null},g.Provider={$$typeof:h,_context:g},g.Consumer=g},Z.createElement=ze,Z.createFactory=function(g){var S=ze.bind(null,g);return S.type=g,S},Z.createRef=function(){return{current:null}},Z.forwardRef=function(g){return{$$typeof:k,render:g}},Z.isValidElement=Te,Z.lazy=function(g){return{$$typeof:q,_payload:{_status:-1,_result:g},_init:je}},Z.memo=function(g,S){return{$$typeof:T,type:g,compare:S===void 0?null:S}},Z.startTransition=function(g){var S=N.transition;N.transition={};try{g()}finally{N.transition=S}},Z.unstable_act=F,Z.useCallback=function(g,S){return Ie.current.useCallback(g,S)},Z.useContext=function(g){return Ie.current.useContext(g)},Z.useDebugValue=function(){},Z.useDeferredValue=function(g){return Ie.current.useDeferredValue(g)},Z.useEffect=function(g,S){return Ie.current.useEffect(g,S)},Z.useId=function(){return Ie.current.useId()},Z.useImperativeHandle=function(g,S,Y){return Ie.current.useImperativeHandle(g,S,Y)},Z.useInsertionEffect=function(g,S){return Ie.current.useInsertionEffect(g,S)},Z.useLayoutEffect=function(g,S){return Ie.current.useLayoutEffect(g,S)},Z.useMemo=function(g,S){return Ie.current.useMemo(g,S)},Z.useReducer=function(g,S,Y){return Ie.current.useReducer(g,S,Y)},Z.useRef=function(g){return Ie.current.useRef(g)},Z.useState=function(g){return Ie.current.useState(g)},Z.useSyncExternalStore=function(g,S,Y){return Ie.current.useSyncExternalStore(g,S,Y)},Z.useTransition=function(){return Ie.current.useTransition()},Z.version="18.3.1",Z}var ad;function is(){return ad||(ad=1,Kr.exports=Lp()),Kr.exports}var od;function zp(){if(od)return En;od=1;var r=is(),c=Symbol.for("react.element"),l=Symbol.for("react.fragment"),u=Object.prototype.hasOwnProperty,m=r.__SECRET_INTERNALS_DO_NOT_USE_OR_YOU_WILL_BE_FIRED.ReactCurrentOwner,h={key:!0,ref:!0,__self:!0,__source:!0};function v(k,w,T){var q,C={},R=null,V=null;T!==void 0&&(R=""+T),w.key!==void 0&&(R=""+w.key),w.ref!==void 0&&(V=w.ref);for(q in w)u.call(w,q)&&!h.hasOwnProperty(q)&&(C[q]=w[q]);if(k&&k.defaultProps)for(q in w=k.defaultProps,w)C[q]===void 0&&(C[q]=w[q]);return{$$typeof:c,type:k,key:R,ref:V,props:C,_owner:m.current}}return En.Fragment=l,En.jsx=v,En.jsxs=v,En}var rd;function Rp(){return rd||(rd=1,Ur.exports=zp()),Ur.exports}var E=Rp(),b=is(),_a={},$r={exports:{}},Ke={},Qr={exports:{}},Jr={};var sd;function Np(){return sd||(sd=1,(function(r){function c(N,Q){var F=N.length;N.push(Q);e:for(;0<F;){var g=F-1>>>1,S=N[g];if(0<m(S,Q))N[g]=Q,N[F]=S,F=g;else break e}}function l(N){return N.length===0?null:N[0]}function u(N){if(N.length===0)return null;var Q=N[0],F=N.pop();if(F!==Q){N[0]=F;e:for(var g=0,S=N.length,Y=S>>>1;g<Y;){var ee=2*(g+1)-1,ie=N[ee],ne=ee+1,le=N[ne];if(0>m(ie,F))ne<S&&0>m(le,ie)?(N[g]=le,N[ne]=F,g=ne):(N[g]=ie,N[ee]=F,g=ee);else if(ne<S&&0>m(le,F))N[g]=le,N[ne]=F,g=ne;else break e}}return Q}function m(N,Q){var F=N.sortIndex-Q.sortIndex;return F!==0?F:N.id-Q.id}if(typeof performance=="object"&&typeof performance.now=="function"){var h=performance;r.unstable_now=function(){return h.now()}}else{var v=Date,k=v.now();r.unstable_now=function(){return v.now()-k}}var w=[],T=[],q=1,C=null,R=3,V=!1,U=!1,B=!1,z=typeof setTimeout=="function"?setTimeout:null,G=typeof clearTimeout=="function"?clearTimeout:null,_=typeof setImmediate<"u"?setImmediate:null;typeof navigator<"u"&&navigator.scheduling!==void 0&&navigator.scheduling.isInputPending!==void 0&&navigator.scheduling.isInputPending.bind(navigator.scheduling);function X(N){for(var Q=l(T);Q!==null;){if(Q.callback===null)u(T);else if(Q.startTime<=N)u(T),Q.sortIndex=Q.expirationTime,c(w,Q);else break;Q=l(T)}}function oe(N){if(B=!1,X(N),!U)if(l(w)!==null)U=!0,je(pe);else{var Q=l(T);Q!==null&&Ie(oe,Q.startTime-N)}}function pe(N,Q){U=!1,B&&(B=!1,G(ze),ze=-1),V=!0;var F=R;try{for(X(Q),C=l(w);C!==null&&(!(C.expirationTime>Q)||N&&!tt());){var g=C.callback;if(typeof g=="function"){C.callback=null,R=C.priorityLevel;var S=g(C.expirationTime<=Q);Q=r.unstable_now(),typeof S=="function"?C.callback=S:C===l(w)&&u(w),X(Q)}else u(w);C=l(w)}if(C!==null)var Y=!0;else{var ee=l(T);ee!==null&&Ie(oe,ee.startTime-Q),Y=!1}return Y}finally{C=null,R=F,V=!1}}var xe=!1,fe=null,ze=-1,We=5,Te=-1;function tt(){return!(r.unstable_now()-Te<We)}function $e(){if(fe!==null){var N=r.unstable_now();Te=N;var Q=!0;try{Q=fe(!0,N)}finally{Q?Qe():(xe=!1,fe=null)}}else xe=!1}var Qe;if(typeof _=="function")Qe=function(){_($e)};else if(typeof MessageChannel<"u"){var lt=new MessageChannel,vt=lt.port2;lt.port1.onmessage=$e,Qe=function(){vt.postMessage(null)}}else Qe=function(){z($e,0)};function je(N){fe=N,xe||(xe=!0,Qe())}function Ie(N,Q){ze=z(function(){N(r.unstable_now())},Q)}r.unstable_IdlePriority=5,r.unstable_ImmediatePriority=1,r.unstable_LowPriority=4,r.unstable_NormalPriority=3,r.unstable_Profiling=null,r.unstable_UserBlockingPriority=2,r.unstable_cancelCallback=function(N){N.callback=null},r.unstable_continueExecution=function(){U||V||(U=!0,je(pe))},r.unstable_forceFrameRate=function(N){0>N||125<N?console.error("forceFrameRate takes a positive int between 0 and 125, forcing frame rates higher than 125 fps is not supported"):We=0<N?Math.floor(1e3/N):5},r.unstable_getCurrentPriorityLevel=function(){return R},r.unstable_getFirstCallbackNode=function(){return l(w)},r.unstable_next=function(N){switch(R){case 1:case 2:case 3:var Q=3;break;default:Q=R}var F=R;R=Q;try{return N()}finally{R=F}},r.unstable_pauseExecution=function(){},r.unstable_requestPaint=function(){},r.unstable_runWithPriority=function(N,Q){switch(N){case 1:case 2:case 3:case 4:case 5:break;default:N=3}var F=R;R=N;try{return Q()}finally{R=F}},r.unstable_scheduleCallback=function(N,Q,F){var g=r.unstable_now();switch(typeof F=="object"&&F!==null?(F=F.delay,F=typeof F=="number"&&0<F?g+F:g):F=g,N){case 1:var S=-1;break;case 2:S=250;break;case 5:S=1073741823;break;case 4:S=1e4;break;default:S=5e3}return S=F+S,N={id:q++,callback:Q,priorityLevel:N,startTime:F,expirationTime:S,sortIndex:-1},F>g?(N.sortIndex=F,c(T,N),l(w)===null&&N===l(T)&&(B?(G(ze),ze=-1):B=!0,Ie(oe,F-g))):(N.sortIndex=S,c(w,N),U||V||(U=!0,je(pe))),N},r.unstable_shouldYield=tt,r.unstable_wrapCallback=function(N){var Q=R;return function(){var F=R;R=Q;try{return N.apply(this,arguments)}finally{R=F}}}})(Jr)),Jr}var ld;function Mp(){return ld||(ld=1,Qr.exports=Np()),Qr.exports}var cd;function Bp(){if(cd)return Ke;cd=1;var r=is(),c=Mp();function l(e){for(var t="https://reactjs.org/docs/error-decoder.html?invariant="+e,i=1;i<arguments.length;i++)t+="&args[]="+encodeURIComponent(arguments[i]);return"Minified React error #"+e+"; visit "+t+" for the full message or use the non-minified dev environment for full errors and additional helpful warnings."}var u=new Set,m={};function h(e,t){v(e,t),v(e+"Capture",t)}function v(e,t){for(m[e]=t,e=0;e<t.length;e++)u.add(t[e])}var k=!(typeof window>"u"||typeof window.document>"u"||typeof window.document.createElement>"u"),w=Object.prototype.hasOwnProperty,T=/^[:A-Z_a-z\u00C0-\u00D6\u00D8-\u00F6\u00F8-\u02FF\u0370-\u037D\u037F-\u1FFF\u200C-\u200D\u2070-\u218F\u2C00-\u2FEF\u3001-\uD7FF\uF900-\uFDCF\uFDF0-\uFFFD][:A-Z_a-z\u00C0-\u00D6\u00D8-\u00F6\u00F8-\u02FF\u0370-\u037D\u037F-\u1FFF\u200C-\u200D\u2070-\u218F\u2C00-\u2FEF\u3001-\uD7FF\uF900-\uFDCF\uFDF0-\uFFFD\-.0-9\u00B7\u0300-\u036F\u203F-\u2040]*$/,q={},C={};function R(e){return w.call(C,e)?!0:w.call(q,e)?!1:T.test(e)?C[e]=!0:(q[e]=!0,!1)}function V(e,t,i,n){if(i!==null&&i.type===0)return!1;switch(typeof t){case"function":case"symbol":return!0;case"boolean":return n?!1:i!==null?!i.acceptsBooleans:(e=e.toLowerCase().slice(0,5),e!=="data-"&&e!=="aria-");default:return!1}}function U(e,t,i,n){if(t===null||typeof t>"u"||V(e,t,i,n))return!0;if(n)return!1;if(i!==null)switch(i.type){case 3:return!t;case 4:return t===!1;case 5:return isNaN(t);case 6:return isNaN(t)||1>t}return!1}function B(e,t,i,n,a,o,s){this.acceptsBooleans=t===2||t===3||t===4,this.attributeName=n,this.attributeNamespace=a,this.mustUseProperty=i,this.propertyName=e,this.type=t,this.sanitizeURL=o,this.removeEmptyString=s}var z={};"children dangerouslySetInnerHTML defaultValue defaultChecked innerHTML suppressContentEditableWarning suppressHydrationWarning style".split(" ").forEach(function(e){z[e]=new B(e,0,!1,e,null,!1,!1)}),[["acceptCharset","accept-charset"],["className","class"],["htmlFor","for"],["httpEquiv","http-equiv"]].forEach(function(e){var t=e[0];z[t]=new B(t,1,!1,e[1],null,!1,!1)}),["contentEditable","draggable","spellCheck","value"].forEach(function(e){z[e]=new B(e,2,!1,e.toLowerCase(),null,!1,!1)}),["autoReverse","externalResourcesRequired","focusable","preserveAlpha"].forEach(function(e){z[e]=new B(e,2,!1,e,null,!1,!1)}),"allowFullScreen async autoFocus autoPlay controls default defer disabled disablePictureInPicture disableRemotePlayback formNoValidate hidden loop noModule noValidate open playsInline readOnly required reversed scoped seamless itemScope".split(" ").forEach(function(e){z[e]=new B(e,3,!1,e.toLowerCase(),null,!1,!1)}),["checked","multiple","muted","selected"].forEach(function(e){z[e]=new B(e,3,!0,e,null,!1,!1)}),["capture","download"].forEach(function(e){z[e]=new B(e,4,!1,e,null,!1,!1)}),["cols","rows","size","span"].forEach(function(e){z[e]=new B(e,6,!1,e,null,!1,!1)}),["rowSpan","start"].forEach(function(e){z[e]=new B(e,5,!1,e.toLowerCase(),null,!1,!1)});var G=/[\-:]([a-z])/g;function _(e){return e[1].toUpperCase()}"accent-height alignment-baseline arabic-form baseline-shift cap-height clip-path clip-rule color-interpolation color-interpolation-filters color-profile color-rendering dominant-baseline enable-background fill-opacity fill-rule flood-color flood-opacity font-family font-size font-size-adjust font-stretch font-style font-variant font-weight glyph-name glyph-orientation-horizontal glyph-orientation-vertical horiz-adv-x horiz-origin-x image-rendering letter-spacing lighting-color marker-end marker-mid marker-start overline-position overline-thickness paint-order panose-1 pointer-events rendering-intent shape-rendering stop-color stop-opacity strikethrough-position strikethrough-thickness stroke-dasharray stroke-dashoffset stroke-linecap stroke-linejoin stroke-miterlimit stroke-opacity stroke-width text-anchor text-decoration text-rendering underline-position underline-thickness unicode-bidi unicode-range units-per-em v-alphabetic v-hanging v-ideographic v-mathematical vector-effect vert-adv-y vert-origin-x vert-origin-y word-spacing writing-mode xmlns:xlink x-height".split(" ").forEach(function(e){var t=e.replace(G,_);z[t]=new B(t,1,!1,e,null,!1,!1)}),"xlink:actuate xlink:arcrole xlink:role xlink:show xlink:title xlink:type".split(" ").forEach(function(e){var t=e.replace(G,_);z[t]=new B(t,1,!1,e,"http://www.w3.org/1999/xlink",!1,!1)}),["xml:base","xml:lang","xml:space"].forEach(function(e){var t=e.replace(G,_);z[t]=new B(t,1,!1,e,"http://www.w3.org/XML/1998/namespace",!1,!1)}),["tabIndex","crossOrigin"].forEach(function(e){z[e]=new B(e,1,!1,e.toLowerCase(),null,!1,!1)}),z.xlinkHref=new B("xlinkHref",1,!1,"xlink:href","http://www.w3.org/1999/xlink",!0,!1),["src","href","action","formAction"].forEach(function(e){z[e]=new B(e,1,!1,e.toLowerCase(),null,!0,!0)});function X(e,t,i,n){var a=z.hasOwnProperty(t)?z[t]:null;(a!==null?a.type!==0:n||!(2<t.length)||t[0]!=="o"&&t[0]!=="O"||t[1]!=="n"&&t[1]!=="N")&&(U(t,i,a,n)&&(i=null),n||a===null?R(t)&&(i===null?e.removeAttribute(t):e.setAttribute(t,""+i)):a.mustUseProperty?e[a.propertyName]=i===null?a.type===3?!1:"":i:(t=a.attributeName,n=a.attributeNamespace,i===null?e.removeAttribute(t):(a=a.type,i=a===3||a===4&&i===!0?"":""+i,n?e.setAttributeNS(n,t,i):e.setAttribute(t,i))))}var oe=r.__SECRET_INTERNALS_DO_NOT_USE_OR_YOU_WILL_BE_FIRED,pe=Symbol.for("react.element"),xe=Symbol.for("react.portal"),fe=Symbol.for("react.fragment"),ze=Symbol.for("react.strict_mode"),We=Symbol.for("react.profiler"),Te=Symbol.for("react.provider"),tt=Symbol.for("react.context"),$e=Symbol.for("react.forward_ref"),Qe=Symbol.for("react.suspense"),lt=Symbol.for("react.suspense_list"),vt=Symbol.for("react.memo"),je=Symbol.for("react.lazy"),Ie=Symbol.for("react.offscreen"),N=Symbol.iterator;function Q(e){return e===null||typeof e!="object"?null:(e=N&&e[N]||e["@@iterator"],typeof e=="function"?e:null)}var F=Object.assign,g;function S(e){if(g===void 0)try{throw Error()}catch(i){var t=i.stack.trim().match(/\n( *(at )?)/);g=t&&t[1]||""}return`
`+g+e}var Y=!1;function ee(e,t){if(!e||Y)return"";Y=!0;var i=Error.prepareStackTrace;Error.prepareStackTrace=void 0;try{if(t)if(t=function(){throw Error()},Object.defineProperty(t.prototype,"props",{set:function(){throw Error()}}),typeof Reflect=="object"&&Reflect.construct){try{Reflect.construct(t,[])}catch(I){var n=I}Reflect.construct(e,[],t)}else{try{t.call()}catch(I){n=I}e.call(t.prototype)}else{try{throw Error()}catch(I){n=I}e()}}catch(I){if(I&&n&&typeof I.stack=="string"){for(var a=I.stack.split(`
`),o=n.stack.split(`
`),s=a.length-1,d=o.length-1;1<=s&&0<=d&&a[s]!==o[d];)d--;for(;1<=s&&0<=d;s--,d--)if(a[s]!==o[d]){if(s!==1||d!==1)do if(s--,d--,0>d||a[s]!==o[d]){var p=`
`+a[s].replace(" at new "," at ");return e.displayName&&p.includes("<anonymous>")&&(p=p.replace("<anonymous>",e.displayName)),p}while(1<=s&&0<=d);break}}}finally{Y=!1,Error.prepareStackTrace=i}return(e=e?e.displayName||e.name:"")?S(e):""}function ie(e){switch(e.tag){case 5:return S(e.type);case 16:return S("Lazy");case 13:return S("Suspense");case 19:return S("SuspenseList");case 0:case 2:case 15:return e=ee(e.type,!1),e;case 11:return e=ee(e.type.render,!1),e;case 1:return e=ee(e.type,!0),e;default:return""}}function ne(e){if(e==null)return null;if(typeof e=="function")return e.displayName||e.name||null;if(typeof e=="string")return e;switch(e){case fe:return"Fragment";case xe:return"Portal";case We:return"Profiler";case ze:return"StrictMode";case Qe:return"Suspense";case lt:return"SuspenseList"}if(typeof e=="object")switch(e.$$typeof){case tt:return(e.displayName||"Context")+".Consumer";case Te:return(e._context.displayName||"Context")+".Provider";case $e:var t=e.render;return e=e.displayName,e||(e=t.displayName||t.name||"",e=e!==""?"ForwardRef("+e+")":"ForwardRef"),e;case vt:return t=e.displayName||null,t!==null?t:ne(e.type)||"Memo";case je:t=e._payload,e=e._init;try{return ne(e(t))}catch{}}return null}function le(e){var t=e.type;switch(e.tag){case 24:return"Cache";case 9:return(t.displayName||"Context")+".Consumer";case 10:return(t._context.displayName||"Context")+".Provider";case 18:return"DehydratedFragment";case 11:return e=t.render,e=e.displayName||e.name||"",t.displayName||(e!==""?"ForwardRef("+e+")":"ForwardRef");case 7:return"Fragment";case 5:return t;case 4:return"Portal";case 3:return"Root";case 6:return"Text";case 16:return ne(t);case 8:return t===ze?"StrictMode":"Mode";case 22:return"Offscreen";case 12:return"Profiler";case 21:return"Scope";case 13:return"Suspense";case 19:return"SuspenseList";case 25:return"TracingMarker";case 1:case 0:case 17:case 2:case 14:case 15:if(typeof t=="function")return t.displayName||t.name||null;if(typeof t=="string")return t}return null}function re(e){switch(typeof e){case"boolean":case"number":case"string":case"undefined":return e;case"object":return e;default:return""}}function he(e){var t=e.type;return(e=e.nodeName)&&e.toLowerCase()==="input"&&(t==="checkbox"||t==="radio")}function Je(e){var t=he(e)?"checked":"value",i=Object.getOwnPropertyDescriptor(e.constructor.prototype,t),n=""+e[t];if(!e.hasOwnProperty(t)&&typeof i<"u"&&typeof i.get=="function"&&typeof i.set=="function"){var a=i.get,o=i.set;return Object.defineProperty(e,t,{configurable:!0,get:function(){return a.call(this)},set:function(s){n=""+s,o.call(this,s)}}),Object.defineProperty(e,t,{enumerable:i.enumerable}),{getValue:function(){return n},setValue:function(s){n=""+s},stopTracking:function(){e._valueTracker=null,delete e[t]}}}}function Nn(e){e._valueTracker||(e._valueTracker=Je(e))}function cs(e){if(!e)return!1;var t=e._valueTracker;if(!t)return!0;var i=t.getValue(),n="";return e&&(n=he(e)?e.checked?"true":"false":e.value),e=n,e!==i?(t.setValue(e),!0):!1}function Mn(e){if(e=e||(typeof document<"u"?document:void 0),typeof e>"u")return null;try{return e.activeElement||e.body}catch{return e.body}}function Ya(e,t){var i=t.checked;return F({},t,{defaultChecked:void 0,defaultValue:void 0,value:void 0,checked:i??e._wrapperState.initialChecked})}function ds(e,t){var i=t.defaultValue==null?"":t.defaultValue,n=t.checked!=null?t.checked:t.defaultChecked;i=re(t.value!=null?t.value:i),e._wrapperState={initialChecked:n,initialValue:i,controlled:t.type==="checkbox"||t.type==="radio"?t.checked!=null:t.value!=null}}function us(e,t){t=t.checked,t!=null&&X(e,"checked",t,!1)}function Za(e,t){us(e,t);var i=re(t.value),n=t.type;if(i!=null)n==="number"?(i===0&&e.value===""||e.value!=i)&&(e.value=""+i):e.value!==""+i&&(e.value=""+i);else if(n==="submit"||n==="reset"){e.removeAttribute("value");return}t.hasOwnProperty("value")?eo(e,t.type,i):t.hasOwnProperty("defaultValue")&&eo(e,t.type,re(t.defaultValue)),t.checked==null&&t.defaultChecked!=null&&(e.defaultChecked=!!t.defaultChecked)}function ps(e,t,i){if(t.hasOwnProperty("value")||t.hasOwnProperty("defaultValue")){var n=t.type;if(!(n!=="submit"&&n!=="reset"||t.value!==void 0&&t.value!==null))return;t=""+e._wrapperState.initialValue,i||t===e.value||(e.value=t),e.defaultValue=t}i=e.name,i!==""&&(e.name=""),e.defaultChecked=!!e._wrapperState.initialChecked,i!==""&&(e.name=i)}function eo(e,t,i){(t!=="number"||Mn(e.ownerDocument)!==e)&&(i==null?e.defaultValue=""+e._wrapperState.initialValue:e.defaultValue!==""+i&&(e.defaultValue=""+i))}var Oi=Array.isArray;function mi(e,t,i,n){if(e=e.options,t){t={};for(var a=0;a<i.length;a++)t["$"+i[a]]=!0;for(i=0;i<e.length;i++)a=t.hasOwnProperty("$"+e[i].value),e[i].selected!==a&&(e[i].selected=a),a&&n&&(e[i].defaultSelected=!0)}else{for(i=""+re(i),t=null,a=0;a<e.length;a++){if(e[a].value===i){e[a].selected=!0,n&&(e[a].defaultSelected=!0);return}t!==null||e[a].disabled||(t=e[a])}t!==null&&(t.selected=!0)}}function to(e,t){if(t.dangerouslySetInnerHTML!=null)throw Error(l(91));return F({},t,{value:void 0,defaultValue:void 0,children:""+e._wrapperState.initialValue})}function hs(e,t){var i=t.value;if(i==null){if(i=t.children,t=t.defaultValue,i!=null){if(t!=null)throw Error(l(92));if(Oi(i)){if(1<i.length)throw Error(l(93));i=i[0]}t=i}t==null&&(t=""),i=t}e._wrapperState={initialValue:re(i)}}function ms(e,t){var i=re(t.value),n=re(t.defaultValue);i!=null&&(i=""+i,i!==e.value&&(e.value=i),t.defaultValue==null&&e.defaultValue!==i&&(e.defaultValue=i)),n!=null&&(e.defaultValue=""+n)}function fs(e){var t=e.textContent;t===e._wrapperState.initialValue&&t!==""&&t!==null&&(e.value=t)}function gs(e){switch(e){case"svg":return"http://www.w3.org/2000/svg";case"math":return"http://www.w3.org/1998/Math/MathML";default:return"http://www.w3.org/1999/xhtml"}}function io(e,t){return e==null||e==="http://www.w3.org/1999/xhtml"?gs(t):e==="http://www.w3.org/2000/svg"&&t==="foreignObject"?"http://www.w3.org/1999/xhtml":e}var Bn,ys=(function(e){return typeof MSApp<"u"&&MSApp.execUnsafeLocalFunction?function(t,i,n,a){MSApp.execUnsafeLocalFunction(function(){return e(t,i,n,a)})}:e})(function(e,t){if(e.namespaceURI!=="http://www.w3.org/2000/svg"||"innerHTML"in e)e.innerHTML=t;else{for(Bn=Bn||document.createElement("div"),Bn.innerHTML="<svg>"+t.valueOf().toString()+"</svg>",t=Bn.firstChild;e.firstChild;)e.removeChild(e.firstChild);for(;t.firstChild;)e.appendChild(t.firstChild)}});function Vi(e,t){if(t){var i=e.firstChild;if(i&&i===e.lastChild&&i.nodeType===3){i.nodeValue=t;return}}e.textContent=t}var _i={animationIterationCount:!0,aspectRatio:!0,borderImageOutset:!0,borderImageSlice:!0,borderImageWidth:!0,boxFlex:!0,boxFlexGroup:!0,boxOrdinalGroup:!0,columnCount:!0,columns:!0,flex:!0,flexGrow:!0,flexPositive:!0,flexShrink:!0,flexNegative:!0,flexOrder:!0,gridArea:!0,gridRow:!0,gridRowEnd:!0,gridRowSpan:!0,gridRowStart:!0,gridColumn:!0,gridColumnEnd:!0,gridColumnSpan:!0,gridColumnStart:!0,fontWeight:!0,lineClamp:!0,lineHeight:!0,opacity:!0,order:!0,orphans:!0,tabSize:!0,widows:!0,zIndex:!0,zoom:!0,fillOpacity:!0,floodOpacity:!0,stopOpacity:!0,strokeDasharray:!0,strokeDashoffset:!0,strokeMiterlimit:!0,strokeOpacity:!0,strokeWidth:!0},Md=["Webkit","ms","Moz","O"];Object.keys(_i).forEach(function(e){Md.forEach(function(t){t=t+e.charAt(0).toUpperCase()+e.substring(1),_i[t]=_i[e]})});function vs(e,t,i){return t==null||typeof t=="boolean"||t===""?"":i||typeof t!="number"||t===0||_i.hasOwnProperty(e)&&_i[e]?(""+t).trim():t+"px"}function xs(e,t){e=e.style;for(var i in t)if(t.hasOwnProperty(i)){var n=i.indexOf("--")===0,a=vs(i,t[i],n);i==="float"&&(i="cssFloat"),n?e.setProperty(i,a):e[i]=a}}var Bd=F({menuitem:!0},{area:!0,base:!0,br:!0,col:!0,embed:!0,hr:!0,img:!0,input:!0,keygen:!0,link:!0,meta:!0,param:!0,source:!0,track:!0,wbr:!0});function no(e,t){if(t){if(Bd[e]&&(t.children!=null||t.dangerouslySetInnerHTML!=null))throw Error(l(137,e));if(t.dangerouslySetInnerHTML!=null){if(t.children!=null)throw Error(l(60));if(typeof t.dangerouslySetInnerHTML!="object"||!("__html"in t.dangerouslySetInnerHTML))throw Error(l(61))}if(t.style!=null&&typeof t.style!="object")throw Error(l(62))}}function ao(e,t){if(e.indexOf("-")===-1)return typeof t.is=="string";switch(e){case"annotation-xml":case"color-profile":case"font-face":case"font-face-src":case"font-face-uri":case"font-face-format":case"font-face-name":case"missing-glyph":return!1;default:return!0}}var oo=null;function ro(e){return e=e.target||e.srcElement||window,e.correspondingUseElement&&(e=e.correspondingUseElement),e.nodeType===3?e.parentNode:e}var so=null,fi=null,gi=null;function Is(e){if(e=mn(e)){if(typeof so!="function")throw Error(l(280));var t=e.stateNode;t&&(t=ra(t),so(e.stateNode,e.type,t))}}function ws(e){fi?gi?gi.push(e):gi=[e]:fi=e}function bs(){if(fi){var e=fi,t=gi;if(gi=fi=null,Is(e),t)for(e=0;e<t.length;e++)Is(t[e])}}function ks(e,t){return e(t)}function Cs(){}var lo=!1;function Ts(e,t,i){if(lo)return e(t,i);lo=!0;try{return ks(e,t,i)}finally{lo=!1,(fi!==null||gi!==null)&&(Cs(),bs())}}function Ui(e,t){var i=e.stateNode;if(i===null)return null;var n=ra(i);if(n===null)return null;i=n[t];e:switch(t){case"onClick":case"onClickCapture":case"onDoubleClick":case"onDoubleClickCapture":case"onMouseDown":case"onMouseDownCapture":case"onMouseMove":case"onMouseMoveCapture":case"onMouseUp":case"onMouseUpCapture":case"onMouseEnter":(n=!n.disabled)||(e=e.type,n=!(e==="button"||e==="input"||e==="select"||e==="textarea")),e=!n;break e;default:e=!1}if(e)return null;if(i&&typeof i!="function")throw Error(l(231,t,typeof i));return i}var co=!1;if(k)try{var Ki={};Object.defineProperty(Ki,"passive",{get:function(){co=!0}}),window.addEventListener("test",Ki,Ki),window.removeEventListener("test",Ki,Ki)}catch{co=!1}function Wd(e,t,i,n,a,o,s,d,p){var I=Array.prototype.slice.call(arguments,3);try{t.apply(i,I)}catch(A){this.onError(A)}}var $i=!1,Wn=null,Fn=!1,uo=null,Fd={onError:function(e){$i=!0,Wn=e}};function Hd(e,t,i,n,a,o,s,d,p){$i=!1,Wn=null,Wd.apply(Fd,arguments)}function jd(e,t,i,n,a,o,s,d,p){if(Hd.apply(this,arguments),$i){if($i){var I=Wn;$i=!1,Wn=null}else throw Error(l(198));Fn||(Fn=!0,uo=I)}}function ti(e){var t=e,i=e;if(e.alternate)for(;t.return;)t=t.return;else{e=t;do t=e,(t.flags&4098)!==0&&(i=t.return),e=t.return;while(e)}return t.tag===3?i:null}function Ps(e){if(e.tag===13){var t=e.memoizedState;if(t===null&&(e=e.alternate,e!==null&&(t=e.memoizedState)),t!==null)return t.dehydrated}return null}function Ss(e){if(ti(e)!==e)throw Error(l(188))}function Gd(e){var t=e.alternate;if(!t){if(t=ti(e),t===null)throw Error(l(188));return t!==e?null:e}for(var i=e,n=t;;){var a=i.return;if(a===null)break;var o=a.alternate;if(o===null){if(n=a.return,n!==null){i=n;continue}break}if(a.child===o.child){for(o=a.child;o;){if(o===i)return Ss(a),e;if(o===n)return Ss(a),t;o=o.sibling}throw Error(l(188))}if(i.return!==n.return)i=a,n=o;else{for(var s=!1,d=a.child;d;){if(d===i){s=!0,i=a,n=o;break}if(d===n){s=!0,n=a,i=o;break}d=d.sibling}if(!s){for(d=o.child;d;){if(d===i){s=!0,i=o,n=a;break}if(d===n){s=!0,n=o,i=a;break}d=d.sibling}if(!s)throw Error(l(189))}}if(i.alternate!==n)throw Error(l(190))}if(i.tag!==3)throw Error(l(188));return i.stateNode.current===i?e:t}function As(e){return e=Gd(e),e!==null?Es(e):null}function Es(e){if(e.tag===5||e.tag===6)return e;for(e=e.child;e!==null;){var t=Es(e);if(t!==null)return t;e=e.sibling}return null}var qs=c.unstable_scheduleCallback,Ds=c.unstable_cancelCallback,Od=c.unstable_shouldYield,Vd=c.unstable_requestPaint,be=c.unstable_now,_d=c.unstable_getCurrentPriorityLevel,po=c.unstable_ImmediatePriority,Ls=c.unstable_UserBlockingPriority,Hn=c.unstable_NormalPriority,Ud=c.unstable_LowPriority,zs=c.unstable_IdlePriority,jn=null,xt=null;function Kd(e){if(xt&&typeof xt.onCommitFiberRoot=="function")try{xt.onCommitFiberRoot(jn,e,void 0,(e.current.flags&128)===128)}catch{}}var ct=Math.clz32?Math.clz32:Jd,$d=Math.log,Qd=Math.LN2;function Jd(e){return e>>>=0,e===0?32:31-($d(e)/Qd|0)|0}var Gn=64,On=4194304;function Qi(e){switch(e&-e){case 1:return 1;case 2:return 2;case 4:return 4;case 8:return 8;case 16:return 16;case 32:return 32;case 64:case 128:case 256:case 512:case 1024:case 2048:case 4096:case 8192:case 16384:case 32768:case 65536:case 131072:case 262144:case 524288:case 1048576:case 2097152:return e&4194240;case 4194304:case 8388608:case 16777216:case 33554432:case 67108864:return e&130023424;case 134217728:return 134217728;case 268435456:return 268435456;case 536870912:return 536870912;case 1073741824:return 1073741824;default:return e}}function Vn(e,t){var i=e.pendingLanes;if(i===0)return 0;var n=0,a=e.suspendedLanes,o=e.pingedLanes,s=i&268435455;if(s!==0){var d=s&~a;d!==0?n=Qi(d):(o&=s,o!==0&&(n=Qi(o)))}else s=i&~a,s!==0?n=Qi(s):o!==0&&(n=Qi(o));if(n===0)return 0;if(t!==0&&t!==n&&(t&a)===0&&(a=n&-n,o=t&-t,a>=o||a===16&&(o&4194240)!==0))return t;if((n&4)!==0&&(n|=i&16),t=e.entangledLanes,t!==0)for(e=e.entanglements,t&=n;0<t;)i=31-ct(t),a=1<<i,n|=e[i],t&=~a;return n}function Xd(e,t){switch(e){case 1:case 2:case 4:return t+250;case 8:case 16:case 32:case 64:case 128:case 256:case 512:case 1024:case 2048:case 4096:case 8192:case 16384:case 32768:case 65536:case 131072:case 262144:case 524288:case 1048576:case 2097152:return t+5e3;case 4194304:case 8388608:case 16777216:case 33554432:case 67108864:return-1;case 134217728:case 268435456:case 536870912:case 1073741824:return-1;default:return-1}}function Yd(e,t){for(var i=e.suspendedLanes,n=e.pingedLanes,a=e.expirationTimes,o=e.pendingLanes;0<o;){var s=31-ct(o),d=1<<s,p=a[s];p===-1?((d&i)===0||(d&n)!==0)&&(a[s]=Xd(d,t)):p<=t&&(e.expiredLanes|=d),o&=~d}}function ho(e){return e=e.pendingLanes&-1073741825,e!==0?e:e&1073741824?1073741824:0}function Rs(){var e=Gn;return Gn<<=1,(Gn&4194240)===0&&(Gn=64),e}function mo(e){for(var t=[],i=0;31>i;i++)t.push(e);return t}function Ji(e,t,i){e.pendingLanes|=t,t!==536870912&&(e.suspendedLanes=0,e.pingedLanes=0),e=e.eventTimes,t=31-ct(t),e[t]=i}function Zd(e,t){var i=e.pendingLanes&~t;e.pendingLanes=t,e.suspendedLanes=0,e.pingedLanes=0,e.expiredLanes&=t,e.mutableReadLanes&=t,e.entangledLanes&=t,t=e.entanglements;var n=e.eventTimes;for(e=e.expirationTimes;0<i;){var a=31-ct(i),o=1<<a;t[a]=0,n[a]=-1,e[a]=-1,i&=~o}}function fo(e,t){var i=e.entangledLanes|=t;for(e=e.entanglements;i;){var n=31-ct(i),a=1<<n;a&t|e[n]&t&&(e[n]|=t),i&=~a}}var se=0;function Ns(e){return e&=-e,1<e?4<e?(e&268435455)!==0?16:536870912:4:1}var Ms,go,Bs,Ws,Fs,yo=!1,_n=[],Nt=null,Mt=null,Bt=null,Xi=new Map,Yi=new Map,Wt=[],eu="mousedown mouseup touchcancel touchend touchstart auxclick dblclick pointercancel pointerdown pointerup dragend dragstart drop compositionend compositionstart keydown keypress keyup input textInput copy cut paste click change contextmenu reset submit".split(" ");function Hs(e,t){switch(e){case"focusin":case"focusout":Nt=null;break;case"dragenter":case"dragleave":Mt=null;break;case"mouseover":case"mouseout":Bt=null;break;case"pointerover":case"pointerout":Xi.delete(t.pointerId);break;case"gotpointercapture":case"lostpointercapture":Yi.delete(t.pointerId)}}function Zi(e,t,i,n,a,o){return e===null||e.nativeEvent!==o?(e={blockedOn:t,domEventName:i,eventSystemFlags:n,nativeEvent:o,targetContainers:[a]},t!==null&&(t=mn(t),t!==null&&go(t)),e):(e.eventSystemFlags|=n,t=e.targetContainers,a!==null&&t.indexOf(a)===-1&&t.push(a),e)}function tu(e,t,i,n,a){switch(t){case"focusin":return Nt=Zi(Nt,e,t,i,n,a),!0;case"dragenter":return Mt=Zi(Mt,e,t,i,n,a),!0;case"mouseover":return Bt=Zi(Bt,e,t,i,n,a),!0;case"pointerover":var o=a.pointerId;return Xi.set(o,Zi(Xi.get(o)||null,e,t,i,n,a)),!0;case"gotpointercapture":return o=a.pointerId,Yi.set(o,Zi(Yi.get(o)||null,e,t,i,n,a)),!0}return!1}function js(e){var t=ii(e.target);if(t!==null){var i=ti(t);if(i!==null){if(t=i.tag,t===13){if(t=Ps(i),t!==null){e.blockedOn=t,Fs(e.priority,function(){Bs(i)});return}}else if(t===3&&i.stateNode.current.memoizedState.isDehydrated){e.blockedOn=i.tag===3?i.stateNode.containerInfo:null;return}}}e.blockedOn=null}function Un(e){if(e.blockedOn!==null)return!1;for(var t=e.targetContainers;0<t.length;){var i=xo(e.domEventName,e.eventSystemFlags,t[0],e.nativeEvent);if(i===null){i=e.nativeEvent;var n=new i.constructor(i.type,i);oo=n,i.target.dispatchEvent(n),oo=null}else return t=mn(i),t!==null&&go(t),e.blockedOn=i,!1;t.shift()}return!0}function Gs(e,t,i){Un(e)&&i.delete(t)}function iu(){yo=!1,Nt!==null&&Un(Nt)&&(Nt=null),Mt!==null&&Un(Mt)&&(Mt=null),Bt!==null&&Un(Bt)&&(Bt=null),Xi.forEach(Gs),Yi.forEach(Gs)}function en(e,t){e.blockedOn===t&&(e.blockedOn=null,yo||(yo=!0,c.unstable_scheduleCallback(c.unstable_NormalPriority,iu)))}function tn(e){function t(a){return en(a,e)}if(0<_n.length){en(_n[0],e);for(var i=1;i<_n.length;i++){var n=_n[i];n.blockedOn===e&&(n.blockedOn=null)}}for(Nt!==null&&en(Nt,e),Mt!==null&&en(Mt,e),Bt!==null&&en(Bt,e),Xi.forEach(t),Yi.forEach(t),i=0;i<Wt.length;i++)n=Wt[i],n.blockedOn===e&&(n.blockedOn=null);for(;0<Wt.length&&(i=Wt[0],i.blockedOn===null);)js(i),i.blockedOn===null&&Wt.shift()}var yi=oe.ReactCurrentBatchConfig,Kn=!0;function nu(e,t,i,n){var a=se,o=yi.transition;yi.transition=null;try{se=1,vo(e,t,i,n)}finally{se=a,yi.transition=o}}function au(e,t,i,n){var a=se,o=yi.transition;yi.transition=null;try{se=4,vo(e,t,i,n)}finally{se=a,yi.transition=o}}function vo(e,t,i,n){if(Kn){var a=xo(e,t,i,n);if(a===null)Mo(e,t,n,$n,i),Hs(e,n);else if(tu(a,e,t,i,n))n.stopPropagation();else if(Hs(e,n),t&4&&-1<eu.indexOf(e)){for(;a!==null;){var o=mn(a);if(o!==null&&Ms(o),o=xo(e,t,i,n),o===null&&Mo(e,t,n,$n,i),o===a)break;a=o}a!==null&&n.stopPropagation()}else Mo(e,t,n,null,i)}}var $n=null;function xo(e,t,i,n){if($n=null,e=ro(n),e=ii(e),e!==null)if(t=ti(e),t===null)e=null;else if(i=t.tag,i===13){if(e=Ps(t),e!==null)return e;e=null}else if(i===3){if(t.stateNode.current.memoizedState.isDehydrated)return t.tag===3?t.stateNode.containerInfo:null;e=null}else t!==e&&(e=null);return $n=e,null}function Os(e){switch(e){case"cancel":case"click":case"close":case"contextmenu":case"copy":case"cut":case"auxclick":case"dblclick":case"dragend":case"dragstart":case"drop":case"focusin":case"focusout":case"input":case"invalid":case"keydown":case"keypress":case"keyup":case"mousedown":case"mouseup":case"paste":case"pause":case"play":case"pointercancel":case"pointerdown":case"pointerup":case"ratechange":case"reset":case"resize":case"seeked":case"submit":case"touchcancel":case"touchend":case"touchstart":case"volumechange":case"change":case"selectionchange":case"textInput":case"compositionstart":case"compositionend":case"compositionupdate":case"beforeblur":case"afterblur":case"beforeinput":case"blur":case"fullscreenchange":case"focus":case"hashchange":case"popstate":case"select":case"selectstart":return 1;case"drag":case"dragenter":case"dragexit":case"dragleave":case"dragover":case"mousemove":case"mouseout":case"mouseover":case"pointermove":case"pointerout":case"pointerover":case"scroll":case"toggle":case"touchmove":case"wheel":case"mouseenter":case"mouseleave":case"pointerenter":case"pointerleave":return 4;case"message":switch(_d()){case po:return 1;case Ls:return 4;case Hn:case Ud:return 16;case zs:return 536870912;default:return 16}default:return 16}}var Ft=null,Io=null,Qn=null;function Vs(){if(Qn)return Qn;var e,t=Io,i=t.length,n,a="value"in Ft?Ft.value:Ft.textContent,o=a.length;for(e=0;e<i&&t[e]===a[e];e++);var s=i-e;for(n=1;n<=s&&t[i-n]===a[o-n];n++);return Qn=a.slice(e,1<n?1-n:void 0)}function Jn(e){var t=e.keyCode;return"charCode"in e?(e=e.charCode,e===0&&t===13&&(e=13)):e=t,e===10&&(e=13),32<=e||e===13?e:0}function Xn(){return!0}function _s(){return!1}function Xe(e){function t(i,n,a,o,s){this._reactName=i,this._targetInst=a,this.type=n,this.nativeEvent=o,this.target=s,this.currentTarget=null;for(var d in e)e.hasOwnProperty(d)&&(i=e[d],this[d]=i?i(o):o[d]);return this.isDefaultPrevented=(o.defaultPrevented!=null?o.defaultPrevented:o.returnValue===!1)?Xn:_s,this.isPropagationStopped=_s,this}return F(t.prototype,{preventDefault:function(){this.defaultPrevented=!0;var i=this.nativeEvent;i&&(i.preventDefault?i.preventDefault():typeof i.returnValue!="unknown"&&(i.returnValue=!1),this.isDefaultPrevented=Xn)},stopPropagation:function(){var i=this.nativeEvent;i&&(i.stopPropagation?i.stopPropagation():typeof i.cancelBubble!="unknown"&&(i.cancelBubble=!0),this.isPropagationStopped=Xn)},persist:function(){},isPersistent:Xn}),t}var vi={eventPhase:0,bubbles:0,cancelable:0,timeStamp:function(e){return e.timeStamp||Date.now()},defaultPrevented:0,isTrusted:0},wo=Xe(vi),nn=F({},vi,{view:0,detail:0}),ou=Xe(nn),bo,ko,an,Yn=F({},nn,{screenX:0,screenY:0,clientX:0,clientY:0,pageX:0,pageY:0,ctrlKey:0,shiftKey:0,altKey:0,metaKey:0,getModifierState:To,button:0,buttons:0,relatedTarget:function(e){return e.relatedTarget===void 0?e.fromElement===e.srcElement?e.toElement:e.fromElement:e.relatedTarget},movementX:function(e){return"movementX"in e?e.movementX:(e!==an&&(an&&e.type==="mousemove"?(bo=e.screenX-an.screenX,ko=e.screenY-an.screenY):ko=bo=0,an=e),bo)},movementY:function(e){return"movementY"in e?e.movementY:ko}}),Us=Xe(Yn),ru=F({},Yn,{dataTransfer:0}),su=Xe(ru),lu=F({},nn,{relatedTarget:0}),Co=Xe(lu),cu=F({},vi,{animationName:0,elapsedTime:0,pseudoElement:0}),du=Xe(cu),uu=F({},vi,{clipboardData:function(e){return"clipboardData"in e?e.clipboardData:window.clipboardData}}),pu=Xe(uu),hu=F({},vi,{data:0}),Ks=Xe(hu),mu={Esc:"Escape",Spacebar:" ",Left:"ArrowLeft",Up:"ArrowUp",Right:"ArrowRight",Down:"ArrowDown",Del:"Delete",Win:"OS",Menu:"ContextMenu",Apps:"ContextMenu",Scroll:"ScrollLock",MozPrintableKey:"Unidentified"},fu={8:"Backspace",9:"Tab",12:"Clear",13:"Enter",16:"Shift",17:"Control",18:"Alt",19:"Pause",20:"CapsLock",27:"Escape",32:" ",33:"PageUp",34:"PageDown",35:"End",36:"Home",37:"ArrowLeft",38:"ArrowUp",39:"ArrowRight",40:"ArrowDown",45:"Insert",46:"Delete",112:"F1",113:"F2",114:"F3",115:"F4",116:"F5",117:"F6",118:"F7",119:"F8",120:"F9",121:"F10",122:"F11",123:"F12",144:"NumLock",145:"ScrollLock",224:"Meta"},gu={Alt:"altKey",Control:"ctrlKey",Meta:"metaKey",Shift:"shiftKey"};function yu(e){var t=this.nativeEvent;return t.getModifierState?t.getModifierState(e):(e=gu[e])?!!t[e]:!1}function To(){return yu}var vu=F({},nn,{key:function(e){if(e.key){var t=mu[e.key]||e.key;if(t!=="Unidentified")return t}return e.type==="keypress"?(e=Jn(e),e===13?"Enter":String.fromCharCode(e)):e.type==="keydown"||e.type==="keyup"?fu[e.keyCode]||"Unidentified":""},code:0,location:0,ctrlKey:0,shiftKey:0,altKey:0,metaKey:0,repeat:0,locale:0,getModifierState:To,charCode:function(e){return e.type==="keypress"?Jn(e):0},keyCode:function(e){return e.type==="keydown"||e.type==="keyup"?e.keyCode:0},which:function(e){return e.type==="keypress"?Jn(e):e.type==="keydown"||e.type==="keyup"?e.keyCode:0}}),xu=Xe(vu),Iu=F({},Yn,{pointerId:0,width:0,height:0,pressure:0,tangentialPressure:0,tiltX:0,tiltY:0,twist:0,pointerType:0,isPrimary:0}),$s=Xe(Iu),wu=F({},nn,{touches:0,targetTouches:0,changedTouches:0,altKey:0,metaKey:0,ctrlKey:0,shiftKey:0,getModifierState:To}),bu=Xe(wu),ku=F({},vi,{propertyName:0,elapsedTime:0,pseudoElement:0}),Cu=Xe(ku),Tu=F({},Yn,{deltaX:function(e){return"deltaX"in e?e.deltaX:"wheelDeltaX"in e?-e.wheelDeltaX:0},deltaY:function(e){return"deltaY"in e?e.deltaY:"wheelDeltaY"in e?-e.wheelDeltaY:"wheelDelta"in e?-e.wheelDelta:0},deltaZ:0,deltaMode:0}),Pu=Xe(Tu),Su=[9,13,27,32],Po=k&&"CompositionEvent"in window,on=null;k&&"documentMode"in document&&(on=document.documentMode);var Au=k&&"TextEvent"in window&&!on,Qs=k&&(!Po||on&&8<on&&11>=on),Js=" ",Xs=!1;function Ys(e,t){switch(e){case"keyup":return Su.indexOf(t.keyCode)!==-1;case"keydown":return t.keyCode!==229;case"keypress":case"mousedown":case"focusout":return!0;default:return!1}}function Zs(e){return e=e.detail,typeof e=="object"&&"data"in e?e.data:null}var xi=!1;function Eu(e,t){switch(e){case"compositionend":return Zs(t);case"keypress":return t.which!==32?null:(Xs=!0,Js);case"textInput":return e=t.data,e===Js&&Xs?null:e;default:return null}}function qu(e,t){if(xi)return e==="compositionend"||!Po&&Ys(e,t)?(e=Vs(),Qn=Io=Ft=null,xi=!1,e):null;switch(e){case"paste":return null;case"keypress":if(!(t.ctrlKey||t.altKey||t.metaKey)||t.ctrlKey&&t.altKey){if(t.char&&1<t.char.length)return t.char;if(t.which)return String.fromCharCode(t.which)}return null;case"compositionend":return Qs&&t.locale!=="ko"?null:t.data;default:return null}}var Du={color:!0,date:!0,datetime:!0,"datetime-local":!0,email:!0,month:!0,number:!0,password:!0,range:!0,search:!0,tel:!0,text:!0,time:!0,url:!0,week:!0};function el(e){var t=e&&e.nodeName&&e.nodeName.toLowerCase();return t==="input"?!!Du[e.type]:t==="textarea"}function tl(e,t,i,n){ws(n),t=na(t,"onChange"),0<t.length&&(i=new wo("onChange","change",null,i,n),e.push({event:i,listeners:t}))}var rn=null,sn=null;function Lu(e){xl(e,0)}function Zn(e){var t=Ci(e);if(cs(t))return e}function zu(e,t){if(e==="change")return t}var il=!1;if(k){var So;if(k){var Ao="oninput"in document;if(!Ao){var nl=document.createElement("div");nl.setAttribute("oninput","return;"),Ao=typeof nl.oninput=="function"}So=Ao}else So=!1;il=So&&(!document.documentMode||9<document.documentMode)}function al(){rn&&(rn.detachEvent("onpropertychange",ol),sn=rn=null)}function ol(e){if(e.propertyName==="value"&&Zn(sn)){var t=[];tl(t,sn,e,ro(e)),Ts(Lu,t)}}function Ru(e,t,i){e==="focusin"?(al(),rn=t,sn=i,rn.attachEvent("onpropertychange",ol)):e==="focusout"&&al()}function Nu(e){if(e==="selectionchange"||e==="keyup"||e==="keydown")return Zn(sn)}function Mu(e,t){if(e==="click")return Zn(t)}function Bu(e,t){if(e==="input"||e==="change")return Zn(t)}function Wu(e,t){return e===t&&(e!==0||1/e===1/t)||e!==e&&t!==t}var dt=typeof Object.is=="function"?Object.is:Wu;function ln(e,t){if(dt(e,t))return!0;if(typeof e!="object"||e===null||typeof t!="object"||t===null)return!1;var i=Object.keys(e),n=Object.keys(t);if(i.length!==n.length)return!1;for(n=0;n<i.length;n++){var a=i[n];if(!w.call(t,a)||!dt(e[a],t[a]))return!1}return!0}function rl(e){for(;e&&e.firstChild;)e=e.firstChild;return e}function sl(e,t){var i=rl(e);e=0;for(var n;i;){if(i.nodeType===3){if(n=e+i.textContent.length,e<=t&&n>=t)return{node:i,offset:t-e};e=n}e:{for(;i;){if(i.nextSibling){i=i.nextSibling;break e}i=i.parentNode}i=void 0}i=rl(i)}}function ll(e,t){return e&&t?e===t?!0:e&&e.nodeType===3?!1:t&&t.nodeType===3?ll(e,t.parentNode):"contains"in e?e.contains(t):e.compareDocumentPosition?!!(e.compareDocumentPosition(t)&16):!1:!1}function cl(){for(var e=window,t=Mn();t instanceof e.HTMLIFrameElement;){try{var i=typeof t.contentWindow.location.href=="string"}catch{i=!1}if(i)e=t.contentWindow;else break;t=Mn(e.document)}return t}function Eo(e){var t=e&&e.nodeName&&e.nodeName.toLowerCase();return t&&(t==="input"&&(e.type==="text"||e.type==="search"||e.type==="tel"||e.type==="url"||e.type==="password")||t==="textarea"||e.contentEditable==="true")}function Fu(e){var t=cl(),i=e.focusedElem,n=e.selectionRange;if(t!==i&&i&&i.ownerDocument&&ll(i.ownerDocument.documentElement,i)){if(n!==null&&Eo(i)){if(t=n.start,e=n.end,e===void 0&&(e=t),"selectionStart"in i)i.selectionStart=t,i.selectionEnd=Math.min(e,i.value.length);else if(e=(t=i.ownerDocument||document)&&t.defaultView||window,e.getSelection){e=e.getSelection();var a=i.textContent.length,o=Math.min(n.start,a);n=n.end===void 0?o:Math.min(n.end,a),!e.extend&&o>n&&(a=n,n=o,o=a),a=sl(i,o);var s=sl(i,n);a&&s&&(e.rangeCount!==1||e.anchorNode!==a.node||e.anchorOffset!==a.offset||e.focusNode!==s.node||e.focusOffset!==s.offset)&&(t=t.createRange(),t.setStart(a.node,a.offset),e.removeAllRanges(),o>n?(e.addRange(t),e.extend(s.node,s.offset)):(t.setEnd(s.node,s.offset),e.addRange(t)))}}for(t=[],e=i;e=e.parentNode;)e.nodeType===1&&t.push({element:e,left:e.scrollLeft,top:e.scrollTop});for(typeof i.focus=="function"&&i.focus(),i=0;i<t.length;i++)e=t[i],e.element.scrollLeft=e.left,e.element.scrollTop=e.top}}var Hu=k&&"documentMode"in document&&11>=document.documentMode,Ii=null,qo=null,cn=null,Do=!1;function dl(e,t,i){var n=i.window===i?i.document:i.nodeType===9?i:i.ownerDocument;Do||Ii==null||Ii!==Mn(n)||(n=Ii,"selectionStart"in n&&Eo(n)?n={start:n.selectionStart,end:n.selectionEnd}:(n=(n.ownerDocument&&n.ownerDocument.defaultView||window).getSelection(),n={anchorNode:n.anchorNode,anchorOffset:n.anchorOffset,focusNode:n.focusNode,focusOffset:n.focusOffset}),cn&&ln(cn,n)||(cn=n,n=na(qo,"onSelect"),0<n.length&&(t=new wo("onSelect","select",null,t,i),e.push({event:t,listeners:n}),t.target=Ii)))}function ea(e,t){var i={};return i[e.toLowerCase()]=t.toLowerCase(),i["Webkit"+e]="webkit"+t,i["Moz"+e]="moz"+t,i}var wi={animationend:ea("Animation","AnimationEnd"),animationiteration:ea("Animation","AnimationIteration"),animationstart:ea("Animation","AnimationStart"),transitionend:ea("Transition","TransitionEnd")},Lo={},ul={};k&&(ul=document.createElement("div").style,"AnimationEvent"in window||(delete wi.animationend.animation,delete wi.animationiteration.animation,delete wi.animationstart.animation),"TransitionEvent"in window||delete wi.transitionend.transition);function ta(e){if(Lo[e])return Lo[e];if(!wi[e])return e;var t=wi[e],i;for(i in t)if(t.hasOwnProperty(i)&&i in ul)return Lo[e]=t[i];return e}var pl=ta("animationend"),hl=ta("animationiteration"),ml=ta("animationstart"),fl=ta("transitionend"),gl=new Map,yl="abort auxClick cancel canPlay canPlayThrough click close contextMenu copy cut drag dragEnd dragEnter dragExit dragLeave dragOver dragStart drop durationChange emptied encrypted ended error gotPointerCapture input invalid keyDown keyPress keyUp load loadedData loadedMetadata loadStart lostPointerCapture mouseDown mouseMove mouseOut mouseOver mouseUp paste pause play playing pointerCancel pointerDown pointerMove pointerOut pointerOver pointerUp progress rateChange reset resize seeked seeking stalled submit suspend timeUpdate touchCancel touchEnd touchStart volumeChange scroll toggle touchMove waiting wheel".split(" ");function Ht(e,t){gl.set(e,t),h(t,[e])}for(var zo=0;zo<yl.length;zo++){var Ro=yl[zo],ju=Ro.toLowerCase(),Gu=Ro[0].toUpperCase()+Ro.slice(1);Ht(ju,"on"+Gu)}Ht(pl,"onAnimationEnd"),Ht(hl,"onAnimationIteration"),Ht(ml,"onAnimationStart"),Ht("dblclick","onDoubleClick"),Ht("focusin","onFocus"),Ht("focusout","onBlur"),Ht(fl,"onTransitionEnd"),v("onMouseEnter",["mouseout","mouseover"]),v("onMouseLeave",["mouseout","mouseover"]),v("onPointerEnter",["pointerout","pointerover"]),v("onPointerLeave",["pointerout","pointerover"]),h("onChange","change click focusin focusout input keydown keyup selectionchange".split(" ")),h("onSelect","focusout contextmenu dragend focusin keydown keyup mousedown mouseup selectionchange".split(" ")),h("onBeforeInput",["compositionend","keypress","textInput","paste"]),h("onCompositionEnd","compositionend focusout keydown keypress keyup mousedown".split(" ")),h("onCompositionStart","compositionstart focusout keydown keypress keyup mousedown".split(" ")),h("onCompositionUpdate","compositionupdate focusout keydown keypress keyup mousedown".split(" "));var dn="abort canplay canplaythrough durationchange emptied encrypted ended error loadeddata loadedmetadata loadstart pause play playing progress ratechange resize seeked seeking stalled suspend timeupdate volumechange waiting".split(" "),Ou=new Set("cancel close invalid load scroll toggle".split(" ").concat(dn));function vl(e,t,i){var n=e.type||"unknown-event";e.currentTarget=i,jd(n,t,void 0,e),e.currentTarget=null}function xl(e,t){t=(t&4)!==0;for(var i=0;i<e.length;i++){var n=e[i],a=n.event;n=n.listeners;e:{var o=void 0;if(t)for(var s=n.length-1;0<=s;s--){var d=n[s],p=d.instance,I=d.currentTarget;if(d=d.listener,p!==o&&a.isPropagationStopped())break e;vl(a,d,I),o=p}else for(s=0;s<n.length;s++){if(d=n[s],p=d.instance,I=d.currentTarget,d=d.listener,p!==o&&a.isPropagationStopped())break e;vl(a,d,I),o=p}}}if(Fn)throw e=uo,Fn=!1,uo=null,e}function de(e,t){var i=t[Go];i===void 0&&(i=t[Go]=new Set);var n=e+"__bubble";i.has(n)||(Il(t,e,2,!1),i.add(n))}function No(e,t,i){var n=0;t&&(n|=4),Il(i,e,n,t)}var ia="_reactListening"+Math.random().toString(36).slice(2);function un(e){if(!e[ia]){e[ia]=!0,u.forEach(function(i){i!=="selectionchange"&&(Ou.has(i)||No(i,!1,e),No(i,!0,e))});var t=e.nodeType===9?e:e.ownerDocument;t===null||t[ia]||(t[ia]=!0,No("selectionchange",!1,t))}}function Il(e,t,i,n){switch(Os(t)){case 1:var a=nu;break;case 4:a=au;break;default:a=vo}i=a.bind(null,t,i,e),a=void 0,!co||t!=="touchstart"&&t!=="touchmove"&&t!=="wheel"||(a=!0),n?a!==void 0?e.addEventListener(t,i,{capture:!0,passive:a}):e.addEventListener(t,i,!0):a!==void 0?e.addEventListener(t,i,{passive:a}):e.addEventListener(t,i,!1)}function Mo(e,t,i,n,a){var o=n;if((t&1)===0&&(t&2)===0&&n!==null)e:for(;;){if(n===null)return;var s=n.tag;if(s===3||s===4){var d=n.stateNode.containerInfo;if(d===a||d.nodeType===8&&d.parentNode===a)break;if(s===4)for(s=n.return;s!==null;){var p=s.tag;if((p===3||p===4)&&(p=s.stateNode.containerInfo,p===a||p.nodeType===8&&p.parentNode===a))return;s=s.return}for(;d!==null;){if(s=ii(d),s===null)return;if(p=s.tag,p===5||p===6){n=o=s;continue e}d=d.parentNode}}n=n.return}Ts(function(){var I=o,A=ro(i),D=[];e:{var P=gl.get(e);if(P!==void 0){var M=wo,H=e;switch(e){case"keypress":if(Jn(i)===0)break e;case"keydown":case"keyup":M=xu;break;case"focusin":H="focus",M=Co;break;case"focusout":H="blur",M=Co;break;case"beforeblur":case"afterblur":M=Co;break;case"click":if(i.button===2)break e;case"auxclick":case"dblclick":case"mousedown":case"mousemove":case"mouseup":case"mouseout":case"mouseover":case"contextmenu":M=Us;break;case"drag":case"dragend":case"dragenter":case"dragexit":case"dragleave":case"dragover":case"dragstart":case"drop":M=su;break;case"touchcancel":case"touchend":case"touchmove":case"touchstart":M=bu;break;case pl:case hl:case ml:M=du;break;case fl:M=Cu;break;case"scroll":M=ou;break;case"wheel":M=Pu;break;case"copy":case"cut":case"paste":M=pu;break;case"gotpointercapture":case"lostpointercapture":case"pointercancel":case"pointerdown":case"pointermove":case"pointerout":case"pointerover":case"pointerup":M=$s}var j=(t&4)!==0,ke=!j&&e==="scroll",y=j?P!==null?P+"Capture":null:P;j=[];for(var f=I,x;f!==null;){x=f;var L=x.stateNode;if(x.tag===5&&L!==null&&(x=L,y!==null&&(L=Ui(f,y),L!=null&&j.push(pn(f,L,x)))),ke)break;f=f.return}0<j.length&&(P=new M(P,H,null,i,A),D.push({event:P,listeners:j}))}}if((t&7)===0){e:{if(P=e==="mouseover"||e==="pointerover",M=e==="mouseout"||e==="pointerout",P&&i!==oo&&(H=i.relatedTarget||i.fromElement)&&(ii(H)||H[Tt]))break e;if((M||P)&&(P=A.window===A?A:(P=A.ownerDocument)?P.defaultView||P.parentWindow:window,M?(H=i.relatedTarget||i.toElement,M=I,H=H?ii(H):null,H!==null&&(ke=ti(H),H!==ke||H.tag!==5&&H.tag!==6)&&(H=null)):(M=null,H=I),M!==H)){if(j=Us,L="onMouseLeave",y="onMouseEnter",f="mouse",(e==="pointerout"||e==="pointerover")&&(j=$s,L="onPointerLeave",y="onPointerEnter",f="pointer"),ke=M==null?P:Ci(M),x=H==null?P:Ci(H),P=new j(L,f+"leave",M,i,A),P.target=ke,P.relatedTarget=x,L=null,ii(A)===I&&(j=new j(y,f+"enter",H,i,A),j.target=x,j.relatedTarget=ke,L=j),ke=L,M&&H)t:{for(j=M,y=H,f=0,x=j;x;x=bi(x))f++;for(x=0,L=y;L;L=bi(L))x++;for(;0<f-x;)j=bi(j),f--;for(;0<x-f;)y=bi(y),x--;for(;f--;){if(j===y||y!==null&&j===y.alternate)break t;j=bi(j),y=bi(y)}j=null}else j=null;M!==null&&wl(D,P,M,j,!1),H!==null&&ke!==null&&wl(D,ke,H,j,!0)}}e:{if(P=I?Ci(I):window,M=P.nodeName&&P.nodeName.toLowerCase(),M==="select"||M==="input"&&P.type==="file")var O=zu;else if(el(P))if(il)O=Bu;else{O=Nu;var K=Ru}else(M=P.nodeName)&&M.toLowerCase()==="input"&&(P.type==="checkbox"||P.type==="radio")&&(O=Mu);if(O&&(O=O(e,I))){tl(D,O,i,A);break e}K&&K(e,P,I),e==="focusout"&&(K=P._wrapperState)&&K.controlled&&P.type==="number"&&eo(P,"number",P.value)}switch(K=I?Ci(I):window,e){case"focusin":(el(K)||K.contentEditable==="true")&&(Ii=K,qo=I,cn=null);break;case"focusout":cn=qo=Ii=null;break;case"mousedown":Do=!0;break;case"contextmenu":case"mouseup":case"dragend":Do=!1,dl(D,i,A);break;case"selectionchange":if(Hu)break;case"keydown":case"keyup":dl(D,i,A)}var $;if(Po)e:{switch(e){case"compositionstart":var J="onCompositionStart";break e;case"compositionend":J="onCompositionEnd";break e;case"compositionupdate":J="onCompositionUpdate";break e}J=void 0}else xi?Ys(e,i)&&(J="onCompositionEnd"):e==="keydown"&&i.keyCode===229&&(J="onCompositionStart");J&&(Qs&&i.locale!=="ko"&&(xi||J!=="onCompositionStart"?J==="onCompositionEnd"&&xi&&($=Vs()):(Ft=A,Io="value"in Ft?Ft.value:Ft.textContent,xi=!0)),K=na(I,J),0<K.length&&(J=new Ks(J,e,null,i,A),D.push({event:J,listeners:K}),$?J.data=$:($=Zs(i),$!==null&&(J.data=$)))),($=Au?Eu(e,i):qu(e,i))&&(I=na(I,"onBeforeInput"),0<I.length&&(A=new Ks("onBeforeInput","beforeinput",null,i,A),D.push({event:A,listeners:I}),A.data=$))}xl(D,t)})}function pn(e,t,i){return{instance:e,listener:t,currentTarget:i}}function na(e,t){for(var i=t+"Capture",n=[];e!==null;){var a=e,o=a.stateNode;a.tag===5&&o!==null&&(a=o,o=Ui(e,i),o!=null&&n.unshift(pn(e,o,a)),o=Ui(e,t),o!=null&&n.push(pn(e,o,a))),e=e.return}return n}function bi(e){if(e===null)return null;do e=e.return;while(e&&e.tag!==5);return e||null}function wl(e,t,i,n,a){for(var o=t._reactName,s=[];i!==null&&i!==n;){var d=i,p=d.alternate,I=d.stateNode;if(p!==null&&p===n)break;d.tag===5&&I!==null&&(d=I,a?(p=Ui(i,o),p!=null&&s.unshift(pn(i,p,d))):a||(p=Ui(i,o),p!=null&&s.push(pn(i,p,d)))),i=i.return}s.length!==0&&e.push({event:t,listeners:s})}var Vu=/\r\n?/g,_u=/\u0000|\uFFFD/g;function bl(e){return(typeof e=="string"?e:""+e).replace(Vu,`
`).replace(_u,"")}function aa(e,t,i){if(t=bl(t),bl(e)!==t&&i)throw Error(l(425))}function oa(){}var Bo=null,Wo=null;function Fo(e,t){return e==="textarea"||e==="noscript"||typeof t.children=="string"||typeof t.children=="number"||typeof t.dangerouslySetInnerHTML=="object"&&t.dangerouslySetInnerHTML!==null&&t.dangerouslySetInnerHTML.__html!=null}var Ho=typeof setTimeout=="function"?setTimeout:void 0,Uu=typeof clearTimeout=="function"?clearTimeout:void 0,kl=typeof Promise=="function"?Promise:void 0,Ku=typeof queueMicrotask=="function"?queueMicrotask:typeof kl<"u"?function(e){return kl.resolve(null).then(e).catch($u)}:Ho;function $u(e){setTimeout(function(){throw e})}function jo(e,t){var i=t,n=0;do{var a=i.nextSibling;if(e.removeChild(i),a&&a.nodeType===8)if(i=a.data,i==="/$"){if(n===0){e.removeChild(a),tn(t);return}n--}else i!=="$"&&i!=="$?"&&i!=="$!"||n++;i=a}while(i);tn(t)}function jt(e){for(;e!=null;e=e.nextSibling){var t=e.nodeType;if(t===1||t===3)break;if(t===8){if(t=e.data,t==="$"||t==="$!"||t==="$?")break;if(t==="/$")return null}}return e}function Cl(e){e=e.previousSibling;for(var t=0;e;){if(e.nodeType===8){var i=e.data;if(i==="$"||i==="$!"||i==="$?"){if(t===0)return e;t--}else i==="/$"&&t++}e=e.previousSibling}return null}var ki=Math.random().toString(36).slice(2),It="__reactFiber$"+ki,hn="__reactProps$"+ki,Tt="__reactContainer$"+ki,Go="__reactEvents$"+ki,Qu="__reactListeners$"+ki,Ju="__reactHandles$"+ki;function ii(e){var t=e[It];if(t)return t;for(var i=e.parentNode;i;){if(t=i[Tt]||i[It]){if(i=t.alternate,t.child!==null||i!==null&&i.child!==null)for(e=Cl(e);e!==null;){if(i=e[It])return i;e=Cl(e)}return t}e=i,i=e.parentNode}return null}function mn(e){return e=e[It]||e[Tt],!e||e.tag!==5&&e.tag!==6&&e.tag!==13&&e.tag!==3?null:e}function Ci(e){if(e.tag===5||e.tag===6)return e.stateNode;throw Error(l(33))}function ra(e){return e[hn]||null}var Oo=[],Ti=-1;function Gt(e){return{current:e}}function ue(e){0>Ti||(e.current=Oo[Ti],Oo[Ti]=null,Ti--)}function ce(e,t){Ti++,Oo[Ti]=e.current,e.current=t}var Ot={},Re=Gt(Ot),Ge=Gt(!1),ni=Ot;function Pi(e,t){var i=e.type.contextTypes;if(!i)return Ot;var n=e.stateNode;if(n&&n.__reactInternalMemoizedUnmaskedChildContext===t)return n.__reactInternalMemoizedMaskedChildContext;var a={},o;for(o in i)a[o]=t[o];return n&&(e=e.stateNode,e.__reactInternalMemoizedUnmaskedChildContext=t,e.__reactInternalMemoizedMaskedChildContext=a),a}function Oe(e){return e=e.childContextTypes,e!=null}function sa(){ue(Ge),ue(Re)}function Tl(e,t,i){if(Re.current!==Ot)throw Error(l(168));ce(Re,t),ce(Ge,i)}function Pl(e,t,i){var n=e.stateNode;if(t=t.childContextTypes,typeof n.getChildContext!="function")return i;n=n.getChildContext();for(var a in n)if(!(a in t))throw Error(l(108,le(e)||"Unknown",a));return F({},i,n)}function la(e){return e=(e=e.stateNode)&&e.__reactInternalMemoizedMergedChildContext||Ot,ni=Re.current,ce(Re,e),ce(Ge,Ge.current),!0}function Sl(e,t,i){var n=e.stateNode;if(!n)throw Error(l(169));i?(e=Pl(e,t,ni),n.__reactInternalMemoizedMergedChildContext=e,ue(Ge),ue(Re),ce(Re,e)):ue(Ge),ce(Ge,i)}var Pt=null,ca=!1,Vo=!1;function Al(e){Pt===null?Pt=[e]:Pt.push(e)}function Xu(e){ca=!0,Al(e)}function Vt(){if(!Vo&&Pt!==null){Vo=!0;var e=0,t=se;try{var i=Pt;for(se=1;e<i.length;e++){var n=i[e];do n=n(!0);while(n!==null)}Pt=null,ca=!1}catch(a){throw Pt!==null&&(Pt=Pt.slice(e+1)),qs(po,Vt),a}finally{se=t,Vo=!1}}return null}var Si=[],Ai=0,da=null,ua=0,it=[],nt=0,ai=null,St=1,At="";function oi(e,t){Si[Ai++]=ua,Si[Ai++]=da,da=e,ua=t}function El(e,t,i){it[nt++]=St,it[nt++]=At,it[nt++]=ai,ai=e;var n=St;e=At;var a=32-ct(n)-1;n&=~(1<<a),i+=1;var o=32-ct(t)+a;if(30<o){var s=a-a%5;o=(n&(1<<s)-1).toString(32),n>>=s,a-=s,St=1<<32-ct(t)+a|i<<a|n,At=o+e}else St=1<<o|i<<a|n,At=e}function _o(e){e.return!==null&&(oi(e,1),El(e,1,0))}function Uo(e){for(;e===da;)da=Si[--Ai],Si[Ai]=null,ua=Si[--Ai],Si[Ai]=null;for(;e===ai;)ai=it[--nt],it[nt]=null,At=it[--nt],it[nt]=null,St=it[--nt],it[nt]=null}var Ye=null,Ze=null,me=!1,ut=null;function ql(e,t){var i=st(5,null,null,0);i.elementType="DELETED",i.stateNode=t,i.return=e,t=e.deletions,t===null?(e.deletions=[i],e.flags|=16):t.push(i)}function Dl(e,t){switch(e.tag){case 5:var i=e.type;return t=t.nodeType!==1||i.toLowerCase()!==t.nodeName.toLowerCase()?null:t,t!==null?(e.stateNode=t,Ye=e,Ze=jt(t.firstChild),!0):!1;case 6:return t=e.pendingProps===""||t.nodeType!==3?null:t,t!==null?(e.stateNode=t,Ye=e,Ze=null,!0):!1;case 13:return t=t.nodeType!==8?null:t,t!==null?(i=ai!==null?{id:St,overflow:At}:null,e.memoizedState={dehydrated:t,treeContext:i,retryLane:1073741824},i=st(18,null,null,0),i.stateNode=t,i.return=e,e.child=i,Ye=e,Ze=null,!0):!1;default:return!1}}function Ko(e){return(e.mode&1)!==0&&(e.flags&128)===0}function $o(e){if(me){var t=Ze;if(t){var i=t;if(!Dl(e,t)){if(Ko(e))throw Error(l(418));t=jt(i.nextSibling);var n=Ye;t&&Dl(e,t)?ql(n,i):(e.flags=e.flags&-4097|2,me=!1,Ye=e)}}else{if(Ko(e))throw Error(l(418));e.flags=e.flags&-4097|2,me=!1,Ye=e}}}function Ll(e){for(e=e.return;e!==null&&e.tag!==5&&e.tag!==3&&e.tag!==13;)e=e.return;Ye=e}function pa(e){if(e!==Ye)return!1;if(!me)return Ll(e),me=!0,!1;var t;if((t=e.tag!==3)&&!(t=e.tag!==5)&&(t=e.type,t=t!=="head"&&t!=="body"&&!Fo(e.type,e.memoizedProps)),t&&(t=Ze)){if(Ko(e))throw zl(),Error(l(418));for(;t;)ql(e,t),t=jt(t.nextSibling)}if(Ll(e),e.tag===13){if(e=e.memoizedState,e=e!==null?e.dehydrated:null,!e)throw Error(l(317));e:{for(e=e.nextSibling,t=0;e;){if(e.nodeType===8){var i=e.data;if(i==="/$"){if(t===0){Ze=jt(e.nextSibling);break e}t--}else i!=="$"&&i!=="$!"&&i!=="$?"||t++}e=e.nextSibling}Ze=null}}else Ze=Ye?jt(e.stateNode.nextSibling):null;return!0}function zl(){for(var e=Ze;e;)e=jt(e.nextSibling)}function Ei(){Ze=Ye=null,me=!1}function Qo(e){ut===null?ut=[e]:ut.push(e)}var Yu=oe.ReactCurrentBatchConfig;function fn(e,t,i){if(e=i.ref,e!==null&&typeof e!="function"&&typeof e!="object"){if(i._owner){if(i=i._owner,i){if(i.tag!==1)throw Error(l(309));var n=i.stateNode}if(!n)throw Error(l(147,e));var a=n,o=""+e;return t!==null&&t.ref!==null&&typeof t.ref=="function"&&t.ref._stringRef===o?t.ref:(t=function(s){var d=a.refs;s===null?delete d[o]:d[o]=s},t._stringRef=o,t)}if(typeof e!="string")throw Error(l(284));if(!i._owner)throw Error(l(290,e))}return e}function ha(e,t){throw e=Object.prototype.toString.call(t),Error(l(31,e==="[object Object]"?"object with keys {"+Object.keys(t).join(", ")+"}":e))}function Rl(e){var t=e._init;return t(e._payload)}function Nl(e){function t(y,f){if(e){var x=y.deletions;x===null?(y.deletions=[f],y.flags|=16):x.push(f)}}function i(y,f){if(!e)return null;for(;f!==null;)t(y,f),f=f.sibling;return null}function n(y,f){for(y=new Map;f!==null;)f.key!==null?y.set(f.key,f):y.set(f.index,f),f=f.sibling;return y}function a(y,f){return y=Yt(y,f),y.index=0,y.sibling=null,y}function o(y,f,x){return y.index=x,e?(x=y.alternate,x!==null?(x=x.index,x<f?(y.flags|=2,f):x):(y.flags|=2,f)):(y.flags|=1048576,f)}function s(y){return e&&y.alternate===null&&(y.flags|=2),y}function d(y,f,x,L){return f===null||f.tag!==6?(f=Hr(x,y.mode,L),f.return=y,f):(f=a(f,x),f.return=y,f)}function p(y,f,x,L){var O=x.type;return O===fe?A(y,f,x.props.children,L,x.key):f!==null&&(f.elementType===O||typeof O=="object"&&O!==null&&O.$$typeof===je&&Rl(O)===f.type)?(L=a(f,x.props),L.ref=fn(y,f,x),L.return=y,L):(L=Ba(x.type,x.key,x.props,null,y.mode,L),L.ref=fn(y,f,x),L.return=y,L)}function I(y,f,x,L){return f===null||f.tag!==4||f.stateNode.containerInfo!==x.containerInfo||f.stateNode.implementation!==x.implementation?(f=jr(x,y.mode,L),f.return=y,f):(f=a(f,x.children||[]),f.return=y,f)}function A(y,f,x,L,O){return f===null||f.tag!==7?(f=hi(x,y.mode,L,O),f.return=y,f):(f=a(f,x),f.return=y,f)}function D(y,f,x){if(typeof f=="string"&&f!==""||typeof f=="number")return f=Hr(""+f,y.mode,x),f.return=y,f;if(typeof f=="object"&&f!==null){switch(f.$$typeof){case pe:return x=Ba(f.type,f.key,f.props,null,y.mode,x),x.ref=fn(y,null,f),x.return=y,x;case xe:return f=jr(f,y.mode,x),f.return=y,f;case je:var L=f._init;return D(y,L(f._payload),x)}if(Oi(f)||Q(f))return f=hi(f,y.mode,x,null),f.return=y,f;ha(y,f)}return null}function P(y,f,x,L){var O=f!==null?f.key:null;if(typeof x=="string"&&x!==""||typeof x=="number")return O!==null?null:d(y,f,""+x,L);if(typeof x=="object"&&x!==null){switch(x.$$typeof){case pe:return x.key===O?p(y,f,x,L):null;case xe:return x.key===O?I(y,f,x,L):null;case je:return O=x._init,P(y,f,O(x._payload),L)}if(Oi(x)||Q(x))return O!==null?null:A(y,f,x,L,null);ha(y,x)}return null}function M(y,f,x,L,O){if(typeof L=="string"&&L!==""||typeof L=="number")return y=y.get(x)||null,d(f,y,""+L,O);if(typeof L=="object"&&L!==null){switch(L.$$typeof){case pe:return y=y.get(L.key===null?x:L.key)||null,p(f,y,L,O);case xe:return y=y.get(L.key===null?x:L.key)||null,I(f,y,L,O);case je:var K=L._init;return M(y,f,x,K(L._payload),O)}if(Oi(L)||Q(L))return y=y.get(x)||null,A(f,y,L,O,null);ha(f,L)}return null}function H(y,f,x,L){for(var O=null,K=null,$=f,J=f=0,qe=null;$!==null&&J<x.length;J++){$.index>J?(qe=$,$=null):qe=$.sibling;var ae=P(y,$,x[J],L);if(ae===null){$===null&&($=qe);break}e&&$&&ae.alternate===null&&t(y,$),f=o(ae,f,J),K===null?O=ae:K.sibling=ae,K=ae,$=qe}if(J===x.length)return i(y,$),me&&oi(y,J),O;if($===null){for(;J<x.length;J++)$=D(y,x[J],L),$!==null&&(f=o($,f,J),K===null?O=$:K.sibling=$,K=$);return me&&oi(y,J),O}for($=n(y,$);J<x.length;J++)qe=M($,y,J,x[J],L),qe!==null&&(e&&qe.alternate!==null&&$.delete(qe.key===null?J:qe.key),f=o(qe,f,J),K===null?O=qe:K.sibling=qe,K=qe);return e&&$.forEach(function(Zt){return t(y,Zt)}),me&&oi(y,J),O}function j(y,f,x,L){var O=Q(x);if(typeof O!="function")throw Error(l(150));if(x=O.call(x),x==null)throw Error(l(151));for(var K=O=null,$=f,J=f=0,qe=null,ae=x.next();$!==null&&!ae.done;J++,ae=x.next()){$.index>J?(qe=$,$=null):qe=$.sibling;var Zt=P(y,$,ae.value,L);if(Zt===null){$===null&&($=qe);break}e&&$&&Zt.alternate===null&&t(y,$),f=o(Zt,f,J),K===null?O=Zt:K.sibling=Zt,K=Zt,$=qe}if(ae.done)return i(y,$),me&&oi(y,J),O;if($===null){for(;!ae.done;J++,ae=x.next())ae=D(y,ae.value,L),ae!==null&&(f=o(ae,f,J),K===null?O=ae:K.sibling=ae,K=ae);return me&&oi(y,J),O}for($=n(y,$);!ae.done;J++,ae=x.next())ae=M($,y,J,ae.value,L),ae!==null&&(e&&ae.alternate!==null&&$.delete(ae.key===null?J:ae.key),f=o(ae,f,J),K===null?O=ae:K.sibling=ae,K=ae);return e&&$.forEach(function(Dp){return t(y,Dp)}),me&&oi(y,J),O}function ke(y,f,x,L){if(typeof x=="object"&&x!==null&&x.type===fe&&x.key===null&&(x=x.props.children),typeof x=="object"&&x!==null){switch(x.$$typeof){case pe:e:{for(var O=x.key,K=f;K!==null;){if(K.key===O){if(O=x.type,O===fe){if(K.tag===7){i(y,K.sibling),f=a(K,x.props.children),f.return=y,y=f;break e}}else if(K.elementType===O||typeof O=="object"&&O!==null&&O.$$typeof===je&&Rl(O)===K.type){i(y,K.sibling),f=a(K,x.props),f.ref=fn(y,K,x),f.return=y,y=f;break e}i(y,K);break}else t(y,K);K=K.sibling}x.type===fe?(f=hi(x.props.children,y.mode,L,x.key),f.return=y,y=f):(L=Ba(x.type,x.key,x.props,null,y.mode,L),L.ref=fn(y,f,x),L.return=y,y=L)}return s(y);case xe:e:{for(K=x.key;f!==null;){if(f.key===K)if(f.tag===4&&f.stateNode.containerInfo===x.containerInfo&&f.stateNode.implementation===x.implementation){i(y,f.sibling),f=a(f,x.children||[]),f.return=y,y=f;break e}else{i(y,f);break}else t(y,f);f=f.sibling}f=jr(x,y.mode,L),f.return=y,y=f}return s(y);case je:return K=x._init,ke(y,f,K(x._payload),L)}if(Oi(x))return H(y,f,x,L);if(Q(x))return j(y,f,x,L);ha(y,x)}return typeof x=="string"&&x!==""||typeof x=="number"?(x=""+x,f!==null&&f.tag===6?(i(y,f.sibling),f=a(f,x),f.return=y,y=f):(i(y,f),f=Hr(x,y.mode,L),f.return=y,y=f),s(y)):i(y,f)}return ke}var qi=Nl(!0),Ml=Nl(!1),ma=Gt(null),fa=null,Di=null,Jo=null;function Xo(){Jo=Di=fa=null}function Yo(e){var t=ma.current;ue(ma),e._currentValue=t}function Zo(e,t,i){for(;e!==null;){var n=e.alternate;if((e.childLanes&t)!==t?(e.childLanes|=t,n!==null&&(n.childLanes|=t)):n!==null&&(n.childLanes&t)!==t&&(n.childLanes|=t),e===i)break;e=e.return}}function Li(e,t){fa=e,Jo=Di=null,e=e.dependencies,e!==null&&e.firstContext!==null&&((e.lanes&t)!==0&&(Ve=!0),e.firstContext=null)}function at(e){var t=e._currentValue;if(Jo!==e)if(e={context:e,memoizedValue:t,next:null},Di===null){if(fa===null)throw Error(l(308));Di=e,fa.dependencies={lanes:0,firstContext:e}}else Di=Di.next=e;return t}var ri=null;function er(e){ri===null?ri=[e]:ri.push(e)}function Bl(e,t,i,n){var a=t.interleaved;return a===null?(i.next=i,er(t)):(i.next=a.next,a.next=i),t.interleaved=i,Et(e,n)}function Et(e,t){e.lanes|=t;var i=e.alternate;for(i!==null&&(i.lanes|=t),i=e,e=e.return;e!==null;)e.childLanes|=t,i=e.alternate,i!==null&&(i.childLanes|=t),i=e,e=e.return;return i.tag===3?i.stateNode:null}var _t=!1;function tr(e){e.updateQueue={baseState:e.memoizedState,firstBaseUpdate:null,lastBaseUpdate:null,shared:{pending:null,interleaved:null,lanes:0},effects:null}}function Wl(e,t){e=e.updateQueue,t.updateQueue===e&&(t.updateQueue={baseState:e.baseState,firstBaseUpdate:e.firstBaseUpdate,lastBaseUpdate:e.lastBaseUpdate,shared:e.shared,effects:e.effects})}function qt(e,t){return{eventTime:e,lane:t,tag:0,payload:null,callback:null,next:null}}function Ut(e,t,i){var n=e.updateQueue;if(n===null)return null;if(n=n.shared,(te&2)!==0){var a=n.pending;return a===null?t.next=t:(t.next=a.next,a.next=t),n.pending=t,Et(e,i)}return a=n.interleaved,a===null?(t.next=t,er(n)):(t.next=a.next,a.next=t),n.interleaved=t,Et(e,i)}function ga(e,t,i){if(t=t.updateQueue,t!==null&&(t=t.shared,(i&4194240)!==0)){var n=t.lanes;n&=e.pendingLanes,i|=n,t.lanes=i,fo(e,i)}}function Fl(e,t){var i=e.updateQueue,n=e.alternate;if(n!==null&&(n=n.updateQueue,i===n)){var a=null,o=null;if(i=i.firstBaseUpdate,i!==null){do{var s={eventTime:i.eventTime,lane:i.lane,tag:i.tag,payload:i.payload,callback:i.callback,next:null};o===null?a=o=s:o=o.next=s,i=i.next}while(i!==null);o===null?a=o=t:o=o.next=t}else a=o=t;i={baseState:n.baseState,firstBaseUpdate:a,lastBaseUpdate:o,shared:n.shared,effects:n.effects},e.updateQueue=i;return}e=i.lastBaseUpdate,e===null?i.firstBaseUpdate=t:e.next=t,i.lastBaseUpdate=t}function ya(e,t,i,n){var a=e.updateQueue;_t=!1;var o=a.firstBaseUpdate,s=a.lastBaseUpdate,d=a.shared.pending;if(d!==null){a.shared.pending=null;var p=d,I=p.next;p.next=null,s===null?o=I:s.next=I,s=p;var A=e.alternate;A!==null&&(A=A.updateQueue,d=A.lastBaseUpdate,d!==s&&(d===null?A.firstBaseUpdate=I:d.next=I,A.lastBaseUpdate=p))}if(o!==null){var D=a.baseState;s=0,A=I=p=null,d=o;do{var P=d.lane,M=d.eventTime;if((n&P)===P){A!==null&&(A=A.next={eventTime:M,lane:0,tag:d.tag,payload:d.payload,callback:d.callback,next:null});e:{var H=e,j=d;switch(P=t,M=i,j.tag){case 1:if(H=j.payload,typeof H=="function"){D=H.call(M,D,P);break e}D=H;break e;case 3:H.flags=H.flags&-65537|128;case 0:if(H=j.payload,P=typeof H=="function"?H.call(M,D,P):H,P==null)break e;D=F({},D,P);break e;case 2:_t=!0}}d.callback!==null&&d.lane!==0&&(e.flags|=64,P=a.effects,P===null?a.effects=[d]:P.push(d))}else M={eventTime:M,lane:P,tag:d.tag,payload:d.payload,callback:d.callback,next:null},A===null?(I=A=M,p=D):A=A.next=M,s|=P;if(d=d.next,d===null){if(d=a.shared.pending,d===null)break;P=d,d=P.next,P.next=null,a.lastBaseUpdate=P,a.shared.pending=null}}while(!0);if(A===null&&(p=D),a.baseState=p,a.firstBaseUpdate=I,a.lastBaseUpdate=A,t=a.shared.interleaved,t!==null){a=t;do s|=a.lane,a=a.next;while(a!==t)}else o===null&&(a.shared.lanes=0);ci|=s,e.lanes=s,e.memoizedState=D}}function Hl(e,t,i){if(e=t.effects,t.effects=null,e!==null)for(t=0;t<e.length;t++){var n=e[t],a=n.callback;if(a!==null){if(n.callback=null,n=i,typeof a!="function")throw Error(l(191,a));a.call(n)}}}var gn={},wt=Gt(gn),yn=Gt(gn),vn=Gt(gn);function si(e){if(e===gn)throw Error(l(174));return e}function ir(e,t){switch(ce(vn,t),ce(yn,e),ce(wt,gn),e=t.nodeType,e){case 9:case 11:t=(t=t.documentElement)?t.namespaceURI:io(null,"");break;default:e=e===8?t.parentNode:t,t=e.namespaceURI||null,e=e.tagName,t=io(t,e)}ue(wt),ce(wt,t)}function zi(){ue(wt),ue(yn),ue(vn)}function jl(e){si(vn.current);var t=si(wt.current),i=io(t,e.type);t!==i&&(ce(yn,e),ce(wt,i))}function nr(e){yn.current===e&&(ue(wt),ue(yn))}var ge=Gt(0);function va(e){for(var t=e;t!==null;){if(t.tag===13){var i=t.memoizedState;if(i!==null&&(i=i.dehydrated,i===null||i.data==="$?"||i.data==="$!"))return t}else if(t.tag===19&&t.memoizedProps.revealOrder!==void 0){if((t.flags&128)!==0)return t}else if(t.child!==null){t.child.return=t,t=t.child;continue}if(t===e)break;for(;t.sibling===null;){if(t.return===null||t.return===e)return null;t=t.return}t.sibling.return=t.return,t=t.sibling}return null}var ar=[];function or(){for(var e=0;e<ar.length;e++)ar[e]._workInProgressVersionPrimary=null;ar.length=0}var xa=oe.ReactCurrentDispatcher,rr=oe.ReactCurrentBatchConfig,li=0,ye=null,Pe=null,Ae=null,Ia=!1,xn=!1,In=0,Zu=0;function Ne(){throw Error(l(321))}function sr(e,t){if(t===null)return!1;for(var i=0;i<t.length&&i<e.length;i++)if(!dt(e[i],t[i]))return!1;return!0}function lr(e,t,i,n,a,o){if(li=o,ye=t,t.memoizedState=null,t.updateQueue=null,t.lanes=0,xa.current=e===null||e.memoizedState===null?np:ap,e=i(n,a),xn){o=0;do{if(xn=!1,In=0,25<=o)throw Error(l(301));o+=1,Ae=Pe=null,t.updateQueue=null,xa.current=op,e=i(n,a)}while(xn)}if(xa.current=ka,t=Pe!==null&&Pe.next!==null,li=0,Ae=Pe=ye=null,Ia=!1,t)throw Error(l(300));return e}function cr(){var e=In!==0;return In=0,e}function bt(){var e={memoizedState:null,baseState:null,baseQueue:null,queue:null,next:null};return Ae===null?ye.memoizedState=Ae=e:Ae=Ae.next=e,Ae}function ot(){if(Pe===null){var e=ye.alternate;e=e!==null?e.memoizedState:null}else e=Pe.next;var t=Ae===null?ye.memoizedState:Ae.next;if(t!==null)Ae=t,Pe=e;else{if(e===null)throw Error(l(310));Pe=e,e={memoizedState:Pe.memoizedState,baseState:Pe.baseState,baseQueue:Pe.baseQueue,queue:Pe.queue,next:null},Ae===null?ye.memoizedState=Ae=e:Ae=Ae.next=e}return Ae}function wn(e,t){return typeof t=="function"?t(e):t}function dr(e){var t=ot(),i=t.queue;if(i===null)throw Error(l(311));i.lastRenderedReducer=e;var n=Pe,a=n.baseQueue,o=i.pending;if(o!==null){if(a!==null){var s=a.next;a.next=o.next,o.next=s}n.baseQueue=a=o,i.pending=null}if(a!==null){o=a.next,n=n.baseState;var d=s=null,p=null,I=o;do{var A=I.lane;if((li&A)===A)p!==null&&(p=p.next={lane:0,action:I.action,hasEagerState:I.hasEagerState,eagerState:I.eagerState,next:null}),n=I.hasEagerState?I.eagerState:e(n,I.action);else{var D={lane:A,action:I.action,hasEagerState:I.hasEagerState,eagerState:I.eagerState,next:null};p===null?(d=p=D,s=n):p=p.next=D,ye.lanes|=A,ci|=A}I=I.next}while(I!==null&&I!==o);p===null?s=n:p.next=d,dt(n,t.memoizedState)||(Ve=!0),t.memoizedState=n,t.baseState=s,t.baseQueue=p,i.lastRenderedState=n}if(e=i.interleaved,e!==null){a=e;do o=a.lane,ye.lanes|=o,ci|=o,a=a.next;while(a!==e)}else a===null&&(i.lanes=0);return[t.memoizedState,i.dispatch]}function ur(e){var t=ot(),i=t.queue;if(i===null)throw Error(l(311));i.lastRenderedReducer=e;var n=i.dispatch,a=i.pending,o=t.memoizedState;if(a!==null){i.pending=null;var s=a=a.next;do o=e(o,s.action),s=s.next;while(s!==a);dt(o,t.memoizedState)||(Ve=!0),t.memoizedState=o,t.baseQueue===null&&(t.baseState=o),i.lastRenderedState=o}return[o,n]}function Gl(){}function Ol(e,t){var i=ye,n=ot(),a=t(),o=!dt(n.memoizedState,a);if(o&&(n.memoizedState=a,Ve=!0),n=n.queue,pr(Ul.bind(null,i,n,e),[e]),n.getSnapshot!==t||o||Ae!==null&&Ae.memoizedState.tag&1){if(i.flags|=2048,bn(9,_l.bind(null,i,n,a,t),void 0,null),Ee===null)throw Error(l(349));(li&30)!==0||Vl(i,t,a)}return a}function Vl(e,t,i){e.flags|=16384,e={getSnapshot:t,value:i},t=ye.updateQueue,t===null?(t={lastEffect:null,stores:null},ye.updateQueue=t,t.stores=[e]):(i=t.stores,i===null?t.stores=[e]:i.push(e))}function _l(e,t,i,n){t.value=i,t.getSnapshot=n,Kl(t)&&$l(e)}function Ul(e,t,i){return i(function(){Kl(t)&&$l(e)})}function Kl(e){var t=e.getSnapshot;e=e.value;try{var i=t();return!dt(e,i)}catch{return!0}}function $l(e){var t=Et(e,1);t!==null&&ft(t,e,1,-1)}function Ql(e){var t=bt();return typeof e=="function"&&(e=e()),t.memoizedState=t.baseState=e,e={pending:null,interleaved:null,lanes:0,dispatch:null,lastRenderedReducer:wn,lastRenderedState:e},t.queue=e,e=e.dispatch=ip.bind(null,ye,e),[t.memoizedState,e]}function bn(e,t,i,n){return e={tag:e,create:t,destroy:i,deps:n,next:null},t=ye.updateQueue,t===null?(t={lastEffect:null,stores:null},ye.updateQueue=t,t.lastEffect=e.next=e):(i=t.lastEffect,i===null?t.lastEffect=e.next=e:(n=i.next,i.next=e,e.next=n,t.lastEffect=e)),e}function Jl(){return ot().memoizedState}function wa(e,t,i,n){var a=bt();ye.flags|=e,a.memoizedState=bn(1|t,i,void 0,n===void 0?null:n)}function ba(e,t,i,n){var a=ot();n=n===void 0?null:n;var o=void 0;if(Pe!==null){var s=Pe.memoizedState;if(o=s.destroy,n!==null&&sr(n,s.deps)){a.memoizedState=bn(t,i,o,n);return}}ye.flags|=e,a.memoizedState=bn(1|t,i,o,n)}function Xl(e,t){return wa(8390656,8,e,t)}function pr(e,t){return ba(2048,8,e,t)}function Yl(e,t){return ba(4,2,e,t)}function Zl(e,t){return ba(4,4,e,t)}function ec(e,t){if(typeof t=="function")return e=e(),t(e),function(){t(null)};if(t!=null)return e=e(),t.current=e,function(){t.current=null}}function tc(e,t,i){return i=i!=null?i.concat([e]):null,ba(4,4,ec.bind(null,t,e),i)}function hr(){}function ic(e,t){var i=ot();t=t===void 0?null:t;var n=i.memoizedState;return n!==null&&t!==null&&sr(t,n[1])?n[0]:(i.memoizedState=[e,t],e)}function nc(e,t){var i=ot();t=t===void 0?null:t;var n=i.memoizedState;return n!==null&&t!==null&&sr(t,n[1])?n[0]:(e=e(),i.memoizedState=[e,t],e)}function ac(e,t,i){return(li&21)===0?(e.baseState&&(e.baseState=!1,Ve=!0),e.memoizedState=i):(dt(i,t)||(i=Rs(),ye.lanes|=i,ci|=i,e.baseState=!0),t)}function ep(e,t){var i=se;se=i!==0&&4>i?i:4,e(!0);var n=rr.transition;rr.transition={};try{e(!1),t()}finally{se=i,rr.transition=n}}function oc(){return ot().memoizedState}function tp(e,t,i){var n=Jt(e);if(i={lane:n,action:i,hasEagerState:!1,eagerState:null,next:null},rc(e))sc(t,i);else if(i=Bl(e,t,i,n),i!==null){var a=He();ft(i,e,n,a),lc(i,t,n)}}function ip(e,t,i){var n=Jt(e),a={lane:n,action:i,hasEagerState:!1,eagerState:null,next:null};if(rc(e))sc(t,a);else{var o=e.alternate;if(e.lanes===0&&(o===null||o.lanes===0)&&(o=t.lastRenderedReducer,o!==null))try{var s=t.lastRenderedState,d=o(s,i);if(a.hasEagerState=!0,a.eagerState=d,dt(d,s)){var p=t.interleaved;p===null?(a.next=a,er(t)):(a.next=p.next,p.next=a),t.interleaved=a;return}}catch{}i=Bl(e,t,a,n),i!==null&&(a=He(),ft(i,e,n,a),lc(i,t,n))}}function rc(e){var t=e.alternate;return e===ye||t!==null&&t===ye}function sc(e,t){xn=Ia=!0;var i=e.pending;i===null?t.next=t:(t.next=i.next,i.next=t),e.pending=t}function lc(e,t,i){if((i&4194240)!==0){var n=t.lanes;n&=e.pendingLanes,i|=n,t.lanes=i,fo(e,i)}}var ka={readContext:at,useCallback:Ne,useContext:Ne,useEffect:Ne,useImperativeHandle:Ne,useInsertionEffect:Ne,useLayoutEffect:Ne,useMemo:Ne,useReducer:Ne,useRef:Ne,useState:Ne,useDebugValue:Ne,useDeferredValue:Ne,useTransition:Ne,useMutableSource:Ne,useSyncExternalStore:Ne,useId:Ne,unstable_isNewReconciler:!1},np={readContext:at,useCallback:function(e,t){return bt().memoizedState=[e,t===void 0?null:t],e},useContext:at,useEffect:Xl,useImperativeHandle:function(e,t,i){return i=i!=null?i.concat([e]):null,wa(4194308,4,ec.bind(null,t,e),i)},useLayoutEffect:function(e,t){return wa(4194308,4,e,t)},useInsertionEffect:function(e,t){return wa(4,2,e,t)},useMemo:function(e,t){var i=bt();return t=t===void 0?null:t,e=e(),i.memoizedState=[e,t],e},useReducer:function(e,t,i){var n=bt();return t=i!==void 0?i(t):t,n.memoizedState=n.baseState=t,e={pending:null,interleaved:null,lanes:0,dispatch:null,lastRenderedReducer:e,lastRenderedState:t},n.queue=e,e=e.dispatch=tp.bind(null,ye,e),[n.memoizedState,e]},useRef:function(e){var t=bt();return e={current:e},t.memoizedState=e},useState:Ql,useDebugValue:hr,useDeferredValue:function(e){return bt().memoizedState=e},useTransition:function(){var e=Ql(!1),t=e[0];return e=ep.bind(null,e[1]),bt().memoizedState=e,[t,e]},useMutableSource:function(){},useSyncExternalStore:function(e,t,i){var n=ye,a=bt();if(me){if(i===void 0)throw Error(l(407));i=i()}else{if(i=t(),Ee===null)throw Error(l(349));(li&30)!==0||Vl(n,t,i)}a.memoizedState=i;var o={value:i,getSnapshot:t};return a.queue=o,Xl(Ul.bind(null,n,o,e),[e]),n.flags|=2048,bn(9,_l.bind(null,n,o,i,t),void 0,null),i},useId:function(){var e=bt(),t=Ee.identifierPrefix;if(me){var i=At,n=St;i=(n&~(1<<32-ct(n)-1)).toString(32)+i,t=":"+t+"R"+i,i=In++,0<i&&(t+="H"+i.toString(32)),t+=":"}else i=Zu++,t=":"+t+"r"+i.toString(32)+":";return e.memoizedState=t},unstable_isNewReconciler:!1},ap={readContext:at,useCallback:ic,useContext:at,useEffect:pr,useImperativeHandle:tc,useInsertionEffect:Yl,useLayoutEffect:Zl,useMemo:nc,useReducer:dr,useRef:Jl,useState:function(){return dr(wn)},useDebugValue:hr,useDeferredValue:function(e){var t=ot();return ac(t,Pe.memoizedState,e)},useTransition:function(){var e=dr(wn)[0],t=ot().memoizedState;return[e,t]},useMutableSource:Gl,useSyncExternalStore:Ol,useId:oc,unstable_isNewReconciler:!1},op={readContext:at,useCallback:ic,useContext:at,useEffect:pr,useImperativeHandle:tc,useInsertionEffect:Yl,useLayoutEffect:Zl,useMemo:nc,useReducer:ur,useRef:Jl,useState:function(){return ur(wn)},useDebugValue:hr,useDeferredValue:function(e){var t=ot();return Pe===null?t.memoizedState=e:ac(t,Pe.memoizedState,e)},useTransition:function(){var e=ur(wn)[0],t=ot().memoizedState;return[e,t]},useMutableSource:Gl,useSyncExternalStore:Ol,useId:oc,unstable_isNewReconciler:!1};function pt(e,t){if(e&&e.defaultProps){t=F({},t),e=e.defaultProps;for(var i in e)t[i]===void 0&&(t[i]=e[i]);return t}return t}function mr(e,t,i,n){t=e.memoizedState,i=i(n,t),i=i==null?t:F({},t,i),e.memoizedState=i,e.lanes===0&&(e.updateQueue.baseState=i)}var Ca={isMounted:function(e){return(e=e._reactInternals)?ti(e)===e:!1},enqueueSetState:function(e,t,i){e=e._reactInternals;var n=He(),a=Jt(e),o=qt(n,a);o.payload=t,i!=null&&(o.callback=i),t=Ut(e,o,a),t!==null&&(ft(t,e,a,n),ga(t,e,a))},enqueueReplaceState:function(e,t,i){e=e._reactInternals;var n=He(),a=Jt(e),o=qt(n,a);o.tag=1,o.payload=t,i!=null&&(o.callback=i),t=Ut(e,o,a),t!==null&&(ft(t,e,a,n),ga(t,e,a))},enqueueForceUpdate:function(e,t){e=e._reactInternals;var i=He(),n=Jt(e),a=qt(i,n);a.tag=2,t!=null&&(a.callback=t),t=Ut(e,a,n),t!==null&&(ft(t,e,n,i),ga(t,e,n))}};function cc(e,t,i,n,a,o,s){return e=e.stateNode,typeof e.shouldComponentUpdate=="function"?e.shouldComponentUpdate(n,o,s):t.prototype&&t.prototype.isPureReactComponent?!ln(i,n)||!ln(a,o):!0}function dc(e,t,i){var n=!1,a=Ot,o=t.contextType;return typeof o=="object"&&o!==null?o=at(o):(a=Oe(t)?ni:Re.current,n=t.contextTypes,o=(n=n!=null)?Pi(e,a):Ot),t=new t(i,o),e.memoizedState=t.state!==null&&t.state!==void 0?t.state:null,t.updater=Ca,e.stateNode=t,t._reactInternals=e,n&&(e=e.stateNode,e.__reactInternalMemoizedUnmaskedChildContext=a,e.__reactInternalMemoizedMaskedChildContext=o),t}function uc(e,t,i,n){e=t.state,typeof t.componentWillReceiveProps=="function"&&t.componentWillReceiveProps(i,n),typeof t.UNSAFE_componentWillReceiveProps=="function"&&t.UNSAFE_componentWillReceiveProps(i,n),t.state!==e&&Ca.enqueueReplaceState(t,t.state,null)}function fr(e,t,i,n){var a=e.stateNode;a.props=i,a.state=e.memoizedState,a.refs={},tr(e);var o=t.contextType;typeof o=="object"&&o!==null?a.context=at(o):(o=Oe(t)?ni:Re.current,a.context=Pi(e,o)),a.state=e.memoizedState,o=t.getDerivedStateFromProps,typeof o=="function"&&(mr(e,t,o,i),a.state=e.memoizedState),typeof t.getDerivedStateFromProps=="function"||typeof a.getSnapshotBeforeUpdate=="function"||typeof a.UNSAFE_componentWillMount!="function"&&typeof a.componentWillMount!="function"||(t=a.state,typeof a.componentWillMount=="function"&&a.componentWillMount(),typeof a.UNSAFE_componentWillMount=="function"&&a.UNSAFE_componentWillMount(),t!==a.state&&Ca.enqueueReplaceState(a,a.state,null),ya(e,i,a,n),a.state=e.memoizedState),typeof a.componentDidMount=="function"&&(e.flags|=4194308)}function Ri(e,t){try{var i="",n=t;do i+=ie(n),n=n.return;while(n);var a=i}catch(o){a=`
Error generating stack: `+o.message+`
`+o.stack}return{value:e,source:t,stack:a,digest:null}}function gr(e,t,i){return{value:e,source:null,stack:i??null,digest:t??null}}function yr(e,t){try{console.error(t.value)}catch(i){setTimeout(function(){throw i})}}var rp=typeof WeakMap=="function"?WeakMap:Map;function pc(e,t,i){i=qt(-1,i),i.tag=3,i.payload={element:null};var n=t.value;return i.callback=function(){Da||(Da=!0,Lr=n),yr(e,t)},i}function hc(e,t,i){i=qt(-1,i),i.tag=3;var n=e.type.getDerivedStateFromError;if(typeof n=="function"){var a=t.value;i.payload=function(){return n(a)},i.callback=function(){yr(e,t)}}var o=e.stateNode;return o!==null&&typeof o.componentDidCatch=="function"&&(i.callback=function(){yr(e,t),typeof n!="function"&&($t===null?$t=new Set([this]):$t.add(this));var s=t.stack;this.componentDidCatch(t.value,{componentStack:s!==null?s:""})}),i}function mc(e,t,i){var n=e.pingCache;if(n===null){n=e.pingCache=new rp;var a=new Set;n.set(t,a)}else a=n.get(t),a===void 0&&(a=new Set,n.set(t,a));a.has(i)||(a.add(i),e=Ip.bind(null,e,t,i),t.then(e,e))}function fc(e){do{var t;if((t=e.tag===13)&&(t=e.memoizedState,t=t!==null?t.dehydrated!==null:!0),t)return e;e=e.return}while(e!==null);return null}function gc(e,t,i,n,a){return(e.mode&1)===0?(e===t?e.flags|=65536:(e.flags|=128,i.flags|=131072,i.flags&=-52805,i.tag===1&&(i.alternate===null?i.tag=17:(t=qt(-1,1),t.tag=2,Ut(i,t,1))),i.lanes|=1),e):(e.flags|=65536,e.lanes=a,e)}var sp=oe.ReactCurrentOwner,Ve=!1;function Fe(e,t,i,n){t.child=e===null?Ml(t,null,i,n):qi(t,e.child,i,n)}function yc(e,t,i,n,a){i=i.render;var o=t.ref;return Li(t,a),n=lr(e,t,i,n,o,a),i=cr(),e!==null&&!Ve?(t.updateQueue=e.updateQueue,t.flags&=-2053,e.lanes&=~a,Dt(e,t,a)):(me&&i&&_o(t),t.flags|=1,Fe(e,t,n,a),t.child)}function vc(e,t,i,n,a){if(e===null){var o=i.type;return typeof o=="function"&&!Fr(o)&&o.defaultProps===void 0&&i.compare===null&&i.defaultProps===void 0?(t.tag=15,t.type=o,xc(e,t,o,n,a)):(e=Ba(i.type,null,n,t,t.mode,a),e.ref=t.ref,e.return=t,t.child=e)}if(o=e.child,(e.lanes&a)===0){var s=o.memoizedProps;if(i=i.compare,i=i!==null?i:ln,i(s,n)&&e.ref===t.ref)return Dt(e,t,a)}return t.flags|=1,e=Yt(o,n),e.ref=t.ref,e.return=t,t.child=e}function xc(e,t,i,n,a){if(e!==null){var o=e.memoizedProps;if(ln(o,n)&&e.ref===t.ref)if(Ve=!1,t.pendingProps=n=o,(e.lanes&a)!==0)(e.flags&131072)!==0&&(Ve=!0);else return t.lanes=e.lanes,Dt(e,t,a)}return vr(e,t,i,n,a)}function Ic(e,t,i){var n=t.pendingProps,a=n.children,o=e!==null?e.memoizedState:null;if(n.mode==="hidden")if((t.mode&1)===0)t.memoizedState={baseLanes:0,cachePool:null,transitions:null},ce(Mi,et),et|=i;else{if((i&1073741824)===0)return e=o!==null?o.baseLanes|i:i,t.lanes=t.childLanes=1073741824,t.memoizedState={baseLanes:e,cachePool:null,transitions:null},t.updateQueue=null,ce(Mi,et),et|=e,null;t.memoizedState={baseLanes:0,cachePool:null,transitions:null},n=o!==null?o.baseLanes:i,ce(Mi,et),et|=n}else o!==null?(n=o.baseLanes|i,t.memoizedState=null):n=i,ce(Mi,et),et|=n;return Fe(e,t,a,i),t.child}function wc(e,t){var i=t.ref;(e===null&&i!==null||e!==null&&e.ref!==i)&&(t.flags|=512,t.flags|=2097152)}function vr(e,t,i,n,a){var o=Oe(i)?ni:Re.current;return o=Pi(t,o),Li(t,a),i=lr(e,t,i,n,o,a),n=cr(),e!==null&&!Ve?(t.updateQueue=e.updateQueue,t.flags&=-2053,e.lanes&=~a,Dt(e,t,a)):(me&&n&&_o(t),t.flags|=1,Fe(e,t,i,a),t.child)}function bc(e,t,i,n,a){if(Oe(i)){var o=!0;la(t)}else o=!1;if(Li(t,a),t.stateNode===null)Pa(e,t),dc(t,i,n),fr(t,i,n,a),n=!0;else if(e===null){var s=t.stateNode,d=t.memoizedProps;s.props=d;var p=s.context,I=i.contextType;typeof I=="object"&&I!==null?I=at(I):(I=Oe(i)?ni:Re.current,I=Pi(t,I));var A=i.getDerivedStateFromProps,D=typeof A=="function"||typeof s.getSnapshotBeforeUpdate=="function";D||typeof s.UNSAFE_componentWillReceiveProps!="function"&&typeof s.componentWillReceiveProps!="function"||(d!==n||p!==I)&&uc(t,s,n,I),_t=!1;var P=t.memoizedState;s.state=P,ya(t,n,s,a),p=t.memoizedState,d!==n||P!==p||Ge.current||_t?(typeof A=="function"&&(mr(t,i,A,n),p=t.memoizedState),(d=_t||cc(t,i,d,n,P,p,I))?(D||typeof s.UNSAFE_componentWillMount!="function"&&typeof s.componentWillMount!="function"||(typeof s.componentWillMount=="function"&&s.componentWillMount(),typeof s.UNSAFE_componentWillMount=="function"&&s.UNSAFE_componentWillMount()),typeof s.componentDidMount=="function"&&(t.flags|=4194308)):(typeof s.componentDidMount=="function"&&(t.flags|=4194308),t.memoizedProps=n,t.memoizedState=p),s.props=n,s.state=p,s.context=I,n=d):(typeof s.componentDidMount=="function"&&(t.flags|=4194308),n=!1)}else{s=t.stateNode,Wl(e,t),d=t.memoizedProps,I=t.type===t.elementType?d:pt(t.type,d),s.props=I,D=t.pendingProps,P=s.context,p=i.contextType,typeof p=="object"&&p!==null?p=at(p):(p=Oe(i)?ni:Re.current,p=Pi(t,p));var M=i.getDerivedStateFromProps;(A=typeof M=="function"||typeof s.getSnapshotBeforeUpdate=="function")||typeof s.UNSAFE_componentWillReceiveProps!="function"&&typeof s.componentWillReceiveProps!="function"||(d!==D||P!==p)&&uc(t,s,n,p),_t=!1,P=t.memoizedState,s.state=P,ya(t,n,s,a);var H=t.memoizedState;d!==D||P!==H||Ge.current||_t?(typeof M=="function"&&(mr(t,i,M,n),H=t.memoizedState),(I=_t||cc(t,i,I,n,P,H,p)||!1)?(A||typeof s.UNSAFE_componentWillUpdate!="function"&&typeof s.componentWillUpdate!="function"||(typeof s.componentWillUpdate=="function"&&s.componentWillUpdate(n,H,p),typeof s.UNSAFE_componentWillUpdate=="function"&&s.UNSAFE_componentWillUpdate(n,H,p)),typeof s.componentDidUpdate=="function"&&(t.flags|=4),typeof s.getSnapshotBeforeUpdate=="function"&&(t.flags|=1024)):(typeof s.componentDidUpdate!="function"||d===e.memoizedProps&&P===e.memoizedState||(t.flags|=4),typeof s.getSnapshotBeforeUpdate!="function"||d===e.memoizedProps&&P===e.memoizedState||(t.flags|=1024),t.memoizedProps=n,t.memoizedState=H),s.props=n,s.state=H,s.context=p,n=I):(typeof s.componentDidUpdate!="function"||d===e.memoizedProps&&P===e.memoizedState||(t.flags|=4),typeof s.getSnapshotBeforeUpdate!="function"||d===e.memoizedProps&&P===e.memoizedState||(t.flags|=1024),n=!1)}return xr(e,t,i,n,o,a)}function xr(e,t,i,n,a,o){wc(e,t);var s=(t.flags&128)!==0;if(!n&&!s)return a&&Sl(t,i,!1),Dt(e,t,o);n=t.stateNode,sp.current=t;var d=s&&typeof i.getDerivedStateFromError!="function"?null:n.render();return t.flags|=1,e!==null&&s?(t.child=qi(t,e.child,null,o),t.child=qi(t,null,d,o)):Fe(e,t,d,o),t.memoizedState=n.state,a&&Sl(t,i,!0),t.child}function kc(e){var t=e.stateNode;t.pendingContext?Tl(e,t.pendingContext,t.pendingContext!==t.context):t.context&&Tl(e,t.context,!1),ir(e,t.containerInfo)}function Cc(e,t,i,n,a){return Ei(),Qo(a),t.flags|=256,Fe(e,t,i,n),t.child}var Ir={dehydrated:null,treeContext:null,retryLane:0};function wr(e){return{baseLanes:e,cachePool:null,transitions:null}}function Tc(e,t,i){var n=t.pendingProps,a=ge.current,o=!1,s=(t.flags&128)!==0,d;if((d=s)||(d=e!==null&&e.memoizedState===null?!1:(a&2)!==0),d?(o=!0,t.flags&=-129):(e===null||e.memoizedState!==null)&&(a|=1),ce(ge,a&1),e===null)return $o(t),e=t.memoizedState,e!==null&&(e=e.dehydrated,e!==null)?((t.mode&1)===0?t.lanes=1:e.data==="$!"?t.lanes=8:t.lanes=1073741824,null):(s=n.children,e=n.fallback,o?(n=t.mode,o=t.child,s={mode:"hidden",children:s},(n&1)===0&&o!==null?(o.childLanes=0,o.pendingProps=s):o=Wa(s,n,0,null),e=hi(e,n,i,null),o.return=t,e.return=t,o.sibling=e,t.child=o,t.child.memoizedState=wr(i),t.memoizedState=Ir,e):br(t,s));if(a=e.memoizedState,a!==null&&(d=a.dehydrated,d!==null))return lp(e,t,s,n,d,a,i);if(o){o=n.fallback,s=t.mode,a=e.child,d=a.sibling;var p={mode:"hidden",children:n.children};return(s&1)===0&&t.child!==a?(n=t.child,n.childLanes=0,n.pendingProps=p,t.deletions=null):(n=Yt(a,p),n.subtreeFlags=a.subtreeFlags&14680064),d!==null?o=Yt(d,o):(o=hi(o,s,i,null),o.flags|=2),o.return=t,n.return=t,n.sibling=o,t.child=n,n=o,o=t.child,s=e.child.memoizedState,s=s===null?wr(i):{baseLanes:s.baseLanes|i,cachePool:null,transitions:s.transitions},o.memoizedState=s,o.childLanes=e.childLanes&~i,t.memoizedState=Ir,n}return o=e.child,e=o.sibling,n=Yt(o,{mode:"visible",children:n.children}),(t.mode&1)===0&&(n.lanes=i),n.return=t,n.sibling=null,e!==null&&(i=t.deletions,i===null?(t.deletions=[e],t.flags|=16):i.push(e)),t.child=n,t.memoizedState=null,n}function br(e,t){return t=Wa({mode:"visible",children:t},e.mode,0,null),t.return=e,e.child=t}function Ta(e,t,i,n){return n!==null&&Qo(n),qi(t,e.child,null,i),e=br(t,t.pendingProps.children),e.flags|=2,t.memoizedState=null,e}function lp(e,t,i,n,a,o,s){if(i)return t.flags&256?(t.flags&=-257,n=gr(Error(l(422))),Ta(e,t,s,n)):t.memoizedState!==null?(t.child=e.child,t.flags|=128,null):(o=n.fallback,a=t.mode,n=Wa({mode:"visible",children:n.children},a,0,null),o=hi(o,a,s,null),o.flags|=2,n.return=t,o.return=t,n.sibling=o,t.child=n,(t.mode&1)!==0&&qi(t,e.child,null,s),t.child.memoizedState=wr(s),t.memoizedState=Ir,o);if((t.mode&1)===0)return Ta(e,t,s,null);if(a.data==="$!"){if(n=a.nextSibling&&a.nextSibling.dataset,n)var d=n.dgst;return n=d,o=Error(l(419)),n=gr(o,n,void 0),Ta(e,t,s,n)}if(d=(s&e.childLanes)!==0,Ve||d){if(n=Ee,n!==null){switch(s&-s){case 4:a=2;break;case 16:a=8;break;case 64:case 128:case 256:case 512:case 1024:case 2048:case 4096:case 8192:case 16384:case 32768:case 65536:case 131072:case 262144:case 524288:case 1048576:case 2097152:case 4194304:case 8388608:case 16777216:case 33554432:case 67108864:a=32;break;case 536870912:a=268435456;break;default:a=0}a=(a&(n.suspendedLanes|s))!==0?0:a,a!==0&&a!==o.retryLane&&(o.retryLane=a,Et(e,a),ft(n,e,a,-1))}return Wr(),n=gr(Error(l(421))),Ta(e,t,s,n)}return a.data==="$?"?(t.flags|=128,t.child=e.child,t=wp.bind(null,e),a._reactRetry=t,null):(e=o.treeContext,Ze=jt(a.nextSibling),Ye=t,me=!0,ut=null,e!==null&&(it[nt++]=St,it[nt++]=At,it[nt++]=ai,St=e.id,At=e.overflow,ai=t),t=br(t,n.children),t.flags|=4096,t)}function Pc(e,t,i){e.lanes|=t;var n=e.alternate;n!==null&&(n.lanes|=t),Zo(e.return,t,i)}function kr(e,t,i,n,a){var o=e.memoizedState;o===null?e.memoizedState={isBackwards:t,rendering:null,renderingStartTime:0,last:n,tail:i,tailMode:a}:(o.isBackwards=t,o.rendering=null,o.renderingStartTime=0,o.last=n,o.tail=i,o.tailMode=a)}function Sc(e,t,i){var n=t.pendingProps,a=n.revealOrder,o=n.tail;if(Fe(e,t,n.children,i),n=ge.current,(n&2)!==0)n=n&1|2,t.flags|=128;else{if(e!==null&&(e.flags&128)!==0)e:for(e=t.child;e!==null;){if(e.tag===13)e.memoizedState!==null&&Pc(e,i,t);else if(e.tag===19)Pc(e,i,t);else if(e.child!==null){e.child.return=e,e=e.child;continue}if(e===t)break e;for(;e.sibling===null;){if(e.return===null||e.return===t)break e;e=e.return}e.sibling.return=e.return,e=e.sibling}n&=1}if(ce(ge,n),(t.mode&1)===0)t.memoizedState=null;else switch(a){case"forwards":for(i=t.child,a=null;i!==null;)e=i.alternate,e!==null&&va(e)===null&&(a=i),i=i.sibling;i=a,i===null?(a=t.child,t.child=null):(a=i.sibling,i.sibling=null),kr(t,!1,a,i,o);break;case"backwards":for(i=null,a=t.child,t.child=null;a!==null;){if(e=a.alternate,e!==null&&va(e)===null){t.child=a;break}e=a.sibling,a.sibling=i,i=a,a=e}kr(t,!0,i,null,o);break;case"together":kr(t,!1,null,null,void 0);break;default:t.memoizedState=null}return t.child}function Pa(e,t){(t.mode&1)===0&&e!==null&&(e.alternate=null,t.alternate=null,t.flags|=2)}function Dt(e,t,i){if(e!==null&&(t.dependencies=e.dependencies),ci|=t.lanes,(i&t.childLanes)===0)return null;if(e!==null&&t.child!==e.child)throw Error(l(153));if(t.child!==null){for(e=t.child,i=Yt(e,e.pendingProps),t.child=i,i.return=t;e.sibling!==null;)e=e.sibling,i=i.sibling=Yt(e,e.pendingProps),i.return=t;i.sibling=null}return t.child}function cp(e,t,i){switch(t.tag){case 3:kc(t),Ei();break;case 5:jl(t);break;case 1:Oe(t.type)&&la(t);break;case 4:ir(t,t.stateNode.containerInfo);break;case 10:var n=t.type._context,a=t.memoizedProps.value;ce(ma,n._currentValue),n._currentValue=a;break;case 13:if(n=t.memoizedState,n!==null)return n.dehydrated!==null?(ce(ge,ge.current&1),t.flags|=128,null):(i&t.child.childLanes)!==0?Tc(e,t,i):(ce(ge,ge.current&1),e=Dt(e,t,i),e!==null?e.sibling:null);ce(ge,ge.current&1);break;case 19:if(n=(i&t.childLanes)!==0,(e.flags&128)!==0){if(n)return Sc(e,t,i);t.flags|=128}if(a=t.memoizedState,a!==null&&(a.rendering=null,a.tail=null,a.lastEffect=null),ce(ge,ge.current),n)break;return null;case 22:case 23:return t.lanes=0,Ic(e,t,i)}return Dt(e,t,i)}var Ac,Cr,Ec,qc;Ac=function(e,t){for(var i=t.child;i!==null;){if(i.tag===5||i.tag===6)e.appendChild(i.stateNode);else if(i.tag!==4&&i.child!==null){i.child.return=i,i=i.child;continue}if(i===t)break;for(;i.sibling===null;){if(i.return===null||i.return===t)return;i=i.return}i.sibling.return=i.return,i=i.sibling}},Cr=function(){},Ec=function(e,t,i,n){var a=e.memoizedProps;if(a!==n){e=t.stateNode,si(wt.current);var o=null;switch(i){case"input":a=Ya(e,a),n=Ya(e,n),o=[];break;case"select":a=F({},a,{value:void 0}),n=F({},n,{value:void 0}),o=[];break;case"textarea":a=to(e,a),n=to(e,n),o=[];break;default:typeof a.onClick!="function"&&typeof n.onClick=="function"&&(e.onclick=oa)}no(i,n);var s;i=null;for(I in a)if(!n.hasOwnProperty(I)&&a.hasOwnProperty(I)&&a[I]!=null)if(I==="style"){var d=a[I];for(s in d)d.hasOwnProperty(s)&&(i||(i={}),i[s]="")}else I!=="dangerouslySetInnerHTML"&&I!=="children"&&I!=="suppressContentEditableWarning"&&I!=="suppressHydrationWarning"&&I!=="autoFocus"&&(m.hasOwnProperty(I)?o||(o=[]):(o=o||[]).push(I,null));for(I in n){var p=n[I];if(d=a?.[I],n.hasOwnProperty(I)&&p!==d&&(p!=null||d!=null))if(I==="style")if(d){for(s in d)!d.hasOwnProperty(s)||p&&p.hasOwnProperty(s)||(i||(i={}),i[s]="");for(s in p)p.hasOwnProperty(s)&&d[s]!==p[s]&&(i||(i={}),i[s]=p[s])}else i||(o||(o=[]),o.push(I,i)),i=p;else I==="dangerouslySetInnerHTML"?(p=p?p.__html:void 0,d=d?d.__html:void 0,p!=null&&d!==p&&(o=o||[]).push(I,p)):I==="children"?typeof p!="string"&&typeof p!="number"||(o=o||[]).push(I,""+p):I!=="suppressContentEditableWarning"&&I!=="suppressHydrationWarning"&&(m.hasOwnProperty(I)?(p!=null&&I==="onScroll"&&de("scroll",e),o||d===p||(o=[])):(o=o||[]).push(I,p))}i&&(o=o||[]).push("style",i);var I=o;(t.updateQueue=I)&&(t.flags|=4)}},qc=function(e,t,i,n){i!==n&&(t.flags|=4)};function kn(e,t){if(!me)switch(e.tailMode){case"hidden":t=e.tail;for(var i=null;t!==null;)t.alternate!==null&&(i=t),t=t.sibling;i===null?e.tail=null:i.sibling=null;break;case"collapsed":i=e.tail;for(var n=null;i!==null;)i.alternate!==null&&(n=i),i=i.sibling;n===null?t||e.tail===null?e.tail=null:e.tail.sibling=null:n.sibling=null}}function Me(e){var t=e.alternate!==null&&e.alternate.child===e.child,i=0,n=0;if(t)for(var a=e.child;a!==null;)i|=a.lanes|a.childLanes,n|=a.subtreeFlags&14680064,n|=a.flags&14680064,a.return=e,a=a.sibling;else for(a=e.child;a!==null;)i|=a.lanes|a.childLanes,n|=a.subtreeFlags,n|=a.flags,a.return=e,a=a.sibling;return e.subtreeFlags|=n,e.childLanes=i,t}function dp(e,t,i){var n=t.pendingProps;switch(Uo(t),t.tag){case 2:case 16:case 15:case 0:case 11:case 7:case 8:case 12:case 9:case 14:return Me(t),null;case 1:return Oe(t.type)&&sa(),Me(t),null;case 3:return n=t.stateNode,zi(),ue(Ge),ue(Re),or(),n.pendingContext&&(n.context=n.pendingContext,n.pendingContext=null),(e===null||e.child===null)&&(pa(t)?t.flags|=4:e===null||e.memoizedState.isDehydrated&&(t.flags&256)===0||(t.flags|=1024,ut!==null&&(Nr(ut),ut=null))),Cr(e,t),Me(t),null;case 5:nr(t);var a=si(vn.current);if(i=t.type,e!==null&&t.stateNode!=null)Ec(e,t,i,n,a),e.ref!==t.ref&&(t.flags|=512,t.flags|=2097152);else{if(!n){if(t.stateNode===null)throw Error(l(166));return Me(t),null}if(e=si(wt.current),pa(t)){n=t.stateNode,i=t.type;var o=t.memoizedProps;switch(n[It]=t,n[hn]=o,e=(t.mode&1)!==0,i){case"dialog":de("cancel",n),de("close",n);break;case"iframe":case"object":case"embed":de("load",n);break;case"video":case"audio":for(a=0;a<dn.length;a++)de(dn[a],n);break;case"source":de("error",n);break;case"img":case"image":case"link":de("error",n),de("load",n);break;case"details":de("toggle",n);break;case"input":ds(n,o),de("invalid",n);break;case"select":n._wrapperState={wasMultiple:!!o.multiple},de("invalid",n);break;case"textarea":hs(n,o),de("invalid",n)}no(i,o),a=null;for(var s in o)if(o.hasOwnProperty(s)){var d=o[s];s==="children"?typeof d=="string"?n.textContent!==d&&(o.suppressHydrationWarning!==!0&&aa(n.textContent,d,e),a=["children",d]):typeof d=="number"&&n.textContent!==""+d&&(o.suppressHydrationWarning!==!0&&aa(n.textContent,d,e),a=["children",""+d]):m.hasOwnProperty(s)&&d!=null&&s==="onScroll"&&de("scroll",n)}switch(i){case"input":Nn(n),ps(n,o,!0);break;case"textarea":Nn(n),fs(n);break;case"select":case"option":break;default:typeof o.onClick=="function"&&(n.onclick=oa)}n=a,t.updateQueue=n,n!==null&&(t.flags|=4)}else{s=a.nodeType===9?a:a.ownerDocument,e==="http://www.w3.org/1999/xhtml"&&(e=gs(i)),e==="http://www.w3.org/1999/xhtml"?i==="script"?(e=s.createElement("div"),e.innerHTML="<script><\/script>",e=e.removeChild(e.firstChild)):typeof n.is=="string"?e=s.createElement(i,{is:n.is}):(e=s.createElement(i),i==="select"&&(s=e,n.multiple?s.multiple=!0:n.size&&(s.size=n.size))):e=s.createElementNS(e,i),e[It]=t,e[hn]=n,Ac(e,t,!1,!1),t.stateNode=e;e:{switch(s=ao(i,n),i){case"dialog":de("cancel",e),de("close",e),a=n;break;case"iframe":case"object":case"embed":de("load",e),a=n;break;case"video":case"audio":for(a=0;a<dn.length;a++)de(dn[a],e);a=n;break;case"source":de("error",e),a=n;break;case"img":case"image":case"link":de("error",e),de("load",e),a=n;break;case"details":de("toggle",e),a=n;break;case"input":ds(e,n),a=Ya(e,n),de("invalid",e);break;case"option":a=n;break;case"select":e._wrapperState={wasMultiple:!!n.multiple},a=F({},n,{value:void 0}),de("invalid",e);break;case"textarea":hs(e,n),a=to(e,n),de("invalid",e);break;default:a=n}no(i,a),d=a;for(o in d)if(d.hasOwnProperty(o)){var p=d[o];o==="style"?xs(e,p):o==="dangerouslySetInnerHTML"?(p=p?p.__html:void 0,p!=null&&ys(e,p)):o==="children"?typeof p=="string"?(i!=="textarea"||p!=="")&&Vi(e,p):typeof p=="number"&&Vi(e,""+p):o!=="suppressContentEditableWarning"&&o!=="suppressHydrationWarning"&&o!=="autoFocus"&&(m.hasOwnProperty(o)?p!=null&&o==="onScroll"&&de("scroll",e):p!=null&&X(e,o,p,s))}switch(i){case"input":Nn(e),ps(e,n,!1);break;case"textarea":Nn(e),fs(e);break;case"option":n.value!=null&&e.setAttribute("value",""+re(n.value));break;case"select":e.multiple=!!n.multiple,o=n.value,o!=null?mi(e,!!n.multiple,o,!1):n.defaultValue!=null&&mi(e,!!n.multiple,n.defaultValue,!0);break;default:typeof a.onClick=="function"&&(e.onclick=oa)}switch(i){case"button":case"input":case"select":case"textarea":n=!!n.autoFocus;break e;case"img":n=!0;break e;default:n=!1}}n&&(t.flags|=4)}t.ref!==null&&(t.flags|=512,t.flags|=2097152)}return Me(t),null;case 6:if(e&&t.stateNode!=null)qc(e,t,e.memoizedProps,n);else{if(typeof n!="string"&&t.stateNode===null)throw Error(l(166));if(i=si(vn.current),si(wt.current),pa(t)){if(n=t.stateNode,i=t.memoizedProps,n[It]=t,(o=n.nodeValue!==i)&&(e=Ye,e!==null))switch(e.tag){case 3:aa(n.nodeValue,i,(e.mode&1)!==0);break;case 5:e.memoizedProps.suppressHydrationWarning!==!0&&aa(n.nodeValue,i,(e.mode&1)!==0)}o&&(t.flags|=4)}else n=(i.nodeType===9?i:i.ownerDocument).createTextNode(n),n[It]=t,t.stateNode=n}return Me(t),null;case 13:if(ue(ge),n=t.memoizedState,e===null||e.memoizedState!==null&&e.memoizedState.dehydrated!==null){if(me&&Ze!==null&&(t.mode&1)!==0&&(t.flags&128)===0)zl(),Ei(),t.flags|=98560,o=!1;else if(o=pa(t),n!==null&&n.dehydrated!==null){if(e===null){if(!o)throw Error(l(318));if(o=t.memoizedState,o=o!==null?o.dehydrated:null,!o)throw Error(l(317));o[It]=t}else Ei(),(t.flags&128)===0&&(t.memoizedState=null),t.flags|=4;Me(t),o=!1}else ut!==null&&(Nr(ut),ut=null),o=!0;if(!o)return t.flags&65536?t:null}return(t.flags&128)!==0?(t.lanes=i,t):(n=n!==null,n!==(e!==null&&e.memoizedState!==null)&&n&&(t.child.flags|=8192,(t.mode&1)!==0&&(e===null||(ge.current&1)!==0?Se===0&&(Se=3):Wr())),t.updateQueue!==null&&(t.flags|=4),Me(t),null);case 4:return zi(),Cr(e,t),e===null&&un(t.stateNode.containerInfo),Me(t),null;case 10:return Yo(t.type._context),Me(t),null;case 17:return Oe(t.type)&&sa(),Me(t),null;case 19:if(ue(ge),o=t.memoizedState,o===null)return Me(t),null;if(n=(t.flags&128)!==0,s=o.rendering,s===null)if(n)kn(o,!1);else{if(Se!==0||e!==null&&(e.flags&128)!==0)for(e=t.child;e!==null;){if(s=va(e),s!==null){for(t.flags|=128,kn(o,!1),n=s.updateQueue,n!==null&&(t.updateQueue=n,t.flags|=4),t.subtreeFlags=0,n=i,i=t.child;i!==null;)o=i,e=n,o.flags&=14680066,s=o.alternate,s===null?(o.childLanes=0,o.lanes=e,o.child=null,o.subtreeFlags=0,o.memoizedProps=null,o.memoizedState=null,o.updateQueue=null,o.dependencies=null,o.stateNode=null):(o.childLanes=s.childLanes,o.lanes=s.lanes,o.child=s.child,o.subtreeFlags=0,o.deletions=null,o.memoizedProps=s.memoizedProps,o.memoizedState=s.memoizedState,o.updateQueue=s.updateQueue,o.type=s.type,e=s.dependencies,o.dependencies=e===null?null:{lanes:e.lanes,firstContext:e.firstContext}),i=i.sibling;return ce(ge,ge.current&1|2),t.child}e=e.sibling}o.tail!==null&&be()>Bi&&(t.flags|=128,n=!0,kn(o,!1),t.lanes=4194304)}else{if(!n)if(e=va(s),e!==null){if(t.flags|=128,n=!0,i=e.updateQueue,i!==null&&(t.updateQueue=i,t.flags|=4),kn(o,!0),o.tail===null&&o.tailMode==="hidden"&&!s.alternate&&!me)return Me(t),null}else 2*be()-o.renderingStartTime>Bi&&i!==1073741824&&(t.flags|=128,n=!0,kn(o,!1),t.lanes=4194304);o.isBackwards?(s.sibling=t.child,t.child=s):(i=o.last,i!==null?i.sibling=s:t.child=s,o.last=s)}return o.tail!==null?(t=o.tail,o.rendering=t,o.tail=t.sibling,o.renderingStartTime=be(),t.sibling=null,i=ge.current,ce(ge,n?i&1|2:i&1),t):(Me(t),null);case 22:case 23:return Br(),n=t.memoizedState!==null,e!==null&&e.memoizedState!==null!==n&&(t.flags|=8192),n&&(t.mode&1)!==0?(et&1073741824)!==0&&(Me(t),t.subtreeFlags&6&&(t.flags|=8192)):Me(t),null;case 24:return null;case 25:return null}throw Error(l(156,t.tag))}function up(e,t){switch(Uo(t),t.tag){case 1:return Oe(t.type)&&sa(),e=t.flags,e&65536?(t.flags=e&-65537|128,t):null;case 3:return zi(),ue(Ge),ue(Re),or(),e=t.flags,(e&65536)!==0&&(e&128)===0?(t.flags=e&-65537|128,t):null;case 5:return nr(t),null;case 13:if(ue(ge),e=t.memoizedState,e!==null&&e.dehydrated!==null){if(t.alternate===null)throw Error(l(340));Ei()}return e=t.flags,e&65536?(t.flags=e&-65537|128,t):null;case 19:return ue(ge),null;case 4:return zi(),null;case 10:return Yo(t.type._context),null;case 22:case 23:return Br(),null;case 24:return null;default:return null}}var Sa=!1,Be=!1,pp=typeof WeakSet=="function"?WeakSet:Set,W=null;function Ni(e,t){var i=e.ref;if(i!==null)if(typeof i=="function")try{i(null)}catch(n){we(e,t,n)}else i.current=null}function Tr(e,t,i){try{i()}catch(n){we(e,t,n)}}var Dc=!1;function hp(e,t){if(Bo=Kn,e=cl(),Eo(e)){if("selectionStart"in e)var i={start:e.selectionStart,end:e.selectionEnd};else e:{i=(i=e.ownerDocument)&&i.defaultView||window;var n=i.getSelection&&i.getSelection();if(n&&n.rangeCount!==0){i=n.anchorNode;var a=n.anchorOffset,o=n.focusNode;n=n.focusOffset;try{i.nodeType,o.nodeType}catch{i=null;break e}var s=0,d=-1,p=-1,I=0,A=0,D=e,P=null;t:for(;;){for(var M;D!==i||a!==0&&D.nodeType!==3||(d=s+a),D!==o||n!==0&&D.nodeType!==3||(p=s+n),D.nodeType===3&&(s+=D.nodeValue.length),(M=D.firstChild)!==null;)P=D,D=M;for(;;){if(D===e)break t;if(P===i&&++I===a&&(d=s),P===o&&++A===n&&(p=s),(M=D.nextSibling)!==null)break;D=P,P=D.parentNode}D=M}i=d===-1||p===-1?null:{start:d,end:p}}else i=null}i=i||{start:0,end:0}}else i=null;for(Wo={focusedElem:e,selectionRange:i},Kn=!1,W=t;W!==null;)if(t=W,e=t.child,(t.subtreeFlags&1028)!==0&&e!==null)e.return=t,W=e;else for(;W!==null;){t=W;try{var H=t.alternate;if((t.flags&1024)!==0)switch(t.tag){case 0:case 11:case 15:break;case 1:if(H!==null){var j=H.memoizedProps,ke=H.memoizedState,y=t.stateNode,f=y.getSnapshotBeforeUpdate(t.elementType===t.type?j:pt(t.type,j),ke);y.__reactInternalSnapshotBeforeUpdate=f}break;case 3:var x=t.stateNode.containerInfo;x.nodeType===1?x.textContent="":x.nodeType===9&&x.documentElement&&x.removeChild(x.documentElement);break;case 5:case 6:case 4:case 17:break;default:throw Error(l(163))}}catch(L){we(t,t.return,L)}if(e=t.sibling,e!==null){e.return=t.return,W=e;break}W=t.return}return H=Dc,Dc=!1,H}function Cn(e,t,i){var n=t.updateQueue;if(n=n!==null?n.lastEffect:null,n!==null){var a=n=n.next;do{if((a.tag&e)===e){var o=a.destroy;a.destroy=void 0,o!==void 0&&Tr(t,i,o)}a=a.next}while(a!==n)}}function Aa(e,t){if(t=t.updateQueue,t=t!==null?t.lastEffect:null,t!==null){var i=t=t.next;do{if((i.tag&e)===e){var n=i.create;i.destroy=n()}i=i.next}while(i!==t)}}function Pr(e){var t=e.ref;if(t!==null){var i=e.stateNode;switch(e.tag){case 5:e=i;break;default:e=i}typeof t=="function"?t(e):t.current=e}}function Lc(e){var t=e.alternate;t!==null&&(e.alternate=null,Lc(t)),e.child=null,e.deletions=null,e.sibling=null,e.tag===5&&(t=e.stateNode,t!==null&&(delete t[It],delete t[hn],delete t[Go],delete t[Qu],delete t[Ju])),e.stateNode=null,e.return=null,e.dependencies=null,e.memoizedProps=null,e.memoizedState=null,e.pendingProps=null,e.stateNode=null,e.updateQueue=null}function zc(e){return e.tag===5||e.tag===3||e.tag===4}function Rc(e){e:for(;;){for(;e.sibling===null;){if(e.return===null||zc(e.return))return null;e=e.return}for(e.sibling.return=e.return,e=e.sibling;e.tag!==5&&e.tag!==6&&e.tag!==18;){if(e.flags&2||e.child===null||e.tag===4)continue e;e.child.return=e,e=e.child}if(!(e.flags&2))return e.stateNode}}function Sr(e,t,i){var n=e.tag;if(n===5||n===6)e=e.stateNode,t?i.nodeType===8?i.parentNode.insertBefore(e,t):i.insertBefore(e,t):(i.nodeType===8?(t=i.parentNode,t.insertBefore(e,i)):(t=i,t.appendChild(e)),i=i._reactRootContainer,i!=null||t.onclick!==null||(t.onclick=oa));else if(n!==4&&(e=e.child,e!==null))for(Sr(e,t,i),e=e.sibling;e!==null;)Sr(e,t,i),e=e.sibling}function Ar(e,t,i){var n=e.tag;if(n===5||n===6)e=e.stateNode,t?i.insertBefore(e,t):i.appendChild(e);else if(n!==4&&(e=e.child,e!==null))for(Ar(e,t,i),e=e.sibling;e!==null;)Ar(e,t,i),e=e.sibling}var De=null,ht=!1;function Kt(e,t,i){for(i=i.child;i!==null;)Nc(e,t,i),i=i.sibling}function Nc(e,t,i){if(xt&&typeof xt.onCommitFiberUnmount=="function")try{xt.onCommitFiberUnmount(jn,i)}catch{}switch(i.tag){case 5:Be||Ni(i,t);case 6:var n=De,a=ht;De=null,Kt(e,t,i),De=n,ht=a,De!==null&&(ht?(e=De,i=i.stateNode,e.nodeType===8?e.parentNode.removeChild(i):e.removeChild(i)):De.removeChild(i.stateNode));break;case 18:De!==null&&(ht?(e=De,i=i.stateNode,e.nodeType===8?jo(e.parentNode,i):e.nodeType===1&&jo(e,i),tn(e)):jo(De,i.stateNode));break;case 4:n=De,a=ht,De=i.stateNode.containerInfo,ht=!0,Kt(e,t,i),De=n,ht=a;break;case 0:case 11:case 14:case 15:if(!Be&&(n=i.updateQueue,n!==null&&(n=n.lastEffect,n!==null))){a=n=n.next;do{var o=a,s=o.destroy;o=o.tag,s!==void 0&&((o&2)!==0||(o&4)!==0)&&Tr(i,t,s),a=a.next}while(a!==n)}Kt(e,t,i);break;case 1:if(!Be&&(Ni(i,t),n=i.stateNode,typeof n.componentWillUnmount=="function"))try{n.props=i.memoizedProps,n.state=i.memoizedState,n.componentWillUnmount()}catch(d){we(i,t,d)}Kt(e,t,i);break;case 21:Kt(e,t,i);break;case 22:i.mode&1?(Be=(n=Be)||i.memoizedState!==null,Kt(e,t,i),Be=n):Kt(e,t,i);break;default:Kt(e,t,i)}}function Mc(e){var t=e.updateQueue;if(t!==null){e.updateQueue=null;var i=e.stateNode;i===null&&(i=e.stateNode=new pp),t.forEach(function(n){var a=bp.bind(null,e,n);i.has(n)||(i.add(n),n.then(a,a))})}}function mt(e,t){var i=t.deletions;if(i!==null)for(var n=0;n<i.length;n++){var a=i[n];try{var o=e,s=t,d=s;e:for(;d!==null;){switch(d.tag){case 5:De=d.stateNode,ht=!1;break e;case 3:De=d.stateNode.containerInfo,ht=!0;break e;case 4:De=d.stateNode.containerInfo,ht=!0;break e}d=d.return}if(De===null)throw Error(l(160));Nc(o,s,a),De=null,ht=!1;var p=a.alternate;p!==null&&(p.return=null),a.return=null}catch(I){we(a,t,I)}}if(t.subtreeFlags&12854)for(t=t.child;t!==null;)Bc(t,e),t=t.sibling}function Bc(e,t){var i=e.alternate,n=e.flags;switch(e.tag){case 0:case 11:case 14:case 15:if(mt(t,e),kt(e),n&4){try{Cn(3,e,e.return),Aa(3,e)}catch(j){we(e,e.return,j)}try{Cn(5,e,e.return)}catch(j){we(e,e.return,j)}}break;case 1:mt(t,e),kt(e),n&512&&i!==null&&Ni(i,i.return);break;case 5:if(mt(t,e),kt(e),n&512&&i!==null&&Ni(i,i.return),e.flags&32){var a=e.stateNode;try{Vi(a,"")}catch(j){we(e,e.return,j)}}if(n&4&&(a=e.stateNode,a!=null)){var o=e.memoizedProps,s=i!==null?i.memoizedProps:o,d=e.type,p=e.updateQueue;if(e.updateQueue=null,p!==null)try{d==="input"&&o.type==="radio"&&o.name!=null&&us(a,o),ao(d,s);var I=ao(d,o);for(s=0;s<p.length;s+=2){var A=p[s],D=p[s+1];A==="style"?xs(a,D):A==="dangerouslySetInnerHTML"?ys(a,D):A==="children"?Vi(a,D):X(a,A,D,I)}switch(d){case"input":Za(a,o);break;case"textarea":ms(a,o);break;case"select":var P=a._wrapperState.wasMultiple;a._wrapperState.wasMultiple=!!o.multiple;var M=o.value;M!=null?mi(a,!!o.multiple,M,!1):P!==!!o.multiple&&(o.defaultValue!=null?mi(a,!!o.multiple,o.defaultValue,!0):mi(a,!!o.multiple,o.multiple?[]:"",!1))}a[hn]=o}catch(j){we(e,e.return,j)}}break;case 6:if(mt(t,e),kt(e),n&4){if(e.stateNode===null)throw Error(l(162));a=e.stateNode,o=e.memoizedProps;try{a.nodeValue=o}catch(j){we(e,e.return,j)}}break;case 3:if(mt(t,e),kt(e),n&4&&i!==null&&i.memoizedState.isDehydrated)try{tn(t.containerInfo)}catch(j){we(e,e.return,j)}break;case 4:mt(t,e),kt(e);break;case 13:mt(t,e),kt(e),a=e.child,a.flags&8192&&(o=a.memoizedState!==null,a.stateNode.isHidden=o,!o||a.alternate!==null&&a.alternate.memoizedState!==null||(Dr=be())),n&4&&Mc(e);break;case 22:if(A=i!==null&&i.memoizedState!==null,e.mode&1?(Be=(I=Be)||A,mt(t,e),Be=I):mt(t,e),kt(e),n&8192){if(I=e.memoizedState!==null,(e.stateNode.isHidden=I)&&!A&&(e.mode&1)!==0)for(W=e,A=e.child;A!==null;){for(D=W=A;W!==null;){switch(P=W,M=P.child,P.tag){case 0:case 11:case 14:case 15:Cn(4,P,P.return);break;case 1:Ni(P,P.return);var H=P.stateNode;if(typeof H.componentWillUnmount=="function"){n=P,i=P.return;try{t=n,H.props=t.memoizedProps,H.state=t.memoizedState,H.componentWillUnmount()}catch(j){we(n,i,j)}}break;case 5:Ni(P,P.return);break;case 22:if(P.memoizedState!==null){Hc(D);continue}}M!==null?(M.return=P,W=M):Hc(D)}A=A.sibling}e:for(A=null,D=e;;){if(D.tag===5){if(A===null){A=D;try{a=D.stateNode,I?(o=a.style,typeof o.setProperty=="function"?o.setProperty("display","none","important"):o.display="none"):(d=D.stateNode,p=D.memoizedProps.style,s=p!=null&&p.hasOwnProperty("display")?p.display:null,d.style.display=vs("display",s))}catch(j){we(e,e.return,j)}}}else if(D.tag===6){if(A===null)try{D.stateNode.nodeValue=I?"":D.memoizedProps}catch(j){we(e,e.return,j)}}else if((D.tag!==22&&D.tag!==23||D.memoizedState===null||D===e)&&D.child!==null){D.child.return=D,D=D.child;continue}if(D===e)break e;for(;D.sibling===null;){if(D.return===null||D.return===e)break e;A===D&&(A=null),D=D.return}A===D&&(A=null),D.sibling.return=D.return,D=D.sibling}}break;case 19:mt(t,e),kt(e),n&4&&Mc(e);break;case 21:break;default:mt(t,e),kt(e)}}function kt(e){var t=e.flags;if(t&2){try{e:{for(var i=e.return;i!==null;){if(zc(i)){var n=i;break e}i=i.return}throw Error(l(160))}switch(n.tag){case 5:var a=n.stateNode;n.flags&32&&(Vi(a,""),n.flags&=-33);var o=Rc(e);Ar(e,o,a);break;case 3:case 4:var s=n.stateNode.containerInfo,d=Rc(e);Sr(e,d,s);break;default:throw Error(l(161))}}catch(p){we(e,e.return,p)}e.flags&=-3}t&4096&&(e.flags&=-4097)}function mp(e,t,i){W=e,Wc(e)}function Wc(e,t,i){for(var n=(e.mode&1)!==0;W!==null;){var a=W,o=a.child;if(a.tag===22&&n){var s=a.memoizedState!==null||Sa;if(!s){var d=a.alternate,p=d!==null&&d.memoizedState!==null||Be;d=Sa;var I=Be;if(Sa=s,(Be=p)&&!I)for(W=a;W!==null;)s=W,p=s.child,s.tag===22&&s.memoizedState!==null?jc(a):p!==null?(p.return=s,W=p):jc(a);for(;o!==null;)W=o,Wc(o),o=o.sibling;W=a,Sa=d,Be=I}Fc(e)}else(a.subtreeFlags&8772)!==0&&o!==null?(o.return=a,W=o):Fc(e)}}function Fc(e){for(;W!==null;){var t=W;if((t.flags&8772)!==0){var i=t.alternate;try{if((t.flags&8772)!==0)switch(t.tag){case 0:case 11:case 15:Be||Aa(5,t);break;case 1:var n=t.stateNode;if(t.flags&4&&!Be)if(i===null)n.componentDidMount();else{var a=t.elementType===t.type?i.memoizedProps:pt(t.type,i.memoizedProps);n.componentDidUpdate(a,i.memoizedState,n.__reactInternalSnapshotBeforeUpdate)}var o=t.updateQueue;o!==null&&Hl(t,o,n);break;case 3:var s=t.updateQueue;if(s!==null){if(i=null,t.child!==null)switch(t.child.tag){case 5:i=t.child.stateNode;break;case 1:i=t.child.stateNode}Hl(t,s,i)}break;case 5:var d=t.stateNode;if(i===null&&t.flags&4){i=d;var p=t.memoizedProps;switch(t.type){case"button":case"input":case"select":case"textarea":p.autoFocus&&i.focus();break;case"img":p.src&&(i.src=p.src)}}break;case 6:break;case 4:break;case 12:break;case 13:if(t.memoizedState===null){var I=t.alternate;if(I!==null){var A=I.memoizedState;if(A!==null){var D=A.dehydrated;D!==null&&tn(D)}}}break;case 19:case 17:case 21:case 22:case 23:case 25:break;default:throw Error(l(163))}Be||t.flags&512&&Pr(t)}catch(P){we(t,t.return,P)}}if(t===e){W=null;break}if(i=t.sibling,i!==null){i.return=t.return,W=i;break}W=t.return}}function Hc(e){for(;W!==null;){var t=W;if(t===e){W=null;break}var i=t.sibling;if(i!==null){i.return=t.return,W=i;break}W=t.return}}function jc(e){for(;W!==null;){var t=W;try{switch(t.tag){case 0:case 11:case 15:var i=t.return;try{Aa(4,t)}catch(p){we(t,i,p)}break;case 1:var n=t.stateNode;if(typeof n.componentDidMount=="function"){var a=t.return;try{n.componentDidMount()}catch(p){we(t,a,p)}}var o=t.return;try{Pr(t)}catch(p){we(t,o,p)}break;case 5:var s=t.return;try{Pr(t)}catch(p){we(t,s,p)}}}catch(p){we(t,t.return,p)}if(t===e){W=null;break}var d=t.sibling;if(d!==null){d.return=t.return,W=d;break}W=t.return}}var fp=Math.ceil,Ea=oe.ReactCurrentDispatcher,Er=oe.ReactCurrentOwner,rt=oe.ReactCurrentBatchConfig,te=0,Ee=null,Ce=null,Le=0,et=0,Mi=Gt(0),Se=0,Tn=null,ci=0,qa=0,qr=0,Pn=null,_e=null,Dr=0,Bi=1/0,Lt=null,Da=!1,Lr=null,$t=null,La=!1,Qt=null,za=0,Sn=0,zr=null,Ra=-1,Na=0;function He(){return(te&6)!==0?be():Ra!==-1?Ra:Ra=be()}function Jt(e){return(e.mode&1)===0?1:(te&2)!==0&&Le!==0?Le&-Le:Yu.transition!==null?(Na===0&&(Na=Rs()),Na):(e=se,e!==0||(e=window.event,e=e===void 0?16:Os(e.type)),e)}function ft(e,t,i,n){if(50<Sn)throw Sn=0,zr=null,Error(l(185));Ji(e,i,n),((te&2)===0||e!==Ee)&&(e===Ee&&((te&2)===0&&(qa|=i),Se===4&&Xt(e,Le)),Ue(e,n),i===1&&te===0&&(t.mode&1)===0&&(Bi=be()+500,ca&&Vt()))}function Ue(e,t){var i=e.callbackNode;Yd(e,t);var n=Vn(e,e===Ee?Le:0);if(n===0)i!==null&&Ds(i),e.callbackNode=null,e.callbackPriority=0;else if(t=n&-n,e.callbackPriority!==t){if(i!=null&&Ds(i),t===1)e.tag===0?Xu(Oc.bind(null,e)):Al(Oc.bind(null,e)),Ku(function(){(te&6)===0&&Vt()}),i=null;else{switch(Ns(n)){case 1:i=po;break;case 4:i=Ls;break;case 16:i=Hn;break;case 536870912:i=zs;break;default:i=Hn}i=Xc(i,Gc.bind(null,e))}e.callbackPriority=t,e.callbackNode=i}}function Gc(e,t){if(Ra=-1,Na=0,(te&6)!==0)throw Error(l(327));var i=e.callbackNode;if(Wi()&&e.callbackNode!==i)return null;var n=Vn(e,e===Ee?Le:0);if(n===0)return null;if((n&30)!==0||(n&e.expiredLanes)!==0||t)t=Ma(e,n);else{t=n;var a=te;te|=2;var o=_c();(Ee!==e||Le!==t)&&(Lt=null,Bi=be()+500,ui(e,t));do try{vp();break}catch(d){Vc(e,d)}while(!0);Xo(),Ea.current=o,te=a,Ce!==null?t=0:(Ee=null,Le=0,t=Se)}if(t!==0){if(t===2&&(a=ho(e),a!==0&&(n=a,t=Rr(e,a))),t===1)throw i=Tn,ui(e,0),Xt(e,n),Ue(e,be()),i;if(t===6)Xt(e,n);else{if(a=e.current.alternate,(n&30)===0&&!gp(a)&&(t=Ma(e,n),t===2&&(o=ho(e),o!==0&&(n=o,t=Rr(e,o))),t===1))throw i=Tn,ui(e,0),Xt(e,n),Ue(e,be()),i;switch(e.finishedWork=a,e.finishedLanes=n,t){case 0:case 1:throw Error(l(345));case 2:pi(e,_e,Lt);break;case 3:if(Xt(e,n),(n&130023424)===n&&(t=Dr+500-be(),10<t)){if(Vn(e,0)!==0)break;if(a=e.suspendedLanes,(a&n)!==n){He(),e.pingedLanes|=e.suspendedLanes&a;break}e.timeoutHandle=Ho(pi.bind(null,e,_e,Lt),t);break}pi(e,_e,Lt);break;case 4:if(Xt(e,n),(n&4194240)===n)break;for(t=e.eventTimes,a=-1;0<n;){var s=31-ct(n);o=1<<s,s=t[s],s>a&&(a=s),n&=~o}if(n=a,n=be()-n,n=(120>n?120:480>n?480:1080>n?1080:1920>n?1920:3e3>n?3e3:4320>n?4320:1960*fp(n/1960))-n,10<n){e.timeoutHandle=Ho(pi.bind(null,e,_e,Lt),n);break}pi(e,_e,Lt);break;case 5:pi(e,_e,Lt);break;default:throw Error(l(329))}}}return Ue(e,be()),e.callbackNode===i?Gc.bind(null,e):null}function Rr(e,t){var i=Pn;return e.current.memoizedState.isDehydrated&&(ui(e,t).flags|=256),e=Ma(e,t),e!==2&&(t=_e,_e=i,t!==null&&Nr(t)),e}function Nr(e){_e===null?_e=e:_e.push.apply(_e,e)}function gp(e){for(var t=e;;){if(t.flags&16384){var i=t.updateQueue;if(i!==null&&(i=i.stores,i!==null))for(var n=0;n<i.length;n++){var a=i[n],o=a.getSnapshot;a=a.value;try{if(!dt(o(),a))return!1}catch{return!1}}}if(i=t.child,t.subtreeFlags&16384&&i!==null)i.return=t,t=i;else{if(t===e)break;for(;t.sibling===null;){if(t.return===null||t.return===e)return!0;t=t.return}t.sibling.return=t.return,t=t.sibling}}return!0}function Xt(e,t){for(t&=~qr,t&=~qa,e.suspendedLanes|=t,e.pingedLanes&=~t,e=e.expirationTimes;0<t;){var i=31-ct(t),n=1<<i;e[i]=-1,t&=~n}}function Oc(e){if((te&6)!==0)throw Error(l(327));Wi();var t=Vn(e,0);if((t&1)===0)return Ue(e,be()),null;var i=Ma(e,t);if(e.tag!==0&&i===2){var n=ho(e);n!==0&&(t=n,i=Rr(e,n))}if(i===1)throw i=Tn,ui(e,0),Xt(e,t),Ue(e,be()),i;if(i===6)throw Error(l(345));return e.finishedWork=e.current.alternate,e.finishedLanes=t,pi(e,_e,Lt),Ue(e,be()),null}function Mr(e,t){var i=te;te|=1;try{return e(t)}finally{te=i,te===0&&(Bi=be()+500,ca&&Vt())}}function di(e){Qt!==null&&Qt.tag===0&&(te&6)===0&&Wi();var t=te;te|=1;var i=rt.transition,n=se;try{if(rt.transition=null,se=1,e)return e()}finally{se=n,rt.transition=i,te=t,(te&6)===0&&Vt()}}function Br(){et=Mi.current,ue(Mi)}function ui(e,t){e.finishedWork=null,e.finishedLanes=0;var i=e.timeoutHandle;if(i!==-1&&(e.timeoutHandle=-1,Uu(i)),Ce!==null)for(i=Ce.return;i!==null;){var n=i;switch(Uo(n),n.tag){case 1:n=n.type.childContextTypes,n!=null&&sa();break;case 3:zi(),ue(Ge),ue(Re),or();break;case 5:nr(n);break;case 4:zi();break;case 13:ue(ge);break;case 19:ue(ge);break;case 10:Yo(n.type._context);break;case 22:case 23:Br()}i=i.return}if(Ee=e,Ce=e=Yt(e.current,null),Le=et=t,Se=0,Tn=null,qr=qa=ci=0,_e=Pn=null,ri!==null){for(t=0;t<ri.length;t++)if(i=ri[t],n=i.interleaved,n!==null){i.interleaved=null;var a=n.next,o=i.pending;if(o!==null){var s=o.next;o.next=a,n.next=s}i.pending=n}ri=null}return e}function Vc(e,t){do{var i=Ce;try{if(Xo(),xa.current=ka,Ia){for(var n=ye.memoizedState;n!==null;){var a=n.queue;a!==null&&(a.pending=null),n=n.next}Ia=!1}if(li=0,Ae=Pe=ye=null,xn=!1,In=0,Er.current=null,i===null||i.return===null){Se=1,Tn=t,Ce=null;break}e:{var o=e,s=i.return,d=i,p=t;if(t=Le,d.flags|=32768,p!==null&&typeof p=="object"&&typeof p.then=="function"){var I=p,A=d,D=A.tag;if((A.mode&1)===0&&(D===0||D===11||D===15)){var P=A.alternate;P?(A.updateQueue=P.updateQueue,A.memoizedState=P.memoizedState,A.lanes=P.lanes):(A.updateQueue=null,A.memoizedState=null)}var M=fc(s);if(M!==null){M.flags&=-257,gc(M,s,d,o,t),M.mode&1&&mc(o,I,t),t=M,p=I;var H=t.updateQueue;if(H===null){var j=new Set;j.add(p),t.updateQueue=j}else H.add(p);break e}else{if((t&1)===0){mc(o,I,t),Wr();break e}p=Error(l(426))}}else if(me&&d.mode&1){var ke=fc(s);if(ke!==null){(ke.flags&65536)===0&&(ke.flags|=256),gc(ke,s,d,o,t),Qo(Ri(p,d));break e}}o=p=Ri(p,d),Se!==4&&(Se=2),Pn===null?Pn=[o]:Pn.push(o),o=s;do{switch(o.tag){case 3:o.flags|=65536,t&=-t,o.lanes|=t;var y=pc(o,p,t);Fl(o,y);break e;case 1:d=p;var f=o.type,x=o.stateNode;if((o.flags&128)===0&&(typeof f.getDerivedStateFromError=="function"||x!==null&&typeof x.componentDidCatch=="function"&&($t===null||!$t.has(x)))){o.flags|=65536,t&=-t,o.lanes|=t;var L=hc(o,d,t);Fl(o,L);break e}}o=o.return}while(o!==null)}Kc(i)}catch(O){t=O,Ce===i&&i!==null&&(Ce=i=i.return);continue}break}while(!0)}function _c(){var e=Ea.current;return Ea.current=ka,e===null?ka:e}function Wr(){(Se===0||Se===3||Se===2)&&(Se=4),Ee===null||(ci&268435455)===0&&(qa&268435455)===0||Xt(Ee,Le)}function Ma(e,t){var i=te;te|=2;var n=_c();(Ee!==e||Le!==t)&&(Lt=null,ui(e,t));do try{yp();break}catch(a){Vc(e,a)}while(!0);if(Xo(),te=i,Ea.current=n,Ce!==null)throw Error(l(261));return Ee=null,Le=0,Se}function yp(){for(;Ce!==null;)Uc(Ce)}function vp(){for(;Ce!==null&&!Od();)Uc(Ce)}function Uc(e){var t=Jc(e.alternate,e,et);e.memoizedProps=e.pendingProps,t===null?Kc(e):Ce=t,Er.current=null}function Kc(e){var t=e;do{var i=t.alternate;if(e=t.return,(t.flags&32768)===0){if(i=dp(i,t,et),i!==null){Ce=i;return}}else{if(i=up(i,t),i!==null){i.flags&=32767,Ce=i;return}if(e!==null)e.flags|=32768,e.subtreeFlags=0,e.deletions=null;else{Se=6,Ce=null;return}}if(t=t.sibling,t!==null){Ce=t;return}Ce=t=e}while(t!==null);Se===0&&(Se=5)}function pi(e,t,i){var n=se,a=rt.transition;try{rt.transition=null,se=1,xp(e,t,i,n)}finally{rt.transition=a,se=n}return null}function xp(e,t,i,n){do Wi();while(Qt!==null);if((te&6)!==0)throw Error(l(327));i=e.finishedWork;var a=e.finishedLanes;if(i===null)return null;if(e.finishedWork=null,e.finishedLanes=0,i===e.current)throw Error(l(177));e.callbackNode=null,e.callbackPriority=0;var o=i.lanes|i.childLanes;if(Zd(e,o),e===Ee&&(Ce=Ee=null,Le=0),(i.subtreeFlags&2064)===0&&(i.flags&2064)===0||La||(La=!0,Xc(Hn,function(){return Wi(),null})),o=(i.flags&15990)!==0,(i.subtreeFlags&15990)!==0||o){o=rt.transition,rt.transition=null;var s=se;se=1;var d=te;te|=4,Er.current=null,hp(e,i),Bc(i,e),Fu(Wo),Kn=!!Bo,Wo=Bo=null,e.current=i,mp(i),Vd(),te=d,se=s,rt.transition=o}else e.current=i;if(La&&(La=!1,Qt=e,za=a),o=e.pendingLanes,o===0&&($t=null),Kd(i.stateNode),Ue(e,be()),t!==null)for(n=e.onRecoverableError,i=0;i<t.length;i++)a=t[i],n(a.value,{componentStack:a.stack,digest:a.digest});if(Da)throw Da=!1,e=Lr,Lr=null,e;return(za&1)!==0&&e.tag!==0&&Wi(),o=e.pendingLanes,(o&1)!==0?e===zr?Sn++:(Sn=0,zr=e):Sn=0,Vt(),null}function Wi(){if(Qt!==null){var e=Ns(za),t=rt.transition,i=se;try{if(rt.transition=null,se=16>e?16:e,Qt===null)var n=!1;else{if(e=Qt,Qt=null,za=0,(te&6)!==0)throw Error(l(331));var a=te;for(te|=4,W=e.current;W!==null;){var o=W,s=o.child;if((W.flags&16)!==0){var d=o.deletions;if(d!==null){for(var p=0;p<d.length;p++){var I=d[p];for(W=I;W!==null;){var A=W;switch(A.tag){case 0:case 11:case 15:Cn(8,A,o)}var D=A.child;if(D!==null)D.return=A,W=D;else for(;W!==null;){A=W;var P=A.sibling,M=A.return;if(Lc(A),A===I){W=null;break}if(P!==null){P.return=M,W=P;break}W=M}}}var H=o.alternate;if(H!==null){var j=H.child;if(j!==null){H.child=null;do{var ke=j.sibling;j.sibling=null,j=ke}while(j!==null)}}W=o}}if((o.subtreeFlags&2064)!==0&&s!==null)s.return=o,W=s;else e:for(;W!==null;){if(o=W,(o.flags&2048)!==0)switch(o.tag){case 0:case 11:case 15:Cn(9,o,o.return)}var y=o.sibling;if(y!==null){y.return=o.return,W=y;break e}W=o.return}}var f=e.current;for(W=f;W!==null;){s=W;var x=s.child;if((s.subtreeFlags&2064)!==0&&x!==null)x.return=s,W=x;else e:for(s=f;W!==null;){if(d=W,(d.flags&2048)!==0)try{switch(d.tag){case 0:case 11:case 15:Aa(9,d)}}catch(O){we(d,d.return,O)}if(d===s){W=null;break e}var L=d.sibling;if(L!==null){L.return=d.return,W=L;break e}W=d.return}}if(te=a,Vt(),xt&&typeof xt.onPostCommitFiberRoot=="function")try{xt.onPostCommitFiberRoot(jn,e)}catch{}n=!0}return n}finally{se=i,rt.transition=t}}return!1}function $c(e,t,i){t=Ri(i,t),t=pc(e,t,1),e=Ut(e,t,1),t=He(),e!==null&&(Ji(e,1,t),Ue(e,t))}function we(e,t,i){if(e.tag===3)$c(e,e,i);else for(;t!==null;){if(t.tag===3){$c(t,e,i);break}else if(t.tag===1){var n=t.stateNode;if(typeof t.type.getDerivedStateFromError=="function"||typeof n.componentDidCatch=="function"&&($t===null||!$t.has(n))){e=Ri(i,e),e=hc(t,e,1),t=Ut(t,e,1),e=He(),t!==null&&(Ji(t,1,e),Ue(t,e));break}}t=t.return}}function Ip(e,t,i){var n=e.pingCache;n!==null&&n.delete(t),t=He(),e.pingedLanes|=e.suspendedLanes&i,Ee===e&&(Le&i)===i&&(Se===4||Se===3&&(Le&130023424)===Le&&500>be()-Dr?ui(e,0):qr|=i),Ue(e,t)}function Qc(e,t){t===0&&((e.mode&1)===0?t=1:(t=On,On<<=1,(On&130023424)===0&&(On=4194304)));var i=He();e=Et(e,t),e!==null&&(Ji(e,t,i),Ue(e,i))}function wp(e){var t=e.memoizedState,i=0;t!==null&&(i=t.retryLane),Qc(e,i)}function bp(e,t){var i=0;switch(e.tag){case 13:var n=e.stateNode,a=e.memoizedState;a!==null&&(i=a.retryLane);break;case 19:n=e.stateNode;break;default:throw Error(l(314))}n!==null&&n.delete(t),Qc(e,i)}var Jc;Jc=function(e,t,i){if(e!==null)if(e.memoizedProps!==t.pendingProps||Ge.current)Ve=!0;else{if((e.lanes&i)===0&&(t.flags&128)===0)return Ve=!1,cp(e,t,i);Ve=(e.flags&131072)!==0}else Ve=!1,me&&(t.flags&1048576)!==0&&El(t,ua,t.index);switch(t.lanes=0,t.tag){case 2:var n=t.type;Pa(e,t),e=t.pendingProps;var a=Pi(t,Re.current);Li(t,i),a=lr(null,t,n,e,a,i);var o=cr();return t.flags|=1,typeof a=="object"&&a!==null&&typeof a.render=="function"&&a.$$typeof===void 0?(t.tag=1,t.memoizedState=null,t.updateQueue=null,Oe(n)?(o=!0,la(t)):o=!1,t.memoizedState=a.state!==null&&a.state!==void 0?a.state:null,tr(t),a.updater=Ca,t.stateNode=a,a._reactInternals=t,fr(t,n,e,i),t=xr(null,t,n,!0,o,i)):(t.tag=0,me&&o&&_o(t),Fe(null,t,a,i),t=t.child),t;case 16:n=t.elementType;e:{switch(Pa(e,t),e=t.pendingProps,a=n._init,n=a(n._payload),t.type=n,a=t.tag=Cp(n),e=pt(n,e),a){case 0:t=vr(null,t,n,e,i);break e;case 1:t=bc(null,t,n,e,i);break e;case 11:t=yc(null,t,n,e,i);break e;case 14:t=vc(null,t,n,pt(n.type,e),i);break e}throw Error(l(306,n,""))}return t;case 0:return n=t.type,a=t.pendingProps,a=t.elementType===n?a:pt(n,a),vr(e,t,n,a,i);case 1:return n=t.type,a=t.pendingProps,a=t.elementType===n?a:pt(n,a),bc(e,t,n,a,i);case 3:e:{if(kc(t),e===null)throw Error(l(387));n=t.pendingProps,o=t.memoizedState,a=o.element,Wl(e,t),ya(t,n,null,i);var s=t.memoizedState;if(n=s.element,o.isDehydrated)if(o={element:n,isDehydrated:!1,cache:s.cache,pendingSuspenseBoundaries:s.pendingSuspenseBoundaries,transitions:s.transitions},t.updateQueue.baseState=o,t.memoizedState=o,t.flags&256){a=Ri(Error(l(423)),t),t=Cc(e,t,n,i,a);break e}else if(n!==a){a=Ri(Error(l(424)),t),t=Cc(e,t,n,i,a);break e}else for(Ze=jt(t.stateNode.containerInfo.firstChild),Ye=t,me=!0,ut=null,i=Ml(t,null,n,i),t.child=i;i;)i.flags=i.flags&-3|4096,i=i.sibling;else{if(Ei(),n===a){t=Dt(e,t,i);break e}Fe(e,t,n,i)}t=t.child}return t;case 5:return jl(t),e===null&&$o(t),n=t.type,a=t.pendingProps,o=e!==null?e.memoizedProps:null,s=a.children,Fo(n,a)?s=null:o!==null&&Fo(n,o)&&(t.flags|=32),wc(e,t),Fe(e,t,s,i),t.child;case 6:return e===null&&$o(t),null;case 13:return Tc(e,t,i);case 4:return ir(t,t.stateNode.containerInfo),n=t.pendingProps,e===null?t.child=qi(t,null,n,i):Fe(e,t,n,i),t.child;case 11:return n=t.type,a=t.pendingProps,a=t.elementType===n?a:pt(n,a),yc(e,t,n,a,i);case 7:return Fe(e,t,t.pendingProps,i),t.child;case 8:return Fe(e,t,t.pendingProps.children,i),t.child;case 12:return Fe(e,t,t.pendingProps.children,i),t.child;case 10:e:{if(n=t.type._context,a=t.pendingProps,o=t.memoizedProps,s=a.value,ce(ma,n._currentValue),n._currentValue=s,o!==null)if(dt(o.value,s)){if(o.children===a.children&&!Ge.current){t=Dt(e,t,i);break e}}else for(o=t.child,o!==null&&(o.return=t);o!==null;){var d=o.dependencies;if(d!==null){s=o.child;for(var p=d.firstContext;p!==null;){if(p.context===n){if(o.tag===1){p=qt(-1,i&-i),p.tag=2;var I=o.updateQueue;if(I!==null){I=I.shared;var A=I.pending;A===null?p.next=p:(p.next=A.next,A.next=p),I.pending=p}}o.lanes|=i,p=o.alternate,p!==null&&(p.lanes|=i),Zo(o.return,i,t),d.lanes|=i;break}p=p.next}}else if(o.tag===10)s=o.type===t.type?null:o.child;else if(o.tag===18){if(s=o.return,s===null)throw Error(l(341));s.lanes|=i,d=s.alternate,d!==null&&(d.lanes|=i),Zo(s,i,t),s=o.sibling}else s=o.child;if(s!==null)s.return=o;else for(s=o;s!==null;){if(s===t){s=null;break}if(o=s.sibling,o!==null){o.return=s.return,s=o;break}s=s.return}o=s}Fe(e,t,a.children,i),t=t.child}return t;case 9:return a=t.type,n=t.pendingProps.children,Li(t,i),a=at(a),n=n(a),t.flags|=1,Fe(e,t,n,i),t.child;case 14:return n=t.type,a=pt(n,t.pendingProps),a=pt(n.type,a),vc(e,t,n,a,i);case 15:return xc(e,t,t.type,t.pendingProps,i);case 17:return n=t.type,a=t.pendingProps,a=t.elementType===n?a:pt(n,a),Pa(e,t),t.tag=1,Oe(n)?(e=!0,la(t)):e=!1,Li(t,i),dc(t,n,a),fr(t,n,a,i),xr(null,t,n,!0,e,i);case 19:return Sc(e,t,i);case 22:return Ic(e,t,i)}throw Error(l(156,t.tag))};function Xc(e,t){return qs(e,t)}function kp(e,t,i,n){this.tag=e,this.key=i,this.sibling=this.child=this.return=this.stateNode=this.type=this.elementType=null,this.index=0,this.ref=null,this.pendingProps=t,this.dependencies=this.memoizedState=this.updateQueue=this.memoizedProps=null,this.mode=n,this.subtreeFlags=this.flags=0,this.deletions=null,this.childLanes=this.lanes=0,this.alternate=null}function st(e,t,i,n){return new kp(e,t,i,n)}function Fr(e){return e=e.prototype,!(!e||!e.isReactComponent)}function Cp(e){if(typeof e=="function")return Fr(e)?1:0;if(e!=null){if(e=e.$$typeof,e===$e)return 11;if(e===vt)return 14}return 2}function Yt(e,t){var i=e.alternate;return i===null?(i=st(e.tag,t,e.key,e.mode),i.elementType=e.elementType,i.type=e.type,i.stateNode=e.stateNode,i.alternate=e,e.alternate=i):(i.pendingProps=t,i.type=e.type,i.flags=0,i.subtreeFlags=0,i.deletions=null),i.flags=e.flags&14680064,i.childLanes=e.childLanes,i.lanes=e.lanes,i.child=e.child,i.memoizedProps=e.memoizedProps,i.memoizedState=e.memoizedState,i.updateQueue=e.updateQueue,t=e.dependencies,i.dependencies=t===null?null:{lanes:t.lanes,firstContext:t.firstContext},i.sibling=e.sibling,i.index=e.index,i.ref=e.ref,i}function Ba(e,t,i,n,a,o){var s=2;if(n=e,typeof e=="function")Fr(e)&&(s=1);else if(typeof e=="string")s=5;else e:switch(e){case fe:return hi(i.children,a,o,t);case ze:s=8,a|=8;break;case We:return e=st(12,i,t,a|2),e.elementType=We,e.lanes=o,e;case Qe:return e=st(13,i,t,a),e.elementType=Qe,e.lanes=o,e;case lt:return e=st(19,i,t,a),e.elementType=lt,e.lanes=o,e;case Ie:return Wa(i,a,o,t);default:if(typeof e=="object"&&e!==null)switch(e.$$typeof){case Te:s=10;break e;case tt:s=9;break e;case $e:s=11;break e;case vt:s=14;break e;case je:s=16,n=null;break e}throw Error(l(130,e==null?e:typeof e,""))}return t=st(s,i,t,a),t.elementType=e,t.type=n,t.lanes=o,t}function hi(e,t,i,n){return e=st(7,e,n,t),e.lanes=i,e}function Wa(e,t,i,n){return e=st(22,e,n,t),e.elementType=Ie,e.lanes=i,e.stateNode={isHidden:!1},e}function Hr(e,t,i){return e=st(6,e,null,t),e.lanes=i,e}function jr(e,t,i){return t=st(4,e.children!==null?e.children:[],e.key,t),t.lanes=i,t.stateNode={containerInfo:e.containerInfo,pendingChildren:null,implementation:e.implementation},t}function Tp(e,t,i,n,a){this.tag=t,this.containerInfo=e,this.finishedWork=this.pingCache=this.current=this.pendingChildren=null,this.timeoutHandle=-1,this.callbackNode=this.pendingContext=this.context=null,this.callbackPriority=0,this.eventTimes=mo(0),this.expirationTimes=mo(-1),this.entangledLanes=this.finishedLanes=this.mutableReadLanes=this.expiredLanes=this.pingedLanes=this.suspendedLanes=this.pendingLanes=0,this.entanglements=mo(0),this.identifierPrefix=n,this.onRecoverableError=a,this.mutableSourceEagerHydrationData=null}function Gr(e,t,i,n,a,o,s,d,p){return e=new Tp(e,t,i,d,p),t===1?(t=1,o===!0&&(t|=8)):t=0,o=st(3,null,null,t),e.current=o,o.stateNode=e,o.memoizedState={element:n,isDehydrated:i,cache:null,transitions:null,pendingSuspenseBoundaries:null},tr(o),e}function Pp(e,t,i){var n=3<arguments.length&&arguments[3]!==void 0?arguments[3]:null;return{$$typeof:xe,key:n==null?null:""+n,children:e,containerInfo:t,implementation:i}}function Yc(e){if(!e)return Ot;e=e._reactInternals;e:{if(ti(e)!==e||e.tag!==1)throw Error(l(170));var t=e;do{switch(t.tag){case 3:t=t.stateNode.context;break e;case 1:if(Oe(t.type)){t=t.stateNode.__reactInternalMemoizedMergedChildContext;break e}}t=t.return}while(t!==null);throw Error(l(171))}if(e.tag===1){var i=e.type;if(Oe(i))return Pl(e,i,t)}return t}function Zc(e,t,i,n,a,o,s,d,p){return e=Gr(i,n,!0,e,a,o,s,d,p),e.context=Yc(null),i=e.current,n=He(),a=Jt(i),o=qt(n,a),o.callback=t??null,Ut(i,o,a),e.current.lanes=a,Ji(e,a,n),Ue(e,n),e}function Fa(e,t,i,n){var a=t.current,o=He(),s=Jt(a);return i=Yc(i),t.context===null?t.context=i:t.pendingContext=i,t=qt(o,s),t.payload={element:e},n=n===void 0?null:n,n!==null&&(t.callback=n),e=Ut(a,t,s),e!==null&&(ft(e,a,s,o),ga(e,a,s)),s}function Ha(e){if(e=e.current,!e.child)return null;switch(e.child.tag){case 5:return e.child.stateNode;default:return e.child.stateNode}}function ed(e,t){if(e=e.memoizedState,e!==null&&e.dehydrated!==null){var i=e.retryLane;e.retryLane=i!==0&&i<t?i:t}}function Or(e,t){ed(e,t),(e=e.alternate)&&ed(e,t)}function Sp(){return null}var td=typeof reportError=="function"?reportError:function(e){console.error(e)};function Vr(e){this._internalRoot=e}ja.prototype.render=Vr.prototype.render=function(e){var t=this._internalRoot;if(t===null)throw Error(l(409));Fa(e,t,null,null)},ja.prototype.unmount=Vr.prototype.unmount=function(){var e=this._internalRoot;if(e!==null){this._internalRoot=null;var t=e.containerInfo;di(function(){Fa(null,e,null,null)}),t[Tt]=null}};function ja(e){this._internalRoot=e}ja.prototype.unstable_scheduleHydration=function(e){if(e){var t=Ws();e={blockedOn:null,target:e,priority:t};for(var i=0;i<Wt.length&&t!==0&&t<Wt[i].priority;i++);Wt.splice(i,0,e),i===0&&js(e)}};function _r(e){return!(!e||e.nodeType!==1&&e.nodeType!==9&&e.nodeType!==11)}function Ga(e){return!(!e||e.nodeType!==1&&e.nodeType!==9&&e.nodeType!==11&&(e.nodeType!==8||e.nodeValue!==" react-mount-point-unstable "))}function id(){}function Ap(e,t,i,n,a){if(a){if(typeof n=="function"){var o=n;n=function(){var I=Ha(s);o.call(I)}}var s=Zc(t,n,e,0,null,!1,!1,"",id);return e._reactRootContainer=s,e[Tt]=s.current,un(e.nodeType===8?e.parentNode:e),di(),s}for(;a=e.lastChild;)e.removeChild(a);if(typeof n=="function"){var d=n;n=function(){var I=Ha(p);d.call(I)}}var p=Gr(e,0,!1,null,null,!1,!1,"",id);return e._reactRootContainer=p,e[Tt]=p.current,un(e.nodeType===8?e.parentNode:e),di(function(){Fa(t,p,i,n)}),p}function Oa(e,t,i,n,a){var o=i._reactRootContainer;if(o){var s=o;if(typeof a=="function"){var d=a;a=function(){var p=Ha(s);d.call(p)}}Fa(t,s,e,a)}else s=Ap(i,t,e,a,n);return Ha(s)}Ms=function(e){switch(e.tag){case 3:var t=e.stateNode;if(t.current.memoizedState.isDehydrated){var i=Qi(t.pendingLanes);i!==0&&(fo(t,i|1),Ue(t,be()),(te&6)===0&&(Bi=be()+500,Vt()))}break;case 13:di(function(){var n=Et(e,1);if(n!==null){var a=He();ft(n,e,1,a)}}),Or(e,1)}},go=function(e){if(e.tag===13){var t=Et(e,134217728);if(t!==null){var i=He();ft(t,e,134217728,i)}Or(e,134217728)}},Bs=function(e){if(e.tag===13){var t=Jt(e),i=Et(e,t);if(i!==null){var n=He();ft(i,e,t,n)}Or(e,t)}},Ws=function(){return se},Fs=function(e,t){var i=se;try{return se=e,t()}finally{se=i}},so=function(e,t,i){switch(t){case"input":if(Za(e,i),t=i.name,i.type==="radio"&&t!=null){for(i=e;i.parentNode;)i=i.parentNode;for(i=i.querySelectorAll("input[name="+JSON.stringify(""+t)+'][type="radio"]'),t=0;t<i.length;t++){var n=i[t];if(n!==e&&n.form===e.form){var a=ra(n);if(!a)throw Error(l(90));cs(n),Za(n,a)}}}break;case"textarea":ms(e,i);break;case"select":t=i.value,t!=null&&mi(e,!!i.multiple,t,!1)}},ks=Mr,Cs=di;var Ep={usingClientEntryPoint:!1,Events:[mn,Ci,ra,ws,bs,Mr]},An={findFiberByHostInstance:ii,bundleType:0,version:"18.3.1",rendererPackageName:"react-dom"},qp={bundleType:An.bundleType,version:An.version,rendererPackageName:An.rendererPackageName,rendererConfig:An.rendererConfig,overrideHookState:null,overrideHookStateDeletePath:null,overrideHookStateRenamePath:null,overrideProps:null,overridePropsDeletePath:null,overridePropsRenamePath:null,setErrorHandler:null,setSuspenseHandler:null,scheduleUpdate:null,currentDispatcherRef:oe.ReactCurrentDispatcher,findHostInstanceByFiber:function(e){return e=As(e),e===null?null:e.stateNode},findFiberByHostInstance:An.findFiberByHostInstance||Sp,findHostInstancesForRefresh:null,scheduleRefresh:null,scheduleRoot:null,setRefreshHandler:null,getCurrentFiber:null,reconcilerVersion:"18.3.1-next-f1338f8080-20240426"};if(typeof __REACT_DEVTOOLS_GLOBAL_HOOK__<"u"){var Va=__REACT_DEVTOOLS_GLOBAL_HOOK__;if(!Va.isDisabled&&Va.supportsFiber)try{jn=Va.inject(qp),xt=Va}catch{}}return Ke.__SECRET_INTERNALS_DO_NOT_USE_OR_YOU_WILL_BE_FIRED=Ep,Ke.createPortal=function(e,t){var i=2<arguments.length&&arguments[2]!==void 0?arguments[2]:null;if(!_r(t))throw Error(l(200));return Pp(e,t,null,i)},Ke.createRoot=function(e,t){if(!_r(e))throw Error(l(299));var i=!1,n="",a=td;return t!=null&&(t.unstable_strictMode===!0&&(i=!0),t.identifierPrefix!==void 0&&(n=t.identifierPrefix),t.onRecoverableError!==void 0&&(a=t.onRecoverableError)),t=Gr(e,1,!1,null,null,i,!1,n,a),e[Tt]=t.current,un(e.nodeType===8?e.parentNode:e),new Vr(t)},Ke.findDOMNode=function(e){if(e==null)return null;if(e.nodeType===1)return e;var t=e._reactInternals;if(t===void 0)throw typeof e.render=="function"?Error(l(188)):(e=Object.keys(e).join(","),Error(l(268,e)));return e=As(t),e=e===null?null:e.stateNode,e},Ke.flushSync=function(e){return di(e)},Ke.hydrate=function(e,t,i){if(!Ga(t))throw Error(l(200));return Oa(null,e,t,!0,i)},Ke.hydrateRoot=function(e,t,i){if(!_r(e))throw Error(l(405));var n=i!=null&&i.hydratedSources||null,a=!1,o="",s=td;if(i!=null&&(i.unstable_strictMode===!0&&(a=!0),i.identifierPrefix!==void 0&&(o=i.identifierPrefix),i.onRecoverableError!==void 0&&(s=i.onRecoverableError)),t=Zc(t,null,e,1,i??null,a,!1,o,s),e[Tt]=t.current,un(e),n)for(e=0;e<n.length;e++)i=n[e],a=i._getVersion,a=a(i._source),t.mutableSourceEagerHydrationData==null?t.mutableSourceEagerHydrationData=[i,a]:t.mutableSourceEagerHydrationData.push(i,a);return new ja(t)},Ke.render=function(e,t,i){if(!Ga(t))throw Error(l(200));return Oa(null,e,t,!1,i)},Ke.unmountComponentAtNode=function(e){if(!Ga(e))throw Error(l(40));return e._reactRootContainer?(di(function(){Oa(null,null,e,!1,function(){e._reactRootContainer=null,e[Tt]=null})}),!0):!1},Ke.unstable_batchedUpdates=Mr,Ke.unstable_renderSubtreeIntoContainer=function(e,t,i,n){if(!Ga(i))throw Error(l(200));if(e==null||e._reactInternals===void 0)throw Error(l(38));return Oa(e,t,i,!1,n)},Ke.version="18.3.1-next-f1338f8080-20240426",Ke}var dd;function Wp(){if(dd)return $r.exports;dd=1;function r(){if(!(typeof __REACT_DEVTOOLS_GLOBAL_HOOK__>"u"||typeof __REACT_DEVTOOLS_GLOBAL_HOOK__.checkDCE!="function"))try{__REACT_DEVTOOLS_GLOBAL_HOOK__.checkDCE(r)}catch(c){console.error(c)}}return r(),$r.exports=Bp(),$r.exports}var ud;function Fp(){if(ud)return _a;ud=1;var r=Wp();return _a.createRoot=r.createRoot,_a.hydrateRoot=r.hydrateRoot,_a}var Hp=Fp();var pd="popstate";function jp(r={}){function c(u,m){let{pathname:h,search:v,hash:k}=u.location;return es("",{pathname:h,search:v,hash:k},m.state&&m.state.usr||null,m.state&&m.state.key||"default")}function l(u,m){return typeof m=="string"?m:Dn(m)}return Op(c,l,null,r)}function ve(r,c){if(r===!1||r===null||typeof r>"u")throw new Error(c)}function gt(r,c){if(!r){typeof console<"u"&&console.warn(c);try{throw new Error(c)}catch{}}}function Gp(){return Math.random().toString(36).substring(2,10)}function hd(r,c){return{usr:r.state,key:r.key,idx:c}}function es(r,c,l=null,u){return{pathname:typeof r=="string"?r:r.pathname,search:"",hash:"",...typeof c=="string"?Hi(c):c,state:l,key:c&&c.key||u||Gp()}}function Dn({pathname:r="/",search:c="",hash:l=""}){return c&&c!=="?"&&(r+=c.charAt(0)==="?"?c:"?"+c),l&&l!=="#"&&(r+=l.charAt(0)==="#"?l:"#"+l),r}function Hi(r){let c={};if(r){let l=r.indexOf("#");l>=0&&(c.hash=r.substring(l),r=r.substring(0,l));let u=r.indexOf("?");u>=0&&(c.search=r.substring(u),r=r.substring(0,u)),r&&(c.pathname=r)}return c}function Op(r,c,l,u={}){let{window:m=document.defaultView,v5Compat:h=!1}=u,v=m.history,k="POP",w=null,T=q();T==null&&(T=0,v.replaceState({...v.state,idx:T},""));function q(){return(v.state||{idx:null}).idx}function C(){k="POP";let z=q(),G=z==null?null:z-T;T=z,w&&w({action:k,location:B.location,delta:G})}function R(z,G){k="PUSH";let _=es(B.location,z,G);T=q()+1;let X=hd(_,T),oe=B.createHref(_);try{v.pushState(X,"",oe)}catch(pe){if(pe instanceof DOMException&&pe.name==="DataCloneError")throw pe;m.location.assign(oe)}h&&w&&w({action:k,location:B.location,delta:1})}function V(z,G){k="REPLACE";let _=es(B.location,z,G);T=q();let X=hd(_,T),oe=B.createHref(_);v.replaceState(X,"",oe),h&&w&&w({action:k,location:B.location,delta:0})}function U(z){return Vp(z)}let B={get action(){return k},get location(){return r(m,v)},listen(z){if(w)throw new Error("A history only accepts one active listener");return m.addEventListener(pd,C),w=z,()=>{m.removeEventListener(pd,C),w=null}},createHref(z){return c(m,z)},createURL:U,encodeLocation(z){let G=U(z);return{pathname:G.pathname,search:G.search,hash:G.hash}},push:R,replace:V,go(z){return v.go(z)}};return B}function Vp(r,c=!1){let l="http://localhost";typeof window<"u"&&(l=window.location.origin!=="null"?window.location.origin:window.location.href),ve(l,"No window.location.(origin|href) available to create URL");let u=typeof r=="string"?r:Dn(r);return u=u.replace(/ $/,"%20"),!c&&u.startsWith("//")&&(u=l+u),new URL(u,l)}function Id(r,c,l="/"){return _p(r,c,l,!1)}function _p(r,c,l,u){let m=typeof c=="string"?Hi(c):c,h=Rt(m.pathname||"/",l);if(h==null)return null;let v=wd(r);Up(v);let k=null;for(let w=0;k==null&&w<v.length;++w){let T=nh(h);k=th(v[w],T,u)}return k}function wd(r,c=[],l=[],u="",m=!1){let h=(v,k,w=m,T)=>{let q={relativePath:T===void 0?v.path||"":T,caseSensitive:v.caseSensitive===!0,childrenIndex:k,route:v};if(q.relativePath.startsWith("/")){if(!q.relativePath.startsWith(u)&&w)return;ve(q.relativePath.startsWith(u),`Absolute route path "${q.relativePath}" nested under path "${u}" is not valid. An absolute child route path must start with the combined path of all its parent routes.`),q.relativePath=q.relativePath.slice(u.length)}let C=zt([u,q.relativePath]),R=l.concat(q);v.children&&v.children.length>0&&(ve(v.index!==!0,`Index routes must not have child routes. Please remove all child routes from route path "${C}".`),wd(v.children,c,R,C,w)),!(v.path==null&&!v.index)&&c.push({path:C,score:Zp(C,v.index),routesMeta:R})};return r.forEach((v,k)=>{if(v.path===""||!v.path?.includes("?"))h(v,k);else for(let w of bd(v.path))h(v,k,!0,w)}),c}function bd(r){let c=r.split("/");if(c.length===0)return[];let[l,...u]=c,m=l.endsWith("?"),h=l.replace(/\?$/,"");if(u.length===0)return m?[h,""]:[h];let v=bd(u.join("/")),k=[];return k.push(...v.map(w=>w===""?h:[h,w].join("/"))),m&&k.push(...v),k.map(w=>r.startsWith("/")&&w===""?"/":w)}function Up(r){r.sort((c,l)=>c.score!==l.score?l.score-c.score:eh(c.routesMeta.map(u=>u.childrenIndex),l.routesMeta.map(u=>u.childrenIndex)))}var Kp=/^:[\w-]+$/,$p=3,Qp=2,Jp=1,Xp=10,Yp=-2,md=r=>r==="*";function Zp(r,c){let l=r.split("/"),u=l.length;return l.some(md)&&(u+=Yp),c&&(u+=Qp),l.filter(m=>!md(m)).reduce((m,h)=>m+(Kp.test(h)?$p:h===""?Jp:Xp),u)}function eh(r,c){return r.length===c.length&&r.slice(0,-1).every((u,m)=>u===c[m])?r[r.length-1]-c[c.length-1]:0}function th(r,c,l=!1){let{routesMeta:u}=r,m={},h="/",v=[];for(let k=0;k<u.length;++k){let w=u[k],T=k===u.length-1,q=h==="/"?c:c.slice(h.length)||"/",C=Qa({path:w.relativePath,caseSensitive:w.caseSensitive,end:T},q),R=w.route;if(!C&&T&&l&&!u[u.length-1].route.index&&(C=Qa({path:w.relativePath,caseSensitive:w.caseSensitive,end:!1},q)),!C)return null;Object.assign(m,C.params),v.push({params:m,pathname:zt([h,C.pathname]),pathnameBase:lh(zt([h,C.pathnameBase])),route:R}),C.pathnameBase!=="/"&&(h=zt([h,C.pathnameBase]))}return v}function Qa(r,c){typeof r=="string"&&(r={path:r,caseSensitive:!1,end:!0});let[l,u]=ih(r.path,r.caseSensitive,r.end),m=c.match(l);if(!m)return null;let h=m[0],v=h.replace(/(.)\/+$/,"$1"),k=m.slice(1);return{params:u.reduce((T,{paramName:q,isOptional:C},R)=>{if(q==="*"){let U=k[R]||"";v=h.slice(0,h.length-U.length).replace(/(.)\/+$/,"$1")}const V=k[R];return C&&!V?T[q]=void 0:T[q]=(V||"").replace(/%2F/g,"/"),T},{}),pathname:h,pathnameBase:v,pattern:r}}function ih(r,c=!1,l=!0){gt(r==="*"||!r.endsWith("*")||r.endsWith("/*"),`Route path "${r}" will be treated as if it were "${r.replace(/\*$/,"/*")}" because the \`*\` character must always follow a \`/\` in the pattern. To get rid of this warning, please change the route path to "${r.replace(/\*$/,"/*")}".`);let u=[],m="^"+r.replace(/\/*\*?$/,"").replace(/^\/*/,"/").replace(/[\\.*+^${}|()[\]]/g,"\\$&").replace(/\/:([\w-]+)(\?)?/g,(v,k,w)=>(u.push({paramName:k,isOptional:w!=null}),w?"/?([^\\/]+)?":"/([^\\/]+)")).replace(/\/([\w-]+)\?(\/|$)/g,"(/$1)?$2");return r.endsWith("*")?(u.push({paramName:"*"}),m+=r==="*"||r==="/*"?"(.*)$":"(?:\\/(.+)|\\/*)$"):l?m+="\\/*$":r!==""&&r!=="/"&&(m+="(?:(?=\\/|$))"),[new RegExp(m,c?void 0:"i"),u]}function nh(r){try{return r.split("/").map(c=>decodeURIComponent(c).replace(/\//g,"%2F")).join("/")}catch(c){return gt(!1,`The URL path "${r}" could not be decoded because it is a malformed URL segment. This is probably due to a bad percent encoding (${c}).`),r}}function Rt(r,c){if(c==="/")return r;if(!r.toLowerCase().startsWith(c.toLowerCase()))return null;let l=c.endsWith("/")?c.length-1:c.length,u=r.charAt(l);return u&&u!=="/"?null:r.slice(l)||"/"}var ah=/^(?:[a-z][a-z0-9+.-]*:|\/\/)/i,oh=r=>ah.test(r);function rh(r,c="/"){let{pathname:l,search:u="",hash:m=""}=typeof r=="string"?Hi(r):r,h;if(l)if(oh(l))h=l;else{if(l.includes("//")){let v=l;l=l.replace(/\/\/+/g,"/"),gt(!1,`Pathnames cannot have embedded double slashes - normalizing ${v} -> ${l}`)}l.startsWith("/")?h=fd(l.substring(1),"/"):h=fd(l,c)}else h=c;return{pathname:h,search:ch(u),hash:dh(m)}}function fd(r,c){let l=c.replace(/\/+$/,"").split("/");return r.split("/").forEach(m=>{m===".."?l.length>1&&l.pop():m!=="."&&l.push(m)}),l.length>1?l.join("/"):"/"}function Xr(r,c,l,u){return`Cannot include a '${r}' character in a manually specified \`to.${c}\` field [${JSON.stringify(u)}].  Please separate it out to the \`to.${l}\` field. Alternatively you may provide the full path as a string in <Link to="..."> and the router will parse it for you.`}function sh(r){return r.filter((c,l)=>l===0||c.route.path&&c.route.path.length>0)}function kd(r){let c=sh(r);return c.map((l,u)=>u===c.length-1?l.pathname:l.pathnameBase)}function Cd(r,c,l,u=!1){let m;typeof r=="string"?m=Hi(r):(m={...r},ve(!m.pathname||!m.pathname.includes("?"),Xr("?","pathname","search",m)),ve(!m.pathname||!m.pathname.includes("#"),Xr("#","pathname","hash",m)),ve(!m.search||!m.search.includes("#"),Xr("#","search","hash",m)));let h=r===""||m.pathname==="",v=h?"/":m.pathname,k;if(v==null)k=l;else{let C=c.length-1;if(!u&&v.startsWith("..")){let R=v.split("/");for(;R[0]==="..";)R.shift(),C-=1;m.pathname=R.join("/")}k=C>=0?c[C]:"/"}let w=rh(m,k),T=v&&v!=="/"&&v.endsWith("/"),q=(h||v===".")&&l.endsWith("/");return!w.pathname.endsWith("/")&&(T||q)&&(w.pathname+="/"),w}var zt=r=>r.join("/").replace(/\/\/+/g,"/"),lh=r=>r.replace(/\/+$/,"").replace(/^\/*/,"/"),ch=r=>!r||r==="?"?"":r.startsWith("?")?r:"?"+r,dh=r=>!r||r==="#"?"":r.startsWith("#")?r:"#"+r;function uh(r){return r!=null&&typeof r.status=="number"&&typeof r.statusText=="string"&&typeof r.internal=="boolean"&&"data"in r}function ph(r){return r.map(c=>c.route.path).filter(Boolean).join("/").replace(/\/\/*/g,"/")||"/"}Object.getOwnPropertyNames(Object.prototype).sort().join("\0");var Td=["POST","PUT","PATCH","DELETE"];new Set(Td);var hh=["GET",...Td];new Set(hh);var ji=b.createContext(null);ji.displayName="DataRouter";var Ja=b.createContext(null);Ja.displayName="DataRouterState";b.createContext(!1);var Pd=b.createContext({isTransitioning:!1});Pd.displayName="ViewTransition";var mh=b.createContext(new Map);mh.displayName="Fetchers";var fh=b.createContext(null);fh.displayName="Await";var yt=b.createContext(null);yt.displayName="Navigation";var Ln=b.createContext(null);Ln.displayName="Location";var Ct=b.createContext({outlet:null,matches:[],isDataRoute:!1});Ct.displayName="Route";var ns=b.createContext(null);ns.displayName="RouteError";function gh(r,{relative:c}={}){ve(zn(),"useHref() may be used only in the context of a <Router> component.");let{basename:l,navigator:u}=b.useContext(yt),{hash:m,pathname:h,search:v}=Rn(r,{relative:c}),k=h;return l!=="/"&&(k=h==="/"?l:zt([l,h])),u.createHref({pathname:k,search:v,hash:m})}function zn(){return b.useContext(Ln)!=null}function ei(){return ve(zn(),"useLocation() may be used only in the context of a <Router> component."),b.useContext(Ln).location}var Sd="You should call navigate() in a React.useEffect(), not when your component is first rendered.";function Ad(r){b.useContext(yt).static||b.useLayoutEffect(r)}function as(){let{isDataRoute:r}=b.useContext(Ct);return r?qh():yh()}function yh(){ve(zn(),"useNavigate() may be used only in the context of a <Router> component.");let r=b.useContext(ji),{basename:c,navigator:l}=b.useContext(yt),{matches:u}=b.useContext(Ct),{pathname:m}=ei(),h=JSON.stringify(kd(u)),v=b.useRef(!1);return Ad(()=>{v.current=!0}),b.useCallback((w,T={})=>{if(gt(v.current,Sd),!v.current)return;if(typeof w=="number"){l.go(w);return}let q=Cd(w,JSON.parse(h),m,T.relative==="path");r==null&&c!=="/"&&(q.pathname=q.pathname==="/"?c:zt([c,q.pathname])),(T.replace?l.replace:l.push)(q,T.state,T)},[c,l,h,m,r])}b.createContext(null);function vh(){let{matches:r}=b.useContext(Ct),c=r[r.length-1];return c?c.params:{}}function Rn(r,{relative:c}={}){let{matches:l}=b.useContext(Ct),{pathname:u}=ei(),m=JSON.stringify(kd(l));return b.useMemo(()=>Cd(r,JSON.parse(m),u,c==="path"),[r,m,u,c])}function xh(r,c){return Ed(r,c)}function Ed(r,c,l,u,m){ve(zn(),"useRoutes() may be used only in the context of a <Router> component.");let{navigator:h}=b.useContext(yt),{matches:v}=b.useContext(Ct),k=v[v.length-1],w=k?k.params:{},T=k?k.pathname:"/",q=k?k.pathnameBase:"/",C=k&&k.route;{let _=C&&C.path||"";qd(T,!C||_.endsWith("*")||_.endsWith("*?"),`You rendered descendant <Routes> (or called \`useRoutes()\`) at "${T}" (under <Route path="${_}">) but the parent route path has no trailing "*". This means if you navigate deeper, the parent won't match anymore and therefore the child routes will never render.

Please change the parent <Route path="${_}"> to <Route path="${_==="/"?"*":`${_}/*`}">.`)}let R=ei(),V;if(c){let _=typeof c=="string"?Hi(c):c;ve(q==="/"||_.pathname?.startsWith(q),`When overriding the location using \`<Routes location>\` or \`useRoutes(routes, location)\`, the location pathname must begin with the portion of the URL pathname that was matched by all parent routes. The current pathname base is "${q}" but pathname "${_.pathname}" was given in the \`location\` prop.`),V=_}else V=R;let U=V.pathname||"/",B=U;if(q!=="/"){let _=q.replace(/^\//,"").split("/");B="/"+U.replace(/^\//,"").split("/").slice(_.length).join("/")}let z=Id(r,{pathname:B});gt(C||z!=null,`No routes matched location "${V.pathname}${V.search}${V.hash}" `),gt(z==null||z[z.length-1].route.element!==void 0||z[z.length-1].route.Component!==void 0||z[z.length-1].route.lazy!==void 0,`Matched leaf route at location "${V.pathname}${V.search}${V.hash}" does not have an element or Component. This means it will render an <Outlet /> with a null value by default resulting in an "empty" page.`);let G=Ch(z&&z.map(_=>Object.assign({},_,{params:Object.assign({},w,_.params),pathname:zt([q,h.encodeLocation?h.encodeLocation(_.pathname.replace(/\?/g,"%3F").replace(/#/g,"%23")).pathname:_.pathname]),pathnameBase:_.pathnameBase==="/"?q:zt([q,h.encodeLocation?h.encodeLocation(_.pathnameBase.replace(/\?/g,"%3F").replace(/#/g,"%23")).pathname:_.pathnameBase])})),v,l,u,m);return c&&G?b.createElement(Ln.Provider,{value:{location:{pathname:"/",search:"",hash:"",state:null,key:"default",...V},navigationType:"POP"}},G):G}function Ih(){let r=Eh(),c=uh(r)?`${r.status} ${r.statusText}`:r instanceof Error?r.message:JSON.stringify(r),l=r instanceof Error?r.stack:null,u="rgba(200,200,200, 0.5)",m={padding:"0.5rem",backgroundColor:u},h={padding:"2px 4px",backgroundColor:u},v=null;return console.error("Error handled by React Router default ErrorBoundary:",r),v=b.createElement(b.Fragment,null,b.createElement("p",null," Hey developer "),b.createElement("p",null,"You can provide a way better UX than this when your app throws errors by providing your own ",b.createElement("code",{style:h},"ErrorBoundary")," or"," ",b.createElement("code",{style:h},"errorElement")," prop on your route.")),b.createElement(b.Fragment,null,b.createElement("h2",null,"Unexpected Application Error!"),b.createElement("h3",{style:{fontStyle:"italic"}},c),l?b.createElement("pre",{style:m},l):null,v)}var wh=b.createElement(Ih,null),bh=class extends b.Component{constructor(r){super(r),this.state={location:r.location,revalidation:r.revalidation,error:r.error}}static getDerivedStateFromError(r){return{error:r}}static getDerivedStateFromProps(r,c){return c.location!==r.location||c.revalidation!=="idle"&&r.revalidation==="idle"?{error:r.error,location:r.location,revalidation:r.revalidation}:{error:r.error!==void 0?r.error:c.error,location:c.location,revalidation:r.revalidation||c.revalidation}}componentDidCatch(r,c){this.props.onError?this.props.onError(r,c):console.error("React Router caught the following error during render",r)}render(){return this.state.error!==void 0?b.createElement(Ct.Provider,{value:this.props.routeContext},b.createElement(ns.Provider,{value:this.state.error,children:this.props.component})):this.props.children}};function kh({routeContext:r,match:c,children:l}){let u=b.useContext(ji);return u&&u.static&&u.staticContext&&(c.route.errorElement||c.route.ErrorBoundary)&&(u.staticContext._deepestRenderedBoundaryId=c.route.id),b.createElement(Ct.Provider,{value:r},l)}function Ch(r,c=[],l=null,u=null,m=null){if(r==null){if(!l)return null;if(l.errors)r=l.matches;else if(c.length===0&&!l.initialized&&l.matches.length>0)r=l.matches;else return null}let h=r,v=l?.errors;if(v!=null){let q=h.findIndex(C=>C.route.id&&v?.[C.route.id]!==void 0);ve(q>=0,`Could not find a matching route for errors on route IDs: ${Object.keys(v).join(",")}`),h=h.slice(0,Math.min(h.length,q+1))}let k=!1,w=-1;if(l)for(let q=0;q<h.length;q++){let C=h[q];if((C.route.HydrateFallback||C.route.hydrateFallbackElement)&&(w=q),C.route.id){let{loaderData:R,errors:V}=l,U=C.route.loader&&!R.hasOwnProperty(C.route.id)&&(!V||V[C.route.id]===void 0);if(C.route.lazy||U){k=!0,w>=0?h=h.slice(0,w+1):h=[h[0]];break}}}let T=l&&u?(q,C)=>{u(q,{location:l.location,params:l.matches?.[0]?.params??{},unstable_pattern:ph(l.matches),errorInfo:C})}:void 0;return h.reduceRight((q,C,R)=>{let V,U=!1,B=null,z=null;l&&(V=v&&C.route.id?v[C.route.id]:void 0,B=C.route.errorElement||wh,k&&(w<0&&R===0?(qd("route-fallback",!1,"No `HydrateFallback` element provided to render during initial hydration"),U=!0,z=null):w===R&&(U=!0,z=C.route.hydrateFallbackElement||null)));let G=c.concat(h.slice(0,R+1)),_=()=>{let X;return V?X=B:U?X=z:C.route.Component?X=b.createElement(C.route.Component,null):C.route.element?X=C.route.element:X=q,b.createElement(kh,{match:C,routeContext:{outlet:q,matches:G,isDataRoute:l!=null},children:X})};return l&&(C.route.ErrorBoundary||C.route.errorElement||R===0)?b.createElement(bh,{location:l.location,revalidation:l.revalidation,component:B,error:V,children:_(),routeContext:{outlet:null,matches:G,isDataRoute:!0},onError:T}):_()},null)}function os(r){return`${r} must be used within a data router.  See https://reactrouter.com/en/main/routers/picking-a-router.`}function Th(r){let c=b.useContext(ji);return ve(c,os(r)),c}function Ph(r){let c=b.useContext(Ja);return ve(c,os(r)),c}function Sh(r){let c=b.useContext(Ct);return ve(c,os(r)),c}function rs(r){let c=Sh(r),l=c.matches[c.matches.length-1];return ve(l.route.id,`${r} can only be used on routes that contain a unique "id"`),l.route.id}function Ah(){return rs("useRouteId")}function Eh(){let r=b.useContext(ns),c=Ph("useRouteError"),l=rs("useRouteError");return r!==void 0?r:c.errors?.[l]}function qh(){let{router:r}=Th("useNavigate"),c=rs("useNavigate"),l=b.useRef(!1);return Ad(()=>{l.current=!0}),b.useCallback(async(m,h={})=>{gt(l.current,Sd),l.current&&(typeof m=="number"?await r.navigate(m):await r.navigate(m,{fromRouteId:c,...h}))},[r,c])}var gd={};function qd(r,c,l){!c&&!gd[r]&&(gd[r]=!0,gt(!1,l))}b.memo(Dh);function Dh({routes:r,future:c,state:l,unstable_onError:u}){return Ed(r,void 0,l,u,c)}function Fi(r){ve(!1,"A <Route> is only ever to be used as the child of <Routes> element, never rendered directly. Please wrap your <Route> in a <Routes>.")}function Lh({basename:r="/",children:c=null,location:l,navigationType:u="POP",navigator:m,static:h=!1,unstable_useTransitions:v}){ve(!zn(),"You cannot render a <Router> inside another <Router>. You should never have more than one in your app.");let k=r.replace(/^\/*/,"/"),w=b.useMemo(()=>({basename:k,navigator:m,static:h,unstable_useTransitions:v,future:{}}),[k,m,h,v]);typeof l=="string"&&(l=Hi(l));let{pathname:T="/",search:q="",hash:C="",state:R=null,key:V="default"}=l,U=b.useMemo(()=>{let B=Rt(T,k);return B==null?null:{location:{pathname:B,search:q,hash:C,state:R,key:V},navigationType:u}},[k,T,q,C,R,V,u]);return gt(U!=null,`<Router basename="${k}"> is not able to match the URL "${T}${q}${C}" because it does not start with the basename, so the <Router> won't render anything.`),U==null?null:b.createElement(yt.Provider,{value:w},b.createElement(Ln.Provider,{children:c,value:U}))}function zh({children:r,location:c}){return xh(ts(r),c)}function ts(r,c=[]){let l=[];return b.Children.forEach(r,(u,m)=>{if(!b.isValidElement(u))return;let h=[...c,m];if(u.type===b.Fragment){l.push.apply(l,ts(u.props.children,h));return}ve(u.type===Fi,`[${typeof u.type=="string"?u.type:u.type.name}] is not a <Route> component. All component children of <Routes> must be a <Route> or <React.Fragment>`),ve(!u.props.index||!u.props.children,"An index route cannot have child routes.");let v={id:u.props.id||h.join("-"),caseSensitive:u.props.caseSensitive,element:u.props.element,Component:u.props.Component,index:u.props.index,path:u.props.path,middleware:u.props.middleware,loader:u.props.loader,action:u.props.action,hydrateFallbackElement:u.props.hydrateFallbackElement,HydrateFallback:u.props.HydrateFallback,errorElement:u.props.errorElement,ErrorBoundary:u.props.ErrorBoundary,hasErrorBoundary:u.props.hasErrorBoundary===!0||u.props.ErrorBoundary!=null||u.props.errorElement!=null,shouldRevalidate:u.props.shouldRevalidate,handle:u.props.handle,lazy:u.props.lazy};u.props.children&&(v.children=ts(u.props.children,h)),l.push(v)}),l}var Ka="get",$a="application/x-www-form-urlencoded";function Xa(r){return typeof HTMLElement<"u"&&r instanceof HTMLElement}function Rh(r){return Xa(r)&&r.tagName.toLowerCase()==="button"}function Nh(r){return Xa(r)&&r.tagName.toLowerCase()==="form"}function Mh(r){return Xa(r)&&r.tagName.toLowerCase()==="input"}function Bh(r){return!!(r.metaKey||r.altKey||r.ctrlKey||r.shiftKey)}function Wh(r,c){return r.button===0&&(!c||c==="_self")&&!Bh(r)}var Ua=null;function Fh(){if(Ua===null)try{new FormData(document.createElement("form"),0),Ua=!1}catch{Ua=!0}return Ua}var Hh=new Set(["application/x-www-form-urlencoded","multipart/form-data","text/plain"]);function Yr(r){return r!=null&&!Hh.has(r)?(gt(!1,`"${r}" is not a valid \`encType\` for \`<Form>\`/\`<fetcher.Form>\` and will default to "${$a}"`),null):r}function jh(r,c){let l,u,m,h,v;if(Nh(r)){let k=r.getAttribute("action");u=k?Rt(k,c):null,l=r.getAttribute("method")||Ka,m=Yr(r.getAttribute("enctype"))||$a,h=new FormData(r)}else if(Rh(r)||Mh(r)&&(r.type==="submit"||r.type==="image")){let k=r.form;if(k==null)throw new Error('Cannot submit a <button> or <input type="submit"> without a <form>');let w=r.getAttribute("formaction")||k.getAttribute("action");if(u=w?Rt(w,c):null,l=r.getAttribute("formmethod")||k.getAttribute("method")||Ka,m=Yr(r.getAttribute("formenctype"))||Yr(k.getAttribute("enctype"))||$a,h=new FormData(k,r),!Fh()){let{name:T,type:q,value:C}=r;if(q==="image"){let R=T?`${T}.`:"";h.append(`${R}x`,"0"),h.append(`${R}y`,"0")}else T&&h.append(T,C)}}else{if(Xa(r))throw new Error('Cannot submit element that is not <form>, <button>, or <input type="submit|image">');l=Ka,u=null,m=$a,v=r}return h&&m==="text/plain"&&(v=h,h=void 0),{action:u,method:l.toLowerCase(),encType:m,formData:h,body:v}}Object.getOwnPropertyNames(Object.prototype).sort().join("\0");function ss(r,c){if(r===!1||r===null||typeof r>"u")throw new Error(c)}function Gh(r,c,l){let u=typeof r=="string"?new URL(r,typeof window>"u"?"server://singlefetch/":window.location.origin):r;return u.pathname==="/"?u.pathname=`_root.${l}`:c&&Rt(u.pathname,c)==="/"?u.pathname=`${c.replace(/\/$/,"")}/_root.${l}`:u.pathname=`${u.pathname.replace(/\/$/,"")}.${l}`,u}async function Oh(r,c){if(r.id in c)return c[r.id];try{let l=await import(r.module);return c[r.id]=l,l}catch(l){return console.error(`Error loading route module \`${r.module}\`, reloading page...`),console.error(l),window.__reactRouterContext&&window.__reactRouterContext.isSpaMode,window.location.reload(),new Promise(()=>{})}}function Vh(r){return r==null?!1:r.href==null?r.rel==="preload"&&typeof r.imageSrcSet=="string"&&typeof r.imageSizes=="string":typeof r.rel=="string"&&typeof r.href=="string"}async function _h(r,c,l){let u=await Promise.all(r.map(async m=>{let h=c.routes[m.route.id];if(h){let v=await Oh(h,l);return v.links?v.links():[]}return[]}));return Qh(u.flat(1).filter(Vh).filter(m=>m.rel==="stylesheet"||m.rel==="preload").map(m=>m.rel==="stylesheet"?{...m,rel:"prefetch",as:"style"}:{...m,rel:"prefetch"}))}function yd(r,c,l,u,m,h){let v=(w,T)=>l[T]?w.route.id!==l[T].route.id:!0,k=(w,T)=>l[T].pathname!==w.pathname||l[T].route.path?.endsWith("*")&&l[T].params["*"]!==w.params["*"];return h==="assets"?c.filter((w,T)=>v(w,T)||k(w,T)):h==="data"?c.filter((w,T)=>{let q=u.routes[w.route.id];if(!q||!q.hasLoader)return!1;if(v(w,T)||k(w,T))return!0;if(w.route.shouldRevalidate){let C=w.route.shouldRevalidate({currentUrl:new URL(m.pathname+m.search+m.hash,window.origin),currentParams:l[0]?.params||{},nextUrl:new URL(r,window.origin),nextParams:w.params,defaultShouldRevalidate:!0});if(typeof C=="boolean")return C}return!0}):[]}function Uh(r,c,{includeHydrateFallback:l}={}){return Kh(r.map(u=>{let m=c.routes[u.route.id];if(!m)return[];let h=[m.module];return m.clientActionModule&&(h=h.concat(m.clientActionModule)),m.clientLoaderModule&&(h=h.concat(m.clientLoaderModule)),l&&m.hydrateFallbackModule&&(h=h.concat(m.hydrateFallbackModule)),m.imports&&(h=h.concat(m.imports)),h}).flat(1))}function Kh(r){return[...new Set(r)]}function $h(r){let c={},l=Object.keys(r).sort();for(let u of l)c[u]=r[u];return c}function Qh(r,c){let l=new Set;return new Set(c),r.reduce((u,m)=>{let h=JSON.stringify($h(m));return l.has(h)||(l.add(h),u.push({key:h,link:m})),u},[])}function Dd(){let r=b.useContext(ji);return ss(r,"You must render this element inside a <DataRouterContext.Provider> element"),r}function Jh(){let r=b.useContext(Ja);return ss(r,"You must render this element inside a <DataRouterStateContext.Provider> element"),r}var ls=b.createContext(void 0);ls.displayName="FrameworkContext";function Ld(){let r=b.useContext(ls);return ss(r,"You must render this element inside a <HydratedRouter> element"),r}function Xh(r,c){let l=b.useContext(ls),[u,m]=b.useState(!1),[h,v]=b.useState(!1),{onFocus:k,onBlur:w,onMouseEnter:T,onMouseLeave:q,onTouchStart:C}=c,R=b.useRef(null);b.useEffect(()=>{if(r==="render"&&v(!0),r==="viewport"){let B=G=>{G.forEach(_=>{v(_.isIntersecting)})},z=new IntersectionObserver(B,{threshold:.5});return R.current&&z.observe(R.current),()=>{z.disconnect()}}},[r]),b.useEffect(()=>{if(u){let B=setTimeout(()=>{v(!0)},100);return()=>{clearTimeout(B)}}},[u]);let V=()=>{m(!0)},U=()=>{m(!1),v(!1)};return l?r!=="intent"?[h,R,{}]:[h,R,{onFocus:qn(k,V),onBlur:qn(w,U),onMouseEnter:qn(T,V),onMouseLeave:qn(q,U),onTouchStart:qn(C,V)}]:[!1,R,{}]}function qn(r,c){return l=>{r&&r(l),l.defaultPrevented||c(l)}}function Yh({page:r,...c}){let{router:l}=Dd(),u=b.useMemo(()=>Id(l.routes,r,l.basename),[l.routes,r,l.basename]);return u?b.createElement(em,{page:r,matches:u,...c}):null}function Zh(r){let{manifest:c,routeModules:l}=Ld(),[u,m]=b.useState([]);return b.useEffect(()=>{let h=!1;return _h(r,c,l).then(v=>{h||m(v)}),()=>{h=!0}},[r,c,l]),u}function em({page:r,matches:c,...l}){let u=ei(),{manifest:m,routeModules:h}=Ld(),{basename:v}=Dd(),{loaderData:k,matches:w}=Jh(),T=b.useMemo(()=>yd(r,c,w,m,u,"data"),[r,c,w,m,u]),q=b.useMemo(()=>yd(r,c,w,m,u,"assets"),[r,c,w,m,u]),C=b.useMemo(()=>{if(r===u.pathname+u.search+u.hash)return[];let U=new Set,B=!1;if(c.forEach(G=>{let _=m.routes[G.route.id];!_||!_.hasLoader||(!T.some(X=>X.route.id===G.route.id)&&G.route.id in k&&h[G.route.id]?.shouldRevalidate||_.hasClientLoader?B=!0:U.add(G.route.id))}),U.size===0)return[];let z=Gh(r,v,"data");return B&&U.size>0&&z.searchParams.set("_routes",c.filter(G=>U.has(G.route.id)).map(G=>G.route.id).join(",")),[z.pathname+z.search]},[v,k,u,m,T,c,r,h]),R=b.useMemo(()=>Uh(q,m),[q,m]),V=Zh(q);return b.createElement(b.Fragment,null,C.map(U=>b.createElement("link",{key:U,rel:"prefetch",as:"fetch",href:U,...l})),R.map(U=>b.createElement("link",{key:U,rel:"modulepreload",href:U,...l})),V.map(({key:U,link:B})=>b.createElement("link",{key:U,nonce:l.nonce,...B})))}function tm(...r){return c=>{r.forEach(l=>{typeof l=="function"?l(c):l!=null&&(l.current=c)})}}var zd=typeof window<"u"&&typeof window.document<"u"&&typeof window.document.createElement<"u";try{zd&&(window.__reactRouterVersion="7.10.1")}catch{}function im({basename:r,children:c,unstable_useTransitions:l,window:u}){let m=b.useRef();m.current==null&&(m.current=jp({window:u,v5Compat:!0}));let h=m.current,[v,k]=b.useState({action:h.action,location:h.location}),w=b.useCallback(T=>{l===!1?k(T):b.startTransition(()=>k(T))},[l]);return b.useLayoutEffect(()=>h.listen(w),[h,w]),b.createElement(Lh,{basename:r,children:c,location:v.location,navigationType:v.action,navigator:h,unstable_useTransitions:l===!0})}var Rd=/^(?:[a-z][a-z0-9+.-]*:|\/\/)/i,Gi=b.forwardRef(function({onClick:c,discover:l="render",prefetch:u="none",relative:m,reloadDocument:h,replace:v,state:k,target:w,to:T,preventScrollReset:q,viewTransition:C,...R},V){let{basename:U,unstable_useTransitions:B}=b.useContext(yt),z=typeof T=="string"&&Rd.test(T),G,_=!1;if(typeof T=="string"&&z&&(G=T,zd))try{let Te=new URL(window.location.href),tt=T.startsWith("//")?new URL(Te.protocol+T):new URL(T),$e=Rt(tt.pathname,U);tt.origin===Te.origin&&$e!=null?T=$e+tt.search+tt.hash:_=!0}catch{gt(!1,`<Link to="${T}"> contains an invalid URL which will probably break when clicked - please update to a valid URL path.`)}let X=gh(T,{relative:m}),[oe,pe,xe]=Xh(u,R),fe=rm(T,{replace:v,state:k,target:w,preventScrollReset:q,relative:m,viewTransition:C,unstable_useTransitions:B});function ze(Te){c&&c(Te),Te.defaultPrevented||fe(Te)}let We=b.createElement("a",{...R,...xe,href:G||X,onClick:_||h?c:ze,ref:tm(V,pe),target:w,"data-discover":!z&&l==="render"?"true":void 0});return oe&&!z?b.createElement(b.Fragment,null,We,b.createElement(Yh,{page:X})):We});Gi.displayName="Link";var nm=b.forwardRef(function({"aria-current":c="page",caseSensitive:l=!1,className:u="",end:m=!1,style:h,to:v,viewTransition:k,children:w,...T},q){let C=Rn(v,{relative:T.relative}),R=ei(),V=b.useContext(Ja),{navigator:U,basename:B}=b.useContext(yt),z=V!=null&&um(C)&&k===!0,G=U.encodeLocation?U.encodeLocation(C).pathname:C.pathname,_=R.pathname,X=V&&V.navigation&&V.navigation.location?V.navigation.location.pathname:null;l||(_=_.toLowerCase(),X=X?X.toLowerCase():null,G=G.toLowerCase()),X&&B&&(X=Rt(X,B)||X);const oe=G!=="/"&&G.endsWith("/")?G.length-1:G.length;let pe=_===G||!m&&_.startsWith(G)&&_.charAt(oe)==="/",xe=X!=null&&(X===G||!m&&X.startsWith(G)&&X.charAt(G.length)==="/"),fe={isActive:pe,isPending:xe,isTransitioning:z},ze=pe?c:void 0,We;typeof u=="function"?We=u(fe):We=[u,pe?"active":null,xe?"pending":null,z?"transitioning":null].filter(Boolean).join(" ");let Te=typeof h=="function"?h(fe):h;return b.createElement(Gi,{...T,"aria-current":ze,className:We,ref:q,style:Te,to:v,viewTransition:k},typeof w=="function"?w(fe):w)});nm.displayName="NavLink";var am=b.forwardRef(({discover:r="render",fetcherKey:c,navigate:l,reloadDocument:u,replace:m,state:h,method:v=Ka,action:k,onSubmit:w,relative:T,preventScrollReset:q,viewTransition:C,...R},V)=>{let{unstable_useTransitions:U}=b.useContext(yt),B=cm(),z=dm(k,{relative:T}),G=v.toLowerCase()==="get"?"get":"post",_=typeof k=="string"&&Rd.test(k),X=oe=>{if(w&&w(oe),oe.defaultPrevented)return;oe.preventDefault();let pe=oe.nativeEvent.submitter,xe=pe?.getAttribute("formmethod")||v,fe=()=>B(pe||oe.currentTarget,{fetcherKey:c,method:xe,navigate:l,replace:m,state:h,relative:T,preventScrollReset:q,viewTransition:C});U&&l!==!1?b.startTransition(()=>fe()):fe()};return b.createElement("form",{ref:V,method:G,action:z,onSubmit:u?w:X,...R,"data-discover":!_&&r==="render"?"true":void 0})});am.displayName="Form";function om(r){return`${r} must be used within a data router.  See https://reactrouter.com/en/main/routers/picking-a-router.`}function Nd(r){let c=b.useContext(ji);return ve(c,om(r)),c}function rm(r,{target:c,replace:l,state:u,preventScrollReset:m,relative:h,viewTransition:v,unstable_useTransitions:k}={}){let w=as(),T=ei(),q=Rn(r,{relative:h});return b.useCallback(C=>{if(Wh(C,c)){C.preventDefault();let R=l!==void 0?l:Dn(T)===Dn(q),V=()=>w(r,{replace:R,state:u,preventScrollReset:m,relative:h,viewTransition:v});k?b.startTransition(()=>V()):V()}},[T,w,q,l,u,c,r,m,h,v,k])}var sm=0,lm=()=>`__${String(++sm)}__`;function cm(){let{router:r}=Nd("useSubmit"),{basename:c}=b.useContext(yt),l=Ah(),u=r.fetch,m=r.navigate;return b.useCallback(async(h,v={})=>{let{action:k,method:w,encType:T,formData:q,body:C}=jh(h,c);if(v.navigate===!1){let R=v.fetcherKey||lm();await u(R,l,v.action||k,{preventScrollReset:v.preventScrollReset,formData:q,body:C,formMethod:v.method||w,formEncType:v.encType||T,flushSync:v.flushSync})}else await m(v.action||k,{preventScrollReset:v.preventScrollReset,formData:q,body:C,formMethod:v.method||w,formEncType:v.encType||T,replace:v.replace,state:v.state,fromRouteId:l,flushSync:v.flushSync,viewTransition:v.viewTransition})},[u,m,c,l])}function dm(r,{relative:c}={}){let{basename:l}=b.useContext(yt),u=b.useContext(Ct);ve(u,"useFormAction must be used inside a RouteContext");let[m]=u.matches.slice(-1),h={...Rn(r||".",{relative:c})},v=ei();if(r==null){h.search=v.search;let k=new URLSearchParams(h.search),w=k.getAll("index");if(w.some(q=>q==="")){k.delete("index"),w.filter(C=>C).forEach(C=>k.append("index",C));let q=k.toString();h.search=q?`?${q}`:""}}return(!r||r===".")&&m.route.index&&(h.search=h.search?h.search.replace(/^\?/,"?index&"):"?index"),l!=="/"&&(h.pathname=h.pathname==="/"?l:zt([l,h.pathname])),Dn(h)}function um(r,{relative:c}={}){let l=b.useContext(Pd);ve(l!=null,"`useViewTransitionState` must be used within `react-router-dom`'s `RouterProvider`.  Did you accidentally import `RouterProvider` from `react-router`?");let{basename:u}=Nd("useViewTransitionState"),m=Rn(r,{relative:c});if(!l.isTransitioning)return!1;let h=Rt(l.currentLocation.pathname,u)||l.currentLocation.pathname,v=Rt(l.nextLocation.pathname,u)||l.nextLocation.pathname;return Qa(m.pathname,v)!=null||Qa(m.pathname,h)!=null}const vd=[{name:"Dashboard",href:"#",current:!0},{name:"Quizzes",href:"#",current:!1},{name:"Mock Exams",href:"#",current:!1},{name:"Progress",href:"#",current:!1}];function pm(...r){return r.filter(Boolean).join(" ")}function hm({onNavigate:r}){const[c,l]=b.useState(!1);return E.jsxs("nav",{className:"bg-gray-900 border-b border-white/10",children:[E.jsx("div",{className:"mx-auto max-w-7xl px-4 sm:px-6 lg:px-8",children:E.jsxs("div",{className:"flex h-16 items-center justify-between",children:[E.jsx(Gi,{to:"/",children:E.jsx("div",{className:"flex items-center",children:E.jsxs("span",{className:"cursor-pointer text-xl font-bold text-white",children:["MedQuiz",E.jsx("span",{className:"text-indigo-400",children:"Pro"})]})})}),E.jsx("div",{className:"hidden sm:flex sm:space-x-4",children:vd.map(u=>E.jsx("button",{type:"button",onClick:()=>{u.name==="Dashboard"&&r("home")},className:pm(u.current?"bg-gray-800 text-white":"text-gray-300 hover:bg-gray-800 hover:text-white","rounded-md px-3 py-2 text-sm font-medium transition-colors"),children:u.name},u.name))}),E.jsxs("div",{className:"hidden sm:flex items-center gap-4",children:[E.jsx("button",{type:"button",className:"rounded-full p-2 text-gray-400 hover:bg-gray-800 hover:text-white",children:""}),E.jsx("button",{type:"button",className:"rounded-md bg-indigo-500 px-3 py-1.5 text-sm font-semibold text-white hover:bg-indigo-400",children:"Log in"})]}),E.jsx("button",{type:"button",onClick:()=>l(!c),className:"sm:hidden rounded-md p-2 text-gray-400 hover:bg-gray-800 hover:text-white",children:c?"":""})]})}),c&&E.jsx("div",{className:"sm:hidden border-t border-white/10 bg-gray-900 px-4 py-3 space-y-1",children:vd.map(u=>E.jsx("button",{type:"button",onClick:()=>{u.name==="Dashboard"&&(r("home"),l(!1))},className:"block w-full text-left rounded-md px-3 py-2 text-base font-medium text-gray-300 hover:bg-gray-800 hover:text-white",children:u.name},u.name))})]})}function mm({onNavigate:r}){const[c,l]=b.useState(!1);return E.jsx("div",{className:"bg-gray-900 min-h-screen",children:E.jsxs("main",{className:"relative isolate px-6 pt-24 lg:px-8",children:[E.jsx("div",{"aria-hidden":"true",className:"absolute inset-x-0 -top-40 -z-10 blur-3xl",children:E.jsx("div",{className:"mx-auto h-96 w-96 bg-gradient-to-tr from-indigo-500 to-purple-500 opacity-30 rounded-full"})}),E.jsxs("div",{className:"mx-auto max-w-2xl py-32 text-center",children:[E.jsx("div",{className:"mb-8 inline-block rounded-full px-4 py-1 text-sm text-gray-400 ring-1 ring-white/10",children:"High-yield questions for real medical exams"}),E.jsxs("h1",{className:"text-5xl sm:text-7xl font-semibold text-white",children:["Master Dermatology.",E.jsx("br",{}),"One Question at a Time."]}),E.jsx("p",{className:"mt-8 text-lg text-gray-400",children:"Practice clinically relevant questions, track your progress, and prepare confidently for your medical exams."}),E.jsxs("div",{className:"mt-10 flex items-center justify-center gap-x-6",children:[E.jsx("button",{className:"rounded-md bg-indigo-500 px-5 py-3 text-sm font-semibold text-white hover:bg-indigo-400",children:E.jsx(Gi,{to:"/QuizList",children:"Start Practicing"})}),E.jsx("button",{onClick:()=>r("quiz-list"),className:"text-sm font-semibold text-white",children:"Explore quizzes "})]})]})]})})}const fm="/React-Derma-Quiz/assets/Bolognia-HcjJ5LTY.png",gm="/React-Derma-Quiz/assets/Rooks-Di8OpaK5.jpeg";function ym(){const r=[{id:1,title:"Bolognia",description:"Entire spectrum of skin diseases, from basic science and diagnosis to treatment.",chapters:159,image:fm},{id:2,title:"Rooks",description:"he world's most comprehensive medical reference for skin diseases.",chapters:18,image:gm}];return E.jsx("main",{className:"min-h-screen bg-gray-900 px-6 py-10",children:E.jsxs("div",{className:"mx-auto max-w-7xl",children:[E.jsxs("div",{className:"mb-10",children:[E.jsx("h1",{className:"text-3xl font-bold text-white",children:"Choose a Quiz"}),E.jsx("p",{className:"mt-2 text-gray-400",children:"Select a subject to view chapters and start practicing."})]}),E.jsx("div",{className:"grid gap-6 sm:grid-cols-2 lg:grid-cols-3",children:r.map(c=>E.jsxs("div",{className:"overflow-hidden rounded-lg border border-white/10 bg-gray-800 transition hover:border-indigo-500/50",children:[E.jsx("img",{src:c.image,alt:c.title,className:"h-40 w-full object-cover"}),E.jsxs("div",{className:"p-6",children:[E.jsx("h2",{className:"text-xl font-semibold text-white",children:c.title}),E.jsx("p",{className:"mt-2 text-sm text-gray-400",children:c.description}),E.jsxs("p",{className:"mt-4 text-sm text-gray-300",children:[" ",c.chapters," chapters"]}),E.jsx(Gi,{to:"/BologniaQuizChapters",children:E.jsx("div",{className:"mt-6",children:E.jsx("button",{className:"mt-6 w-full rounded-md bg-indigo-500 px-4 py-2 text-white hover:bg-indigo-400",children:"View Chapters "})})})]})]},c.id))})]})})}const xd=JSON.parse(`[{"id":1,"title":"Basic Principles of Dermatology","description":"All students of dermatology, whether beginners or advanced scholars,require a conceptual framework upon which to organize thousands ofskin diseases.","image":"images/BologniaChapters/Basic Principles of Dermatology.jpg"},{"id":2,"title":"Anatomy and Pathophysiology","description":"Relationship between structure and function of the skin is best demonstrated by presenting diseases.","image":"images/BologniaChapters/Anatomy and Pathophysiology.jpeg"},{"id":3,"title":"Skin Development and Maintenance","description":"Development of the human embryo is a complex process involvinghighly orchestrated cell movements, proliferation, death, and differentiation.","image":"images/BologniaChapters/Skin Development and Maintenance.jpg"},{"id":4,"title":"Molecular Biology","description":"Advances in molecular biology are rapidly changing our understanding of skin biology and disease. Increased knowledge is being translated into new molecular diagnostic tests that are transforming clinical practice.","image":"images/BologniaChapters/Molecular Biology.jpg"},{"id":5,"title":"Immunology","description":"As a major barrier against the external environment, one of the skins major functions is defense against potential insults by microbial, chemical, and physical agents.","image":"images/BologniaChapters/Immunology.jpg"},{"id":6,"title":"Cutaneous Neurophysiology","description":"The skin contains a network of highly specialized afferent sensory nerves that convey sensations such as pain, itch, temperature, and touch.","image":"images/BologniaChapters/cutaneous.jpg"},{"id":7,"title":"Pruritus and Dysesthesia","description":"Pruritus can be defined as an unpleasant sensation that elicits a desire to scratch. The presumed biologic purpose of pruritus is to provoke scratching to remove a parasite or other harmful pruritogen.","image":"images/BologniaChapters/Pruritus and Dysesthesia.webp"},{"id":8,"title":"Psychocutaneous Diseases","description":"'Psychodermatology' refers to any aspect of dermatology in which psychological factors play a significant role in the genesis, exacerbation, or sequelae of a skin condition.","image":"images/BologniaChapters/Psychocutaneous Diseases.jpeg"},{"id":9,"title":"Psoriasis","description":"Psoriasis is an immune-mediated polygenic skin disorder1. Various environmental triggering factors, e.g. trauma, infections, medications, may elicit disease in predisposed individuals","image":"images/BologniaChapters/Psoriasis.jpeg"},{"id":10,"title":"Other Papulosquamous Disorders","description":"Since the introduction of the term parapsoriasis by Brocq in 1902, there has been much confusion and debate regarding this controversial topic","image":"images/BologniaChapters/Papulosquamous Disorders.webp"},{"id":11,"title":"Erythroderma","description":"Erythroderma is defined as generalized erythema and scaling involving > 80% of the body surface area (BSA).","image":"images/BologniaChapters/Erythroderma.jpg"},{"id":12,"title":"Lichen Planus and Lichenoid Dermatoses","description":"Lichen planus (LP), the prototype of lichenoid dermatoses, is an idiopathic inflammatory disease of the skin and mucous membranes. Classic LP is characterized by pruritic, violaceous papules that favor the extremities","image":"images/BologniaChapters/Lichen Planus and Lichenoid Dermatoses.jpg"},{"id":13,"title":"Atopic Dermatitis","description":"Atopic dermatitis (AD) is the most common chronic inflammatory skindisease, and its increasing prevalence presents a major public healthproblem worldwide.","image":"images/BologniaChapters/Atopic dermatitis.webp"},{"id":14,"title":"Other Eczematous Eruptions","description":"In addition to contact and atopic dermatitis, there exists a heteroge- neous group of inflammatory skin diseases that obviously share thehallmarks of eczema, but display characteristic additional features.","image":"images/BologniaChapters/Other Eczematous Eruptions.jpeg"},{"id":15,"title":"Allergic Contact Dermatitis","description":"When the skin comes in contact with external agents, many adverse events can occur including contact dermatitis, which can be either allergic or irritant.","image":"images/BologniaChapters/Allergic Contact Dermatitis.webp"},{"id":16,"title":"Irritant Contact Dermatitis","description":"ICD is the most common form of occupational skin disease, estimated to constitute between 70% and 80% of all occupational skin disorders.","image":"images/BologniaChapters/Irritant Contact Dermatitis.webp"},{"id":17,"title":"Occupational Dermatoses","description":"Contact dermatitis accounts for the majority of occupational skin disease that predominantly affects the hands.","image":"images/BologniaChapters/Occupational Dermatoses.jpeg"},{"id":18,"title":"Dermatoses Due to Plants","description":"Contrary to the belief of patients, just because a product is natural and not artificial, it doesnt mean it is safe. When patients discover that a 'natural' skin care product is harming them, they are dumbfounded.","image":"images/BologniaChapters/Dermatoses due to plants.png"},{"id":19,"title":"Urticaria and Angioedema","description":"Urticaria is a common reason for patients to present to primary care practitioners, emergency rooms, dermatologists, and allergists. It is characterized by the rapidity of its fluctuation","image":"images/BologniaChapters/Urticaria and Angioedema.jpg"},{"id":20,"title":"Figurate Erythemas","description":"Erythema represents a change in the color of the skin that is due to thedilation of blood vessels, especially those in the papillary and reticular dermis","image":"images/BologniaChapters/Figurate Erythemas.jpg"},{"id":21,"title":"Erythema Multiforme, StevensJohnson Syndrome, and Toxic Epidermal Necrolysis","description":"Erythema multiforme (EM) is an acute, self-limited skin disease characterized by the abrupt onset of symmetric fixed red papules, some of which evolve into typical and/or occasionally 'atypical' papular targetlesions","image":"./images/BologniaChapters/Necrolysis.jpg"},{"id":22,"title":"Drug Reactions","description":"The skin is one of the most common sites for adverse drug reactions. Although eruptions are usually observed in 0.1% to 1% of patients enrolled in pre-marketing trials of most systemic drugs, up to 5% of patients treated with antibiotics or aromatic anticonvulsants may develop a cutaneous eruption","image":"./images/BologniaChapters/Drug Reactions.jpeg"},{"id":23,"title":"Purpura: Mechanismsand Differential Diagnosis","description":"This chapter addresses the evaluation and classification of patients presenting with purpura, defined as visible hemorrhage within the skin or mucous membranes.","image":"./images/BologniaChapters/Purpura.webp"},{"id":24,"title":"Cutaneous Manifestations of Microvascular Occlusion Syndromes","description":"The differential diagnosis of microvascular syndromes involving theskin is extensive. It is critical to distinguish between inflammatory injury and non-inflammatory occlusive injury to vessels.","image":"./images/BologniaChapters/Cutaneous Manifestations.png"},{"id":25,"title":"Cutaneous Vasculitis","description":"Vasculitis is defined as inflammation and destruction of blood vesselswith resultant downstream ischemic tissue damage.","image":"./images/BologniaChapters/Cutaneous Vasculitis.jpeg"},{"id":26,"title":"Neutrophilic Dermatoses","description":"The neutrophilic dermatoses constitute a heterogeneous but linked spectrum of diseases, with significant overlapping histopathologic findings and similar pathogenic mechanisms and therapeutic approaches.","image":"./images/BologniaChapters/Neutrophilic Dermatoses.jpg"},{"id":27,"title":"Eosinophil-Associated Dermatoses","description":"The eosinophil is a leukocyte ~1016 microns in diameter that possesses a segmented (usually bi-lobed) nucleus. It is produced in the bone marrow and circulates transiently (818 hours) in the peripheral blood.","image":"./images/BologniaChapters/Eosinophil-Associated Dermatoses.jpg"},{"id":28,"title":"Pregnancy Dermatoses","description":"For decades, the specific dermatoses of pregnancy represented a confusing group of overlapping entities, understood largely through anecdotes and case reports.","image":"./images/BologniaChapters/Pregnancy Dermatoses.jpeg"},{"id":29,"title":"The Biology of the Basement Membrane","description":"Basement membranes are specialized structures located between cells and their underlying stroma or between different cell types1. Basement membranes of various tissues differ ultrastructurally, biochemically, and functionally.","image":"./images/BologniaChapters/Basement.png"},{"id":30,"title":"Pemphigus","description":"The term pemphigus stems from the Greek pemphix, meaning blister or bubble, and it describes a group of chronic blistering skin diseases in which autoantibodies are directed against the cell surface of keratino-cytes, resulting in the loss of cellcell adhesion of keratinocytes through a process called acantholysis","image":"./images/BologniaChapters/Pemphigus.jpeg"},{"id":31,"title":"Pemphigoid Group","description":"Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease. It typically presents in older adults as a general-ized pruritic bullous eruption and is often associated with significant morbidity.","image":"./images/BologniaChapters/Pemphigoid Group.jpg"},{"id":32,"title":"Dermatitis Herpetiformis and Linear IgA Bullous Dermatosis","description":"Dermatitis herpetiformis (DH) is a cutaneous manifestation of gluten sensitivity. Although over 90% of DH patients have evidence of a gluten- sensitive enteropathy (GSE), only about 20% have intestinal symptoms of celiac disease (CD).","image":"./images/BologniaChapters/Dermatitis Herpetiformis.jpg"},{"id":33,"title":"Epidermolysis Bullosa","description":"Inherited epidermolysis bullosa (EB), the prototypic mechanobullous disease, is characterized by the development of blisters following seemingly minor or insignificant trauma or traction to the skin","image":"./images/BologniaChapters/Epidermolysis Bullosa.webp"},{"id":34,"title":"Other Vesiculobullous Diseases","description":"Vesiculobullous diseases of the skin encompass a wide range of entities, including autoimmune bullous diseases and inherited blistering disorders.","image":"./images/BologniaChapters/Other Vesiculobullous Diseases.jpeg"},{"id":35,"title":"Vesiculopustular and Erosive Disorders in Newborns and Infants","description":"A wide variety of conditions can cause vesicles, pustules, bullae, erosions, and ulcerations during the newborn period and infancy.","image":"./images/BologniaChapters/Vesiculopustular.jpg"},{"id":36,"title":"Structure and Function of Eccrine, Apocrine, and Sebaceous Glands","description":"Humans have both eccrine and apocrine sweat glands, which are distinct from one another structurally, developmentally, and functionally.","image":"./images/BologniaChapters/Apocrine.jpeg"},{"id":37,"title":"Acne Vulgaris","description":"Acne vulgaris is a multifactorial disorder of the pilosebaceous unit. The clinical picture can vary significantly, from mild comedonal acne to fulminant systemic disease.","image":"./images/BologniaChapters/Acne Vulgaris.jpeg"},{"id":38,"title":"Rosacea and Related Disorders","description":"The term 'rosacea' encompasses a constellation of clinical findings, with either fixed centrofacial erythema in a characteristic patternthat may periodically intensify or phymatous changes classified as diagnostic features","image":"./images/BologniaChapters/Rosacea and Related Disorders.jpeg"},{"id":39,"title":"Folliculitis, Follicular Occlusion Tetrad and Other Follicular Disorders","description":"This chapter reviews both superficial and deep forms of folliculitis as well as disorders of follicular keratinization.","image":"./images/BologniaChapters/Follicular.jpg"},{"id":40,"title":"Diseases of the Eccrine and Apocrine Sweat Glands","description":"In humans, sweating is essential for thermoregulatory homeostasis. There are two main mechanisms for cooling the body: radiative cooling via cutaneous vasodilation and evaporative cooling via sweat.","image":"./images/BologniaChapters/apocrine-glands.jpg"},{"id":41,"title":"Autoantibodies Encountered in Patients with Autoimmune Connective Tissue Diseases","description":"Autoimmune connective tissue diseases (AI-CTDs) represent polygenic clinical disorders with heterogeneous and overlapping clinical features. AI-CTDs are characterized by an immune dysregulation that includes the production of antibodies to self-antigens, termed autoantibodies (aAb).","image":"./images/BologniaChapters/AutoAntibodies.jpg"},{"id":42,"title":"Lupus Erythematosus","description":"Lupus erythematosus is a multisystem disorder that often affects the skin. Cutaneous lesions can be a source of disability and, on many occasions, indicate and correlate with internal disease.","image":"./images/BologniaChapters/Lupus Erythematosus.jpg"},{"id":43,"title":"Dermatomyositis","description":"Along with polymyositis and inclusion body myositis, dermatomyo- sitis is classified as one of the idiopathic inflammatory myopathies. Dermatomyositis is a disease of presumed autoimmune pathogenesis that presents with a symmetric, proximal, extensor inflammatory myopathy and a characteristic cutaneous eruption.","image":"./images/BologniaChapters/Dermatomyositis.jpeg"},{"id":44,"title":"Systemic Sclerosis (Scleroderma) and Related Disorders","description":"Systemic sclerosis (SSc, scleroderma) is an autoimmune connective tissue disease (AI-CTD) of unknown etiology that affects the skin, blood vessels, and internal organs","image":"./images/BologniaChapters/Systemic Sclerosis.jpeg"},{"id":45,"title":"Morphea and Lichen Sclerosus","description":"Morphea and lichen sclerosus (LS) are inflammatory skin diseases that ultimately evolve into two distinct modes of cutaneous sclerosis. In morphea, there is inflammation of the dermis that may extend into subcutaneous structures.","image":"./images/BologniaChapters/Morphea and Lichen Sclerosus.jpeg"},{"id":46,"title":"Other Rheumatologic Disorders and Autoinflammatory Diseases","description":"Disorders such as systemic-onset juvenile idiopathic arthritis (Still disease) and inherited autoinflammatory diseases are related to abnormalities in the innate immune system whereas other disorders, including rheumatoid arthritis and Sjgren syndrome, are characterized by autoimmune-mediated tissue damage via autoreactive antigen-specific T cells and the presence of character- istic autoantibodies.","image":"./images/BologniaChapters/Rheumatologic.jpeg"},{"id":47,"title":"Mucinoses","description":"The cutaneous mucinoses are a heterogeneous group of disorders in which an abnormal amount of mucin accumulates in the skin, either diffusely or focally.","image":"./images/BologniaChapters/Mucinoses.jpg"},{"id":48,"title":"Amyloidosis","description":"Amyloidosis is not a single disease; rather, the term is used to refer to several diseases that share the common feature of abnormal extracel- lular deposition of amyloid, a fibrillar proteinaceous material, within tissues.","image":"./images/BologniaChapters/Amyloidosis.jpg"},{"id":49,"title":"Deposition Diseases","description":"The cutaneous deposition disorders are a heterogeneous group of condi- tions characterized by the presence of primarily endogenous substances within the dermis or the subcutis","image":"./images/BologniaChapters/Deposition Diseases.jpg"},{"id":50,"title":"Porphyria","description":"The porphyrias are metabolic disorders, each arising from a predominantly hereditary deficiency of one of the eight enzymes of the porphyrinheme biosynthetic pathway.","image":"./images/BologniaChapters/Porphyria.webp"},{"id":51,"title":"Calcifying and Ossifying Disorders of the Skin","description":"Calcifying disorders of the skin are generally divided into five broad categories: dystrophic, metastatic, idiopathic, iatrogenic, and mixed calcification.","image":"./images/BologniaChapters/Calcifying .jpg"},{"id":52,"title":"Nutritional Diseases","description":"Proper nutrition is fundamental to human life. From fetal development to adulthood, proper nutrition is essential for survival, physical growth, mental development, productivity, and overall health.","image":"./images/BologniaChapters/Nutritional Diseases.png"},{"id":53,"title":"Graft-versus-Host Disease","description":"Graft-versus-host disease (GVHD) is a multi-organ disorder most commonly due to the transfer of foreign donor hematopoietic stem cells into a host recipient via an allogeneic hematopoietic stem cell transplant (HSCT).","image":"./images/BologniaChapters/Graft-versus-Host Disease.webp"},{"id":54,"title":"Dermatologic Manifestations in Patients with Systemic Disease","description":"Skin disease is often associated with internal manifestations, e.g. psoriatic arthritis, and there are many cutaneous disorders that are traditionally associated with systemic disease","image":"./images/BologniaChapters/Dermatologic Manifestations in Patients.webp"},{"id":55,"title":"Basic Principles of Genetics","description":"The complete sequencing of the human genome, with an estimated size of 3.2 gigabases (Gb) containing ~20 00025 000 genes, represented a major scientific accomplishment.","image":"./images/BologniaChapters/Basic Principles of Genetics.jpg"},{"id":56,"title":"Genetic Basis of Cutaneous Diseases","description":"In 1987, deletions in the steroid sulfatase gene were found to underlie X-linked recessive ichthyosis1. This heralded an era of tremendous progress in the elucidation of the genetic bases of inherited skin disorders, made possible by rapid advances in molecular technology.","image":"./images/BologniaChapters/Genetic Basis of Cutaneous Diseases.jpeg"},{"id":57,"title":"Biology of Keratinocytes","description":"The main function of the epidermis is to provide a barrier between the organism and the environment.","image":"./images/BologniaChapters/Biology of Keratinocytes.jpeg"},{"id":58,"title":"Ichthyoses, Erythrokeratodermas, and Related Disorders","description":"Ichthyoses and erythrokeratodermas are disorders of cornification in which abnormal differentiation and desquamation of the epidermis result in a defective cutaneous barrier.","image":"./images/BologniaChapters/Erythrokeratodermas.jpeg"},{"id":59,"title":"Palmoplantar Keratodermas","description":"Palmoplantar keratodermas (PPKs) represent a heterogeneous group of hereditary and acquired disorders of cornification characterized by prominent hyperkeratosis of the skin on the palms and soles.","image":"./images/BologniaChapters/Palmoplantar Keratodermas.jpeg"},{"id":60,"title":"Darier Disease and HaileyHailey Disease","description":"Darier disease is an autosomal dominant genodermatosis with characteristic mucocutaneous findings such as keratotic papules on the upper trunk and longitudinal erythronychia.","image":"./images/BologniaChapters/Darier Disease and HaileyHailey Disease.jpeg"},{"id":61,"title":"Primary Immunodeficiencies","description":"Primary immunodeficiencies represent a heterogeneous group of inherited disorders characterized by immune system defects that result in susceptibility to infections as well as additional manifestations such as autoimmunity, allergy, and malignancy.","image":"./images/BologniaChapters/Immunodeficiencies.webp"},{"id":62,"title":"Neurofibromatosis and Tuberous Sclerosis Complex","description":"Neurofibromatosis (NF) and tuberous sclerosis complex (TSC) are neurocutaneous disorders, or phakomatoses. They are characterized by cutaneous lesions as well as peripheral and/or central nervous system neoplasms.","image":"./images/BologniaChapters/Neurofibromatosis and Tuberous.png"},{"id":63,"title":"Mosaicism and Linear Lesions","description":"The term mosaic is used to describe individuals composed of cells of different genotypes that are derived from a genetically homogeneous zygote.","image":"./images/BologniaChapters/Mosaicism and Linear Lesions.webp"},{"id":64,"title":"Other Genodermatoses","description":"Disorders characterized by cutaneous or mucosal tumors in conjunction with a variety of extracutaneous neoplasias, both benign and malignant.","image":"./images/BologniaChapters/Other Genodermatoses.jpeg"},{"id":65,"title":"Developmental Anomalies","description":"Developmental anomalies are a diverse group of congenital disorders that result from faulty morphogenesis.","image":"./images/BologniaChapters/Developmental Anomalies.jpg"},{"id":66,"title":"Melanocyte Biology","description":"In order to understand the underlying pathophysiology of cutaneous disorders of hypopigmentation and hyperpigmentation, as well as the process of normal physiologic pigment production, an appreciation of the structure and function of the melanocyte is required.","image":"./images/BologniaChapters/Melanocyte Biology.jpg"},{"id":67,"title":"Vitiligo and Other Disorders of Hypopigmentation","description":"Leukoderma and hypopigmentation are general terms used to designate disorders characterized by lightening of the skin.","image":"./images/BologniaChapters/Vitiligo and Other Disorders.jpg"},{"id":68,"title":"Disorders of Hyperpigmentation","description":"Skin color depends upon the amount and distribution of melanin and other pigments such as hemoglobin, which can influence light absorption, reflection, and scattering.","image":"./images/BologniaChapters/Disorders of Hyperpigmentation.jpeg"},{"id":69,"title":"Biology of Hair and Nails","description":"Skin adnexa in mammals develop through evolutionarily conserved mechanisms. Similar processes lead to modifications of epithelial cells and proteins in order to form functional structures such as hairs, feathers, nails, glands, and teeth.","image":"./images/BologniaChapters/Biology of Hair and Nails.jpg"},{"id":70,"title":"Alopecias","description":"Androgenetic alopecia (AGA) is an androgen-dependent disorder charac- terized by the conversion of terminal scalp hairs into miniaturized vellus hairs in a characteristic pattern.","image":"./images/BologniaChapters/Alopecias.jpeg"},{"id":71,"title":"Hypertrichosis and Hirsutism","description":"Hypertrichosis describes the growth of excessive hair anywhere onthe body.","image":"./images/BologniaChapters/Hypertrichosis and Hirsutism.jpeg"},{"id":72,"title":"Nail Disorders","description":"The clinical signs of various nail disorders depend upon the component of the nail apparatus that has been affected: nail plate alterations are due to matrix damage whereas nail plate detachment and/or uplifting arise from dyfunction of the hyponychium or nail bed.","image":"./images/BologniaChapters/Nail Disorders.jpeg"},{"id":73,"title":"Oral Diseases","description":"From both a clinical and histologic standpoint, the oral cavity is a diverse anatomic region reflecting its various functions and environmental interactions.","image":"./images/BologniaChapters/Oral Diseases.webp"},{"id":74,"title":"Anogenital (Non-venereal) Diseases","description":"The diagnosis and management of skin diseases in the anogenital region may be complex. The juxtaposition of urinary, genital, and alimentary tracts gives rise to special considerations at this site","image":"./images/BologniaChapters/Anogenital (Non-venereal) Diseases.webp"},{"id":75,"title":"Bacterial Diseases","description":"Impetigo is a common, contagious, superficial skin infection that can present in non-bullous and bullous forms","image":"./images/BologniaChapters/Bacterial Diseases.jpeg"},{"id":76,"title":"Mycobacterial Infections","description":"In 1896, the name 'mycobacteria' was given to a large group of bacteria that produce filamentous pellicles similar to molds when grown in liquid media.","image":"./images/BologniaChapters/Mycobacterial Infections.jpg"},{"id":77,"title":"Rickettsial Diseases","description":"Members of the order Rickettsiales are small, obligately intracellular, Gram-negative bacteria that reside within an arthropod host for at least part of their life cycle","image":"./images/BologniaChapters/Rickettsial Diseases.jpeg"},{"id":78,"title":"Fungal Diseases","description":"Superficial mycoses are due to fungi that only invade fully keratinized tissues, i.e. stratum corneum, hair, and nails.","image":"./images/BologniaChapters/Fungal Diseases.jpeg"},{"id":79,"title":"Cutaneous Manifestations of HIV Infection","description":"Mucocutaneous disorders not only provide important clues to the diagnosis of HIV disease and significantly impact quality of life, but they also serve as markers of progression and possible associated systemic disease.","image":"./images/BologniaChapters/Cutaneous Manifestations of HIV Infection.jpeg"},{"id":80,"title":"Human Papillomaviruses","description":"Papillomaviruses are a large group of DNA viruses that are widely distributed in animals and humans, most commonly inducing benign papillomas or warts","image":"./images/BologniaChapters/Human Papillomaviruses.jpeg"},{"id":81,"title":"Human Herpesviruses","description":"The human herpesviruses (HHVs) are categorized into three groups: alpha, beta, and gamma herpesvirinae.","image":"./images/BologniaChapters/Human Herpesviruses.jpeg"},{"id":82,"title":"Other Viral Diseases","description":"Viral infections are frequently associated with cutaneous manifesta- tions, especially in children, in whom they are the most common cause of exanthems.","image":"./images/BologniaChapters/Other Viral Diseases.jpeg"},{"id":83,"title":"Sexually Transmitted Infections","description":"The term 'venereal diseases' was historically used to refer to infections that are sexually transmitted, i.e. syphilis, gonorrhea, chancroid, lymphogranuloma venereum, and granuloma inguinale.","image":"./images/BologniaChapters/Sexually Transmitted Infections.jpeg"},{"id":84,"title":"Protozoa and Worms","description":"Leishmaniasis encompasses a spectrum of chronic infections in humans and several animal species. It is caused by over 20 species of Leishmania.","image":"./images/BologniaChapters/Protozoa and Worms.jpg"},{"id":85,"title":"Infestations","description":"The scabies mite continues to plague all countries of the world. An estimated 150200 million individuals are affected globally, with an overall worldwide prevalence of ~2.5%.","image":"./images/BologniaChapters/Infestations.jpeg"},{"id":86,"title":"Bites and Stings","description":"Insect bites and stings are prevalent throughout the world. In temperate climates they are primarily a seasonal phenomenon, although indoor infestations can persist year-round.","image":"./images/BologniaChapters/Bites and Stings.webp"},{"id":87,"title":"Ultraviolet Radiation","description":"Dermatologists are confronted daily with the effects of UV light on the skin and often deal with them in a seemingly contradictory way.","image":"./images/BologniaChapters/Ultraviolet Radiation.jpeg"},{"id":88,"title":"Photodermatologic Disorders","description":"All skin phototypes react to sunlight because the skin contains molecules (chromophores) capable of absorbing ultraviolet radiation (UVR) or visible light.","image":"./images/BologniaChapters/Photodermatologic Disorders.webp"},{"id":89,"title":"Environmental and Sports-Related Skin Diseases","description":"Despite technologic advances that have allowed humans to live, work and play in most of the environments on this planet, deliberate or inadvertent exposure to those environments may subject individuals to injury.","image":"./images/BologniaChapters/Environmental and Sports-Related.jpg"},{"id":90,"title":"Signs of Substance Use Disorder","description":"The 2013 Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) defines substance use disorder as 'a cluster of cognitive, behavioral, and physiological symptoms indicating that the individual continues using the substance despite significant substance-related problems'","image":"./images/BologniaChapters/Signs of Substance Use Disorder.webp"},{"id":91,"title":"Skin Signs of Abuse","description":"Child abuse encompasses the broad spectrum of non-accidental maltreatment of children, including physical, emotional, and sexual abuse as well as neglect.","image":"./images/BologniaChapters/Skin Signs of Abuse.jpeg"},{"id":92,"title":"Histiocytoses","description":"The histiocytoses represent a group of proliferative disorders that share a common CD34+ progenitor cell in the bone marrow.","image":"./images/BologniaChapters/Histiocytoses.jpg"},{"id":93,"title":"Xanthomas","description":"Cutaneous xanthomas develop as a result of deposition of lipid in the dermis, primarily within macrophages (foam cells) but also extracellularly.","image":"./images/BologniaChapters/Xanthomas.jpeg"},{"id":94,"title":"Non-infectious Granulomas","description":"The granulomatous diseases discussed in this chapter may be defined as having an inflammatory cutaneous infiltrate in which histiocytes are the preponderant inflammatory cells.","image":"./images/BologniaChapters/Non-infectious Granulomas.jpeg"},{"id":95,"title":"Foreign Body Reactions","description":"Literally, any material  living or non-living  introduced into the body is a 'foreign body' and is treated by our immune system as 'non-self' in order to elicit an appropriate response.","image":"./images/BologniaChapters/Foreign Body Reactions.jpg"},{"id":96,"title":"Biology of the Extracellular Matrix","description":"The different types of extracellular matrix (ECM) represent specifically organized assemblies of the matrix macromolecules.","image":"./images/BologniaChapters/Biology of the Extracellular Matrix.png"},{"id":97,"title":"Perforating Diseases","description":"The perforating diseases are a group of papulonodular skin disorders characterized by keratotic plugs or crusts in which dermal connective tissue 'perforates' or is eliminated through the epidermis","image":"./images/BologniaChapters/Perforating Diseases.jpg"},{"id":98,"title":"Heritable Disorders of Connective Tissu","description":"Heritable connective tissue diseases manifest with a broad range of phenotypic abnormalities, including variable degrees of cutaneous and extracutaneous involvement.","image":"./images/BologniaChapters/Heritable Disorders of Connective Tissu.png"},{"id":99,"title":"Dermal Hypertrophies","description":"All wounds heal with some degree of scar formation, but the mechanisms that govern whether the result will be a fine thin scar, a prominent hypertrophic scar, or a tumor-like keloid remain unclear.","image":"./images/BologniaChapters/Dermal Hypertrophies.webp"},{"id":100,"title":"Atrophies of Connective Tissue","description":"Atrophies of the skin that are due to a diminution or loss of collagen and/or elastic fibers are discussed in this chapter.","image":"./images/BologniaChapters/Atrophies of Connective Tissue.png"},{"id":101,"title":"Panniculitis","description":"Panniculitis is a diagnostically challenging arena for both dermatologists and pathologists.","image":"./images/BologniaChapters/Panniculitis.jpeg"},{"id":102,"title":"Lipodystrophies","description":"Clinically, lipodystrophy can be broadly classified into inherited or acquired forms and then further subclassified based on the extent of fat loss, in conjunction with genetic mutations, age of onset, and systemic manifestations","image":"./images/BologniaChapters/Lipodystrophies.jpg"},{"id":103,"title":"Vascular Biology","description":"Blood vessels are essential for supplying sufficient oxygen and nutrients, maintaining normal tissue homeostasis and function, and meeting the increased nutritional needs in various pathologic conditions.","image":"./images/BologniaChapters/Vascular Biology.jpg"},{"id":104,"title":"Infantile Hemangiomas","description":"Infantile hemangiomas (IHs) are benign proliferations of endothelial cells and their supporting tissues and they represent the most common tumors arising in the neonatal period.","image":"./images/BologniaChapters/Infantile Hemangiomas.jpg"},{"id":105,"title":"Vascular Malformations","description":"According to the classification system adopted by the International Society for the Study of Vascular Anomalies (ISSVA), there are two types of vascular anomalies: vascular tumors (most commonly the infantile hemangioma) and vascular malformations.","image":"./images/BologniaChapters/Vascular Malformations.jpeg"},{"id":106,"title":"Ulcers","description":"A chronic wound is defined as one that fails to progress through a normal orderly and timely sequence of repair or a wound that passes through the repair process without restoring a functional result","image":"./images/BologniaChapters/Ulcers.jpg"},{"id":107,"title":"Other Vascular Disorders","description":"This chapter will cover several disorders of the skin vasculature, including livedo reticularis, flushing, and erythromelalgia, as well as vascular ectasias such as telangiectasias and venous lakes.","image":"./images/BologniaChapters/Other Vascular Disorders.jpg"},{"id":108,"title":"Principles of Cutaneous Tumor Biology","description":"Worldwide, skin cancer is the most common type of cancer in fair-skinned individuals. This chapter will introduce our current under- standing of the fundamental principles underlying cancer development.","image":"./images/BologniaChapters/Principles of Cutaneous Tumor Biology.png"},{"id":109,"title":"Actinic Keratosis, Basal Cell Carcinoma, and Squamous Cell Carcinoma","description":"Keratinocyte carcinomas, specifically basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC), represent the most frequently observed malignancy among White individuals.","image":"./images/BologniaChapters/Actinic Keratosis, Basal Cell Carcinoma.jpeg"},{"id":110,"title":"Benign Epidermal Tumors and Proliferations","description":"Solar lentigines are present in 90% of White individuals over the age of 60 years, and their incidence increases with advancing age. They also occur, but less often, in younger individuals and in Asians as a consequence of acute or chronic sun exposure.","image":"./images/BologniaChapters/Benign Epidermal Tumors and Proliferations.webp"},{"id":111,"title":"Cysts","description":"Cysts are common cutaneous lesions. Patients with cysts may present to clinicians because of medical or cosmetic concerns, or due to discomfort from mechanical irritation or inflammation of the cyst.","image":"./images/BologniaChapters/Cysts.jpg"},{"id":112,"title":"Adnexal Neoplasms","description":"The nosology of adnexal neoplasms has been confused for decades, and a key problem has been the lack of a logical classification scheme.","image":"./images/BologniaChapters/Adnexal Neoplasms.png"},{"id":113,"title":"Benign Melanocytic Neoplasms and Melanotic Lesions","description":"Melanocytic nevi are benign melanocytic neoplasms that most commonly develop within the epidermis or dermis.","image":"./images/BologniaChapters/Benign Melanocytic Neoplasms.jpeg"},{"id":114,"title":"Melanoma","description":"Melanoma is a malignant tumor that arises from melanocytes and is most commonly cutaneous in origin. It can also arise on mucosal surfaces (e.g. oral, conjunctival, vaginal) and within the uveal tract of the eye as well as the leptomeninges.","image":"./images/BologniaChapters/Melanoma.jpeg"},{"id":115,"title":"Vascular Neoplasms and Neoplastic-Like Proliferations","description":"In this chapter we use the term neoplasm synonymously with tumor in a general, albeit imperfect, sense, consistent with its common usage: an abnormal proliferation ('new growth') of cells that appears to be relatively autonomous (i.e. not reactive).","image":"./images/BologniaChapters/Vascular Neoplasms and.webp"},{"id":116,"title":"Neural and Neuroendocrine Neoplasms (Other than Neurofibromatosis)","description":"In the past, neural tumors were often misdiagnosed histopathologically because of confusing classifications. As a result, their clinical relevance was poorly understood.","image":"./images/BologniaChapters/Neural and Neuroendocrine Neoplasms.jpg"},{"id":117,"title":"Fibroblastic, Myofibroblastic, and 'Fibrohistiocytic' Proliferations and Neoplasms of the Skin","description":"Skin tags are very common, presenting as soft, skin-colored to slightly hyperpigmented, pedunculated papules that favor the neck, axilla, and groin","image":"./images/BologniaChapters/Fibroblastic, Myofibroblastic, and.jpeg"},{"id":118,"title":"Smooth Muscle, Adipose, and Cartilage Neoplasms","description":"Smooth muscle, adipose, and cartilage neoplasms arising in the skin and subcutis comprise a wide spectrum of benign and malignant neoplasms that show myocyte, adipocyte, and chondrocyte differentiation, respectively.","image":"./images/BologniaChapters/Smooth Muscle, Adipose, and Cartilage.webp"},{"id":119,"title":"Mastocytosis","description":"Mastocytosis represents a spectrum of clinical disorders with a common phenotype of tissue mast cell hyperplasia that can involve the skin, bone marrow, and other organs.","image":"./images/BologniaChapters/Mastocytosis.jpeg"},{"id":120,"title":"B Cell Lymphomas of the Skin","description":"Although B cell lymphomas represent the majority of non-Hodgkin lymphomas (NHLs) arising within lymph nodes, they represent a minority of the NHLs whose primary site is the skin.","image":"./images/BologniaChapters/B Cell Lymphomas of the Skin.jpeg"},{"id":121,"title":"Cutaneous T Cell Lymphoma","description":"The term cutaneous T cell lymphoma (CTCL) describes a heterogeneous group of neoplasms of skin-homing T cells that show considerable variation in clinical presentation, histologic appearance, immunophenotype, and prognosis.","image":"./images/BologniaChapters/Cutaneous T Cell Lymphoma.jpg"},{"id":122,"title":"Other Lymphoproliferative and Myeloproliferative Diseases","description":"Benign lymphocytic infiltrate of the skin remains a controversial entity. Several authors believe it is a variant of cutaneous lupus erythematosus (primarily LE tumidus).","image":"./images/BologniaChapters/Other Lymphoproliferative and.jpeg"},{"id":123,"title":"Cutaneous Metastases","description":"Given their prognostic implications, cutaneous metastases represent an important dermatologic entity. The skin is not a particularly common site for metastatic spread, and because the clinical appearance of cutaneous metastases can mimic more common disorders.","image":"./images/BologniaChapters/Cutaneous Metastases.jpeg"},{"id":124,"title":"Public Health and Dermatology","description":"As a dermatologist walks into the examination room of the patient, several diagnostic possibilities likely come to mind. The patients history, additional physical findings, and other clues help narrow the differential diagnosis","image":"./images/BologniaChapters/Public Health and Dermatology.jpg"},{"id":125,"title":"Skin Barrier","description":"The skin provides the largest interface between the human body and the external environment. Therefore, one of its most important functions is to prevent ingress of potentially harmful exogenous substances (outside-in barrier).","image":"./images/BologniaChapters/Skin Barrier.jpg"},{"id":126,"title":"Glucocorticoids","description":"When examining the chemical structure of glucocorticoids, it is important to recognize that active agents such as hydrocortisone  have a hydroxyl group at the 11 position.","image":"./images/BologniaChapters/Glucocorticoids.jpg"},{"id":127,"title":"Retinoids","description":"Vitamin A (retinol) and related compounds with either structural (retinol derivative) or functional (vitamin A activity) similarities are known as retinoids","image":"./images/BologniaChapters/Retinoids.jpg"},{"id":128,"title":"Antimicrobial Drugs","description":"With hundreds of antibiotics now available, physicians have abundant therapeutic options, which can potentially be confusing and overwhelming.","image":"./images/BologniaChapters/Antimicrobial Drugs.jpeg"},{"id":129,"title":"Systemic Immunomodulators","description":"Interferons (IFNs) are a family of secretory glycoproteins produced by most eukaryotic cells in response to a variety of viral and non-viral stimuli.","image":"./images/BologniaChapters/Systemic Immunomodulators.jpg"},{"id":130,"title":"Other Topical Medications","description":"Topical medications are fundamental in the armamentarium of dermatologic therapeutics, offering the ability to deliver treatment directly to the skin while limiting systemic side effects.","image":"./images/BologniaChapters/Other Topical Medications.jpeg"},{"id":131,"title":"Other Systemic Drugs","description":"This chapter is designed to be a broad overview of selected systemic therapies for dermatologic diseases. It provides an historical perspective for each drug, a discussion of its mechanism of action and side effects, and touches on indications and clinical use.","image":"./images/BologniaChapters/Other Systemic Drugs.png"},{"id":132,"title":"Drug Interactions","description":"There are two concerns in drug safety: drug reactions and drug inter- actions. When multiple medications are prescribed, drug interactions become an important safety and efficacy consideration for patients and physicians alike.","image":"./images/BologniaChapters/Drug Interactions.jpg"},{"id":133,"title":"Sunscreens and Photoprotection","description":"Evidence exists that even ancient civilizations sought protection from the damaging effects of the sun. The concept of excessive sun exposure as unhealthy or at least cosmetically unacceptable eventually spread to Northern Europe, especially among the aristocracy, and continued into the nineteenth century until the period of the Industrial Revolution","image":"./images/BologniaChapters/Sunscreens and Photoprotection.png"},{"id":134,"title":"Complementary and Alternative Medicine","description":"Complementary and alternative medicine (CAM) represents a diverse set of healthcare systems, practices, and treatments that are grouped together because they are not considered part of conventional medicine","image":"./images/BologniaChapters/Complementary and Alternative Medicine.jpg"},{"id":135,"title":"Ultraviolet Therapy","description":"Over the past half-century, phototherapy has greatly influenced treatment concepts in dermatology. Studies focusing on the effects of electromagnetic radiation on the skin have induced fruitful collaborations between basic scientists and clinicians.","image":"./images/BologniaChapters/Ultraviolet Therapy.jpg"},{"id":136,"title":"Photodynamic Therapy","description":"Photodynamic therapy (PDT) requires the sequential administration of a photosensitizing agent that is then activated by light in order to generate singlet oxygen within biologic tissues","image":"./images/BologniaChapters/Photodynamic Therapy.png"},{"id":137,"title":"Lasers and Other Energy-Based Technologies  Principles and Skin Interactions","description":"LASER is an acronym for light amplification by stimulated emission of radiation. It is a physical process that can be explained by Einsteins principles of electromagnetic radiation","image":"./images/BologniaChapters/Laser.jpg"},{"id":138,"title":"Lasers and Other Energy-Based Therapies","description":"This chapter considers laser and light applications for both medical and aesthetic purposes as related to the skin. Anderson and Parrish developed the concept of selective photothermolysis.","image":"./images/BologniaChapters/Lasers and Other Energy-Based Therapies.jpg"},{"id":139,"title":"Cryosurgery","description":"Reducing the temperature of the skin was initially done to provide anesthesia or lessen inflammation. With the advent of potent cryogens, selective destruction of tissue became possible.","image":"./images/BologniaChapters/Cryosurgery.jpeg"},{"id":140,"title":"Radiotherapy","description":"In dermatology, the primary role of radiotherapy is to treat basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (SCC).","image":"./images/BologniaChapters/Radiotherapy.jpg"},{"id":141,"title":"Electrosurgery","description":"Modern electrosurgery encompasses a group of techniques by which high-frequency alternating electrical current is applied to living tissues in order to achieve superficial coagulation, deep coagulation, or cutting of the skin.","image":"./images/BologniaChapters/Electrosurgery.jpeg"},{"id":142,"title":"Biology of Wound Healing","description":"Restoration of skin integrity and homeostasis following injury is a fundamental process that ensures survival. The primary goal of the wound healing response is to promptly re-establish a functional skin barrier.","image":"./images/BologniaChapters/Biology of Wound Healing.jpg"},{"id":143,"title":"Surgical Anatomy of the Head and Neck","description":"It is possible to pinpoint underlying anatomic structures of the head and neck by observing surface anatomy. The bony structure of the face serves as a simple anatomic framework.","image":"./images/BologniaChapters/Surgical Anatomy of the Head and Neck.jpeg"},{"id":144,"title":"Anesthesia","description":"Effective anesthesia is an essential component of dermatologic surgery, and almost all dermatologic surgical procedures can be performed under local anesthesia.","image":"./images/BologniaChapters/Anesthesia.jpeg"},{"id":145,"title":"Wound Closure Materials and Instruments","description":"As dermatologic surgery continues to expand as a specialty, so does the variety of materials and instruments that are available to facilitate the ever-growing complexity of tissue excision and repair that are encoun- tered during its practice.","image":"./images/BologniaChapters/Suturing-Instruments.png"},{"id":146,"title":"Dressings","description":"Dermatologists are involved in the care of a variety of acute and chronic wounds including surgical incisions. The range of treatment options is substantial and expanding, providing therapeutic flexibility.","image":"./images/BologniaChapters/Dressings.jpeg"},{"id":147,"title":"Biopsy Techniques and Basic Excisions","description":"The cornerstone of dermatologic diagnosis is the correlation of clinical and histologic findings. A biopsy procedure is required in order to obtain tissue for pathologic examination.","image":"./images/BologniaChapters/Biopsy Techniques and Basic Excisions.webp"},{"id":148,"title":"Flaps","description":"Cutaneous reconstruction has played an important role in the estab- lishment of dermatologic surgery as a vital discipline within dermatology.","image":"./images/BologniaChapters/Flaps.png"},{"id":149,"title":"Grafts","description":"Skin grafting procedures originated approximately 2500 to 3000 years ago, when surgeons of the Hindu Tilemaker caste replaced noses amputated as punishment for theft and adultery with skin grafts harvested from the gluteal region","image":"./images/BologniaChapters/Grafts.png"},{"id":150,"title":"Nail Surgery","description":"An accurate diagnosis of nail disorders often requires clinicopathologic correlation. When performing a biopsy of the nail unit, it is important that: (1) the most appropriate surgical procedure be performed correctly; (2) there is precise handling of the specimen in the histopathology laboratory; and (3) a dermatopathologist with knowledge of the nuances of nail pathology examine the tissue","image":"./images/BologniaChapters/Nail Surgery.jpeg"},{"id":151,"title":"Mohs Micrographic Surgery","description":"Mohs micrographic surgery (MMS) is a specialized method for skin cancer removal that combines surgery with pathology resulting in an excellent cure rate.","image":"./images/BologniaChapters/Mohs Micrographic Surgery.jpeg"},{"id":152,"title":"Surgical Complications and Optimizing Outcomes","description":"Surgical complications are deviations from the original planned outcome, usually resulting from multiple interrelated events","image":"./images/BologniaChapters/Surgical Complications and.jpg"},{"id":153,"title":"Evaluation of Beauty and the Aging Face","description":"Recognizing beauty and understanding its significance may be far easier than actually defining it. Anthropometry represents the quantitative measurement of facial features and an assessment of resultant ratios","image":"./images/BologniaChapters/Evaluation of Beauty and the Aging Face.webp"},{"id":154,"title":"Cosmetics and Cosmeceuticals","description":"Cosmetics and skin care products are assuming an increasingly important role within dermatology as the sophistication of raw materials and the resulting formulations provide for the development of products that impact the functioning of the skin","image":"./images/BologniaChapters/Cosmetics and Cosmeceuticals.webp"},{"id":155,"title":"Chemical and Mechanical Skin Resurfacing","description":"Resurfacing procedures to improve the health and appearance of the skin have been utilized by humans for thousands of years. The ancient Egyptians applied various chemicals to the skin and may have even used abrasives like sandpaper to obtain a smoother skin surface","image":"./images/BologniaChapters/Chemical and Mechanical Skin Resurfacing.webp"},{"id":156,"title":"Phlebology and Treatment of Leg Veins","description":"Varicose and telangiectatic leg veins increase in extent and severity with increasing age. The evolution of safe and effective treatment options has made sclerotherapy, ambulatory phlebectomy, endovenous laser ablation (LA), and radiofrequency (RF) ablation expanding areas within dermatologic surgery","image":"./images/BologniaChapters/Phlebology and Treatment of Leg Veins.jpg"},{"id":157,"title":"Body Contouring: Liposuction and Non-invasive Modalities","description":"Liposuction is an effective method for surgically improving localized areas of excess subcutaneous fat. Liposuction has undergone many changes since initial reports in the late 1970s","image":"./images/BologniaChapters/Body Contouring: Liposuction and.webp"},{"id":158,"title":"Hair Restoration","description":"Hair frames our face and its length, color, and style reflect our personality and how we perceive ourselves. The framing preserves a youthful facial appearance by shortening the face and returning the viewers focus to the center of the face.","image":"./images/BologniaChapters/Hair Restoration.jpg"},{"id":159,"title":"Injectable Soft Tissue Augmentation","description":"Interventions for the aging face can be broadly categorized into the four 'Rs' of facial rejuvenation: Resurfacing (chemical peels, dermabrasion, and ablative and non-ablative lasers); Redraping (the various pulling and lifting facial surgical procedures); Relaxing (chemodenervation with paralytic agents); and Replacement/Recontouring (the use of filling agents for superficial and deep soft tissue augmentation)","image":"./images/BologniaChapters/Injectable Soft Tissue Augmentation.jpeg"},{"id":160,"title":"Botulinum Toxin","description":"Botulinum toxin (BoNT) injections are commonly used to improve facial aesthetics by smoothing hyperdynamic rhytides of the face and neck. In recent years, the use of BoNT has evolved to reflect a more three-dimensional approach to facial rejuvenation, often in combination with soft-tissue augmentation or other restorative procedures.","image":"./images/BologniaChapters/Botulinum Toxin.jpg"}]`),Zr=12;function vm(){const[r,c]=b.useState(1),l=Math.ceil(xd.length/Zr),u=(r-1)*Zr,m=xd.slice(u,u+Zr);return E.jsx("main",{className:"min-h-screen bg-gray-900 px-6 py-10",children:E.jsxs("div",{className:"mx-auto max-w-7xl",children:[E.jsxs("div",{className:"mb-10",children:[E.jsx("h1",{className:"text-3xl font-bold text-white",children:"Bolognia  Quiz Chapters"}),E.jsx("p",{className:"mt-2 text-gray-400",children:"Select a chapter to start practicing."})]}),E.jsx("div",{className:"grid gap-6 sm:grid-cols-2 lg:grid-cols-3",children:m.map(h=>E.jsxs("div",{className:"overflow-hidden rounded-lg border border-white/10 bg-gray-800 hover:border-indigo-500/50 transition",children:[E.jsx("img",{src:`/React-Derma-Quiz/${h.image}`,alt:h.title,className:"h-40 w-full object-cover"}),E.jsxs("div",{className:"p-6",children:[E.jsxs("h2",{className:"text-lg font-semibold text-white",children:[h.id,". ",h.title]}),E.jsx("p",{className:"mt-2 text-sm text-gray-400",children:h.description}),E.jsx(Gi,{to:`/QuizTest/${h.id}`,children:E.jsx("button",{className:"mt-6 w-full rounded-md bg-indigo-500 px-4 py-2 text-sm font-semibold text-white hover:bg-indigo-400 transition",children:"Start Quiz "})})]})]},h.id))}),E.jsxs("div",{className:"mt-10 flex items-center justify-center gap-2",children:[E.jsx("button",{disabled:r===1,onClick:()=>c(h=>h-1),className:"rounded-md px-3 py-1.5 text-sm font-medium text-white disabled:opacity-40 hover:bg-gray-800",children:" Prev"}),Array.from({length:l},(h,v)=>v+1).slice(Math.max(0,r-3),Math.min(l,r+2)).map(h=>E.jsx("button",{onClick:()=>c(h),className:`rounded-md px-3 py-1.5 text-sm font-medium ${h===r?"bg-indigo-500 text-white":"text-gray-300 hover:bg-gray-800"}`,children:h},h)),E.jsx("button",{disabled:r===l,onClick:()=>c(h=>h+1),className:"rounded-md px-3 py-1.5 text-sm font-medium text-white disabled:opacity-40 hover:bg-gray-800",children:"Next "})]})]})})}const xm=JSON.parse(`[{"id":1,"chapterId":1,"question":"What analogy is frequently used to provide a conceptual framework for organising the thousands of skin diseases?","options":["A layered geological strata model","A tree with a trunk, branches, and leaves","A complex interconnected web","A binary flowchart system"],"correctIndex":1,"explanation":"A useful analogy for organizing the numerous skin diseases is that of a tree, which includes a trunk, major branches, minor branches, twigs, and leaves [1]."},{"id":2,"chapterId":1,"question":"What are the two major early 'branch points' used to classify dermatologic disorders based on etiology?","options":["Infectious versus Non-Infectious","Autoimmune versus Metabolic","Inflammatory versus Neoplastic","Vesiculobullous versus Papulosquamous"],"correctIndex":2,"explanation":"An early and major 'branch point' in classifying skin diseases involves deciding if a condition is 'neoplastic' (benign or malignant) or 'inflammatory' (infectious or non-infectious) [2, 3]."},{"id":3,"chapterId":1,"question":"In dermatology, what does the term 'morphology' primarily refer to?","options":["The underlying etiology of the lesion","The general appearance of a skin lesion","The functional capacity of the skin","The microscopic findings upon biopsy"],"correctIndex":1,"explanation":"Morphology refers to the general appearance of a skin lesion, regardless of the underlying etiology or pathophysiology [4, 5]."},{"id":4,"chapterId":1,"question":"Which characteristic differentiates Macules and Patches from Papules and Plaques?","options":["Presence of hyperpigmentation","Size (less than 1 cm vs greater than 1 cm)","Palpability (flat vs elevated)","Involvement of the dermis"],"correctIndex":2,"explanation":"The key difference between macules/patches and papules/plaques is that macules and patches are flush with the surrounding skin and cannot be appreciated by palpation, whereas papules and plaques must be palpable [6]."},{"id":5,"chapterId":1,"question":"A small, fluid-filled, elevated, and circumscribed lesion less than 1 cm in diameter is known as a:","options":["Bulla","Wheal","Vesicle","Nodule"],"correctIndex":2,"explanation":"A Vesicle is elevated, circumscribed, less than 1 cm in diameter, and filled with fluid (clear, serous, or hemorrhagic) [7]."},{"id":6,"chapterId":1,"question":"Which primary lesion is defined as a transient elevation of the skin caused by dermal edema?","options":["Papule","Nodule","Bulla","Wheal"],"correctIndex":3,"explanation":"A Wheal is a transient elevation of the skin that occurs due to dermal edema [7]."},{"id":7,"chapterId":1,"question":"What size criterion defines a Nodule, distinguishing it from a Papule?","options":["A nodule is always less than 1 cm.","A nodule is greater than 1 cm, usually.","A nodule is defined by epidermal involvement.","A nodule must be soft to palpation."],"correctIndex":1,"explanation":"A Nodule is palpable, circumscribed, has a larger volume than a papule, and is usually greater than 1 cm in diameter [8]."},{"id":8,"chapterId":1,"question":"What is the defining characteristic of a Patch?","options":["Palpable, >1 cm, due to epidermal thickening.","Flat (non-palpable), >1 cm, differing in color from surrounding skin.","Flat (non-palpable), <1 cm, due to vascular changes.","Elevated, >1 cm, due to dermal edema."],"correctIndex":1,"explanation":"A Patch is flat (non-palpable), circumscribed, differs in color from the surrounding skin, and is greater than 1 cm in diameter [9]."},{"id":9,"chapterId":1,"question":"What secondary feature is characterized as 'Dried serum (serous), blood (hemorrhagic), or pus on the surface of the skin'?","options":["Scale","Fissure","Crust","Lichenification"],"correctIndex":2,"explanation":"A Crust is defined as dried serum (serous), blood (hemorrhagic), or pus on the surface of the skin, and may include bacteria [10]."},{"id":10,"chapterId":1,"question":"What is the underlying cause of a Fissure, described as a linear cleft in the skin?","options":["Full-thickness epidermal loss (ulceration)","Partial loss of the epidermis (erosion)","Marked drying, skin thickening, and loss of elasticity","Exogenous injury to the epidermis"],"correctIndex":2,"explanation":"A Fissure is a linear cleft in the skin resulting from marked drying, skin thickening, and loss of elasticity [11, 12]."},{"id":11,"chapterId":1,"question":"What determines if the redness (erythema) of a skin lesion is 'non-blanchable' upon pressure?","options":["Increased epidermal thickness","Vasodilation and increased blood flow","Infiltration of inflammatory cells","Extravasation of erythrocytes into the skin"],"correctIndex":3,"explanation":"If erythema is non-blanchable (i.e. does not disappear with pressure), it is caused by the extravasation of erythrocytes into the skin (purpura) [13, 14]."},{"id":12,"chapterId":1,"question":"Necrosis of the skin, resulting from conditions like vascular compromise or vasculitis, typically results in which color?","options":["White","Yellow","Black (or graywhite to purple)","Green"],"correctIndex":2,"explanation":"Necrosis of the skin can result in a color ranging from graywhite to purple to black [15, 16]."},{"id":13,"chapterId":1,"question":"According to the Fitzpatrick Scale, which skin phototype is described as 'Rarely burns, tans easily'?","options":["Skin phototype II","Skin phototype III","Skin phototype IV","Skin phototype V"],"correctIndex":2,"explanation":"Skin phototype IV is characterized by Brown skin color, rarely burns, and tans easily [17]."},{"id":14,"chapterId":1,"question":"The development of new skin lesions at sites of trauma in previously unaffected skin, characteristic of psoriasis and lichen planus, is known as the:","options":["Wolf isotopic response","Locus minoris resistentiae","Koebner phenomenon (isomorphic response)","Sporotrichoid pattern"],"correctIndex":2,"explanation":"A linear arrangement of lesions can result from the trauma-induced Koebner phenomenon (an isomorphic response), observed in conditions such as psoriasis and lichen planus [18, 19]."},{"id":15,"chapterId":1,"question":"A distribution pattern encompassing the head, neck, and upper trunk, reflecting areas high in sebaceous glands, is termed:","options":["Photodistribution","Flexural distribution","Acral distribution","Seborrheic distribution"],"correctIndex":3,"explanation":"A seborrheic distribution pattern includes the head, neck, and upper trunk, which are areas rich in sebaceous glands [17]."},{"id":16,"chapterId":1,"question":"What is the primary function of a Woods lamp in dermatology?","options":["To obtain magnified views of the skin surface (dermoscopy)","To perform virtual biopsies of the epidermis (RCM)","To emit primarily ultraviolet A radiation (365 nm) for diagnosis of pigmentary and infectious disorders","To provide deep imaging of the subcutis (Ultrasound)"],"correctIndex":2,"explanation":"A Woods lamp emits primarily ultraviolet A radiation with a peak wavelength of 365 nm and is often used to assist in the diagnosis of pigmentary disorders and infectious diseases [20]."},{"id":17,"chapterId":1,"question":"Which finding during a Wood's lamp examination fluoresces coral red?","options":["Tinea capitis due to Microsporum spp.","Vitiligo","*Corynebacterium minutissimum*","*Pseudomonas aeruginosa*"],"correctIndex":2,"explanation":"*Corynebacterium minutissimum* fluoresces coral red under Wood's lamp examination [21]."},{"id":18,"chapterId":1,"question":"Which biopsy technique is the 'preferred technique' when melanoma is strongly suspected?","options":["Superficial shave biopsy","Punch biopsy (4 mm)","Curettage","Excisional biopsy"],"correctIndex":3,"explanation":"Excisional biopsy is the preferred technique when melanoma is strongly suspected [22, 23]."},{"id":19,"chapterId":1,"question":"When performing a skin biopsy for suspected autoimmune blistering disorders, where is the preferred site for sampling?","options":["The oldest, crusted lesion","The center of a large, flaccid bulla","An edematous papule/plaque or the edge of a fresh, intact vesicle/bulla plus surrounding inflamed skin","A scarred area (in the case of DLE)"],"correctIndex":2,"explanation":"For autoimmune blistering disorders, an edematous papule/plaque or an early vesicle is preferred; if only large bullae are present, biopsy the edge of the bulla plus surrounding inflamed skin [24]."},{"id":20,"chapterId":1,"question":"What type of artifact can compromise the diagnostic utility of a biopsy, particularly for lymphomas and Merkel cell carcinoma, if excessive lateral pressure is applied by forceps?","options":["Desiccation artifact","Crush artifact","Sampling error","Thermal artifact"],"correctIndex":1,"explanation":"Excessive lateral pressure by forceps on small punch biopsy specimens can distort cellular infiltrates, especially lymphomas and Merkel cell carcinoma, creating 'crush' artifact [25, 26]."},{"id":21,"chapterId":1,"question":"What is the standard stain routinely used in dermatopathology?","options":["Periodic acid Schiff (PAS)","Grocott methenamine silver (GMS)","Hematoxylin and Eosin (H&E)","Verhoeffvan Gieson (VVG)"],"correctIndex":2,"explanation":"The standard stain in dermatopathology is hematoxylin and eosin (H&E) [27]."},{"id":22,"chapterId":1,"question":"In the histopathologic classification of inflammatory skin diseases, what is the core principle of Pattern Analysis (developed by Pinkus and Ackerman)?","options":["Analyzing the age and duration of the lesion.","Identifying a major pattern based on the distribution of the inflammatory infiltrate.","Determining the patient's genetic predisposition.","Exclusively identifying neoplastic versus non-neoplastic processes."],"correctIndex":1,"explanation":"Histopathologic assessment by pattern analysis involves first identifying a major pattern, then using additional histologic features to subcategorize the disease process [28]."},{"id":23,"chapterId":1,"question":"What histopathologic pattern is characterized by inflammation and/or degenerative changes primarily at the dermalepidermal junction?","options":["Perivascular dermatitis","Spongiotic dermatitis","Interface dermatitis","Psoriasiform dermatitis"],"correctIndex":2,"explanation":"Interface dermatitis is characterized by inflammation and/or degenerative change(s) at the dermalepidermal junction [29]."},{"id":24,"chapterId":1,"question":"What is the term for the discohesion of keratinocytes resulting from the disruption of desmosomes, often leading to intraepidermal vesicles?","options":["Acanthosis","Spongiosis","Acantholysis","Parakeratosis"],"correctIndex":2,"explanation":"Acantholysis refers to the discohesion of keratinocytes due to disruption of desmosomes (intercellular connections), which can result in intraepidermal blister formation [30]."},{"id":25,"chapterId":1,"question":"Which major histopathologic pattern is defined by a regular pattern of epidermal hyperplasia (elongation of the rete ridges)?","options":["Perivascular dermatitis","Interface dermatitis","Psoriasiform dermatitis","Nodular dermatitis"],"correctIndex":2,"explanation":"The term 'psoriasiform' refers to a regular pattern of epidermal hyperplasia (elongation of the rete ridges) [31]."},{"id":26,"chapterId":1,"question":"What is the most common form of cutaneous vasculitis, mediated chiefly by neutrophils and affecting the postcapillary venule?","options":["Lymphocytic vasculitis","Granulomatous vasculitis","Medium-sized vessel vasculitis","Leukocytoclastic vasculitis"],"correctIndex":3,"explanation":"The most common form of cutaneous vasculitis is leukocytoclastic vasculitis, which is mediated by neutrophils and primarily affects the postcapillary venule [32]."},{"id":27,"chapterId":1,"question":"In nodular and diffuse dermatitis patterns, what term is used when histiocytes predominate in one or more foci?","options":["Fibrosing","Xanthomatous","Granulomatous","Septal"],"correctIndex":2,"explanation":"When histiocytes predominate in one or more foci within the nodular and diffuse pattern, the pattern is designated granulomatous [33]."},{"id":28,"chapterId":1,"question":"Which type of granuloma is typified by the predominant distribution of histiocytes between dermal collagen bundles?","options":["Tuberculoid granuloma","Sarcoidal granuloma","Palisaded granuloma","Interstitial granuloma"],"correctIndex":3,"explanation":"Interstitial granuloma is typified by the predominant distribution of histiocytes between dermal collagen bundles [34]."},{"id":29,"chapterId":1,"question":"Dermoscopy is defined as a non-invasive diagnostic technique that allows observation of morphologic features not visible to the naked eye, serving as a link between what two fields?","options":["Radiology and Pathology","Macroscopic Clinical Dermatology and Microscopic Dermatopathology","Confocal Microscopy and Artificial Intelligence","Genetics and Epidemiology"],"correctIndex":1,"explanation":"Dermoscopy is a non-invasive diagnostic technique that allows observation of morphologic features not visible to the naked eye, linking macroscopic clinical dermatology and microscopic dermatopathology [35]."},{"id":30,"chapterId":1,"question":"What are the three criteria that comprise the '3-point dermoscopy checklist' used for screening lesions suspicious for skin cancer?","options":["Irregular streaks, Multiple colors, Dots/globules","Asymmetry, Atypical network, Bluewhite structures","Globular pattern, Homogeneous blue pigmentation, Parallel pattern","Leaf-like structures, Arborizing vessels, Ulceration"],"correctIndex":1,"explanation":"The three criteria for the 3-point dermoscopy checklist are asymmetry, atypical network, and bluewhite structures [36, 37]."},{"id":1,"chapterId":2,"question":"Which specific structure within the stratum corneum primarily serves as a physiologic barrier preventing fluid and solute loss from within the body?","options":["Basal layer stem cells","Laminated stratum corneum","Merkel cells","Melanosomes"],"correctIndex":1,"explanation":"The laminated stratum corneum is a surface aggregate of keratinized squamous epithelial cells that serves as a physiologic barrier that prevents fluid and solute loss from within [1]."},{"id":2,"chapterId":2,"question":"Approximately how long does it take for a keratinocyte to move from the basal layer stem cell pool through the nucleated compartment and ultimately through the stratum corneum under normal conditions?","options":["About one week","About four weeks","About six months","About three days"],"correctIndex":1,"explanation":"Under normal conditions, keratinocytes require about two weeks to exit the nucleated compartment and another two weeks to move through the stratum corneum [1]."},{"id":3,"chapterId":2,"question":"Melanocytes manufacture melanin, which plays a major role in protecting the skin from the harmful effects of what type of radiation?","options":["Infrared (IR) radiation","X-rays","Ultraviolet (UV) radiation","Visible light"],"correctIndex":2,"explanation":"Melanocytes manufacture the light-absorbing pigment melanin, which plays a major role in protecting the skin from the harmful effects of ultra-violet (UV) radiation [2]."},{"id":4,"chapterId":2,"question":"Melanosomes, containing melanin, are transferred from melanocytes to nearby keratinocytes. Where is their preferred protective location within the keratinocyte?","options":["Near the cell membrane","Within the mitochondria","Above the nucleus","Scattered evenly throughout the cytoplasm"],"correctIndex":2,"explanation":"Melanosomes are transferred to nearby keratinocytes, where their preferred location is above the nucleus, providing protection for genetic material [2]."},{"id":5,"chapterId":2,"question":"What is the critical function of activated Langerhans cells after they migrate from the epidermis to regional lymph nodes?","options":["Production of melanin","Thermoregulation","Antigen presentation during immunity induction and regulation","Secretion of neuroendocrine peptides"],"correctIndex":2,"explanation":"After activation, Langerhans cells migrate from the epidermis to regional lymph nodes, where they play a critical role in antigen presentation during the induction and regulation of immunity [2]."},{"id":6,"chapterId":2,"question":"Merkel cells are found in the basal layer of the epidermis and contain neuroendocrine peptides. Their physiological role is thought to involve:","options":["Immune memory","Mechanoreceptor responses","Fluid balance regulation","Structural support"],"correctIndex":1,"explanation":"Merkel cells contain neuroendocrine peptides and are thought to play a role in mechanoreceptor responses [3]."},{"id":7,"chapterId":2,"question":"What primary functions are provided by the dermis layer of the skin?","options":["Fluid barrier and microbial defence","Antigen presentation and thermoregulation","Mechanical support, circulation, and nutrition","Synthesis of Vitamin D and neuroendocrine communication"],"correctIndex":2,"explanation":"The dermis provides structural and nutritional support [4]. The dermis also provides mechanical support, circulation, and nutrition [5]."},{"id":8,"chapterId":2,"question":"Which cell population is NOT one of the four major resident populations found in the human epidermis?","options":["Keratinocytes","Langerhans cells","Fibroblasts","Melanocytes"],"correctIndex":2,"explanation":"The human epidermis contains four major resident populations: keratinocytes, melanocytes, Langerhans cells, and Merkel cells. Fibroblasts are residents of the dermis [6, 7]."},{"id":9,"chapterId":2,"question":"The basal layer (stratum basale) represents the outermost layer of the epidermis.","options":["Stratum corneum","Stratum spinosum","Granular layer","Basal layer"],"correctIndex":0,"explanation":"The epidermal layers from the surface are: (1) the cornified layer (stratum corneum); (2) the granular layer (stratum granulosum); (3) the spinous layer (stratum spinosum); and (4) the basal layer (stratum basale) [8]."},{"id":10,"chapterId":2,"question":"What two key structural proteins form the fibrous connective tissue matrix of the dermis?","options":["Fibrin and keratin","Collagen and elastin","Desmoglein and integrin","Laminin and fibronectin"],"correctIndex":1,"explanation":"The dermis is composed of a fibrous connective tissue matrix containing collagen and elastin [7]."},{"id":11,"chapterId":2,"question":"The specialized aggregation of attachment molecules and associated matrix at the boundary between the epidermis and dermis is called the:","options":["Stratum granulosum","Extracellular matrix","Basement membrane","Rete ridges"],"correctIndex":2,"explanation":"The boundary between the epidermis and dermis consists of a specialized aggregation of attachment molecules and associated matrix, collectively known as the basement membrane [9]."},{"id":12,"chapterId":2,"question":"Which specific anatomic site requires a markedly thickened stratum corneum to protect against mechanical stress?","options":["The scalp","The flank","The palms and soles","The eyelid"],"correctIndex":2,"explanation":"The histopathologic features of normal plantar skin show a markedly thickened stratum corneum, compared to other body regions, which protects against mechanical stress [10, 11]."},{"id":13,"chapterId":2,"question":"What is the evolutionary advantage of light skin pigmentation in areas where UV radiation is scarce?","options":["Increased photoprotection","Improved folate stability","Advantageous for vitamin D biosynthesis","Enhanced immune recognition"],"correctIndex":2,"explanation":"Lightly pigmented skin is advantageous for vitamin D biosynthesis in areas where UV radiation is scarce [12]."},{"id":14,"chapterId":2,"question":"What is the primary mechanism of disease in Pemphigus vulgaris?","options":["Autoantibodies targeting collagen VII","T-cell destruction of basal keratinocytes","Genetic defects in the basement membrane","Autoantibodies targeting desmogleins, compromising cellcell adhesion"],"correctIndex":3,"explanation":"In pemphigus vulgaris, autoantibodies directed against desmogleins compromise cellcell adhesion, resulting in intraepithelial acantholysis and widespread erosions [13, 14]."},{"id":15,"chapterId":2,"question":"When the skin fails to maintain its barrier function, what two major clinical problems commonly arise?","options":["Autoimmunity and cancer","Infarction and pruritus","Infection and dehydration","Hypothermia and hyperthermia"],"correctIndex":2,"explanation":"The requirements and failings of skin include that failure to maintain a barrier leads to infection and dehydration [15]."},{"id":16,"chapterId":2,"question":"The massive death of keratinocytes leading to epidermal detachment in Toxic Epidermal Necrolysis (TEN) is often triggered by:","options":["Bacterial toxins","Genetic mutations","Drug exposure","UV radiation exposure"],"correctIndex":2,"explanation":"Toxic epidermal necrolysis (TEN) is a drug-induced disease where rapid death of keratinocytes leads to detachment of the epidermis over large areas of the body, often associated with sulfonamides, aromatic anticonvulsants, and nonsteroidal anti-inflammatory drugs [16]."},{"id":17,"chapterId":2,"question":"Topical application of keratolytic agents like salicylic acid carries a risk of systemic toxicity (salicylism) in patients with ichthyosis because this disease features:","options":["Increased dermal vascularity","Impaired barrier function of the stratum corneum","Loss of sweat glands","Excessive TGF- activity"],"correctIndex":1,"explanation":"Salicylism can occur in patients with ichthyosis or other cutaneous disorders with impaired barrier function because the stratum corneum is defective and less resistant to chemical penetration [17]."},{"id":18,"chapterId":2,"question":"The high incidence of skin cancer in patients with xeroderma pigmentosum supports the assertion that this disease involves a deficiency in:","options":["Melanin production","Collagen synthesis","DNA repair mechanisms for UVR damage","T-cell mediated cytotoxic response"],"correctIndex":2,"explanation":"The high incidence of several types of skin cancer in these patients supports the assertion that UVR-induced DNA damage is an important cause of skin cancer in humans, illustrating that cancers develop more quickly when DNA repair mechanisms are disrupted [18]."},{"id":19,"chapterId":2,"question":"What is the function of the one-way lymphatic circulatory system in the skin?","options":["Nutritional support and oxygen delivery","Heat dissipation via vasoconstriction","Returns leukocytes and interstitial fluids to the central venous system","Mediates pruritus and pain sensation"],"correctIndex":2,"explanation":"The lymphatic system is a one-way system that returns leukocytes and interstitial fluids, first to draining lymph nodes and then, via the thoracic duct, into the central venous system [19]."},{"id":20,"chapterId":2,"question":"The anastomosing arteries and veins in the skin, which include arteriovenous anastomoses, primarily serve which major function?","options":["Structural support","Heat regulation (thermoregulation)","Delivery of antigens","Wound healing"],"correctIndex":1,"explanation":"The anastomosing arteries and veins that participate in heat regulation include arteriovenous anastomoses [20]."},{"id":21,"chapterId":2,"question":"What is the critical element illustrated by embolic occlusion of arteries, which results in rapid ischemic necrosis of distal cutaneous structures?","options":["The role of the stratum corneum","The dependence of skin on arterial circulation for survival","The importance of lymphatic drainage","The role of dermal edema"],"correctIndex":1,"explanation":"Occlusion followed by cutaneous necrosis vividly demonstrates the dependence of skin on arterial circulation [21]."},{"id":22,"chapterId":2,"question":"Chronic inflammation associated with recurrent streptococcal infection can cause permanent edema and verrucous change known as:","options":["Bullous pemphigoid","Psoriasis","Elephantiasis nostras verrucosa","Paraneoplastic pemphigus"],"correctIndex":2,"explanation":"Blockage of lymphatic drainage due to chronic infection can result in permanent edema associated with widespread verrucous change at the skin surface, a condition described as elephantiasis nostras verrucosa [22]."},{"id":23,"chapterId":2,"question":"Some small nerve endings penetrate the basement membrane and travel into the epidermis, where they are known to modulate what process?","options":["Collagen synthesis","Pigment transfer","Immune responsiveness","Keratinocyte division"],"correctIndex":2,"explanation":"Some small nerve endings penetrate the basement membrane and travel into the epidermis, where they can modulate immune responsiveness [23]."},{"id":24,"chapterId":2,"question":"Intradermal injections of botulinum toxin are used in dermatology to inhibit which disabling condition, besides minimizing facial lines?","options":["Alopecia areata","Excessive sweating (hyperhidrosis)","Vitiligo","Melasma"],"correctIndex":1,"explanation":"Intradermal injections of botulinum toxin are used to inhibit the excessive sweating that characterizes disabling axillary and palmar hyperhidrosis [24]."},{"id":25,"chapterId":2,"question":"Loss of sensory function, such as that seen in patients with peripheral neuropathies associated with diabetes mellitus and Hansen disease, primarily leads to vulnerability of the skin to:","options":["Systemic infection","Autoimmune reactions","Traumatic injury","Chronic pruritus"],"correctIndex":2,"explanation":"The loss of sensory function results in the patients inability to recognize, and therefore avoid, cutaneous trauma [25]."},{"id":26,"chapterId":2,"question":"In the hormonal function of skin, Vitamin D3 (cholecalciferol) is produced in the epidermis by the action of UVR on which precursor molecule?","options":["Ergosterol","7-dehydrocholesterol","Melanin","Adrenocorticotropic hormone (ACTH)"],"correctIndex":1,"explanation":"Vitamin D3 (cholecalciferol) is produced in the epidermis by the action of UVR on 7-dehydrocholesterol [26]."},{"id":27,"chapterId":2,"question":"Excessive secretion of which hormone indirectly gives rise to the hyperpigmentation seen in patients with Addison disease?","options":["Insulin","Adrenocorticotropic hormone (ACTH)","Cortisol","Thyroid-stimulating hormone (TSH)"],"correctIndex":1,"explanation":"Diminished production of adrenocortical hormones causes excessive secretion of ACTH, which indirectly gives rise to the hyperpigmentation seen in patients with Addison disease [26]."},{"id":28,"chapterId":2,"question":"Aberrant levels of which three key cytokines have emerged as critical targets for immunomodulators used to treat psoriasis?","options":["IL-1, IL-6, and IL-8","TGF-, TNF, and IL-1","TNF, IL-17, and IL-23","IL-4, IL-13, and IL-33"],"correctIndex":2,"explanation":"Aberrant levels of TNF, IL-17, and IL-23 have emerged as critical targets of immunomodulators used to treat psoriasis [27]."},{"id":29,"chapterId":2,"question":"The primary defect in patients with hypohidrotic ectodermal dysplasia that compromises thermoregulation is:","options":["Excessive vasoconstriction","An almost complete absence of sweat glands","Failure of the lymphatic system","Impaired DNA repair"],"correctIndex":1,"explanation":"In patients with hypohidrotic ectodermal dysplasia, the defining defect is an almost complete absence of sweat glands, which demonstrates the importance of sweating for cooling and survival [28]."},{"id":30,"chapterId":2,"question":"Vitiligo is a pigmentary disorder characterized by the absence of epidermal melanin due to the autoimmune destruction of which cell type?","options":["Keratinocytes","Langerhans cells","Merkel cells","Melanocytes"],"correctIndex":3,"explanation":"Vitiligo is characterized by the absence of epidermal melanin due to the autoimmune destruction of melanocytes [29]."},{"id":1,"chapterId":3,"question":"What is the single cell layer that covers the developing epidermis, believed to exchange substances across fetal skin and protect against interepithelial adhesions?","options":["Stratum corneum","Periderm","Intermediate cell layer","Basal layer"],"correctIndex":1,"explanation":"Primitive keratinocytes generate cells of the periderm, a single cell layer that covers the developing epidermis until the cornified cell layer is formed, and it is believed to exchange substances and protect against interepithelial adhesions [1]."},{"id":2,"chapterId":3,"question":"At approximately what Estimated Gestational Age (EGA) does the embryonic epidermis begin the process of stratification?","options":["4 weeks' EGA","8 weeks' EGA","15 weeks' EGA","24 weeks' EGA"],"correctIndex":1,"explanation":"The embryonic epidermis begins to stratify at approximately 8 weeks estimated gestational age (EGA) [2]."},{"id":3,"chapterId":3,"question":"Which gene expression is required for epidermal stratification to occur during development?","options":["HRAS","TP63","ABCA12","SHH"],"correctIndex":1,"explanation":"Expression of TP63 is required for epidermal stratification [2], and mutations in TP63 are linked to ectodermal dysplasias resulting from disruption of cross-talk between the developing epidermis and dermis [3]."},{"id":4,"chapterId":3,"question":"When does terminal differentiation, resulting in the formation of mature keratinizing epidermal cells, begin?","options":["During the first trimester","During the second trimester","At birth","At 3 weeks postnatal age"],"correctIndex":1,"explanation":"Terminal differentiation, the process resulting in the formation of mature keratinizing epidermal cells, begins during the second trimester [4]."},{"id":5,"chapterId":3,"question":"In the interfollicular epidermis, cornification does not typically commence until which Estimated Gestational Age (EGA)?","options":["1011 weeks' EGA","15 weeks' EGA","2224 weeks' EGA","38 weeks' EGA"],"correctIndex":2,"explanation":"Early cornification is observed within the hair canal at approximately 15 weeks EGA, but it does not commence in the interfollicular epidermis until 2224 weeks EGA [4]."},{"id":6,"chapterId":3,"question":"After keratinization begins, the periderm detaches and is sloughed off into the amniotic fluid, with remnants contributing to which coating found on newborns?","options":["Vernix caseosa","Lanugo hair","Collodion membrane","Sebaceous film"],"correctIndex":0,"explanation":"At the time of keratinization, the periderm detaches from the underlying epidermis and is sloughed off into the amniotic fluid, with remnants contributing to the vernix caseosa that coats newborns [4]."},{"id":7,"chapterId":3,"question":"Which cell lineage gives rise to melanocytes in the skin?","options":["Surface ectoderm","Lateral plate mesoderm","Neuroectoderm (Neural crest)","Endoderm"],"correctIndex":2,"explanation":"The melanocyte is an important neural crest-derived cell in the skin [5]. Melanocytes are derived from the neural crest that forms along the dorsal neural tube [6]."},{"id":8,"chapterId":3,"question":"From which germ layer are the keratinocytes of the embryonic epidermis ultimately derived?","options":["Endoderm","Mesoderm","Surface ectoderm","Dermomyotome"],"correctIndex":2,"explanation":"Surface ectodermal cells eventually differentiate into the keratinocytes of the embryonic epidermis [5]. The ectoderm that covers the developing embryo is a single-layered epithelium [1]."},{"id":9,"chapterId":3,"question":"The dermis of the face and frontal scalp is derived from which embryonic source?","options":["Lateral plate mesoderm","Dermomyotome","Neural crest ectoderm","Surface ectoderm"],"correctIndex":2,"explanation":"The dermal mesenchyme of the face and anterior scalp is derived from neural crest ectoderm [5, 7]."},{"id":10,"chapterId":3,"question":"The dermal mesenchyme of the back originates from which embryonic structure?","options":["Lateral plate mesoderm","Dermomyotome of the embryonic somite","Neural crest","Dermal papilla"],"correctIndex":1,"explanation":"The dermal mesenchyme of the back originates from the dermomyotome of the embryonic somite [7]."},{"id":11,"chapterId":3,"question":"Langerhans cell precursors, which are hematopoietic in origin, are detectable in the fetal epidermis as early as:","options":["2224 weeks' EGA","12 weeks' EGA","40 days' EGA","5 months' EGA"],"correctIndex":2,"explanation":"Langerhans cell precursors appear within the epidermis during the first trimester and are detectable as early as 40 days EGA [8]."},{"id":12,"chapterId":3,"question":"Although once controversial, genetic fate mapping studies have demonstrated that mammalian Merkel cells are derived from which lineage?","options":["Neural crest lineage","Epidermal lineage","Endothelial lineage","Hematopoietic lineage"],"correctIndex":1,"explanation":"Genetic fate mapping studies have demonstrated that mammalian Merkel cells are derived from an epidermal rather than neural crest lineage [5, 9]."},{"id":13,"chapterId":3,"question":"At approximately what Estimated Gestational Age (EGA) does melanosome transfer from melanocytes to keratinocytes begin?","options":["50 days' EGA","34 months' EGA","5 months' EGA","At birth"],"correctIndex":2,"explanation":"Epidermal melanin production does not begin until 34 months EGA, and melanosome transfer to keratinocytes is not seen until 5 months EGA [10]."},{"id":14,"chapterId":3,"question":"What is the characteristic distribution pattern that mosaic skin conditions, such as epidermal nevi, often follow, reflecting epidermal cell migration pathways during development?","options":["Photodistribution","Dermatomal patterns","Lines of Blaschko","Sporotrichoid pattern"],"correctIndex":2,"explanation":"Mosaic skin conditions often have a distribution pattern that follows the lines of Blaschko, which are thought to represent the migration pathways of epidermal cells during embryonic development [11]."},{"id":15,"chapterId":3,"question":"A 'collodion baby' is born encased in a taut membrane formed by aberrant stratum corneum. This condition results from genetic abnormalities affecting:","options":["Dermal matrix organization","Epidermal specification","Epidermal differentiation and barrier formation","Hair follicle induction"],"correctIndex":2,"explanation":"One clinical presentation of conditions resulting from generalized abnormalities in epidermal differentiation and barrier formation is a 'collodion baby' [12]."},{"id":16,"chapterId":3,"question":"Mutations in the ABCA12 gene, which encodes a lipid transporter, cause which severe disorder of cornification?","options":["Pemphigus vulgaris","Harlequin Ichthyosis (HI)","Goltz syndrome","EhlersDanlos syndrome"],"correctIndex":1,"explanation":"More deleterious mutations in ABCA12 cause harlequin ichthyosis (HI), an especially severe disorder of cornification characterized by aberrant epidermal maturation [13]."},{"id":17,"chapterId":3,"question":"Compared to the adult dermis (which has a ratio of collagen I to collagen III greater than 1), what is the ratio of collagen III to collagen I in the developing embryonic dermal cells?","options":["1:1","1:3","3:1","4:1"],"correctIndex":2,"explanation":"The ratio of collagen III to collagen I is 3:1 in embryonic dermal cells, which is the reverse of what is seen in the adult dermis [14]."},{"id":18,"chapterId":3,"question":"By what point in gestation does the dermis shift from a non-scarring to a scarring form of wound repair?","options":["End of the first trimester","End of the second trimester","Mid third trimester","After birth"],"correctIndex":1,"explanation":"By the end of the second trimester, the dermis shifts from a non-scarring to a scarring form of wound repair [15]."},{"id":19,"chapterId":3,"question":"What is the molecular basis for Goltz syndrome (focal dermal hypoplasia), an X-linked dominant disorder characterized by dermal hypoplasia following the lines of Blaschko?","options":["Mutations in TP63","Mutations in PORCN, an effector of the Wnt signaling pathway","Mutations in collagen VII","Mutations in TGM1"],"correctIndex":1,"explanation":"Goltz syndrome is caused by mutations in PORCN, an effector of the Wnt signaling pathway, which likely regulates Wnt signaling to the developing dermis [16]."},{"id":20,"chapterId":3,"question":"The dermalepidermal junction (DEJ) mediates adhesion and provides resistance against shearing forces. When do skin-specific components of the DEJ start to appear?","options":["At 4 weeks' EGA","After the embryonicfetal transition at 8 weeks' EGA","During the third trimester","Only after birth"],"correctIndex":1,"explanation":"The DEJ becomes progressively more complex, and skin-specific components start to appear after the embryonicfetal transition at 8 weeks EGA, coincident with the onset of epidermal stratification [17]."},{"id":21,"chapterId":3,"question":"Epidermolysis bullosa (EB), a group of genetic blistering disorders, results from mutations in genes that encode components of which skin structure?","options":["Hair follicle bulge","Sebaceous gland","Dermalepidermal junction (DEJ)","Stratum corneum lipids"],"correctIndex":2,"explanation":"Epidermolysis bullosa (EB) is a heterogeneous group of genetic disorders characterized by blister formation due to mechanical fragility of the skin, resulting from mutations in genes that encode several different components of the DEJ [18]."},{"id":22,"chapterId":3,"question":"What are the focal epidermal thickenings that initiate hair follicle formation, first seen on the scalp and face between 10 and 11 weeks EGA?","options":["Dermal papilla","Placodes","Hair germs","Rete ridges"],"correctIndex":1,"explanation":"Follicle formation is initiated by signals from the dermis that direct the embryonic epidermis to form focal thickenings, called placodes [19]."},{"id":23,"chapterId":3,"question":"What structure is directed by the epidermal placode to condense and form beneath the epidermis?","options":["Arrector pili muscle","Sebaceous gland","Presumptive dermal papilla","Outer root sheath"],"correctIndex":2,"explanation":"The epidermal placodes instruct the underlying dermal cells to condense and form the presumptive dermal papilla [19]."},{"id":24,"chapterId":3,"question":"What signaling molecule secreted by the developing hair follicle is required for the maturation of the dermal papilla and progression to the hair peg stage, and is also critical for the telogen-to-anagen transition postnatally?","options":["Wnt","Sonic hedgehog (SHH)","Transforming growth factor-beta (TGF-)","Vascular endothelial growth factor (VEGF)"],"correctIndex":1,"explanation":"Sonic hedgehog (SHH), a signaling molecule secreted by cells of the developing hair follicle, is required for the maturation of the dermal papilla and for the progression of the follicle placode to the peg hair stage [20]."},{"id":25,"chapterId":3,"question":"Which skin appendage is the first to keratinize during fetal development, doing so at around 11 weeks EGA?","options":["Eccrine glands","Sebaceous glands","Nail bed on the dorsal digit","Interfollicular epidermis on the head"],"correctIndex":2,"explanation":"The nail bed on the dorsal digit is the first skin structure to keratinize, at around 11 weeks EGA [21]."},{"id":26,"chapterId":3,"question":"The parallel ectodermal ridges that develop over mesenchymal pads on the palms and soles during the second trimester eventually form what characteristic features?","options":["Dermalepidermal junction","Dermatoglyphics (fingerprints)","Lanugo hair","Sweat gland primordia"],"correctIndex":1,"explanation":"The curves and whorls formed by these ridges result in characteristic dermatoglyphics (fingerprints), which can be seen on the digit tips by the fifth month of gestation [22]."},{"id":27,"chapterId":3,"question":"Which ectodermal dysplasia, characterized by hypohidrosis, hypotrichosis, and hypodontia, is caused by mutations in the Ectodysplasin A (EDA) signaling pathway?","options":["Goltz syndrome","Xeroderma pigmentosum","Hypohidrotic ectodermal dysplasia (HED)","Basal cell nevus syndrome"],"correctIndex":2,"explanation":"Hypohidrotic ectodermal dysplasia (HED) is a relatively common type of ectodermal dysplasia caused by mutations in genes encoding components of the ectodysplasin A (EDA) signaling pathway [23]."},{"id":28,"chapterId":3,"question":"What are the two defining properties of somatic stem cells?","options":["Rapid symmetrical division and production of paracrine factors","Ability to self-renew and ability to produce differentiating daughter cells","Low clonogenic potential and transient tissue contribution","Lack of specific molecular markers and rapid proliferation"],"correctIndex":1,"explanation":"Somatic stem cells have two defining properties: (1) the ability to produce daughter cells that can differentiate to renew or repair the tissue; and (2) the ability to produce a new stem cell (self-renewal) [24]."},{"id":29,"chapterId":3,"question":"The hair follicle bulge, located just deep to the sebaceous gland, is the protective niche thought to harbor which type of stem cells?","options":["Epidermal stem cells","Melanocyte stem cells","Hair follicle stem cells","Langerhans cells"],"correctIndex":2,"explanation":"The hair follicle bulge... is thought to harbor hair follicle stem cells [25]. It is located in the outer root sheath just deep to the sebaceous gland and adjacent to the arrector pili muscle attachment site [25]."},{"id":30,"chapterId":3,"question":"In the hierarchical model of keratinocyte stem cells, what do stem cells generate when they undergo infrequent asymmetric division?","options":["Two new stem cells","Two progenitor cells","One new stem cell and one daughter transit amplifying (TA) cell","One melanocyte and one keratinocyte"],"correctIndex":2,"explanation":"In the hierarchical model, stem cells undergo infrequent asymmetric division, generating one new stem cell and one daughter transit amplifying (TA) cell [26]."},{"id":1,"chapterId":4,"question":"Which fixation method is generally used for electron microscopy analysis of a tissue sample?","options":["Formalin","Glutaraldehyde","Liquid nitrogen freezing","Paraffin embedding"],"correctIndex":1,"explanation":"Glutaraldehyde is used for electron microscopy analysis of a tissue sample."},{"id":2,"chapterId":4,"question":"What is the primary advantage of analyzing cryosections from frozen tissue samples compared to formalin-fixed, paraffin-embedded tissues?","options":["Higher quality tissue architecture","Faster staining process","Better preservation of DNA, RNA, and protein","Reduced risk of contamination"],"correctIndex":2,"explanation":"Cryosections from frozen samples preserve DNA, RNA, and protein better than sections from formalin-fixed tissues, even though the latter have lower quality tissue architecture."},{"id":3,"chapterId":4,"question":"Which standard molecular biology technique is used to amplify a specific piece of DNA from a complex mixture?","options":["Western blot","Flow cytometry","Polymerase chain reaction (PCR)","Reverse transcription (RT)"],"correctIndex":2,"explanation":"Polymerase chain reaction (PCR) is a standard technique for amplifying DNA."},{"id":4,"chapterId":4,"question":"In a standard PCR reaction, what is the theoretical increase in the number of PCR products after 'n' cycles?","options":["n times the original amount","n + 2 times the original amount","2n times the original amount","Exponentially, but not quantifiable"],"correctIndex":2,"explanation":"Each cycle increases the number of PCR products twofold. The total number of PCR products after n cycles will be 2n times the original amount."},{"id":5,"chapterId":4,"question":"What common issue can cause misleading results in PCR due to its high sensitivity?","options":["Thermal cycler malfunction","Contamination of the sample","Polymerase incorporating correct nucleotides","Primer annealing to the exact target sequence"],"correctIndex":1,"explanation":"Because of its high sensitivity, contamination can cause misleading results in PCR."},{"id":6,"chapterId":4,"question":"What is the technique called when the amount of PCR product is monitored during each amplification cycle to quantify the original amount of DNA?","options":["Sanger sequencing","Fluorescence in situ hybridization (FISH)","Real-time quantitative PCR","Mass spectrometry"],"correctIndex":2,"explanation":"Because the amount of PCR product is monitored during each amplification cycle, this technique is called 'real-time' quantitative PCR."},{"id":7,"chapterId":4,"question":"What is the typical first step in analyzing RNA, given its unstable nature?","options":["Amplification by PCR directly","Separation via polyacrylamide gel","Conversion into DNA using reverse transcription","Sequencing via nanopore technology"],"correctIndex":2,"explanation":"RNA is also easy to purify, but is more unstable and degrades much faster than DNA. Therefore, a typical first step in the analysis of RNA is to convert it into DNA using reverse transcription (RT)."},{"id":8,"chapterId":4,"question":"The conversion of mRNA into complementary DNA (cDNA) utilizes which enzyme?","options":["DNA polymerase","Reverse transcriptase","Cas9 nuclease","RNA ligase"],"correctIndex":1,"explanation":"Many methods that study RNA first convert RNA to cDNA with an enzyme called reverse transcriptase, because cDNA is more stable than RNA."},{"id":9,"chapterId":4,"question":"Which type of primer is used in RT-PCR to convert mRNA to cDNA by hybridizing to the poly-A tail found at the end of mRNA molecules?","options":["Gene-specific primer","Random hexamer primers","Oligo dT primers","Sequencing adapters"],"correctIndex":2,"explanation":"Oligo dT primers contain only dT nucleotides and hybridize to the complementary string of dA nucleotides that are present at the end of mRNA molecules (poly-A tail)."},{"id":10,"chapterId":4,"question":"Which technique relies on using fluorescently labeled nucleic acid probes that hybridize to complementary sequences in tissue sections to assess DNA or RNA?","options":["Western blot","Fluorescence in situ hybridization (FISH)","Enzyme-linked immunosorbent assay (ELISA)","Mass cytometry"],"correctIndex":1,"explanation":"Fluorescence in situ hybridization (FISH) is employed to assess the presence or expression of DNA or RNA. This technique relies on the use of fluorescently labeled nucleic acid probes that are complementary to the DNA or RNA sequences of interest in the tissue sections."},{"id":11,"chapterId":4,"question":"In Fluorescence in situ hybridization (FISH), how is the signal of the hybridized probe detected?","options":["Using an enzymatic reaction that generates a colored product","Measuring the time-of-flight of the probe","Examining the slide using fluorescence microscopy","Analyzing the sequencing reads computationally"],"correctIndex":2,"explanation":"The signal is detected using fluorescence microscopy after the probes are hybridized to the target sequences in the tissue."},{"id":12,"chapterId":4,"question":"Immunohistochemistry (IHC) is primarily used in tissue sections to assess the expression and location of which molecules?","options":["DNA sequences","RNA sequences","Proteins","Lipids"],"correctIndex":2,"explanation":"Immunohistochemistry is employed to assess the expression of proteins in tissue sections."},{"id":13,"chapterId":4,"question":"Flow cytometry is used on tissue samples that have been processed into what form?","options":["Formalin-fixed blocks","Single-cell suspension","Cryosection slides","Intact excised tissue"],"correctIndex":1,"explanation":"Once tissue is dissociated and living cells are in a single cell suspension, flow cytometry can be used to identify populations of cells."},{"id":14,"chapterId":4,"question":"Which advanced technique combines the principles of flow cytometry and elemental mass spectrometry, allowing the analysis of 40 or more parameters for each single cell?","options":["Quantitative RT-PCR","Mass cytometry","Massively parallel sequencing","Laser microdissection"],"correctIndex":1,"explanation":"Mass cytometry analyzes 40 or more parameters for each cell by combining the principles of flow cytometry and elemental mass spectrometry."},{"id":15,"chapterId":4,"question":"What is the purpose of laser microdissection?","options":["To separate proteins based on size and charge","To selectively procure individual cells or microanatomic regions from tissue sections","To sequence millions of DNA fragments simultaneously","To induce targeted gene deletion in a mouse model"],"correctIndex":1,"explanation":"Laser microdissection allows selection of microanatomic regions for analysis and is used to selectively procure individual cells or clusters of cells from tissue sections."},{"id":16,"chapterId":4,"question":"Massively parallel sequencing is also commonly known as:","options":["Sanger sequencing","Next-generation sequencing (NGS)","Nanopore technology","Chromatin Immunoprecipitation sequencing (ChIP-seq)"],"correctIndex":1,"explanation":"Massively parallel sequencing is also known as next-generation sequencing."},{"id":17,"chapterId":4,"question":"A key advantage of massively parallel sequencing (NGS) over Sanger sequencing is its ability to infer what genomic feature based on the proportionality of amplified DNA?","options":["RNA degradation rates","Protein translation efficiency","DNA copy number changes","Melanosome transfer rates"],"correctIndex":2,"explanation":"The advent of massively parallel sequencing not only allows access to DNA sequences, but it also allows one to infer DNA copy number changes."},{"id":18,"chapterId":4,"question":"What is a major limitation of massively parallel sequencing for clinical practice?","options":["The read lengths are too long (over 1000 bp).","It is simpler and cheaper than Sanger sequencing.","The need for sophisticated bioinformatics and data analyses that are challenging to standardize.","It requires unstable RNA as a starting material."],"correctIndex":2,"explanation":"One limitation of massively parallel sequencing is that its increased power and reading depth requires bioinformatics and sophisticated data analyses, which are challenging to standardize in clinical practice."},{"id":19,"chapterId":4,"question":"How does Mass Spectrometry determine the mass of proteins and peptides?","options":["By measuring how they fluoresce under UV light.","By measuring the time required for charged peptide ions to move to a detector (time-of-flight).","By binding them to a microchip and measuring hybridization levels.","By measuring the enzymatic reaction rate generated by a substrate."],"correctIndex":1,"explanation":"Mass spectrometry measures the size or mass of proteins and peptides by ionizing the protein and measuring the time-of-flight through a tube to a detector on the opposite end."},{"id":20,"chapterId":4,"question":"Before Mass Spectrometry analysis, what is typically used to reduce the complexity of the protein mixture?","options":["Single-cell sorting (FACS)","PCR amplification","Two-dimensional gel electrophoresis or capillary electrophoresis","Immunohistochemistry"],"correctIndex":2,"explanation":"In most instances, the proteins are separated by two-dimensional gel electrophoresis or capillary electrophoresis before mass spectrometry."},{"id":21,"chapterId":4,"question":"The Western blot technique is also referred to as an immunoblot because it uses which component to detect the protein of interest?","options":["A nucleic acid probe","A fluorescent dye","An antibody","A polyacrylamide gel"],"correctIndex":2,"explanation":"The Western blot is also called an immunoblot because an antibody is used to detect the protein of interest."},{"id":22,"chapterId":4,"question":"What characteristic defines a monoclonal antibody used in molecular assays?","options":["It reacts to several epitopes on a protein.","It is isolated from the serum of an injected animal.","It reacts to only one specific epitope of a protein.","It is labeled with a fluorescent probe that produces light."],"correctIndex":2,"explanation":"Monoclonal antibodies react to only one epitope of a protein."},{"id":23,"chapterId":4,"question":"In the traditional approach to creating transgenic mice, where is the gene of interest microinjected?","options":["Into an adult mouse fibroblast","Into a fertilized mouse egg","Into the hair follicle bulge","Into the dermal papilla"],"correctIndex":1,"explanation":"The traditional approach is to microinject the gene of interest into a fertilized mouse egg, where it randomly integrates into the mouse genome."},{"id":24,"chapterId":4,"question":"In a transgenic mouse model, how is the expression of a randomly integrated gene of interest limited or targeted to a specific cell type, such as melanocytes?","options":["By using a gene that self-activates only in that cell type.","By linking the gene to a cell-specific promoter/enhancer regulatory region.","By introducing the gene using a self-inactivating retroviral vector.","By employing the Sleeping Beauty transposon system."],"correctIndex":1,"explanation":"The transgene will only be expressed in cells where the promoter/enhancer regulatory region is active. For example, a promoter that ensures expression only in melanocytes would be a promoter of a gene involved in melanin biosynthesis."},{"id":25,"chapterId":4,"question":"What is the fundamental goal of creating a 'knockout' transgenic mouse model?","options":["To increase the expression of a specific protein.","To study the biologic effects from the loss of expression of a specific gene product.","To introduce a human gene into the mouse genome.","To generate induced pluripotent stem cells (iPS cells)."],"correctIndex":1,"explanation":"Knockout transgenic mice make it possible to study the biologic effects from loss of gene expression, as both alleles of a normal endogenous gene are modified, mutated, or deleted so that protein can no longer be produced."},{"id":26,"chapterId":4,"question":"The conditional knockout mouse model using the Cre-lox system allows for the gene of interest to be selectively deleted in a specific tissue by linking the Cre gene to what element?","options":["A Sleeping Beauty transposon","A tissue-specific promoter","A non-homologous end joining (NHEJ) repair enzyme","A zinc finger nuclease (ZFN)"],"correctIndex":1,"explanation":"In the conditional knockout model using the Cre-lox system, a target gene can be selectively deleted in a particular organ or tissue by mating a mouse with the Cre gene linked to a tissue-specific promoter to a mouse with loxP sites flanking the target gene."},{"id":27,"chapterId":4,"question":"What is the advantage of using inducible systems (like tamoxifen or Tet-On/Off) in conditional knockout mouse models?","options":["They prevent any gene deletion errors.","They ensure the deletion occurs in all mouse cells.","They allow investigators to trigger deletion of the gene at a particular point in time.","They eliminate the need for the Cre-lox system."],"correctIndex":2,"explanation":"A further refinement is to trigger deletion of the gene at a particular point in time, including during development. This can circumvent problems that arise from gene deletion in all mouse cells, which often impact normal mouse development."},{"id":28,"chapterId":4,"question":"In the CRISPR-Cas9 system, what is the repair mechanism that leads to a 'knockout' (deletion of a DNA region that disrupts gene function)?","options":["Homology-directed repair (HDR)","Reverse transcription (RT)","Nonhomologous end joining (NHEJ)","Antibody-mediated cleavage"],"correctIndex":2,"explanation":"A double-strand break [induced by Cas9] may be repaired by non-homologous end-joining (NHEJ) that leads to the formation of short insertions or deletions that disrupts gene function (knockout)."},{"id":29,"chapterId":4,"question":"In the context of skin gene therapy, what is the main advantage of the ex vivo approach over the direct in vivo approach?","options":["It is simpler and less technically demanding.","It avoids the use of viral vectors.","It is superior at achieving long-term expression in a higher percentage of cells.","It carries no risk for insertional mutagenesis."],"correctIndex":2,"explanation":"Ex vivo approaches are more complicated and technically demanding than in vivo approaches, but are superior at achieving long-term expression in a higher percentage of cells."},{"id":30,"chapterId":4,"question":"Short interfering RNA (siRNA) achieves sequence-specific gene silencing by being incorporated into which complex that subsequently degrades the target mRNA?","options":["Reverse transcriptase","Ribosome complex","RNA-induced silencing complex (RISC)","Dermalepidermal junction (DEJ)"],"correctIndex":2,"explanation":"Short (small) interfering RNA (siRNA) is unwound, and the guide antisense strand is incorporated into an RNA-induced silencing complex (RISC) that degrades a specific target mRNA sequence."},{"id":1,"chapterId":5,"question":"What term has been coined to reflect the importance of the cutaneous immune response in tissue homeostasis and repair?","options":["Cutaneous Immune Defence System (CIDS)","Skin-Associated Lymphoid Tissues (SALT)","Epidermal Barrier Complex (EBC)","Dermal Immune Surveillance (DIS)"],"correctIndex":1,"explanation":"The term 'Skin-associated lymphoid tissues' (SALT) reflects the importance of the cutaneous immune response in tissue homeostasis and repair [1]."},{"id":2,"chapterId":5,"question":"What characteristic defines the classical immune response, also known as the adaptive immune response?","options":["Rapid, non-specific action","Specificity and the accumulation of memory","Reliance solely on tissue-resident cells","Activation triggered only by microbial carbohydrates"],"correctIndex":1,"explanation":"The adaptive immune response is characterized by specificity due to immunologic memory, enabling improvement with each successive encounter with a particular antigen [1, 2]."},{"id":3,"chapterId":5,"question":"Adaptive immune responses in the skin are not always protective, but can be harmful, such as in the case of:","options":["Protection against tumor cells","Allergic or autoimmune reactions","Clearance of intracellular pathogens by macrophages","Response to pathogen-associated molecular patterns (PAMPs)"],"correctIndex":1,"explanation":"Adaptive immune responses in the skin can also be harmful in nature, such as allergic or autoimmune reactions [1]."},{"id":4,"chapterId":5,"question":"Which of the following cell types is an essential tissue-resident component of the cutaneous innate immune system?","options":["B cells","Cytotoxic T lymphocytes (CTLs)","Mast cells","Plasmacytoid dendritic cells (pDCs) in healthy skin"],"correctIndex":2,"explanation":"Essential components of the cutaneous innate immune system include tissue-resident cells such as mast cells, macrophages, dendritic cells (DCs), non-classical T cells, natural killer (NK) cells, and innate lymphoid cells [3]."},{"id":5,"chapterId":5,"question":"Innate immune cells respond immediately to harmful signals through the expression of danger sensing receptors, such as:","options":["T Cell Receptors (TCRs)","Major Histocompatibility Complex (MHC) class I","Toll-like receptors (TLRs)","FcRI high-affinity IgE receptor"],"correctIndex":2,"explanation":"Innate immune cells are characterized by their capacity to immediately respond to harmful signals by virtue of expression of danger sensing receptors such as Toll-like receptors (TLRs) [3]."},{"id":6,"chapterId":5,"question":"What triggers the classical pathway of the complement system's proteolytic cascade?","options":["Polysaccharides derived from microbial cell walls","Antigenantibody complexes","Bacterial CpG DNA sequences","Intracellular double-stranded DNA"],"correctIndex":1,"explanation":"The classical pathway is stimulated by antigenantibody complexes [4]."},{"id":7,"chapterId":5,"question":"All three complement pathways (classical, alternative, and lectin) converge to activate which central component?","options":["C5a","C9","C3","C1q"],"correctIndex":2,"explanation":"All three pathways lead to activation of the central C3 component [4]."},{"id":8,"chapterId":5,"question":"Which specific complement fragments are referred to as anaphylatoxins and induce the release of inflammatory mediators from mast cells?","options":["C3b, C4b, C5b","C3a, C4a, and C5a","C6, C7, C8, C9","C1q, C2b"],"correctIndex":1,"explanation":"C3a, C4a, and C5a, also called anaphylatoxins, induce the release of inflammatory mediators from mast cells [5]."},{"id":9,"chapterId":5,"question":"The Membrane-Attack Complex (MAC) is formed by the assembly of C5b, C6, C7, C8, and C9, leading to cell death through:","options":["Caspase activation","Phagocytosis enhancement","Osmotic lysis via pore generation","Inhibition of C3 convertase"],"correctIndex":2,"explanation":"Assembly of the complement components C5b, C6, C7, C8, and C9 forms the membrane-attack complex (MAC), which generates pores in cell membranes and leads to death by osmotic lysis [5]."},{"id":10,"chapterId":5,"question":"Which specific Toll-like Receptor (TLR) recognizes bacterial CpG DNA sequences?","options":["TLR4 (Lipopolysaccharide)","TLR5 (Flagellin)","TLR9 (Endosomal)","TLR2 (Lipoproteins)"],"correctIndex":2,"explanation":"TLR9 recognizes bacterial CpG DNA sequences and resides within endosomal vesicles [6, 7]."},{"id":11,"chapterId":5,"question":"Which signaling molecule is primarily utilized by all TLRs except TLR3 for signaling, ultimately leading to activation of NF-B?","options":["TRIF","MyD88","IRF3","TRAF6"],"correctIndex":1,"explanation":"All TLRs except TLR3 utilize myeloid differentiation factor 88 (MyD88) for signaling [7]."},{"id":12,"chapterId":5,"question":"Activation of Toll-like receptors can result in the release of interferons (IFNs) via the activation of which transcription factor?","options":["NF-B","IRAK","IRF3","TIRAP"],"correctIndex":2,"explanation":"Activation of TLRs can also result in the release of interferons (IFNs) via activation of interferon regulatory factor 3 (IRF3) [8]."},{"id":13,"chapterId":5,"question":"Which inflammasome is considered the most important because it is triggered by numerous pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs)?","options":["Aim2","NLRP1","NLRP3","NLRC4"],"correctIndex":2,"explanation":"NLRP3 is triggered by numerous PAMPs and DAMPs and is thus the most important inflammasome [9]."},{"id":14,"chapterId":5,"question":"The ultimate result of inflammasome activation is the cleavage of pro-IL-1 into which highly potent inflammatory mediator?","options":["Active caspase-1","Active IL-1","Active IL-18","Active TNF-"],"correctIndex":1,"explanation":"The ultimate result of activation of inflammasomes is the cleavage of pro-IL-1 into active IL-1, a highly potent inflammatory mediator [9]."},{"id":15,"chapterId":5,"question":"Dysregulation of inflammasomes is the cause of a group of inherited autoinflammatory diseases known as:","options":["Systemic Lupus Erythematosus (SLE)","Cryopyrin-Associated Periodic Syndromes (CAPS)","Hyper-IgE Syndrome","Pemphigus Vulgaris"],"correctIndex":1,"explanation":"Dysregulation of inflammasomes is the cause of a group of inherited autoinflammatory diseases called cryopyrin-associated periodic syndromes (CAPS) [9]."},{"id":16,"chapterId":5,"question":"What was the first antimicrobial peptide (AMP) to be isolated from human skin?","options":["Psoriasin (S100A7)","Human -defensin-2 (hBD-2)","LL-37/Cathelicidin","Antileukoprotease (ALP)"],"correctIndex":1,"explanation":"The first AMP to be isolated from human skin was human -defensin-2 (hBD-2) [10]."},{"id":17,"chapterId":5,"question":"The antimicrobial peptide LL-37 mediates DC activation in psoriasis by binding self-DNA and forming structures that stimulate which TLR?","options":["TLR3","TLR7","TLR9","TLR4"],"correctIndex":2,"explanation":"The antimicrobial peptide LL-37 mediates DC activation in psoriasis by binding self-DNA and forming structures that stimulate TLR9 [11]."},{"id":18,"chapterId":5,"question":"Monocytes that migrate into tissues can give rise to inflammatory DCs and macrophages, whose functions are defined by:","options":["Their initial bone marrow progenitor","The duration of their circulation in the blood","The tissue environment and tissue type","The expression of CD45RO"],"correctIndex":2,"explanation":"Monocytes circulate in the bloodstream and migrate into tissues to respond to inflammation and infection. Within tissue, they can give rise to inflammatory DCs and macrophages whose functions are defined by the tissue environment and tissue type [12]."},{"id":19,"chapterId":5,"question":"Macrophages possess receptors for carbohydrates that are usually not expressed on vertebrate cells (e.g., mannose), allowing them to discriminate between:","options":["T helper cell subsets","CD4+ and CD8+ T cells","Fibrotic and healthy tissue","Foreign and self molecules"],"correctIndex":3,"explanation":"Monocyte-derived macrophages express receptors for carbohydrates that are usually not expressed on vertebrate cells (e.g. mannose). Through this mechanism, macrophages can discriminate between foreign and self molecules [13]."},{"id":20,"chapterId":5,"question":"What is the oxygen-dependent mechanism used by neutrophils to kill phagocytosed organisms, involving the production of hydrogen peroxide and hydroxyl radicals?","options":["Oxygen-independent killing","Osmotic lysis","The respiratory burst","Caspase activation"],"correctIndex":2,"explanation":"The oxygen-dependent mechanism used by neutrophils to kill phagocytosed organisms is called the respiratory burst, involving the production of hydrogen peroxide, hydroxyl radicals, and singlet oxygen [14]."},{"id":21,"chapterId":5,"question":"Neutrophilic extracellular traps (NETs) are released by neutrophils and, although they entrap pathogens, they can also induce autoimmunity by stimulating immune responses against:","options":["Antibody-complement complexes","NET-associated nuclear antigens","Cell surface adhesion molecules","Innate lymphoid cells (ILCs)"],"correctIndex":1,"explanation":"NETs can induce autoimmunity by stimulating immune responses against the NET-associated nuclear antigens [15]."},{"id":22,"chapterId":5,"question":"The major function of eosinophils is most likely to protect the host from infections by which type of pathogen?","options":["Viruses","Intracellular bacteria","Parasites, particularly nematodes","Commensal fungi"],"correctIndex":2,"explanation":"The major function of eosinophils is most likely to protect the host from infections by parasites, particularly nematodes [16]."},{"id":23,"chapterId":5,"question":"Which surface receptor is expressed on both basophils and mast cells, allowing them to avidly bind IgE?","options":["FcRIII (CD16)","FcRI (High-affinity receptor for IgE)","CD40","CD88 (C5a receptor)"],"correctIndex":1,"explanation":"Both basophils and mast cells express high-affinity receptors for IgE (FcRI) that avidly bind IgE [17]."},{"id":24,"chapterId":5,"question":"Which cell lineage lacks T and B cell receptors and conventional hematopoietic lineage markers, but is responsible for producing type 1, 2, or 3 cytokines depending on the subgroup?","options":["Monocytes and Macrophages","Innate Lymphoid Cells (ILCs)","Natural Killer T (NK T) cells","Cytotoxic T (Tc) cells"],"correctIndex":1,"explanation":"Innate lymphoid cells (ILCs) are lymphoid progenitor-derived leukocytes which lack T and B cell receptors and do not express conventional hematopoietic lineage markers, and are grouped into subgroups based on cytokine and transcription factor expression profiles (ILC1s, ILC2s, ILC3s) [18]."},{"id":25,"chapterId":5,"question":"What specialized rod-shaped organelles are associated with Langerhans cells (LCs) and result from the antigen-capture function of the lectin langerin (CD207)?","options":["Melanosomes","Birbeck granules","Phagolysosomes","Endosomes"],"correctIndex":1,"explanation":"Ultrastructurally, LCs have rod-shaped organelles termed Birbeck granules. A Ca2+-dependent lectin with mannose-binding specificity called langerin (CD207) is associated with and responsible for the formation of Birbeck granules [19, 20]."},{"id":26,"chapterId":5,"question":"CD4+ T cells recognize antigens only in association with which type of MHC molecule?","options":["MHC class I molecules","MHC class II molecules","CD1d molecules","MHC class III molecules"],"correctIndex":1,"explanation":"CD4+ T cells recognize antigens in association with MHC class II molecules [21]."},{"id":27,"chapterId":5,"question":"What is the fate of developing T cells in the thymus that fail to recognize MHC complexes on thymic DCs (a process called positive selection)?","options":["Differentiation into B cells","Differentiation into memory cells","Apoptotic cell death","Migration to the periphery as regulatory T cells"],"correctIndex":2,"explanation":"When the T cells are unable to recognize these MHC molecules via their TCR, they undergo apoptotic cell death. More than 95% of the developing T cells die in the thymus because they are not selected [22]."},{"id":28,"chapterId":5,"question":"Signaling through the T cell receptor (TCR) complex alone is insufficient for naive T cell activation. What is the minimum requirement for a productive T cell immune response?","options":["Signal 1 (TCR interaction) and cytokine signal only","Signal 1 (TCR interaction) only","Signal 1 (TCR interaction) and Signal 2 (costimulatory signals)","Downregulation of CD28 expression"],"correctIndex":2,"explanation":"Signaling through the TCR complex alone is not sufficient for naive T cell activation. The presence of costimulatory signals is needed for T cells to undergo antigen-specific clonal expansion, requiring at least two types of stimuli (Signal 1: TCR/MHC interaction; Signal 2: costimulatory molecules) [23, 24]."},{"id":29,"chapterId":5,"question":"Which cytokine is the major driver for Th0 cells towards a Th1 phenotype?","options":["IL-4","IL-12","IL-17","TGF-"],"correctIndex":1,"explanation":"Macrophages stimulated by IFN- release IL-12, the major cytokine that drives Th0 cells towards a Th1 phenotype [25, 26]."},{"id":30,"chapterId":5,"question":"Which surface molecule is expressed by memory T cells recruited to the skin, enabling their initial tethering to the endothelium of cutaneous postcapillary venules?","options":["CCR7","Cutaneous Lymphocyte Antigen (CLA)","P-selectin glycoprotein ligand-1 (PSGL-1)","ICAM-1 (CD54)"],"correctIndex":1,"explanation":"Memory T cells entering the skin express cutaneous lymphocyte antigen (CLA). The function of CLA is to allow the early tethering of T cells to the endothelium of cutaneous postcapillary venules [27]."},{"id":1,"chapterId":6,"question":"What is the approximate range of conduction velocities for C fibers uniquely identified to transmit itch?","options":["230 m/second","Greater than 30 m/second","0.31.0 m/second","Less than 0.3 m/second"],"correctIndex":2,"explanation":"C fibers that transmit itch have exceptionally slow conduction velocities, typically ranging from 0.31.0 m/second [1]."},{"id":2,"chapterId":6,"question":"Histamine-sensitive C fibers are generally sensitive to which combination of stimuli, while generally lacking response to mechanical stimuli?","options":["Mechanical and cold stimuli","Heat and prurito-genic stimuli","Capsaicin and low pH","Light touch and moving stimuli"],"correctIndex":1,"explanation":"Histamine-sensitive C fibers are sensitive to heat as well as prurito-genic stimuli but generally not to mechanical stimuli [1]."},{"id":3,"chapterId":6,"question":"The intense itch caused by the tropical legume cowhage (*Mucuna pruriens*) is induced by the release of which specific protease?","options":["Tryptase","Cathepsin S","Mucunain","Kallikrein 7"],"correctIndex":2,"explanation":"Cowhage spicules induce itch via release of the protease mucunain [2]."},{"id":4,"chapterId":6,"question":"Mucunain, the protease released by cowhage, activates which pair of receptors to elicit itch transmission?","options":["Histamine H1 and H4 receptors","MAS-related G protein-coupled receptors (MRGPRs)","Proteinase-activated receptor (PAR)-2 and PAR-4","Transient receptor potential vanilloid (TRPV1) and ankyrin 1 (TRPA1)"],"correctIndex":2,"explanation":"Cowhage spicules induce itch via release of the protease mucunain, which activates proteinase-activated receptor (PAR)-2 and PAR-4 [2]."},{"id":5,"chapterId":6,"question":"MAS-related G protein-coupled receptor D (MRGPRD) is exclusively expressed by which subset of pruriceptive C fibers?","options":["Histamine-sensitive C fibers","Type 1 non-peptidergic (NP1) neurons","Type 2 non-peptidergic (NP2) neurons","Type 3 non-peptidergic (NP3) neurons"],"correctIndex":1,"explanation":"MAS-related G protein-coupled receptor D (MRGPRD) is a -alanine receptor that is exclusively expressed by a subset of pruriceptive C fibers classified as type 1 non-peptidergic (NP1) neurons [3]."},{"id":6,"chapterId":6,"question":"The pharmacologic pruritogen chloroquine directly activates which type of sensory neuron?","options":["NP1 neurons","NP2 neurons","NP3 neurons","A-delta fibers"],"correctIndex":1,"explanation":"The pharmacologic pruritogen chloroquine directly activates NP2 (type 2) neurons [3]."},{"id":7,"chapterId":6,"question":"Which specific Th2 cytokine elicits itch primarily via activation of NP3 (type 3) neurons?","options":["Interleukin-4 (IL-4)","Interleukin-13 (IL-13)","Interleukin-31 (IL-31)","Interleukin-2 (IL-2)"],"correctIndex":2,"explanation":"The Th2 cytokine IL-31 elicits itch via NP3 (type 3) neurons [3]."},{"id":8,"chapterId":6,"question":"What was the first itch-specific receptor identified in the spinal cord, serving as a key downstream mediator of non-histaminergic itch responses?","options":["Gastrin-releasing peptide receptor (GRPR)","Neurokinin-1 receptor (NK1R)","MRGPRX4","Histamine H4 receptor"],"correctIndex":0,"explanation":"The first itch-specific receptor to be identified, gastrin-releasing peptide receptor (GRPR), is found in the spinal cord and represents a key downstream mediator of non-histaminergic itch responses [4]."},{"id":9,"chapterId":6,"question":"Which itch-selective neuropeptide, found in dorsal root ganglia neurons, is believed to act upstream of the GRPR itch spinal circuit?","options":["Substance P","Gastrin-releasing peptide (GRP)","Calcitonin gene related peptide (CGRP)","B-type natriuretic peptide (BNP)"],"correctIndex":3,"explanation":"B-type natriuretic peptide, an itch-selective neuropeptide found in dorsal root ganglia neurons, is believed to act upstream of the GRPR itch spinal circuit [4]."},{"id":10,"chapterId":6,"question":"Pruriceptive C fibers synapse with secondary sensory neurons in which specific area of the spinal cord?","options":["Lamina I of the dorsal horn gray matter","Ventral horn white matter","Dorsal root ganglion","Periaqueductal gray matter"],"correctIndex":0,"explanation":"In the spinal cord, pruriceptive C fibers synapse with secondary sensory neurons in the gray matter of the dorsal horn [5]."},{"id":11,"chapterId":6,"question":"What is the typical sensory nerve classification for the nerve fibers that mediate pruritus (itch)?","options":["Peptidergic A-delta (A delta)","Large myelinated A-beta (A beta)","Non-peptidergic (NP) C fibers","Sympathetic postganglionic fibers"],"correctIndex":2,"explanation":"Pruritus (itch) is mediated by sensory nerves traditionally classified as non-peptidergic (NP) [6]."},{"id":12,"chapterId":6,"question":"The finding that histamine-induced itch and cowhage-induced itch stimulate distinct populations of spinothalamic tract neurons supports the idea of:","options":["The Gate Control Theory of Pain","A single, dedicated central itch pathway","Parallel, distinct non-histaminergic pathways for itch transmission","A uniform response regardless of the peripheral mediator"],"correctIndex":2,"explanation":"Neurophysiologic experiments in primates found that cowhage-induced itch stimulates a distinct population of spinothalamic tract neurons that are not involved in the transmission of histamine-mediated itch, supporting the existence of distinct parallel pathways [7, 8]."},{"id":13,"chapterId":6,"question":"Which brain region is potentially involved in coordinating the itchscratch cycle, based on studies showing its activation during scratching?","options":["Anterior cingulate cortex","Insulaclaustrum complex","Thalamus","Cerebellum"],"correctIndex":3,"explanation":"Scratching has been found to activate the prefrontal cortex and cerebellum. It is possible that the cerebellum plays a role in coordinating the itchscratch cycle [9]."},{"id":14,"chapterId":6,"question":"Removal of which layer of the skin largely abolishes the perception of itch?","options":["Dermis","Hypodermis","Epidermis","Subcutaneous fat"],"correctIndex":2,"explanation":"Removal of the epidermis largely abolishes the perception of itch [10]."},{"id":15,"chapterId":6,"question":"Which of the following receptors involved in itch sensation is expressed by keratinocytes?","options":["IL-31 receptor A (IL-31RA)","Neurotrophic tyrosine kinase receptor type 1 (NTRK1)","Gastrin-releasing peptide receptor (GRPR)","P-selectin glycoprotein ligand-1 (PSGL-1)"],"correctIndex":1,"explanation":"Keratinocytes express a variety of neural mediators and receptors involved in the sensation of itch... including neurotrophic tyrosine kinase receptor type 1 (NTRK1) [11]."},{"id":16,"chapterId":6,"question":"A-delta fibers, compared to C fibers, are characterized by which combination of physical properties?","options":["Large diameter and myelinated","Small diameter and myelinated","Small diameter and unmyelinated","Large diameter and unmyelinated"],"correctIndex":1,"explanation":"A-delta fibers are small and myelinated, with a conduction velocity of 230 m/s [12]."},{"id":17,"chapterId":6,"question":"The high-affinity IgE receptor (FcRI), the KIT receptor, and MRGPRX2 are all receptors that, upon activation, can lead to the release of histamine from which cell type?","options":["Keratinocytes","Macrophages","Dermal mast cells","Dorsal horn neurons"],"correctIndex":2,"explanation":"Histamine can be released from mast cells upon activation of a range of receptors, including the high-affinity IgE receptor (FcRI), the KIT receptor, MRGPRX2, and receptors for various neuropeptides [13]."},{"id":18,"chapterId":6,"question":"Which protease, released by activated mast cells, cleaves PAR-2 on C-fiber terminals to expose a tethered ligand domain and initiate itch transmission?","options":["Mucunain","Cathepsin S","Tryptase","Kallikrein 7"],"correctIndex":2,"explanation":"Mast cells produce two proteases, tryptase and chymase. Tryptase, released by activated mast cells, cleaves PAR-2... this exposes a tethered ligand domain and thereby self-activates PAR-2, leading to itch transmission [14]."},{"id":19,"chapterId":6,"question":"Generalized pruritus may occur due to an imbalance between the central and peripheral systems of which endogenous neuromediators?","options":["Histamine and Serotonin","Substance P and CGRP","The mu ()-opioid system (MOR) and kappa ()-opioid system ","IL-31 and TSLP"],"correctIndex":2,"explanation":"Generalized pruritus may be induced by an imbalance between mu ()-opioid system (MOR) and kappa ()-opioid system, activation of which stimulates and inhibits itch perception, respectively [15]."},{"id":20,"chapterId":6,"question":"Activation of which specific opioid receptor stimulates itch perception, and whose agonists (e.g., morphine) may cause generalized pruritus?","options":["kappa ()-opioid receptor","mu ()-opioid receptor","Delta -opioid receptor","Neurokinin-1 receptor"],"correctIndex":1,"explanation":"Activation of the mu ()-opioid stimulates itch perception. Morphine as well as other exogenous and endogenous mu ()-opioid receptor agonists may cause generalized pruritus [16]."},{"id":21,"chapterId":6,"question":"Substance P, when released from cutaneous sensory nerves, causes immediate mast cell degranulation primarily by activating which receptor?","options":["H1 receptor","Neurokinin-1 (NK-1) receptor","MRGPRX2 receptor","PAR-2"],"correctIndex":2,"explanation":"High concentrations of substance P can cause immediate mast cell degranulation via MRGPRX2 receptors [17]."},{"id":22,"chapterId":6,"question":"Which primary mediator of pruritus is listed as 'highly active' (+++) for pruritus but having 'no activity' (-) for pain, according to Table 5.2?","options":["Histamine","Tryptase","Gastrin-releasing peptide (GRP)","Substance P"],"correctIndex":2,"explanation":"Gastrin-releasing peptide (GRP) is listed as highly active (+++) for pruritus and having no activity () for pain [18, 19]."},{"id":23,"chapterId":6,"question":"Increased levels of Nerve Growth Factor (NGF) in involved skin are associated with which change in cutaneous nerve fibers?","options":["Vasodilation only","Inhibition of peptide release","Reduced axonal transport","Proliferation and sprouting of terminal cutaneous nerves"],"correctIndex":3,"explanation":"Increased levels of epidermal NGF correlate with proliferation of terminal cutaneous nerves and upregu-lated expression of neuropeptides such as substance P [20]. NGF can also induce sprouting of nerve fibers [20]."},{"id":24,"chapterId":6,"question":"The activity of prostaglandins, such as PGE1, in pruritus is characterized by:","options":["Directly causing intense itch","Blocking H1 receptors","Lowering the threshold to pruritus induced by other mediators","Inhibiting the function of C fibers"],"correctIndex":2,"explanation":"Prostaglandins... enhance histamine-induced itch [21]. PGE1 is not itself pruritogenic but enhances pruritus due to lowering threshold to pruritus induced by other mediators [18, 21]."},{"id":25,"chapterId":6,"question":"Which transient receptor potential (TRP) ion channel is located on C fibers, mediates heat pain, and is required for the experimental induction of histamine-mediated itch?","options":["TRPV3","TRPM8","TRPA1","TRPV1"],"correctIndex":3,"explanation":"TRP vanilloid 1 (TRPV1) is located on C fibers... and experimental induction of histamine-mediated itch requires cooperation of TRPV1 ion channels [22]."},{"id":26,"chapterId":6,"question":"Gain-of-function missense mutations in which TRP channel, expressed in keratinocytes and dorsal root ganglion neurons, result in chronic itch and atopic-like dermatitis in mice and Olmsted syndrome in humans?","options":["TRPA1","TRPV3","TRPM8","TRPV1"],"correctIndex":1,"explanation":"TRPV3 is a thermosensor of warmth (>33C, 91F) that is expressed in keratinocytes and dorsal root ganglion neurons. Gain-of-function missense mutations in TRPV3 result in chronic itch [23]."},{"id":27,"chapterId":6,"question":"What term describes the phenomenon in chronic itch where stimuli that normally do not induce itch (such as light touch or gentle warming) cause itch in the skin surrounding a pruritic area?","options":["Hyperalgesia","Allodynia","Hyperknesis","Alloknesis"],"correctIndex":3,"explanation":"In alloknesis, stimuli that normally do not induce itch such as touch or gentle warming do so in the skin that surrounds a pruritic area [24]."},{"id":28,"chapterId":6,"question":"Which neuropeptide, a proteolytically cleaved product of proenkephalin A, is a potent activator of MRGPRs and can stimulate itch accompanied by a stinging or burning sensation?","options":["Gastrin-releasing peptide (GRP)","Bovine adrenal medulla 8-22 (BAM8-22) peptide","Substance P","Neurotrophin 4"],"correctIndex":1,"explanation":"The bovine adrenal medulla 8-22 (BAM8-22) peptide, a proteolytically cleaved product of proenkephalin A, is a potent activator of MRGPRs and can stimulate itch [25]."},{"id":29,"chapterId":6,"question":"The IL-31 receptor (IL-31R), which is found on cutaneous C fibers, is composed of which heterodimer subunits?","options":["gp130 and IL-7R","Neurokinin-1 receptor and TSLP receptor","The oncostatin M receptor beta and interleukin-31 receptor A","TRPV1 and TRPA1"],"correctIndex":2,"explanation":"The IL-31 receptor (IL-31R) is a heterodimer composed of the oncostatin M receptor (OSMR) beta protein plus the (IL-31) receptor A (IL-31RA)."},{"id":30,"chapterId":6,"question":"Which systemic drug, used to treat pruritus, functions as a kappa-opioid receptor agonist and is FDA-approved for renal pruritus?","options":["Naltrexone","Butorphanol","Aprepitant","Difelikefalin"],"correctIndex":3,"explanation":"Difelikefalin, a kappa-opioid receptor agonist, is utilized as a therapy for chronic pruritus and controlled trials show efficacy for renal pruritus, with difelikefalin being FDA-approved for this indication."},{"id":1,"chapterId":7,"question":"Chronic pruritus is formally defined as lasting for at least how many weeks?","options":["2 weeks","4 weeks","6 weeks","8 weeks"],"correctIndex":2,"explanation":"The self-reported point, 12-month, and lifetime prevalences of chronic pruritus (lasting  6 weeks) were assessed in a German study [1]. Prurigo nodularis is associated with chronic itch (i.e. lasting  6 weeks) [2]."},{"id":2,"chapterId":7,"question":"According to the International Forum for the Study of Itch classification proposed in 2007, which of the following is NOT one of the three major groups of chronic pruritus?","options":["Chronic pruritus of lesional (inflamed) skin","Chronic pruritus of psychogenic origin","Chronic pruritus of non-lesional (non-inflamed) skin","Chronic pruritus presenting with secondary scratch-induced lesions"],"correctIndex":1,"explanation":"In this system, there are three major groups of pruritus: (1) chronic pruritus of lesional (inflamed) skin; (2) chronic pruritus of non-lesional (non-inflamed) skin; and (3) chronic pruritus presenting with secondary scratch-induced lesions (e.g. prurigo nodularis, lichen simplex chronicus) [3]."},{"id":3,"chapterId":7,"question":"Generalized pruritus is a manifestation of an underlying systemic disease in approximately what percentage of affected individuals?","options":["Less than 5%","15%50%","50%75%","Greater than 75%"],"correctIndex":1,"explanation":"Pruritus often arises from a primary cutaneous disorder but can be a manifestation of an underlying systemic disease in 15%50% of affected individuals, especially when generalized [4]."},{"id":4,"chapterId":7,"question":"In the physical examination of a patient with pruritus, lesions localized to the mid upper back, the 'butterfly sign,' typically suggest:","options":["An underlying systemic disease","A primary skin disease","Chronic kidney disease-associated pruritus","Generalized pruritus of unknown etiology"],"correctIndex":1,"explanation":"Lesions on the mid upper back suggest a primary skin disease, since this difficult-to-reach area is typically spared (the 'butterfly sign') in patients with skin lesions secondary to scratching [5]."},{"id":5,"chapterId":7,"question":"Which specific condition listed in the sources has pruritus as a 100% diagnostic criterion?","options":["Psoriasis","Lichen planus","End-stage kidney disease","Atopic dermatitis"],"correctIndex":3,"explanation":"Pruritus is such an important aspect of atopic dermatitis that 'the diagnosis of active atopic dermatitis cannot be made if there is no history of pruritus' [6]. Atopic dermatitis is listed with a reported prevalence of pruritus of 100% (diagnostic criterion) [7]."},{"id":6,"chapterId":7,"question":"In urticaria, which mediator plays a primary role in pruritus, allowing H1-receptor antagonists to usually decrease or eliminate the sensation?","options":["Interleukin-31 (IL-31)","Substance P","Histamine","Calcitonin gene-related peptide (CGRP)"],"correctIndex":2,"explanation":"Histamine plays a primary role in the pruritus of urticaria, and H1-receptor antagonists usually decrease or eliminate this sensation as well as the wheals themselves [6]."},{"id":7,"chapterId":7,"question":"Which group of cytokines plays a key role in the inflammation and subsequent pruritus associated with atopic dermatitis, leading to targeted therapies like dupilumab and nemolizumab?","options":["Th1 cytokines (e.g., IFN-, IL-2)","Th2 cytokines (e.g., IL-4, IL-13, IL-31)","Th17 cytokines (e.g., IL-17)","Regulatory T cell cytokines (e.g., TGF-)"],"correctIndex":1,"explanation":"Type 2 cytokines such as IL-4, IL-13, IL-31, and thymic stromal lymphopoietin play a key role in the inflammation of atopic dermatitis. As a result, therapies that target Th2 signaling via IL-4/-13 (e.g. dupilumab, tralokinumab, lebrikizumab), IL-31 (nemolizumab), or Janus kinase (JAK) 1/2 have anti-pruritic effects [8]."},{"id":8,"chapterId":7,"question":"What is the clinical finding in prurigo nodularis that corresponds to chronic, focused scratching or picking, and is one of the three major groups of chronic pruritus?","options":["Xerosis","Eczema craquel","Lichenification","Multiple pruritic papulonodules"],"correctIndex":3,"explanation":"Prurigo nodularis is associated with chronic itch (i.e. lasting  6 weeks), where skin lesions are produced by repetitive, focused scratching or picking of the skin [2]. Multiple pruritic papulonodules are the most commonly observed clinical lesions [9]."},{"id":9,"chapterId":7,"question":"In prurigo nodularis, which of the following statements accurately describes the distribution of nerve fibers found on histological analysis?","options":["Increased density of epidermal nerve fibers","Hypertrophy and increased density of dermal nerve fibers","Normal number of nerve fibers in both dermis and epidermis","Complete atrophy of all dermal nerve fibers"],"correctIndex":1,"explanation":"Possibly as a result of intense scratching, pruriginous lesions demonstrate hypertrophy and an increased density of dermal nerve fibers. In contrast, the number of nerve fibers within the epidermis is reduced [10]."},{"id":10,"chapterId":7,"question":"Which Janus kinase (JAK) inhibitor led to rapid improvement of polycythemia vera and its associated aquagenic pruritus in controlled trials?","options":["Tofacitinib","Upadacitinib","Ruxolitinib","Baricitinib"],"correctIndex":2,"explanation":"In RCTs, the JAK 1/2 inhibitor ruxolitinib led to rapid improvement of polycythemia vera and its associated pruritus [11]."},{"id":11,"chapterId":7,"question":"Pruritus in patients with scabies is typically characterized by which pattern?","options":["Generalized and most intense during the day","Localized to the head and neck, sparing the rest of the body","Localized or generalized, more intense at night, and typically spares the head","Sudden onset with blistering, irrespective of the time of day"],"correctIndex":2,"explanation":"In patients with scabies, pruritus can be localized or generalized, and it may have a burning component. It is usually more intense at night and typically spares the head [12]."},{"id":12,"chapterId":7,"question":"Which condition is characterized by epidermal hypertrophy secondary to chronic, habitual rubbing or scratching of localized areas of skin, resulting in plaques with exaggerated skin lines ('leathery' appearance)?","options":["Psoriasis","Lichen Simplex Chronicus (LSC)","Prurigo Nodularis","Urticaria"],"correctIndex":1,"explanation":"In lichen simplex chronicus (LSC), there is epidermal hypertrophy secondary to chronic, habitual rubbing or scratching of localized areas of skin. Lesions of LSC are broader and thinner than those of prurigo and are characterized by well-defined plaques exhibiting exaggerated skin lines (lichenification) with a 'leathery' appearance [13]."},{"id":13,"chapterId":7,"question":"What is the most frequent finding on the buttocks, extensor aspects of the extremities, and lumbosacral region in patients with prurigo nodularis?","options":["Pruritic papulonodules","Plaques of lichen simplex chronicus","Bullae and erosions","Targetoid lesions"],"correctIndex":0,"explanation":"Multiple pruritic papulonodules are most commonly observed on the extensor aspects of the extremities, and their distribution is usually symmetric. The upper back, lumbosacral region, and buttocks may also be involved [9]."},{"id":14,"chapterId":7,"question":"Which IL-31 targeted therapy has been shown in Randomized Controlled Trials (RCTs) to significantly reduce pruritus and cutaneous lesions in adults with prurigo nodularis?","options":["Dupilumab","Tralokinumab","Nemolizumab","Omalizumab"],"correctIndex":2,"explanation":"The IL-31 receptor inhibitor nemolizumab was also found in RCTs to significantly reduce pruritus and cutaneous lesions in adults with prurigo nodularis [13, 14]. Dupilumab (which targets IL-4/-13) was also FDA approved for prurigo nodularis [14]."},{"id":15,"chapterId":7,"question":"Pruritus ani is localized to the anus and perianal skin and occurs in 1%5% of the general population, with what approximate male-to-female ratio?","options":["1:4","1:1","2:1","4:1"],"correctIndex":3,"explanation":"Pruritus localized to the anus and perianal skin occurs in 1%5% of the general population, with a male : female ratio of  4 : 1."},{"id":16,"chapterId":7,"question":"Which characteristic sensation is typical of aquagenic pruritus, occurring within 30 minutes of water contact?","options":["Intense burning followed by large wheals","Painful blistering and ulceration","Prickling, tingling, burning, or stinging sensations","Deep, unrelenting pressure"],"correctIndex":2,"explanation":"Aquagenic pruritus presents with prickling, tingling, burning, or stinging sensations within 30 minutes of water contact, irrespective of its temperature or salinity [16]."},{"id":17,"chapterId":7,"question":"Which of the following is commonly spared in primary (idiopathic) aquagenic pruritus?","options":["Lower extremities","Trunk","Head, palms, soles, and mucosae","Upper arms"],"correctIndex":2,"explanation":"Typically, symptoms begin on the lower extremities and then generalize, with sparing of the head, palms, soles, and mucosae [16]."},{"id":18,"chapterId":7,"question":"Chronic kidney disease-associated pruritus (CKD-aP) is also known by the synonym 'uremic pruritus,' but this term is considered incorrect because:","options":["The symptoms are primarily psychogenic.","It incorrectly implies the symptom is secondary to elevated serum urea levels.","The condition is primarily mediated by histamine release.","It only occurs in patients receiving peritoneal dialysis."],"correctIndex":1,"explanation":"Although the term 'uremic pruritus' is used synonymously [17], it incorrectly implies that the symptom is secondary to elevated serum urea levels [17]. Nowadays, chronic kidney disease-associated pruritus (CKD-aP), rather than renal pruritus, is the preferred term [17]."},{"id":19,"chapterId":7,"question":"What is the FDA/EMA-approved treatment for CKD-aP in hemodialysis patients that functions as a peripherally acting -opioid receptor agonist?","options":["Naltrexone","Gabapentin","Difelikefalin","Aprepitant"],"correctIndex":2,"explanation":"Difelikefalin, a peripherally acting -opioid receptor agonist, was shown in an RCT to significantly reduce itch intensity in hemodialysis patients and is now an FDA/EMA-approved treatment for CKD-aP [18]."},{"id":20,"chapterId":7,"question":"Which endogenous enzyme, responsible for the production of lysophosphatidic acid (LPA), shows serum levels that correlate with the intensity of itch in patients with cholestasis?","options":["Alkaline phosphatase","Serum transaminase","Autotaxin (ATX)","Tryptase"],"correctIndex":2,"explanation":"Other studies have provided evidence that lysophosphatidic acid (LPA), a neuronal activator, and autotaxin (ATX, lysophospholipase D), the enzyme responsible for production of LPA from lysophosphatidyl-choline, play significant roles in cholestatic pruritus. Unlike other putative mediators, ATX levels correlate with the intensity of itch in patients with cholestasis [19]."},{"id":21,"chapterId":7,"question":"What is the primary bile acid receptor expressed in sensory neurons that is activated by bile acids and may contribute to cholestatic pruritus?","options":["MRGPRX4","NK1 receptor","IL-31 receptor","TRPV1"],"correctIndex":0,"explanation":"Mas-related G-protein coupled receptor member X4 (MRGPRX4), a bile acid receptor expressed in sensory neurons, is involved in itch transmission and may represent a therapeutic target [20-22]."},{"id":22,"chapterId":7,"question":"Aquagenic pruritus may precede the diagnosis of which myeloproliferative neoplasm by several years, eventually affecting 30%50% of these patients?","options":["Chronic lymphocytic leukemia (CLL)","Hodgkin lymphoma","Polycythemia vera","Non-Hodgkin lymphoma"],"correctIndex":2,"explanation":"Aquagenic pruritus may precede the development of polycythemia vera by several years and eventually affects 30%  50% of polycythemia vera patients [11]."},{"id":23,"chapterId":7,"question":"In Polycythemia vera patients, the constitutive activation and agonist hypersensitivity in basophils are linked to which somatic mutation?","options":["EGFR inhibition","JAK2 (V617F) mutation","TTC7A mutation","SCN9A mutation"],"correctIndex":1,"explanation":"Approximately 97% of patients with polycythemia vera have a somatic mutation (V617F) in the Janus kinase 2 gene (JAK2) that results in constitutive activation and agonist hypersensitivity in basophils [11]."},{"id":24,"chapterId":7,"question":"Paraneoplastic itch is most frequently associated with which group of malignancies?","options":["Solid tumors (e.g., breast or lung cancer)","Melanoma","Myeloproliferative neoplasms and lymphomas","Sarcomas"],"correctIndex":2,"explanation":"Paraneoplastic itch is most frequent with myeloproliferative neoplasms (e.g. polycythemia vera > essential thrombocythemia), lymphoma (Hodgkin > non-Hodgkin), and cancers of the liver or biliary system [23]."},{"id":25,"chapterId":7,"question":"Notalgia paresthetica, a common sensory neuropathy of the upper back, is believed to result from the entrapment and injury of which spinal nerve rami?","options":["Posterior rami of T2T6","Anterior rami of C5C6","Lateral femoral cutaneous nerve","Superficial branch of the radial nerve"],"correctIndex":0,"explanation":"Most evidence suggests that notalgia paresthetica represents a sensory neuropathy. The posterior rami of T2T6 pursue a right-angle course through the multifidus spinae muscle that extends along the vertebral column, potentially predisposing these nerves to entrapment and injury [24]."},{"id":26,"chapterId":7,"question":"Brachioradial pruritus, a chronic sensory neuropathy, is exacerbated by which environmental factor due to hypersensitivity of cutaneous nerves?","options":["Cold water exposure","Cumulative sun exposure (UV light)","High concentrations of histamine","Heavy physical labour"],"correctIndex":1,"explanation":"Cumulative sun exposure represents another predisposing factor. Due to hypersensitivity of cutaneous nerves, acute UV light exposure can also exacerbate the condition, and patients living in temperate climates often experience remissions during the fall and winter [25]."},{"id":27,"chapterId":7,"question":"Meralgia paresthetica is caused by pressure on which specific nerve as it passes under the inguinal ligament?","options":["Posterior tibial nerve","Sciatic nerve","Lateral femoral cutaneous nerve","Sural nerve"],"correctIndex":2,"explanation":"Meralgia paresthetica occurs in the territory of the lateral femoral cutaneous nerve, and it results from pressure on this nerve as it passes under the inguinal ligament [26]."},{"id":28,"chapterId":7,"question":"Which antimalarial drug is noted in the sources as a common pharmacologic etiology of pruritus via MRGPR stimulation?","options":["Hydroxychloroquine","Chloroquine","Quinine","Mefloquine"],"correctIndex":1,"explanation":"Chloroquine (pruritus may be generalized, localized to the hands/feet, or aquagenic; most common in individuals of African descent) causes MRGPR stimulation [27]."},{"id":29,"chapterId":7,"question":"Trigeminal Trophic Syndrome classically presents as a self-induced ulcerative condition that favors which specific facial location?","options":["Lower lip vermilion border","Medial cheek","Nasal ala (wing of the nose)","Ocular conjunctiva"],"correctIndex":2,"explanation":"Trigeminal trophic syndrome is a self-induced ulcerative condition of the central face that classically involves the nasal ala [28]."},{"id":30,"chapterId":7,"question":"Which systemic drug class, due to its action on the central nervous system, is often associated with generalized pruritus (e.g., when administered intrathecally or epidurally)?","options":["NSAIDs","ACE inhibitors","Opioids (e.g., morphine, fentanyl)","Beta-blockers"],"correctIndex":2,"explanation":"Neurologic medications associated with pruritus include tramadol, codeine, cocaine, and morphine, with pruritus being more likely with intrathecal/epidural than systemic administration [29]."},{"id":1,"chapterId":8,"question":"In which category of psychodermatologic disorders are the cutaneous lesions typically self-induced, and the patient usually has no primary skin disease?","options":["Secondary psychodermatologic disorders","Psychophysiologic disorders","Primary psychodermatologic disorders","Psychogenic pruritus and dysesthesia"],"correctIndex":2,"explanation":"Primary psychodermatologic disorders are those in which the patient typically has no primary skin disease and cutaneous lesions are self-induced (e.g., delusional infestation, body-focused repetitive behaviors) [1], [2]."},{"id":2,"chapterId":8,"question":"Which term describes a primary skin disorder, such as psoriasis or atopic dermatitis, that is worsened by psychological or behavioral factors like stress or anxiety?","options":["Dermatitis artefacta","Psychophysiologic disorder","Secondary psychodermatologic disorder","Psychogenic dysesthesia"],"correctIndex":1,"explanation":"Psychophysiologic disorders are those in which a primary skin disorder (e.g. atopic dermatitis, psoriasis) is exacerbated by psychologic or behavioral factors (e.g. stress, anxiety) [3], [2]."},{"id":3,"chapterId":8,"question":"Delusional Infestation (DI) is classified as a somatic type of delusional disorder, which falls under which broader DSM-5 category?","options":["Obsessive-compulsive and related disorders","Somatic symptom and related disorders","Schizophrenia spectrum and other psychotic disorders","Adjustment disorders"],"correctIndex":2,"explanation":"Delusional infestation (DI) is classified as a somatic type of delusional disorder within the broad group of schizophrenia spectrum and other psychotic disorders [4]."},{"id":4,"chapterId":8,"question":"What fixed, false belief characterizes Delusional Infestation (DI)?","options":["That the patient has a non-existent or slight defect in appearance","That the skin is infested with animate organisms (e.g., parasites) or inanimate materials (e.g., fibers) despite contrary evidence","That recurrent, unwanted thoughts or urges (obsessions) must be neutralized by repetitive behaviors (compulsions)","That the patient has or is acquiring a serious illness despite mild or absent somatic symptoms"],"correctIndex":1,"explanation":"Delusions are defined as fixed false beliefs that are not amenable to change despite conflicting evidence [4]. DI is characterized by the fixed, false belief that the skin is infested with animate organisms (e.g. insects, parasites) or inanimate materials (e.g. fibers) despite evidence to the contrary [3], [4]."},{"id":5,"chapterId":8,"question":"The term 'Morgellons disease' is currently used by patients to describe what falsely perceived cutaneous element?","options":["Fungal plaques","Fibers extruding from their skin","Deep burrowing mites","Metallic shards"],"correctIndex":1,"explanation":"More recently, the term 'Morgellons disease' has been used by patients to describe what they falsely perceive as fibers extruding from their skin [5]."},{"id":6,"chapterId":8,"question":"The 'matchbox sign' refers to which clinical presentation in patients with Delusional Infestation?","options":["The collection of hypopigmented scars on the mid-back","The unique pattern of linear excoriations suggesting self-infliction","Samples of alleged 'parasites' or fibers (e.g., bits of skin, lint) brought in by the patient","The patients inability to grasp the concept of delusion"],"correctIndex":2,"explanation":"Patients frequently bring in bits of skin, lint, and other samples that they believe represent 'parasites'/fibers, which is referred to as the 'matchbox sign' (Fig. 7.2) [6]."},{"id":7,"chapterId":8,"question":"For a patient to fulfill the DSM-5 diagnostic criteria for a delusional disorder, the delusion must be present for at least how long?","options":["1 week","1 month","6 months","1 year"],"correctIndex":1,"explanation":"The DSM-5 diagnostic criteria for a delusional disorder require that the delusion must be present for  1 month."},{"id":8,"chapterId":8,"question":"Which demographic group experiences Delusional Infestation at least twice as often as men among individuals over 50 years of age?","options":["Men of lower socioeconomic status","Women","Younger patients with substance abuse history","Individuals of Asian descent"],"correctIndex":1,"explanation":"Among individuals over 50 years of age, women experience the disorder at least twice as often as men."},{"id":9,"chapterId":8,"question":"What phenomenon describes two people sharing the same delusion, sometimes seen with Delusional Infestation?","options":["Psychosis encapsulated","Somatic symptom disorder","Folie  deux","Illness anxiety disorder"],"correctIndex":2,"explanation":"Folie  deux ('craziness for two') is the term used to describe two people who share the same delusion. Occasionally, larger numbers of people harbor the same delusion [8]."},{"id":10,"chapterId":8,"question":"Which class of medication is the mainstay of therapy for Delusional Infestation?","options":["Selective serotonin reuptake inhibitors (SSRIs)","Mood stabilizers","Antipsychotics","Benzodiazepines"],"correctIndex":2,"explanation":"The most challenging aspect of treatment is getting patients to agree to a trial of an antipsychotic agent, which is the mainstay of therapy for DI [9]."},{"id":11,"chapterId":8,"question":"Which antipsychotic drug has traditionally been used first-line for Delusional Infestation and may be better accepted by patients because it has no psychiatric FDA indication?","options":["Risperidone","Pimozide","Olanzapine","Aripiprazole"],"correctIndex":1,"explanation":"First-line treatment has traditionally been pimozide, which is usually effective at a very low dose and may be better accepted by patients because it has no psychiatric FDA indication [9], [10]."},{"id":12,"chapterId":8,"question":"Which side effect of pimozide is rated '+++' (highest severity) in comparison to other listed side effects in Table 7.3?","options":["Sedation/somnolence","Weight gain","Tardive dyskinesia","Anticholinergic effects"],"correctIndex":2,"explanation":"Pimozide is associated with Tardive dyskinesia (+++) and Extrapyramidal effects (+++)."},{"id":13,"chapterId":8,"question":"What is the recommended starting dose for Risperidone when treating Delusional Infestation in dermatology patients?","options":["2.5 mg/day","0.5 mg/day","10 mg/day","2 mg/day"],"correctIndex":1,"explanation":"The dosage for risperidone (Second-generation antipsychotic) in dermatologic indications is to start at 0.5 mg/day at bedtime [12]."},{"id":14,"chapterId":8,"question":"Compared to first-generation antipsychotics like pimozide, second-generation antipsychotics (SGAs) are preferred in DI primarily due to a decreased risk of:","options":["Weight gain","Metabolic side effects","Extrapyramidal side effects (EPS) and Tardive Dyskinesia (TD)","QT prolongation"],"correctIndex":2,"explanation":"Second-generation antipsychotics (SGAs) such as risperidone have reduced neurologic sequelae and a decreased incidence of extrapyramidal side effects (EPS) and tardive dyskinesia, but a greater risk of metabolic side effects [13], [9]."},{"id":15,"chapterId":8,"question":"What is the minimum duration a therapeutic dose of risperidone should typically be maintained once an adequate clinical response is reached for Delusional Infestation?","options":["1 week","1 month","3 months","1 year"],"correctIndex":2,"explanation":"Once an adequate clinical response has been reached, maintain therapeutic dose for at least three months, followed by a gradual taper [14]."},{"id":16,"chapterId":8,"question":"When initiating risperidone, monitoring guidelines recommend measuring the patient's weight at which frequency intervals initially?","options":["Baseline only","Baseline, 4 weeks, 8 weeks, 12 weeks, Quarterly, Annually","Annually only","Only if weight gain is reported"],"correctIndex":1,"explanation":"Monitoring guidelines for risperidone suggest measuring weight at Baseline, 4 weeks, 8 weeks, 12 weeks, Quarterly, and Annually [14]."},{"id":17,"chapterId":8,"question":"Which benzodiazepine is specifically listed for the treatment of acute anxiety, with the caveat that treatment should not exceed 4 weeks due to dependency risk?","options":["Buspirone","Alprazolam","Doxepin","Venlafaxine"],"correctIndex":1,"explanation":"For acute anxiety, Benzodiazepines such as Alprazolam (0.1250.25 mg every 68 hours, as needed) can be used, but treatment should not exceed 4 weeks because of dependency/addiction risk [15]."},{"id":18,"chapterId":8,"question":"Which Selective Serotonin Reuptake Inhibitor (SSRI) is noted for potentially causing dose-dependent QT prolongation?","options":["Fluoxetine","Sertraline","Bupropion XL","Citalopram"],"correctIndex":3,"explanation":"Citalopram and escitalopram can cause dose-dependent QT prolongation [16]."},{"id":19,"chapterId":8,"question":"Which tricyclic antidepressant is often used at a low dose (e.g., 1025 mg at bedtime) for pruritus due to its sedating and potent antihistamine properties?","options":["Clomipramine","Paroxetine","Doxepin","Venlafaxine"],"correctIndex":2,"explanation":"Doxepin (1025 mg, at bedtime) is sedating and may be helpful for pruritus [17], [18], [19]."},{"id":20,"chapterId":8,"question":"Body Dysmorphic Disorder (BDD) is estimated to affect what percentage of patients seen in dermatology and cosmetic surgery practices?","options":["~2%","~5%","10%15%","Greater than 20%"],"correctIndex":2,"explanation":"The prevalence of body dysmorphic disorder is estimated to be as high as 10%15% in dermatology and cosmetic surgery patients [20], [21]."},{"id":21,"chapterId":8,"question":"The OCD variant of Body Dysmorphic Disorder is primarily treated with which combination of therapies?","options":["Antipsychotics alone","Benzodiazepines and phototherapy","Cognitive behavioral therapy (CBT) typically combined with an SSRI","Pimozide and high-dose doxepin"],"correctIndex":2,"explanation":"The first-line therapy for patients with the OCD variant of this disease includes cognitive behavioral therapy (CBT), typically in conjunction with an SSRI (often requiring a relatively high dose) [12]."},{"id":22,"chapterId":8,"question":"Trichotillomania is characterized by the recurrent pulling out of ones hair, most commonly from which sites?","options":["Axilla and chest","Scalp, eyebrows, and eyelashes","Pubic region and legs","Vellus hairs on the face and neck"],"correctIndex":1,"explanation":"The most common sites of hair pulling are the scalp, eyebrows, eyelashes, and pubic region [22], [23]."},{"id":23,"chapterId":8,"question":"What is the term for the chewing and swallowing of hair that has been pulled out by patients with trichotillomania, which can lead to intestinal obstruction?","options":["Trichoclasis","Trichophagy","Trichoptilosis","Trichodynia"],"correctIndex":1,"explanation":"Some patients practice trichophagy, the chewing and swallowing of the hair that has been pulled out, which can lead to intestinal obstruction from tricho bezoars [22]."},{"id":24,"chapterId":8,"question":"The mainstay of treatment for Trichotillomania is:","options":["High-dose systemic steroids","Behavior modification therapy (e.g., habit reversal training)","First-generation antipsychotics","Antibiotics and antifungal agents"],"correctIndex":1,"explanation":"Behavior modification therapy (e.g. habit reversal training, CBT) is the mainstay of treatment [23], [24]."},{"id":25,"chapterId":8,"question":"Which mucocutaneous finding is associated with the body-focused repetitive behavior of lip licking?","options":["Bite fibroma","Paronychia","Irritant contact dermatitis","Pseudo-knuckle pads"],"correctIndex":2,"explanation":"Lip licking is associated with Irritant contact dermatitis, secondary bacterial or yeast infections [25]."},{"id":26,"chapterId":8,"question":"Which agent, classified as a glutamatergic agent, has been shown in randomized controlled studies to lead to improvement in adults with trichotillomania and excoriation disorder?","options":["Mirtazapine","N-acetylcysteine","Venlafaxine","Gabapentin"],"correctIndex":1,"explanation":"In other randomized controlled studies, treatment with... N-acetylcysteine (a glutamatergic agent; 12002400 mg/day) led to more improvement in adults with trichotillomania than did placebo [24]. N-acetylcysteine (12003000 mg/day)} led to more improvement than placebo in a randomized controlled study of adults with excoriation disorder [26]."},{"id":27,"chapterId":8,"question":"Acne excorie is categorized as a subset of which primary disorder?","options":["Body Dysmorphic Disorder","Somatic Symptom Disorder","Excoriation Disorder","Psychogenic Pruritus"],"correctIndex":2,"explanation":"Acne excorie is a subset of excoriation disorder [27]."},{"id":28,"chapterId":8,"question":"Dermatitis Artefacta is a type of factitious disorder where patients inflict cutaneous lesions upon themselves to satisfy a psychological need, and the motive is usually:","options":["For conscious financial gain (malingering)","To attract attention/sympathy for a diagnosed illness","Subconscious, with patients denying their role in causation","To reduce negative emotions (nonsuicidal self-injury)"],"correctIndex":2,"explanation":"Dermatitis artefacta is characterized by the key feature that the motive is usually subconscious and patients deny their role in causation [28]. Patients inflict cutaneous lesions upon themselves to satisfy a psychologic need of which they are usually not consciously aware [29]."},{"id":29,"chapterId":8,"question":"A characteristic clue to the diagnosis of Dermatitis Artefacta is the presentation of lesions with unusual shapes, particularly those with:","options":["A targetoid configuration","A 'butterfly' distribution","Angulated edges suggesting an external method of induction","Central clearing with surrounding scale"],"correctIndex":2,"explanation":"A clue to the diagnosis is unusual shapes, particularly with angulated edges, that suggest an external method of induction [30]."},{"id":30,"chapterId":8,"question":"Nonsuicidal self-injury, characterized by repeated self-cutting or burning, is primarily performed for what purpose?","options":["To fulfill the criteria for factitious disorder","To gain conscious monetary or social reward (malingering)","To reduce negative emotions or resolve an interpersonal difficulty, without suicidal intent","To extract perceived parasites from the skin"],"correctIndex":2,"explanation":"Nonsuicidal self-injury features repeated infliction of shallow injuries... There is no suicidal intent, and the purpose is usually to reduce negative emotions or resolve an interpersonal difficulty [31]."},{"id":1,"chapterId":9,"question":"Psoriasis was recognized as an entity distinct from leprosy during which historical period?","options":["460377 BCE (Hippocrates era)","The nineteenth century","1879 (Koebner's description)","1910 (von Zumbusch's description)"],"correctIndex":1,"explanation":"It was not until the nineteenth century that psoriasis was recognized as an entity distinct from leprosy [1]."},{"id":2,"chapterId":9,"question":"What is the approximate worldwide prevalence of psoriasis commonly cited in reviews?","options":["0.4%0.7%","2%","4.6%","10%"],"correctIndex":1,"explanation":"In most reviews, the prevalence of psoriasis is said to be 2% of the worlds population [2]."},{"id":3,"chapterId":9,"question":"Psoriatic arthritis is found to affect what percentage of patients with cutaneous psoriasis?","options":["Less than 5%","5%30%","35%50%","79%"],"correctIndex":1,"explanation":"Psoriatic arthritis has been found to affect 5%30% of patients with cutaneous psoriasis, depending upon the series [3]."},{"id":4,"chapterId":9,"question":"What are the two reported peaks in the age of onset for psoriasis?","options":["2030 years of age and 5060 years","Infancy and the eighth decade of life","1019 years and 4050 years","Before age 20 and after age 70"],"correctIndex":0,"explanation":"Two peaks in age of onset have been reported: one at 2030 years of age and a second peak at 5060 years [3]."},{"id":5,"chapterId":9,"question":"If both parents have psoriasis, what is the reported risk of their child developing the disease, according to a large German study?","options":["6%","14%","35%","41%"],"correctIndex":3,"explanation":"Based on a large survey-based study in Germany, if both parents had psoriasis, the risk of their child developing psoriasis was 41% [4]."},{"id":6,"chapterId":9,"question":"Psoriasis is fundamentally a chronic, immune-mediated disorder resulting from a polygenic predisposition combined with what general factors?","options":["Epidermal differentiation errors","Environmental triggers (e.g., trauma, infections, medications)","Primary biochemical defects in the keratinocyte","Constant activation of the IL-10 pathway"],"correctIndex":1,"explanation":"Psoriasis is a chronic, immune-mediated disorder that results from a polygenic predisposition combined with environmental triggers, e.g. trauma, infections, medications, psychological stress [5]."},{"id":7,"chapterId":9,"question":"Which of the following describes typical histologic findings in a psoriatic plaque?","options":["Epidermal atrophy and dermal fibrosis","Hypogranulosis and parakeratosis","Loss of lymphocytes and mast cell degranulation","Absent rete ridges and spongiosis"],"correctIndex":1,"explanation":"Typical histologic findings include acanthosis with elongated rete ridges, hypogranulosis, hyper- and parakeratosis, dilated blood vessels, and a perivascular infiltrate of lymphocytes [6]."},{"id":8,"chapterId":9,"question":"Which comorbidity has an increased relative risk in patients with moderate to severe psoriasis, alongside metabolic syndrome and depression?","options":["Rheumatoid arthritis","Atherosclerotic cardiovascular disease","Mycosis fungoides","Thyroid disease"],"correctIndex":1,"explanation":"In addition, in patients with moderate to severe psoriasis, there is an increased relative risk for metabolic syndrome, atherosclerotic cardiovascular disease, and depression [7]."},{"id":9,"chapterId":9,"question":"Which specific HLA allele is strongly associated with psoriasis, conferring a relative risk of 13 in the White population?","options":["HLA-B27","HLA-Cw6","HLA-DRB1*0701","HLA-A3"],"correctIndex":1,"explanation":"Psoriasis is associated with HLA-Cw6, with the presence of HLA-Cw6 conferring a relative risk of 13 for developing psoriasis in the White population and 25 in the Japanese [8]."},{"id":10,"chapterId":9,"question":"Which psoriasis susceptibility region (PSORS) is the most important genetic region, accounting for up to 50% of psoriasis risk?","options":["PSORS1 (on chromosome 6p)","PSORS2 (on chromosome 17q25)","PSORS13 (on chromosome 19p13)","PSORS9 (on chromosome 4q)"],"correctIndex":0,"explanation":"By far the most important genetic region was PSORS1 (on chromosome 6p), which is estimated to account for up to 50% of psoriasis risk [9]."},{"id":11,"chapterId":9,"question":"What is the chromosomal location of the major histocompatibility complex (MHC), which contains the PSORS1 region?","options":["The short arm (p) of chromosome 6","The long arm (q) of chromosome 17","Chromosome 4q31","Chromosome 1p"],"correctIndex":0,"explanation":"The major histocompatibility complex (MHC) is situated on the short arm (p) of chromosome 6 [8]."},{"id":12,"chapterId":9,"question":"Which gene, besides *HLA-C*, is contained within the highly linked PSORS1 region?","options":["*IL36RN*","*CDSN* (corneodesmosin)","*CARD14*","*ERAP1*"],"correctIndex":1,"explanation":"PSORS1 contains genes such as HLA-C (with the HLA-Cw6 risk allele; see above) and corneodesmosin (CDSN) [9]."},{"id":13,"chapterId":9,"question":"Which antimicrobial peptide released by stressed keratinocytes forms complexes with self DNA or RNA to trigger IFN- release by plasmacytoid DCs (pDCs)?","options":["-defensin-1 (hBD1)","LL37 (cathelicidin)","SKALP/elafin","ADAMTSL5"],"correctIndex":1,"explanation":"Complexes of self DNA or RNA (from keratinocytes) plus antimicrobial peptide LL37 trigger IFN- release by pDCs."},{"id":14,"chapterId":9,"question":"What is the most common phenotype of T cells that infiltrate the epidermis of psoriatic lesions?","options":["CD4+ T cells","CD8+ T cells","Natural killer T cells (NKT)","B cells"],"correctIndex":1,"explanation":"Most of the epidermal T cells are CD8+, whereas the dermal infiltrate is a mixture of CD4+ and CD8+ cells [12]."},{"id":15,"chapterId":9,"question":"Which transcription factor is expressed by keratinocytes within psoriatic plaques and induces upregulation of genes like *ICAM1* and *TGF-*?","options":["NF-kappa B (NF-B) ","STAT3","T-bet","IRF4"],"correctIndex":1,"explanation":"Within psoriatic plaques, keratinocytes express the transcription factor STAT3, and STAT3 induces upregulation of a number of psoriasis-relevant genes (e.g. ICAM1, TGF-)."},{"id":16,"chapterId":9,"question":"Which specific chemokine is believed to mediate the prominent infiltration of neutrophils often seen in psoriatic lesions?","options":["CCL17","CCL20","CXCL8","Chemerin"],"correctIndex":2,"explanation":"CXCL8 is thought to mediate the often-prominent infiltration by neutrophils [14]. Neutrophil-recruiting chemokines include CXCL1, CXCL3, CXCL5, and CXCL8 [11]."},{"id":17,"chapterId":9,"question":"What is the typical lag time between skin trauma and the appearance of psoriatic lesions in the Koebner (isomorphic) phenomenon?","options":["26 weeks","Within 48 hours","3 months","More than 6 months"],"correctIndex":0,"explanation":"The lag time between the trauma and the appearance of skin lesions is usually 26 weeks [15]."},{"id":18,"chapterId":9,"question":"Which endogenous factor, when released from fibroblasts, contributes to the initiation phase by recruiting plasmacytoid dendritic cells (pDCs) into the skin?","options":["Interferon-gamma (IFN-)","Tumor necrosis factor (TNF)","Chemerin","Interleukin-17A (IL-17A)"],"correctIndex":2,"explanation":"Plasmacytoid dendritic cells (pDCs) are recruited into the skin via fibroblast-released chemerin [11, 14]."},{"id":19,"chapterId":9,"question":"The Auspitz sign (pinpoint bleeding upon scale removal) is the clinical reflection of which histological abnormality?","options":["Elongated vessels in dermal papillae covered by a thinned suprapapillary epidermis","Microabscesses of Munro in the stratum corneum","Spongiform pustules of Kogoj in the stratum spinosum","Coalescence of rete ridges"],"correctIndex":0,"explanation":"The Auspitz sign... is the clinical reflection of elongated vessels in the dermal papillae together with thinning of the suprapapillary epidermis [16]."},{"id":20,"chapterId":9,"question":"What is the clinical finding of a pale blanching ring sometimes observed surrounding psoriatic lesions?","options":["Woronoffs ring","The butterfly sign","Koebners halo","Oil drop phenomenon"],"correctIndex":0,"explanation":"Psoriatic lesions are sometimes surrounded by a pale blanching ring, which is referred to as Woronoffs ring [17]."},{"id":21,"chapterId":9,"question":"Guttate psoriasis is frequently preceded by an infection involving which pathogen?","options":["Staphylococcus aureus","Group A streptococci","Human Papillomavirus (HPV)","Candida species"],"correctIndex":1,"explanation":"Guttate psoriasis is more commonly seen in children and adolescents and is frequently preceded by an upper respiratory tract infection... indicating a recent streptococcal infection [18]."},{"id":22,"chapterId":9,"question":"Which severe, generalized pattern of pustular psoriasis is associated with fever, systemic illness, and abrupt onset of widespread erythema and pustulation?","options":["Localized pattern","Von Zumbusch pattern","Annular pattern","Exanthematic type"],"correctIndex":1,"explanation":"The von Zumbusch pattern is a generalized eruption starting abruptly with erythema and pustulation... The patient has a fever and feels ill [19]."},{"id":23,"chapterId":9,"question":"Pustulosis of the palms and soles is strongly associated with which syndrome that includes synovitis, acne, hyperostosis, and osteitis?","options":["Trigeminal Trophic Syndrome","SAPHO syndrome","DITRA syndrome","Reactive arthritis"],"correctIndex":1,"explanation":"Pustulosis of the palms and soles is one of the entities most commonly associated with SAPHO syndrome, which consists of synovitis, acne, pustulosis, hyperostosis and osteitis [20]."},{"id":24,"chapterId":9,"question":"Flexural psoriasis (inverse psoriasis) lesions primarily differ from chronic plaque psoriasis by exhibiting minimal to absent:","options":["Erythema","Induration","Scale","Sharp demarcation"],"correctIndex":2,"explanation":"Flexural lesions are characterized by shiny, pink to red, sharply demarcated thin plaques... There is much less scale than in untreated chronic plaque psoriasis [21]."},{"id":25,"chapterId":9,"question":"Which nail finding is indicative of involvement of the nail bed in psoriasis?","options":["Nail pitting","Leukonychia","Oil drop or salmon patch phenomenon","Crumbly nail appearance (due to matrix involvement)"],"correctIndex":2,"explanation":"Psoriatic changes of the nail bed result in the oil drop or salmon patch phenomenon [22]."},{"id":26,"chapterId":9,"question":"Involvement of the DIP and PIP joints of a single digit, leading to a 'sausage' digit, is a classic finding in which type of psoriatic arthritis?","options":["Arthritis mutilans","Mono- and asymmetric oligoarthritis","Symmetric polyarthritis (RA-like)","Spondylitis and sacroiliitis"],"correctIndex":1,"explanation":"Involvement of the PIP or both the DIP and PIP joints of a single digit can result in the classic sausage digit (Fig. 8.18). This is characteristic of Mono- and asymmetric oligoarthritis [23, 24]."},{"id":27,"chapterId":9,"question":"Psoriasiform lesions on the plantar surface in reactive arthritis, characterized by thick yellow scale and pustules, are known as:","options":["Acrodermatitis continua","Balanitis circinata","Keratoderma blennorrhagicum","Rupioid psoriasis"],"correctIndex":2,"explanation":"The lesions on the plantar surface usually have thick yellow scale and are often pustular (keratoderma blennorrhagicum) [25]."},{"id":28,"chapterId":9,"question":"Histologically, the accumulation of neutrophils and/or neutrophil remnants in the stratum corneum, surrounded by parakeratosis, is referred to as the:","options":["Spongiform pustule of Kogoj","Microabscess of Munro","Papillary edema","Acanthosis"],"correctIndex":1,"explanation":"The accumulation of neutrophils and/or neutrophil remnants in the stratum corneum, surrounded by parakeratosis, as a microabscess of Munro [26]."},{"id":29,"chapterId":9,"question":"What is an absolute contraindication for the use of Methotrexate in treating psoriasis?","options":["Impaired kidney function (creatinine clearance <60 ml/min)","Pregnancy or lactation","History of excessive photo(chemo)therapy","Concomitant use of topical corticosteroids"],"correctIndex":1,"explanation":"Pregnancy or lactation is listed as an absolute contraindication for methotrexate [27]."},{"id":30,"chapterId":9,"question":"Which classic systemic therapy for psoriasis is contraindicated in women of childbearing potential unless adequate contraception is guaranteed during and up to 3 years following discontinuation?","options":["Methotrexate","Cyclosporine","Acitretin (Systemic Retinoid)","Apremilast"],"correctIndex":2,"explanation":"Acitretin is contraindicated for women of childbearing potential who cannot guarantee adequate contraception during and up to 3 years following discontinuation of acitretin [28, 29]. Acitretin is known for fetal exposure leading to 'retinoic acid embryopathy' [30]."},{"id":1,"chapterId":10,"question":"Small Plaque Parapsoriasis (SPP) typically presents as round to oval patches generally measuring less than what diameter?","options":["2 cm","5 cm","10 cm","15 cm"],"correctIndex":1,"explanation":"Small plaque parapsoriasis typically presents as round to oval patches that are generally <5 cm in diameter [1], [2]."},{"id":2,"chapterId":10,"question":"Which specific presentation of Small Plaque Parapsoriasis is described as elongated, finger-like patches symmetrically distributed on the flanks?","options":["Xantho-erythrodermia perstans","Digitate dermatosis","Chronic superficial dermatitis","Parapsoriasis en gouttes"],"correctIndex":1,"explanation":"A distinct and perhaps the most typical presentation is 'digitate dermatosis', which presents as elongated, finger-like patches symmetrically distributed on the flanks [1], [2]."},{"id":3,"chapterId":10,"question":"The histologic findings in Small Plaque Parapsoriasis generally include a nonspecific spongiotic dermatitis with focal parakeratosis and a predominance of which cell type in the lymphocytic infiltrate?","options":["CD8+ T cells","Neutrophils","CD4+ T cells","B cells"],"correctIndex":2,"explanation":"The sparse lymphoid infiltrates within the superficial dermis in Small Plaque Parapsoriasis are composed primarily of CD4+ T cells [2], [3]."},{"id":4,"chapterId":10,"question":"Which specific finding is absent in the pathology of Small Plaque Parapsoriasis but characteristic of Mycosis Fungoides (MF)?","options":["Spongiotic dermatitis","Exocytosis of lymphocytes","Focal parakeratosis","Pautrier micro-abscesses"],"correctIndex":3,"explanation":"Patches of small plaque parapsoriasis exhibit a mild, nonspecific spongiotic dermatitis, but there are neither Pautrier micro-abscesses nor atypical lymphocytes [4]."},{"id":5,"chapterId":10,"question":"Small Plaque Parapsoriasis shows a male predominance with an approximate male to female ratio of:","options":["1:1","3:1","1:3","5:1"],"correctIndex":1,"explanation":"There is a male predominance in Small Plaque Parapsoriasis (male : female ratio ~3 : 1) [3]."},{"id":6,"chapterId":10,"question":"What is the reported risk of Small Plaque Parapsoriasis progressing to Mycosis Fungoides (MF)?","options":["5%10%","25%","Very rare (<20 cases reported)","Approximately 50%"],"correctIndex":2,"explanation":"Progression of Small Plaque Parapsoriasis to MF is very rare, with <20 cases reported to date in the literature [1], [5]."},{"id":7,"chapterId":10,"question":"Pityriasis Rosea is distinguished from Small Plaque Parapsoriasis based on which key clinical difference?","options":["Presence of a chronic, asymptomatic course","Larger lesion size (over 5 cm)","Spontaneous resolution within a few months and the presence of a herald patch","Predominantly CD8+ T cell infiltrate on biopsy"],"correctIndex":2,"explanation":"Pityriasis rosea is distinguished from small plaque parapsoriasis by the presence of a herald patch and spontaneous resolution within a few months [6]."},{"id":8,"chapterId":10,"question":"What is considered a standard therapy for Small Plaque Parapsoriasis, according to retrospective studies and case series?","options":["PUVA phototherapy (Psoralen plus UVA)","Topical calcineurin inhibitors","Topical corticosteroids and narrowband ultraviolet B (NB-UVB)","Topical nitrogen mustard"],"correctIndex":2,"explanation":"Standard therapy for Small Plaque Parapsoriasis includes topical corticosteroids and narrowband ultraviolet B (NB-UVB) therapy [7], [8]."},{"id":9,"chapterId":10,"question":"Many authorities in the field of cutaneous lymphomas consider Large Plaque Parapsoriasis to be an early manifestation of which condition?","options":["Pityriasis lichenoides chronica (PLC)","Mycosis Fungoides (MF)","Pityriasis Rubra Pilaris (PRP)","Pityriasis Rotunda"],"correctIndex":1,"explanation":"While some authors believe that large plaque parapsoriasis represents an entity distinct from MF, many authorities in the field of cutaneous lymphomas consider it to be an early manifestation of MF [9], [10]."},{"id":10,"chapterId":10,"question":"Pityriasis Lichenoides is an uncommon disorder that encompasses which two major forms on a disease spectrum?","options":["Small Plaque Parapsoriasis and Large Plaque Parapsoriasis","Pityriasis Rotunda and Granular Parakeratosis","Pityriasis lichenoides et varioliformis acuta (PLEVA) and Pityriasis lichenoides chronica (PLC)","Guttate Parapsoriasis and Febrile Ulceronecrotic MuchaHabermann Disease (FUMHD)"],"correctIndex":2,"explanation":"Pityriasis lichenoides is an uncommon disorder that encompasses pityriasis lichenoides et varioliformis acuta (PLEVA) and pityriasis lichenoides chronica (PLC) [11], [12]."},{"id":11,"chapterId":10,"question":"The lesions of Pityriasis Lichenoides et Varioliformis Acuta (PLEVA) are characterized by being:","options":["Smooth, hypo-pigmented macules","Scattered, erythematous plaques with thick scale","Crusted and occasionally vesiculopustular","Waxy, orange-red follicular papules"],"correctIndex":2,"explanation":"Lesions of PLEVA are crusted and occasionally vesiculopustular, whereas in PLC they are scaly [11]. In patients with PLEVA, individual lesions develop crusts, ulcers, and occasionally vesicles or pustules [13]."},{"id":12,"chapterId":10,"question":"Which entity was previously referred to as 'parapsoriasis en gouttes' but is no longer used?","options":["Small plaque parapsoriasis","Pityriasis lichenoides","Pityriasis rosea","Pityriasis rubra pilaris"],"correctIndex":1,"explanation":"The term 'parapsoriasis en gouttes' is no longer used as it specifically refers to the entity pityriasis lichenoides [5]."},{"id":13,"chapterId":10,"question":"Which clinical feature is characteristic of the chronic form, Pityriasis Lichenoides Chronica (PLC)?","options":["Large, confluent necrotic skin lesions","Recurrent crops of spontaneously regressing erythematous papules that are scaly","Widespread erythema with fever and malaise","Hypopigmented halo surrounding hyperpigmented centers"],"correctIndex":1,"explanation":"Both entities [PLEVA and PLC] are characterized by recurrent crops of spontaneously regressing erythematous papules [11]. In PLC, the papules are erythematous to redbrown and scaly [14]."},{"id":14,"chapterId":10,"question":"What severe variant of Pityriasis Lichenoides et Varioliformis Acuta (PLEVA) is associated with fever, systemic symptoms, and a reported mortality rate up to 15%?","options":["Atypical pityriasis lichenoides","Lymphomatoid papulosis","Febrile ulceronecrotic MuchaHabermann disease (FUMHD)","Pityriasis lichenoides chronica (PLC)"],"correctIndex":2,"explanation":"The term febrile ulceronecrotic MuchaHabermann disease (FUMHD) has been used to refer to such severe variants in which large, confluent necrotic skin lesions as well as mucosal, gastrointestinal, and pulmonary involvement can be observed [15], [12]. In the latter group, an associated mortality rate of up to 15% has been reported [15]."},{"id":15,"chapterId":10,"question":"Which viral infection is supported by some evidence as a potential trigger for PLEVA?","options":["Human Papillomavirus (HPV)","Varicellazoster virus (VZV)","Cytomegalovirus (CMV)","Measles virus"],"correctIndex":1,"explanation":"There is some evidence to support PLEVA being associated with viral infections, especially varicellazoster virus [16]."},{"id":16,"chapterId":10,"question":"On histology, Pityriasis Lichenoides exhibits a superficial perivascular interface dermatitis. In the more acute lesions (PLEVA), the infiltrate is often described as:","options":["Top-heavy and wedge-shaped","Periadnexal and deep","Composed primarily of plasma cells","Lacking epidermal damage"],"correctIndex":0,"explanation":"Pityriasis lichenoides exhibits a superficial perivascular interface dermatitis in all cases. Those lesions at the acute end of the spectrum contain a denser infiltrate that may be top-heavy and wedge-shaped [17]."},{"id":17,"chapterId":10,"question":"For Pityriasis Lichenoides, which systemic therapy may be required for more fulminant cases?","options":["Oral Retinoids","Low-dose weekly methotrexate","Topical Calcineurin Inhibitors","Antihistamines"],"correctIndex":1,"explanation":"More fulminant cases may require low-dose weekly methotrexate [18]."},{"id":18,"chapterId":10,"question":"What is the typical clinical course duration for the classic adult form (Type I) of Pityriasis Rubra Pilaris (PRP)?","options":["Lifelong and progressive","Acute, resolving within weeks","Self-limited, typically clearing within 35 years","Chronic course lasting more than 10 years"],"correctIndex":2,"explanation":"The classic types (adult and juvenile) typically resolve within 35 years [19]. Type I (classic adult) PRP is the most common form and is typically self-limited, clearing within 3 years in 80% of patients [20]."},{"id":19,"chapterId":10,"question":"Which clinical finding in Pityriasis Rubra Pilaris results in rough papules on the dorsal aspect of the proximal fingers, resembling a 'nutmeg grater'?","options":["Ichthyosiform scaling","Follicular hyperkeratosis on an erythematous base","Scleroderma-like changes of the hands","Nodulocystic lesions"],"correctIndex":1,"explanation":"Follicular hyperkeratosis on an erythematous base is a key finding, especially on the dorsal aspect of the proximal fingers, reminiscent of a nutmeg grater [21]."},{"id":20,"chapterId":10,"question":"Pityriasis Rubra Pilaris is clinically characterized by the coalescence of orangered plaques with distinctive:","options":["Targetoid lesions","Islands of sparing","Pautrier microabscesses","Rete ridge flattening"],"correctIndex":1,"explanation":"The papules in PRP can coalesce to form large salmon-colored to orangered plaques with distinctive 'islands of sparing' [21], [19]."},{"id":21,"chapterId":10,"question":"What is the characteristic feature of the palms and soles involvement in classic Pityriasis Rubra Pilaris?","options":["Deep fissuring and pain","Prominent scaling without color change","A distinctive orangered waxy keratoderma","Vesiculobullous lesions"],"correctIndex":2,"explanation":"The palms and soles are commonly involved with a distinctive orangered waxy keratoderma [21], [19]."},{"id":22,"chapterId":10,"question":"The dominantly inherited form of PRP, specifically Type V (atypical juvenile), is associated with heterozygous gain-of-function mutations in which gene?","options":["HLA-Cw6","CARD14","IL-36RN","CARD15"],"correctIndex":1,"explanation":"The dominantly inherited form of PRP is associated with heterozygous gain-of-function mutations in CARD14 [22]. Type V, the atypical juvenile form, is frequently due to CARD14 mutations [19], [23]."},{"id":23,"chapterId":10,"question":"Which histologic feature is considered distinctive for Pityriasis Rubra Pilaris?","options":["Microabscesses of Munro","Spongiform pustules of Kogoj","Alternating vertical and horizontal ortho- and parakeratosis ('checkerboard pattern')","Lichenoid infiltrate with basal layer vacuolisation"],"correctIndex":2,"explanation":"Psoriasiform dermatitis with irregular hyperkeratosis and alternating vertical and horizontal ortho- and parakeratosis ('checkerboard pattern') is distinctive [24]."},{"id":24,"chapterId":10,"question":"What is the primary first-line systemic treatment recommended for Pityriasis Rubra Pilaris in adults, yielding an excellent response in >40% of patients?","options":["Methotrexate","Systemic retinoids (Isotretinoin or Acitretin)","Cyclosporine","TNF inhibitors"],"correctIndex":1,"explanation":"Systemic retinoids represent a first-line treatment for PRP in both adults and children; an excellent response is seen in >40% of patients [25]."},{"id":25,"chapterId":10,"question":"Pityriasis Rosea is a common, self-limited eruption seen primarily in which age group?","options":["Infants (<2 years)","Middle-aged adults (4060 years)","Adolescents and young adults (1035 years)","Elderly individuals (>65 years)"],"correctIndex":2,"explanation":"Most cases of pityriasis rosea occur in young healthy persons, the majority of whom are between the ages of 10 and 35 years [26]."},{"id":26,"chapterId":10,"question":"The initial solitary lesion in Pityriasis Rosea, which predates the widespread eruption, is called the:","options":["Satellite lesion","Collarette patch","Herald patch","Target lesion"],"correctIndex":2,"explanation":"A solitary lesion appears on the trunk and is referred to as the 'herald patch' because it heralds the onset of the disease [27]."},{"id":27,"chapterId":10,"question":"The orientation of the numerous oval plaques in Pityriasis Rosea on the posterior trunk, where their long axes follow Langer cleavage lines, results in the appearance known as the:","options":["Woronoffs ring","Fir tree or Christmas tree pattern","Nutmeg grater appearance","Oil drop sign"],"correctIndex":1,"explanation":"The lesions are usually round to oval in shape, with their long axis following Langer cleavage lines [28]. On the posterior trunk, such an orientation leads to what is often referred to as a 'fir tree' or 'Christmas tree' pattern [28]."},{"id":28,"chapterId":10,"question":"Which term describes the atypical variant of Pityriasis Rosea localized to the axillae and inguinal areas?","options":["Inverse pityriasis rosea","Purpuric pityriasis rosea","Pityriasis lichenoides-like","Pityriasis rotunda-like"],"correctIndex":0,"explanation":"Inverse pityriasis rosea involves the axillae and inguinal areas and sometimes the face [29]."},{"id":29,"chapterId":10,"question":"Pityriasis Rotunda is an unusual asymptomatic dermatosis characterized by large, circular, and polycyclic scaly patches, predominantly observed in which populations?","options":["Northern European Caucasians","Individuals of Far Eastern and Mediterranean basin descent, and African descent","Native North Americans","Australasian Aboriginal populations"],"correctIndex":1,"explanation":"Pityriasis rotunda is most commonly observed in adults in their 30s and in children [30]. It has been described in the Far East (Japan and China), the Mediterranean basin (Morocco, Italy, and Israel), and in Africans, African-Americans, and Afro-Caribbeans [30]."},{"id":30,"chapterId":10,"question":"What is the pathognomonic finding on histopathology for Granular Parakeratosis?","options":["Retention of basophilic keratohyalin granules within areas of parakeratosis in the stratum corneum","Spongiform pustules of Kogoj","Absent granular cell layer with basket-weave hyperkeratosis","Dense perivascular plasma cell infiltrate"],"correctIndex":0,"explanation":"The characteristic feature [of Granular Parakeratosis] is an unusual form of parakeratosis [31]. There is visible retention of basophilic keratohyalin granules within these areas of parakeratosis in the stratum corneum [32], [31]."},{"id":1,"chapterId":11,"question":"Erythroderma is clinically defined as generalized erythema and scaling involving more than what percentage of the body surface area (BSA)?","options":["50%","70%","80%","90%"],"correctIndex":2,"explanation":"Erythroderma is defined as generalized erythema and scaling involving >80% of the body surface area (BSA) [1]. Although originally more strictly defined as erythema and scaling involving >90% of BSA, nowadays the term erythroderma is often more liberally applied when there is >80% of involvement [2]."},{"id":2,"chapterId":11,"question":"Based on large patient series, which underlying cause is the most common etiology of erythroderma in adults?","options":["Cutaneous T cell lymphoma (CTCL)","Psoriasis","Dermatitis","Drug reactions"],"correctIndex":2,"explanation":"Based upon several large series of patients, dermatitis (24%), psoriasis (20%), drug reactions (19%), and CTCL (8%) represented the most common underlying causes of erythroderma [3]."},{"id":3,"chapterId":11,"question":"What is the approximate male-to-female ratio commonly reported for erythroderma?","options":["1:1","2:1 to 4:1","4:1 to 6:1","Less than 1:1"],"correctIndex":1,"explanation":"Men are more commonly affected, with the male-to-female ratio ranging from approximately 2:1 to 4:1 [4]."},{"id":4,"chapterId":11,"question":"In approximately what percentage of adult patients is the underlying cause of erythroderma not found despite extensive investigation, leading to the designation of 'idiopathic erythroderma'?","options":["5%","15%","25%","50%"],"correctIndex":2,"explanation":"Despite multiple skin biopsies, an in-depth clinical investigation and a detailed medical history, the underlying cause of erythroderma is not found in at least 25% of patients [5]. In approximately one-quarter of the patients, no specific etiology is found, and these cases are called 'idiopathic erythroderma' [1], [6]."},{"id":5,"chapterId":11,"question":"In chronic erythroderma, the daily loss of scales significantly increases. This large loss of material can lead to which systemic complications?","options":["Hypercalcemia and hypertension","Hypoalbuminemia and anemia of chronic disease","Thrombocytosis and hyperglycemia","Polycythemia and hyperthermia"],"correctIndex":1,"explanation":"In chronic erythroderma protein loss can be significant, leading to hypoalbuminemia and contributing to anemia of chronic disease [7]. The daily loss of scales increases from 5001000 mg to 2030 g [7]."},{"id":6,"chapterId":11,"question":"The historical term 'red man syndrome' is synonymous with idiopathic erythroderma, but should not be confused with the acute cutaneous reaction associated with the rapid infusion of which drug?","options":["Phenytoin","Vancomycin","Methotrexate","Lithium"],"correctIndex":1,"explanation":"Idiopathic erythroderma is also referred to as 'red man syndrome' (not to be confused with the acute cutaneous reaction to rapid infusion of vancomycin) [4], [8]. The synonyms listed include 'Red man syndrome (becoming historical term)' [6]."},{"id":7,"chapterId":11,"question":"What is the most frequent subjective complaint, reported in up to 90% of erythrodermic patients, which is most severe in patients with dermatitis or Szary syndrome?","options":["Pain","Fatigue","Pruritus","Fever"],"correctIndex":2,"explanation":"Pruritus, the most frequent complaint, is observed in up to 90% of patients and it varies according to the underlying cause, but is most severe in patients with dermatitis or Szary syndrome [9]."},{"id":8,"chapterId":11,"question":"In psoriasis-associated erythroderma, the typical clinical features of psoriasis are often lost after generalization. What feature may still be visible, providing a clue to the diagnosis?","options":["Leonine facies","Widespread purpura","Oil-drop changes, onycholysis, or nail pits","Spongiotic vesicles"],"correctIndex":2,"explanation":"After generalization of the erythema, the typical features of psoriasis are often lost... Due to a slower turnover rate, nail changes, such as oil-drop changes, onycholysis or nail pits, may still be visible and provide clues to the diagnosis of psoriatic erythroderma [10]."},{"id":9,"chapterId":11,"question":"In infants and neonates, which of the following is considered a common cause of erythroderma?","options":["Systemic lupus erythematosus","Infections (e.g., staphylococcal scalded skin syndrome)","Pemphigus foliaceus","Chronic actinic dermatitis"],"correctIndex":1,"explanation":"Erythroderma in neonates and infants is rare and causes include inherited ichthyoses, dermatitides, psoriasis, immunodeficiencies (e.g. Omenn syndrome), and consequences of infection (e.g. staphylococcal scalded skin syndrome) [7]."},{"id":10,"chapterId":11,"question":"What is the characteristic clinical sign that favors the diagnosis of erythrodermic Pityriasis Rubra Pilaris (PRP) over Psoriasis?","options":["Severe pruritus","Oil-drop nail changes","Salmon to orangered color with islands of uninvolved skin (nappes claires)","Absence of lymphadenopathy"],"correctIndex":2,"explanation":"The combination of follicular keratotic papules on the knees, elbows and dorsal aspects of the fingers plus nappes claires (islands of uninvolved skin within the erythroderma) favors the diagnosis of PRP [11]. Usually, the lesions have a salmon to orangered color [11]."},{"id":11,"chapterId":11,"question":"Which complication is a serious threat to erythrodermic patients due to markedly increased blood flow and fluid loss by transpiration?","options":["Bradycardia","High-output cardiac failure","Hypotension","Stroke"],"correctIndex":1,"explanation":"Because of the markedly increased blood flow through the skin and increased fluid loss by transpiration, tachycardia affects 40% of patients, and there is a risk of high-output cardiac failure, particularly in the elderly [12]. Loss of fluid, electrolytes and albumin with subsequent tachycardia and cardiac failure are serious threats to the erythrodermic patient [2]."},{"id":12,"chapterId":11,"question":"In which form of erythroderma is the onset typically acute and resolution usually occurs within 26 weeks after withdrawal of the causative agent?","options":["Psoriatic erythroderma","Idiopathic erythroderma","Drug reactions","Szary syndrome"],"correctIndex":2,"explanation":"An acute onset most commonly occurs when the underlying cause is a drug reaction or dermatitis [13]. While drug-induced erythrodermas have the shortest duration, usually resolving 26 weeks after withdrawal of the responsible drug, rarely erythroderma persists despite withdrawal of the putative drug [14]."},{"id":13,"chapterId":11,"question":"The triad defining Szary syndrome includes erythroderma, generalized lymphadenopathy, and:","options":["Eosinophilia","Peripheral blood lymphocytosis with morphologically abnormal Szary cells","Nail pitting and oil-drop signs","Acute onset with facial edema"],"correctIndex":1,"explanation":"Szary syndrome is defined by the triad of erythroderma, generalized lymphadenopathy, and peripheral blood lymphocytosis with morphologically abnormal Szary cells [15]."},{"id":14,"chapterId":11,"question":"Which laboratory finding, when elevated, is associated with Atopic Dermatitis-associated erythroderma?","options":["Serum urea nitrogen","Serum IgE and eosinophilia","C-reactive protein","Serum creatinine"],"correctIndex":1,"explanation":"Increased serum IgE and eosinophilia may accompany other signs and symptoms of atopy [16]. Atopic dermatitis is also listed with elevated serum IgE and eosinophilia as additional hints [17]."},{"id":15,"chapterId":11,"question":"Which clinical manifestation of chronic erythroderma is seen in ~30% of patients and is often an early sign of pityriasis rubra pilaris?","options":["Diffuse non-scarring alopecia","Ectropion","Palmoplantar keratoderma","Prurigo nodularis"],"correctIndex":2,"explanation":"Palmoplantar keratoderma appears in ~30% of erythrodermic patients and is often an early sign in pityriasis rubra pilaris [9]. Chronic erythrodermas may also be accompanied by palmoplantar keratoderma [2]."},{"id":16,"chapterId":11,"question":"In the idiopathic erythroderma group, lymphadenopathy is found in approximately what percentage of patients?","options":["20%","44%","54%","68%"],"correctIndex":3,"explanation":"When this group [idiopathic erythroderma] was compared with the entire group of erythrodermic patients, lymphadenopathy (68% vs 44%) and peripheral edema (54% vs 40%) were found to be more common than in other types of erythroderma [8]."},{"id":17,"chapterId":11,"question":"In infants, which finding is characteristic of Netherton syndrome?","options":["Classic epidermolytic hyperkeratosis on biopsy","Collodion baby presentation","Trichorrhexis invaginata ('bamboo hair')","Diaper area sparing"],"correctIndex":2,"explanation":"Netherton syndrome manifests as an ichthyosiform erythroderma in neonates. It is associated with trichorrhexis invaginata (bamboo hair), elevated serum levels of IgE, and an immune defect [18]. Netherton syndrome: Examine eyebrows and eyelashes as well as scalp hairs for trichorrhexis invaginata (bamboo hair) [19]."},{"id":18,"chapterId":11,"question":"Ectropion and purulent conjunctivitis are noted as ocular complications that can develop in patients with erythroderma [2], [20]. Which other chronic cutaneous manifestation can be seen?","options":["Alopecia","Urticaria","Lentigo maligna","Bullous lesions"],"correctIndex":0,"explanation":"Bilateral ectropion and purulent conjunctivitis can also develop as ocular complications [20]. Diffuse non-scarring alopecia of the scalp or other sites appears in 20% of patients with chronic erythroderma [21]. Chronic erythrodermas may also be accompanied by diffuse alopecia, nail dystrophy, and ectropion [2]."},{"id":19,"chapterId":11,"question":"The mechanism of Staphylococcal Scalded Skin Syndrome (SSSS) involves the cleavage of which protein by exfoliative toxin A?","options":["Keratin 1","Desmoglein 1","Filaggrin","Transglutaminase 1"],"correctIndex":1,"explanation":"SSSS is due to a circulating exfoliative toxin produced by *S. aureus*. Since desmoglein 1 is cleaved by exfoliative toxin A, pemphigus foliaceus and SSSS exhibit clinical similarities [22]. ET-A produced by *S. aureus* specifically cleaves desmoglein 1 [23]."},{"id":20,"chapterId":11,"question":"Histologically, Psoriatic erythroderma is characterized by which finding that contrasts with Pityriasis Rubra Pilaris (PRP)?","options":["The presence of a normal granular layer","Alternating vertical and horizontal parakeratosis","Neutrophils within the epidermis, often forming microabscesses","Prominent spongiosis and eosinophils"],"correctIndex":2,"explanation":"Histologic clues for Psoriasis include neutrophils within epidermis; sparse lymphohistiocytic infiltrate within dermis [24]. Histopathology of Psoriasis shows neutrophils within the stratum corneum, and a small subcorneal pustule [25]. In contrast, PRP histology is characterized by alternating vertical and horizontal ortho- and parakeratosis, and a normal granular layer is present [26], [25]. Psoriatic histology includes epidermal hyperplasia with bottleneck-like rete ridges and reduced or absent granular layer [24]."},{"id":21,"chapterId":11,"question":"In drug-induced erythroderma, which histologic finding can be present irrespective of the specific pattern observed (perivascular, lichenoid, spongiotic, or pseudolymphomatous)?","options":["Pautrier micro-abscesses","Subcorneal bullae","Eosinophils","Acantholysis"],"correctIndex":2,"explanation":"In drug reactions, variable patterns are seen, including perivascular, lichenoid, spongiotic, and pseudolymphomatous. Eosinophils can be present, irrespective of pattern [27]."},{"id":22,"chapterId":11,"question":"What is the most common extracutaneous manifestation of erythroderma, found in approximately half of patients?","options":["Hepatomegaly","Splenomegaly","Peripheral lymphadenopathy","Nephrotic syndrome"],"correctIndex":2,"explanation":"The most common extracutaneous manifestation of erythroderma is peripheral lymphadenopathy, which is found in approximately half of the patients [28]."},{"id":23,"chapterId":11,"question":"Papuloerythroderma of Ofuji is a distinctive reaction pattern most often seen in elderly men, characterized clinically by widespread, pruritic, reddish-brown papules with sparing of which areas?","options":["Hands and feet","Central face","Skin folds ('deck-chair' sign)","Scalp and eyebrows"],"correctIndex":2,"explanation":"Papuloerythroderma of Ofuji... is characterized by widespread, pruritic, flat-topped, redbrown papules that can become confluent. It includes sparing of skin folds (deck-chair sign) [29], [30]. It favors elderly men [29]."},{"id":24,"chapterId":11,"question":"Which drug is specifically listed as a common cause of drug-associated erythroderma?","options":["Ciprofloxacin","Allopurinol","Lamotrigine","Codeine"],"correctIndex":1,"explanation":"Common drugs associated with erythroderma include Allopurinol, -lactam antibiotics, Carbamazepine/oxcarbazepine, Gold, Phenobarbital, Phenytoins, Sulfasalazine, Sulfonamides, and Zalcitabine [31]."},{"id":25,"chapterId":11,"question":"In infants, what is the term for the characteristic skin appearance in Congenital Ichthyosiform Erythroderma (CIE) within the first few days of life (in 90% of cases)?","options":["Harlequin ichthyosis","Collodion baby","Ichthyosis linearis circumflexa","Corrugated hyperkeratosis"],"correctIndex":1,"explanation":"As a rule, CIE presents as a collodion baby (90% of the cases), and within a few days after birth, an erythroderma with fine white scaling appears [18]."},{"id":26,"chapterId":11,"question":"Erythroderma due to Psoriasis is most often caused by the withdrawal of which treatment modalities?","options":["Topical emollients or antihistamines","Topical or oral corticosteroids, cyclosporine, or methotrexate","Narrowband UVB phototherapy","Nonsteroidal anti-inflammatory drugs (NSAIDs)"],"correctIndex":1,"explanation":"Psoriatic erythroderma... is most often due to withdrawal of potent topical or oral corticosteroids, cyclosporine or methotrexate; occasionally, widespread flares follow a systemic infection... or withdrawal of targeted immunomodulators (biologics) [10]. It is also listed as a clinical hint that withdrawal of corticosteroids, methotrexate, cyclosporine or targeted immunomodulators can precede psoriatic erythroderma [24], [17]."},{"id":27,"chapterId":11,"question":"For the initial management of erythroderma, which topical agents should be avoided in neonates and children due to increased transcutaneous absorption?","options":["Low-potency corticosteroid ointments","Bland emollients","Topical antibiotics","Salicylic and lactic acid"],"correctIndex":3,"explanation":"Due to increased transcutaneous absorption, topical salicylic and lactic acid should be avoided [32]. Topical therapy includes bland emollients or low-potency corticosteroid ointments [33]."},{"id":28,"chapterId":11,"question":"In the severe variant of drug reaction known as DRESS/DIHS, which organ system involvement is commonly seen in addition to fever and peripheral blood eosinophilia?","options":["Hepatitis","Renal failure requiring dialysis","Pulmonary fibrosis","Severe musculoskeletal myalgia"],"correctIndex":0,"explanation":"A minority of patients with DRESS (drug reaction with eosinophilia and systemic symptoms) syndrome... can develop peripheral blood eosinophilia, hepatitis, and peripheral lymphadenopathy [8]."},{"id":29,"chapterId":11,"question":"Which form of bullous dermatosis is the most likely, although rare, cause to present as erythroderma, often preceded by localized lesions on the face and upper trunk?","options":["Bullous pemphigoid","Dermatitis herpetiformis","Pemphigus foliaceus","Epidermolysis bullosa acquisita"],"correctIndex":2,"explanation":"Among the bullous dermatoses, pemphigus foliaceus is the one most likely, albeit rarely, to present as erythroderma [18]. The erythroderma is usually preceded by localized lesions on the face and upper trunk [18]."},{"id":30,"chapterId":11,"question":"Why is the administration of systemic corticosteroids generally preferred to be avoided in the treatment of psoriatic erythroderma?","options":["Increased risk of fungal infections","It is an absolute contraindication in all cases","Risk of a severe pustular flare when corticosteroids are tapered","It suppresses all immune responses indiscriminately"],"correctIndex":2,"explanation":"In the case of psoriatic erythroderma, administration of methotrexate, acitretin, cyclosporine or targeted immunomodulators (biologics) is preferred over systemic corticosteroids, given the risk of a pustular flare when corticosteroids are tapered [32]."},{"id":1,"chapterId":12,"question":"Lichen Planus (LP) most commonly has its onset during which decades of life?","options":["First or second decade","Third or fourth decade","Fifth or sixth decade","Eighth or ninth decade"],"correctIndex":2,"explanation":"LP most commonly has its onset during the fifth or sixth decade, with two-thirds of patients developing the disease between the ages of 30 and 60 years [1]."},{"id":2,"chapterId":12,"question":"What percentage of patients with cutaneous Lichen Planus (LP) are observed to also have mucosal involvement, particularly oral lesions?","options":["10%20%","30%50%","Up to 75%","Nearly 100%"],"correctIndex":2,"explanation":"Mucosal involvement, particularly oral lesions, is observed in up to 75% of patients with cutaneous LP, but the former can be the only manifestation of the disease [2]."},{"id":3,"chapterId":12,"question":"Which specific histological finding is characteristic of classic Lichen Planus?","options":["Epidermal atrophy with a perivascular lymphocytic infiltrate","Spongiosis and microvesiculation of the epidermis","A dense, band-like lymphocytic infiltrate with destruction of the basal cell layer","Suprapapillary thinning and microabscesses of Munro"],"correctIndex":2,"explanation":"Histologically, there is a dense, band-like lymphocytic infiltrate and keratinocyte apoptosis with destruction of the epidermal basal cell layer [3]. The primary features are hyperkeratosis without parakeratosis, focal increases in the granular cell layer, irregular acanthosis with a 'sawtooth' appearance, vacuolar degeneration of the basal cell layer, and a band-like lymphocytic infiltrate at the dermalepidermal junction [4]."},{"id":4,"chapterId":12,"question":"What clinical feature in Lichen Planus (LP) corresponds histologically to focal thickening of the granular layer?","options":["Koebner phenomenon","Violaceous color","Umbilicated papules","Wickham striae"],"correctIndex":3,"explanation":"The surface of the characteristic papule of LP is slightly shiny or transparent, and a network of fine white lines called 'Wickham striae' or small graywhite puncta are also seen. The latter correspond histologically to focal thickening of the granular layer [5]."},{"id":5,"chapterId":12,"question":"The pathogenesis of Lichen Planus (LP) is primarily understood as a T cell-mediated autoimmune reaction targeting which epidermal layer?","options":["Stratum corneum","Stratum spinosum","Basal keratinocytes","Stratum lucidum"],"correctIndex":2,"explanation":"There is a growing body of evidence that LP represents T cell-mediated autoimmune damage to basal keratinocytes that express altered self-antigens on their surface [6], [3]."},{"id":6,"chapterId":12,"question":"What is the most common and characteristic form of oral Lichen Planus?","options":["Atrophic pattern","Plaque-like pattern","Erosive pattern","Reticular pattern"],"correctIndex":3,"explanation":"The most common and characteristic form of oral LP is the reticular pattern, characterized by slightly raised, whitish linear lines in a lace-like pattern or in rings with short radiating spines [7]."},{"id":7,"chapterId":12,"question":"Which type of Lichen Planus is defined by vesicles and bullae developing within pre-existing LP lesions due to intense lichenoid inflammation and epidermal damage?","options":["Annular LP","LP Pemphigoides","Bullous LP","Linear LP"],"correctIndex":2,"explanation":"In bullous LP, vesicles and bullae develop within pre-existing lesions of LP as a result of intense lichenoid inflammation and significant epidermal damage [8]."},{"id":8,"chapterId":12,"question":"Patients with Lichen Planus Pemphigoides (LPP) have circulating IgG autoantibodies directed against which antigen?","options":["Desmoglein 3","180 kDa BP antigen (BP180; BPAG2)","Type VII collagen","Laminin-5 subunits"],"correctIndex":1,"explanation":"In contrast [to bullous LP], patients with LP pemphigoides have circulating IgG autoantibodies directed against the 180 kDa BP antigen (BP180; BPAG2), as in idiopathic BP [8]."},{"id":9,"chapterId":12,"question":"Which clinical variant of LP is also referred to as LP verrucosus and is highly pruritic, primarily favoring the shins or dorsal aspects of the feet?","options":["Hypertrophic LP","Inverse LP","Lichen planopilaris","Actinic LP"],"correctIndex":0,"explanation":"Hypertrophic LP, also referred to as LP verrucosus, presents as extremely pruritic, thick, hyperkeratotic plaques seen primarily on the shins or dorsal aspect of the feet [9]."},{"id":10,"chapterId":12,"question":"Which infectious agent has received significant attention as a possible exogenous trigger for LP, particularly the oral form, in certain geographic regions?","options":["Human Papillomavirus (HPV)","Varicellazoster virus (VZV)","Hepatitis C virus (HCV)","Human herpesvirus (HHV)-6"],"correctIndex":2,"explanation":"Significant attention has been focused on the possible role of viruses, particularly hepatitis C [10]. Of the various types of LP, it is the oral form that is most commonly viewed as a manifestation of HCV infection [11]."},{"id":11,"chapterId":12,"question":"The cytotoxic activity against basal keratinocytes in LP is primarily mediated by the release of perforin and granzyme B, which is characteristic of which pathway?","options":["Fas/Fas-ligand system","Granule exocytosis","NF-kappa B (NF-B) pathway","TLR signaling"],"correctIndex":1,"explanation":"More recent studies have shown that granule exocytosis with release of perforin and granzyme B, rather than the Fas/Fas-ligand system, is the main pathway of cytotoxicity mediated by CD4+ and CD8+ T cells in humans [12]."},{"id":12,"chapterId":12,"question":"Which of the following chemokines is critical for recruiting CXCR3-expressing effector memory T cells (Th1 cells) into the skin in the induction phase of LP?","options":["TARC (CCL17)","CTACK (CCL27)","IP-10 (CXCL10)","RANTES (CCL5)"],"correctIndex":2,"explanation":"Type 1 IFN signaling and type 1 IFN-inducible chemokines (e.g. IP-10/CXCL10) then serve to recruit chemokine receptor CXCR3-expressing effector memory T cells (Th1 cells) into the skin via CXCR3/IP-10 interactions [13], [14], [15]."},{"id":13,"chapterId":12,"question":"Which drug is specifically listed as one of the most commonly incriminated medications causing lichenoid drug eruptions?","options":["Acetaminophen","Gold","Acyclovir","Furosemide"],"correctIndex":1,"explanation":"The most commonly incriminated drugs include angiotensin-converting enzyme (ACE) inhibitors, thiazide diuretics, antimalarials, quinidine, and, especially in the past, gold [16]."},{"id":14,"chapterId":12,"question":"Which key clinical feature is usually absent in lichenoid drug eruptions but commonly present in idiopathic Lichen Planus?","options":["Hyperpigmentation","Koebner phenomenon","Wickham striae","Generalized distribution"],"correctIndex":2,"explanation":"Wickham striae are uncommon in Lichenoid drug eruption but present in Idiopathic lichen planus [17]."},{"id":15,"chapterId":12,"question":"What is the typical mean age of a patient presenting with a lichenoid drug eruption, compared to idiopathic Lichen Planus?","options":["35 years (LDE) vs 30 years (LP)","50 years (LDE) vs 65 years (LP)","65 years (LDE) vs 50 years (LP)","25 years (LDE) vs 40 years (LP)"],"correctIndex":2,"explanation":"The mean age for Lichenoid drug eruption is 65 years, compared to 50 years for Idiopathic lichen planus [17]."},{"id":16,"chapterId":12,"question":"In the vulvovaginalgingival syndrome, vulvovaginal LP often coexists with mucosal involvement at which other common site?","options":["Esophagus","Buccal mucosa (oral LP)","Glans penis","Nail apparatus"],"correctIndex":1,"explanation":"Vaginal involvement occurs in up to 70% of women with erosive vulvar LP, and because there is often oral mucosal involvement as well, the term 'vulvovaginalgingival syndrome' has been introduced [18]."},{"id":17,"chapterId":12,"question":"The lesions of Actinic Lichen Planus primarily involve which areas of the body?","options":["Flexor wrists and forearms","Intertriginous zones (axillae, groin)","Sun-exposed skin of the face, neck, and dorsal surfaces of the hands and arms","Shins and soles"],"correctIndex":2,"explanation":"Lesions primarily involve sun-exposed skin of the face, followed by the neck and dorsal surfaces of the hands and arms [19]."},{"id":18,"chapterId":12,"question":"Which systemic drug, classified as a retinoid, has been reported to clear oral, esophageal, and cutaneous LP in case reports, and is a first-line systemic therapy for LP?","options":["Methotrexate","Cyclosporine","Alitretinoin","Hydroxychloroquine"],"correctIndex":2,"explanation":"Acitretin is the only systemic retinoid that has a relatively good level of evidence [20]. In case reports, alitretinoin, up to 25 mg/day for 4 weeks, was reported to clear oral, esophageal, and cutaneous LP [20]."},{"id":19,"chapterId":12,"question":"In the pathology of Lichen Planus (LP), what term is used to describe the small separations between the epidermis and the dermis resulting from confluent vacuolar degeneration of the basal layer?","options":["Pautrier micro-abscesses","Munro microabscesses","Max-Joseph spaces","Civatte bodies"],"correctIndex":2,"explanation":"Vacuolar changes within the basal cell layer may become confluent and result in small separations between the epidermis and the dermis, termed 'Max-Joseph spaces' [4]."},{"id":20,"chapterId":12,"question":"The term 'Lichen planopilaris' describes the involvement of which structure, leading to permanent alopecia?","options":["Nail bed","Hair follicle","Glans penis mucosa","Oral gingivae"],"correctIndex":1,"explanation":"In lichen planopilaris, involvement of the hair follicle is observed, both clinically and histologically [21]. The inflammatory process may result in scarring and loss of follicular structure, i.e. a permanent alopecia [21]."},{"id":21,"chapterId":12,"question":"Lichen Striatus (LS) is characterized by a linear distribution pattern that follows which specific anatomical lines?","options":["Langer cleavage lines","Lines of Blaschko","Dermatomal segments","Flexure creases"],"correctIndex":1,"explanation":"Lichen striatus... is an asymptomatic, uncommon, self-limited, linear dermatosis of unknown etiology that generally affects children. Its distribution along the lines of Blaschko plus the age of the patient usually narrows the differential diagnosis rather quickly [22]."},{"id":22,"chapterId":12,"question":"What is the typical resolution time frame for Lichen Striatus (LS)?","options":["Lifelong and persistent","Chronic, lasting 35 years","Spontaneously resolves over months to a few years","Acute, resolving within days"],"correctIndex":2,"explanation":"The eruption usually appears suddenly, develops fully over days to weeks, and after several months to a year or more, undergoes spontaneous resolution [23]."},{"id":23,"chapterId":12,"question":"Lichen Nitidus (LN) is characterized histologically by a lymphohistiocytic infiltrate confined to the width of how many dermal papillae, exhibiting a 'ball and claw' configuration?","options":["One to three","Four to five","Six to ten","The entire papillary and reticular dermis"],"correctIndex":0,"explanation":"The histologic correlate of the papule is a well-circumscribed infiltrate composed of lymphocytes and epithelioid cells confined to the width of two to three dermal papillae [24]. In most lesions, the infiltrate is confined to the width of one to three dermal papillae [25]."},{"id":24,"chapterId":12,"question":"In Lichen Nitidus, the infiltrate is described as being 'clutched' by surrounding hyperplastic rete ridges, forming which characteristic configuration?","options":["Sawtooth appearance","Ball and claw configuration","Deck-chair sign","Fir tree pattern"],"correctIndex":1,"explanation":"A dense, well-circumscribed infiltrate composed of lymphocytes, epithelioid cells, and occasional Langhans giant cells is typically 'clutched' by the surrounding hyperplastic rete ridges in a 'ball and claw' configuration [25]."},{"id":25,"chapterId":12,"question":"Erythema Dyschromicum Perstans (EDP) is also known by which synonym, derived from the Spanish term 'los cenicientos'?","options":["Keratosis pilaris","Ashy dermatosis","Lichen ruber planus","Zosteriform lichen"],"correctIndex":1,"explanation":"Erythema Dyschromicum Perstans is synonymous with 'Ashy dermatosis' [26]. Ramrez referred to these patients as los cenicientos (the ash-colored ones) and named the condition 'dermatitis cenicienta' [27]."},{"id":26,"chapterId":12,"question":"The persistent gray, grayblue, or graybrown color of inactive Erythema Dyschromicum Perstans (EDP) lesions is a reflection of which primary histological finding?","options":["Epidermal necrosis","Parakeratotic cap","Dermal melanophages and pigment incontinence","Neutrophilic microabscesses"],"correctIndex":2,"explanation":"In inactive ashy-colored lesions [of EDP], a considerable amount of pigment incontinence with variable epidermal change... is seen [28]. Histologic examination demonstrates primarily dermal melanophages [26]."},{"id":27,"chapterId":12,"question":"Which population group is most commonly affected by Erythema Dyschromicum Perstans (EDP)?","options":["Northern European Caucasians","Individuals of Far Eastern descent","More darkly pigmented Latin Americans","Sub-Saharan Africans"],"correctIndex":2,"explanation":"It has been observed that EDP occurs most often in more darkly pigmented Latin Americans [29]. The disorder clearly favors individuals with skin phototypes III and IV [29]."},{"id":28,"chapterId":12,"question":"Keratosis Lichenoides Chronica is characterized by violaceous, keratotic, lichenoid papules arranged in a linear and reticulated pattern, along with a seborrheic dermatitis-like eruption primarily involving which area?","options":["Upper portion of the face (mediofacial)","Glans penis","Palms and soles","Flexural joints"],"correctIndex":0,"explanation":"Another prominent feature [of Keratosis lichenoides chronica] is a greasy and scaly eruption involving the upper portion of the face which has been described as a seborrheic dermatitis-like medio facial eruption or psoriasiform scaling plaques [30]."},{"id":29,"chapterId":12,"question":"Which chronic complication may arise in longstanding Hypertrophic Lichen Planus and Ulcerative Lichen Planus lesions?","options":["Basal cell carcinoma","Melanoma","Squamous cell carcinoma (SCC)","Dermatofibrosarcoma protuberans"],"correctIndex":2,"explanation":"Squamous cell carcinoma (SCC) may arise within longstanding hypertrophic LP [9]. Chronic ulcerative lesions [of LP] are at risk of developing SCC [31]."},{"id":30,"chapterId":12,"question":"In the initial management of severe, acute Lichen Planus, which systemic therapy remains a commonly employed intervention, typically tapered over several weeks?","options":["Low-dose weekly methotrexate","Systemic corticosteroids","Acitretin","Cyclosporine"],"correctIndex":1,"explanation":"In severe, acute LP, systemic corticosteroids remain a commonly employed intervention. The dose is tapered over several weeks [32], [20]."},{"id":1,"chapterId":13,"question":"According to the World Allergy Organization (WAO) consensus nomenclature, the non-IgE-associated form of dermatitis in patients displaying the clinical phenotype of Atopic Dermatitis (AD) was formerly known as:","options":["Extrinsic AD","Intrinsic AD","Allergic Rhinoconjunctivitis","Eosinophilic Esophagitis"],"correctIndex":1,"explanation":"Patients exhibiting the clinical phenotype of AD but showing no evidence of IgE-sensitization are categorized as having a non-IgE-associated or non-allergic form of dermatitis, formerly known as intrinsic AD [1]."},{"id":2,"chapterId":13,"question":"What is the approximate current prevalence of Atopic Dermatitis (AD) in children in most high-income countries?","options":["2%5%","5%10%","10%30%","30%50%"],"correctIndex":2,"explanation":"The current prevalence of AD in most high-income and some low-income countries is approximately 10%30% in children [2]."},{"id":3,"chapterId":13,"question":"The age-dependent sequence in which Atopic Dermatitis and food allergy favor infants, followed by asthma and then allergic rhinoconjunctivitis in adolescents, is referred to as:","options":["The Allergic Cascade","The Atopic March","The Th2 Shift","The Epidermal Defect Pathway"],"correctIndex":1,"explanation":"This age-dependent sequence, where AD and food allergy favor infants and young children, while asthma favors older children and rhinoconjunctivitis predominates in adolescents, is referred to as the 'atopic march' [3], [4]."},{"id":4,"chapterId":13,"question":"The definition of 'early-onset AD' is Atopic Dermatitis beginning within which time frame?","options":["The first 6 months of life","The first year of life","The first 2 years of life","Before 5 years of age"],"correctIndex":2,"explanation":"Early-onset AD is defined as AD beginning in the first 2 years of life [5]."},{"id":5,"chapterId":13,"question":"Which of the following conditions is an essential feature that must be present and is sufficient for the clinical diagnosis of Atopic Dermatitis?","options":["Xerosis","Onset during infancy or early childhood","Pruritus","Personal history of atopy"],"correctIndex":2,"explanation":"Pruritus is listed as an essential feature that must be present and is sufficient for the diagnosis of Atopic Dermatitis [6]."},{"id":6,"chapterId":13,"question":"The pathogenesis of Atopic Dermatitis is divided into three major interacting categories. Which of the following is NOT one of these primary categories?","options":["Epidermal barrier dysfunction","Immune dysregulation","Alteration of the microbiome","Systemic vasculitis"],"correctIndex":3,"explanation":"The pathogenesis of AD is divided into three major categories: (1) epidermal barrier dysfunction; (2) immune dysregulation; and (3) alteration of the microbiome [7], [8], [9]."},{"id":7,"chapterId":13,"question":"Loss-of-function (LOF) variants in the gene encoding which protein represent the strongest known genetic risk factor for Atopic Dermatitis?","options":["Claudin-1","Corneodesmosin","Loricrin","Filaggrin"],"correctIndex":3,"explanation":"Filaggrin is a major structural component of the stratum corneum, and *FLG* loss-of-function (LOF) variants represent the strongest known genetic risk factor for AD [10]."},{"id":8,"chapterId":13,"question":"A defective epidermal permeability barrier in Atopic Dermatitis is consistently characterized by an increase in which measurable parameter?","options":["Serum IgE levels","Filaggrin expression","Transepidermal water loss (TEWL)","Stratum corneum lipid organization"],"correctIndex":2,"explanation":"Manifestations of epidermal barrier dysfunction include increases in transepidermal water loss (TEWL), pH, and permeability [11]."},{"id":9,"chapterId":13,"question":"Loss-of-function mutations in the *FLG* gene have been linked to an increased risk for all the following conditions in patients with pre-existing Atopic Dermatitis, EXCEPT:","options":["Ichthyosis vulgaris","Irritant contact dermatitis","Development of asthma","Pemphigus foliaceus"],"correctIndex":3,"explanation":"*FLG* LOF variants are associated with ichthyosis vulgaris, irritant contact dermatitis, hand eczema, HSV infections, food allergy, and enhanced epicutaneous sensitization [10], [12]. The association with asthma is seen only in patients with pre-existing AD [12]. Pemphigus foliaceus is mentioned in the differential diagnosis but not directly linked to *FLG* mutations [13]."},{"id":10,"chapterId":13,"question":"LEKTI (lymphoepithelial Kazal-type trypsin inhibitor) deficiency, seen in conditions like Netherton syndrome and modulated in AD, leads to excessive degradation of which corneodesmosomal component?","options":["Filaggrin","Loricrin","Desmoglein-1 (Dsg1)","Involucrin"],"correctIndex":2,"explanation":"LEKTI deficiency results in excessive degradation of the corneodesmosomal component desmoglein-1 (Dsg1), causing abnormal stratum corneum detachment and disrupting the epidermal barrier [14]."},{"id":11,"chapterId":13,"question":"Acute Atopic Dermatitis lesions are primarily dominated by which type of cytokine response?","options":["Th1","Th2","Th17","Th22"],"correctIndex":1,"explanation":"Acute AD lesions have a predominance of Th2 cytokines (IL-4, IL-5, and IL-13) [9], [15]."},{"id":12,"chapterId":13,"question":"Which keratinocyte-derived cytokine is known as the 'master-switch of allergic inflammation' due to its central role in evoking a Th2 response via dendritic cell activation?","options":["IL-4","IL-33","IL-25","Thymic stromal lymphopoietin (TSLP)"],"correctIndex":3,"explanation":"Thymic stromal lymphopoietin (TSLP) is an IL-7-like cytokine known as the 'master-switch of allergic inflammation' because of its central role in evoking a Th2 response via dendritic cell activation [16], [17]."},{"id":13,"chapterId":13,"question":"Which Th2 cytokine, highly expressed in lesional skin of AD patients, targets receptors on cutaneous C nerve fibers and has been successfully targeted by nemolizumab to reduce pruritus?","options":["IL-4","IL-13","IL-31","IL-17"],"correctIndex":2,"explanation":"IL-31 is a Th2 cytokine highly expressed in lesional skin and serum of AD patients; its heterodimeric receptor is expressed by cutaneous C nerve fibers, and blocking it with nemolizumab significantly reduces pruritus [18]."},{"id":14,"chapterId":13,"question":"Approximately what percentage of patients with Atopic Dermatitis have skin colonisation with *Staphylococcus aureus*?","options":["5%","35%","50%","More than 90%"],"correctIndex":3,"explanation":"More than 90% of patients with AD have skin colonised with *S. aureus*, compared to about 5% of unaffected individuals [19]."},{"id":15,"chapterId":13,"question":"Infantile Atopic Dermatitis (age <2 years) typically involves which body areas, often with sparing of the central face and diaper area?","options":["Flexural folds (antecubital/popliteal fossae)","Cheeks, scalp, and extensor aspects of the extremities","Hands and feet only","Axillae and groin"],"correctIndex":1,"explanation":"Infantile AD typically involves edematous papules and papulovesicles on the cheeks, with sparing of the central face, as well as the scalp, neck, and extensor aspects of the extremities, usually sparing the diaper area [20]."},{"id":16,"chapterId":13,"question":"The classic sites of predilection for lesions in childhood Atopic Dermatitis (age 2 to 12 years) are:","options":["The face and central trunk","The diaper area and lower legs","The antecubital and popliteal fossae (flexural eczema)","Palms and soles"],"correctIndex":2,"explanation":"In childhood AD, the classic sites of predilection are the antecubital and popliteal fossae, often referred to as flexural eczema [21]."},{"id":17,"chapterId":13,"question":"Which regional variant of Atopic Dermatitis typically occurs after puberty, primarily involves the face, scalp, and neck, and may be aggravated by *Malassezia* yeasts?","options":["Juvenile plantar dermatosis","Head and neck dermatitis","Cheilitis sicca","Dyshidrotic eczema"],"correctIndex":1,"explanation":"'Head and neck dermatitis' represents a variant of AD occurring typically after puberty, involving the face, scalp, and neck, where *Malassezia* yeasts may be an aggravating factor [22], [23]."},{"id":18,"chapterId":13,"question":"Eyelid eczema, when it occurs as a manifestation of Atopic Dermatitis, is specifically characterized by which finding, distinguishing it from eyelid eczema due to other causes?","options":["Prominent oozing and crusting","Lichenification of the periorbital skin","Pustules and vesicles","Hypopigmentation (pityriasis alba)"],"correctIndex":1,"explanation":"Eyelid eczema in AD is characterized by lichenification of the periorbital skin, in contrast to eyelid eczema due to other causes [24]."},{"id":19,"chapterId":13,"question":"Atopic Hand Eczema affects what approximate percentage of adults with Atopic Dermatitis, sometimes as the sole manifestation?","options":["~10%","~30%","~60%","~90%"],"correctIndex":2,"explanation":"Atopic hand eczema affects approximately ~60% of adults with AD and may be the only manifestation of the condition [23]."},{"id":20,"chapterId":13,"question":"The morphological change defined by thickened and leathery skin with exaggerated markings, resulting from repeated rubbing and scratching in AD, is known as:","options":["Spongiosis","Lichenification","Keratosis pilaris","Pityriasis alba"],"correctIndex":1,"explanation":"With repeated rubbing and scratching, the skin becomes thickened and leathery with exaggerated skin markings, referred to as lichenification [25]."},{"id":21,"chapterId":13,"question":"A physical finding defined as symmetric, prominent horizontal fold(s) just beneath the margin of the lower eyelid is known as:","options":["Hertoghe sign","Periorbital darkening ('allergic shiners')","White dermographism","DennieMorgan folds ('atopic pleats')"],"correctIndex":3,"explanation":"DennieMorgan folds ('atopic pleats') are defined as symmetric, prominent horizontal fold(s) just beneath the margin of the lower lid [26], [27]."},{"id":22,"chapterId":13,"question":"The hypopigmented macules and patches known as Pityriasis alba are thought to result from low-grade dermatitis that disrupts the transfer of which cellular components?","options":["Melanocyte destruction","Melanosomes from melanocytes to keratinocytes","Lipids across the stratum corneum","Keratin filaments in the upper epidermis"],"correctIndex":1,"explanation":"Pityriasis alba is thought to result from a low-grade eczematous dermatitis that disrupts the transfer of melanosomes from melanocytes to keratinocytes [28]."},{"id":23,"chapterId":13,"question":"A severe viral infection complication of AD, presenting most often with numerous monomorphic, punched-out erosions with hemorrhagic crusting, is known as:","options":["Impetiginization","Eczema herpeticum","Molluscum contagiosum","Dermatophytosis"],"correctIndex":1,"explanation":"Eczema herpeticum represents rapid dissemination of a herpes simplex viral infection over eczematous skin and affected individuals often present with numerous monomorphic, punched-out erosions with hemorrhagic crusting [29]."},{"id":24,"chapterId":13,"question":"Which extracutaneous complication is associated with Atopic Dermatitis in adulthood, as identified in a systematic review and meta-analysis of cohort studies?","options":["Type 1 Diabetes Mellitus","Major cardiovascular outcomes (e.g., angina, myocardial infarction)","Rheumatoid Arthritis","Chronic Kidney Disease"],"correctIndex":1,"explanation":"A recent meta-analysis of cohort studies found that AD is associated with an increased risk of cardiovascular complications such as angina and myocardial infarction, cerebrovascular accidents, and heart failure during adulthood [30], [31]."},{"id":25,"chapterId":13,"question":"The Harmonizing Outcome Measures for Eczema (HOME) initiative recommends which validated scoring system as the core instrument to measure symptoms in all future clinical trials?","options":["EASI (Eczema Area Scoring Index)","SCORAD (SCORing Atopic Dermatitis)","vIGA-AD (Validated Investigator Global Assessment)","POEM (Patient-Oriented Eczema Measure)"],"correctIndex":3,"explanation":"The Harmonizing Outcome Measures for Eczema (HOME) initiative recommends that the Patient-Oriented Eczema Measure (POEM) be utilized as the core instrument in all future clinical trials [32], [33]."},{"id":26,"chapterId":13,"question":"What is the hallmark histologic feature of acute, exudative eczematous lesions in Atopic Dermatitis?","options":["Acanthosis","Lichenification","Spongiosis","Dermal fibrosis"],"correctIndex":2,"explanation":"Acute, exudative eczema is characterized by marked spongiosis, with intraepidermal fluid collection leading to the formation of vesicles [34]."},{"id":27,"chapterId":13,"question":"For the proactive maintenance phase of Atopic Dermatitis management, RCTs have shown that the risk of relapse can be significantly reduced by applying a mid-potency topical corticosteroid how often to the usual areas of involvement when clear?","options":["Daily","Twice-weekly","Monthly","Only during flares"],"correctIndex":1,"explanation":"Randomized Controlled Trials (RCTs) have demonstrated that the risk of relapse can be significantly reduced by proactive maintenance with twice-weekly application of a mid-potency topical corticosteroid to the usual areas of involvement when clear [35]."},{"id":28,"chapterId":13,"question":"Topical Calcineurin Inhibitors (TCIs) are particularly advantageous for Atopic Dermatitis affecting which areas due to heightened concern over corticosteroid-induced skin atrophy?","options":["Thick, lichenified plaques on extremities","Palms and soles","Face and intertriginous areas","Scalp"],"correctIndex":2,"explanation":"TCIs are particularly useful for AD affecting the face and intertriginous areas, where corticosteroid-induced skin atrophy is of increased concern [36]."},{"id":29,"chapterId":13,"question":"Which injectable systemic agent, FDA-approved for moderate to severe AD in patients 6 months of age, targets the IL-4R subunit to block IL-4 and IL-13 signaling?","options":["Tralokinumab","Nemolizumab","Omalizumab","Dupilumab"],"correctIndex":3,"explanation":"Dupilumab is a human monoclonal antibody that targets the IL-4R subunit of heterodimeric IL-4 and IL-13 receptors, blocking signaling by these cytokines [37]."},{"id":30,"chapterId":13,"question":"Why are systemic corticosteroids generally not recommended for routine long-term management of Atopic Dermatitis?","options":["Lack of efficacy in chronic disease","High incidence of anaphylaxis","Propensity for significant rebound flares upon discontinuation","Minimal systemic absorption"],"correctIndex":2,"explanation":"Systemic corticosteroids are not recommended for routine AD management due to a propensity for significant rebound flares upon discontinuation and the unacceptable side effects of long-term administration [38], [39]."},{"id":1,"chapterId":14,"question":"Which of the following describes the key sites favored by Seborrheic Dermatitis lesions?","options":["Extensor aspects of extremities and trunk","Flexural folds (antecubital/popliteal fossae)","Scalp, ears, face, central chest, and intertriginous areas","Palms and soles exclusively"],"correctIndex":2,"explanation":"Seborrheic dermatitis lesions favor the scalp, ears, face, central chest, and intertriginous areas, which are regions with high sebum production [1]."},{"id":2,"chapterId":14,"question":"The commensal yeast strongly linked to the etiology and aggravation of Seborrheic Dermatitis is a species of which genus?","options":["Candida","Cutibacterium","Malassezia","Trichophyton"],"correctIndex":2,"explanation":"Seborrheic dermatitis has an etiologic link to the commensal yeast *Malassezia* (Pityrosporum) species, including *M. furfur* [1], [2]."},{"id":3,"chapterId":14,"question":"In the pathogenesis of Seborrheic Dermatitis, which finding regarding skin surface lipids is typically observed?","options":["Decreased triglycerides and elevated free fatty acids","Elevated squalene and decreased cholesterol","Elevated triglycerides and cholesterol but decreased squalene and free fatty acids","Normalisation of all lipid components compared to controls"],"correctIndex":2,"explanation":"In patients with seborrheic dermatitis, triglycerides and cholesterol are elevated but squalene and free fatty acids are significantly decreased in the skin surface lipids [3]."},{"id":4,"chapterId":14,"question":"A severe or extensive presentation of Seborrheic Dermatitis in an adult should raise suspicion for which underlying condition?","options":["Langerhans cell histiocytosis","Chronic renal failure","HIV infection","Systemic Lupus Erythematosus"],"correctIndex":2,"explanation":"Extensive and severe seborrheic dermatitis should raise the suspicion of underlying HIV infection, with 2% of patients tested for HIV in one study found positive, often in a late stage of their disease [1], [4]."},{"id":5,"chapterId":14,"question":"Which mildest form of Seborrheic Dermatitis of the scalp is defined by diffuse, fine white or greasy scaling without significant erythema or irritation?","options":["Cradle cap","Pityriasis simplex capillitii (dandruff)","Sebopsoriasis","Pityriasis amiantacea"],"correctIndex":1,"explanation":"*Pityriasis simplex capillitii* (dandruff) is considered the mildest form of seborrheic dermatitis of the scalp, characterized by diffuse, slight to moderate, fine white or greasy scaling without significant erythema [5]."},{"id":6,"chapterId":14,"question":"Infantile Seborrheic Dermatitis presenting as a coherent, scaly, and crusty mass covering most of the scalp is commonly referred to as:","options":["Psoriasiform diaper dermatitis","Cradle cap","Leiner disease","Pityriasis alba"],"correctIndex":1,"explanation":"Initially mild greasy scales that extend over the entire scalp, potentially resulting in a coherent scaly and crusty mass, are referred to as 'cradle cap' in infantile seborrheic dermatitis [6], [7]."},{"id":7,"chapterId":14,"question":"What is the primary class of topical therapy recommended as the mainstay for treating adult Seborrheic Dermatitis?","options":["Topical calcineurin inhibitors","High-potency topical steroids","Topical azoles (e.g., ketoconazole)","Systemic retinoids"],"correctIndex":2,"explanation":"The mainstay of therapy for adult seborrheic dermatitis is the use of topical azoles (e.g., ketoconazole), utilized as shampoos or creams [8]."},{"id":8,"chapterId":14,"question":"Seborrheic Dermatitis-like eruptions have been reported as a side effect with which class of antineoplastic agents?","options":["Alkylating agents","Tyrosine kinase inhibitors","Anthracyclines","Platinum-based compounds"],"correctIndex":1,"explanation":"Seborrheic dermatitis-like eruptions have been reported with antineoplastic agents such as tyrosine kinase inhibitors [9]."},{"id":9,"chapterId":14,"question":"Asteatotic Eczema is characterized by superficial cracking that resembles a 'dried riverbed' and has which synonym?","options":["Pompholyx","Eczema craquel","Dyshidrotic eczema","Nummular eczema"],"correctIndex":1,"explanation":"Asteatotic Eczema is synonymous with 'Eczema craquel', 'Winter eczema', 'Winter itch', and 'Desiccation dermatitis'. It exhibits a criss-cross pattern of superficial cracks ('crazy-paving', 'dried riverbed') [10], [11]."},{"id":10,"chapterId":14,"question":"Asteatotic Eczema most commonly begins on which area of the body?","options":["The face and neck","The shins","The palms and soles","The intertriginous areas"],"correctIndex":1,"explanation":"Xerosis, which precedes asteatotic eczema, first arises on the shins [11]. The shins, lower flanks, and posterior axillary line are the sites of predilection for the eczema [12]."},{"id":11,"chapterId":14,"question":"What is the primary mechanism responsible for xerosis in aging skin leading to Asteatotic Eczema?","options":["Increased sebum production","Deficient stratum corneum lipid production and reduced water-binding capacity","Loss of sweat gland function only","Fungal infection of the stratum corneum"],"correctIndex":1,"explanation":"Xerosis of aging skin is caused by a complex dysfunction of the stratum corneum, including a decrease of intercellular lipids, an altered ratio of fatty acids to ceramide 1, and reduced synthesis of 'natural moisturizing factor' (NMF), leading to reduced water-binding capacity [13]."},{"id":12,"chapterId":14,"question":"Disseminated Eczema (Autosensitization) is defined by secondary lesions that appear distant from the primary site of exposure and most frequently develops in association with:","options":["Acne vulgaris and rosacea","Allergic contact dermatitis and stasis dermatitis","Psoriasis and dermatomyositis","Tinea corporis and impetigo"],"correctIndex":1,"explanation":"Disseminated Eczema, or secondary dissemination, is most often observed in allergic contact dermatitis, particularly if associated with stasis dermatitis [14], [15]."},{"id":13,"chapterId":14,"question":"The hypothesized underlying physiological mechanism that allows distant skin to react in Disseminated Eczema is known as:","options":["The Atopic March","The Koebner phenomenon","The excited skin syndrome ('angry back')","The Seborrheic Cascade"],"correctIndex":2,"explanation":"Inflammatory processes of the skin, whether allergic or irritant, lower the irritancy threshold of distant skin, facilitating an eczematous reaction. This is referred to as 'excited skin syndrome' or 'angry back' [16]."},{"id":14,"chapterId":14,"question":"Which type of generalized condition often presents with numerous monomorphic, punched-out erosions with hemorrhagic crusting, which must be distinguished from disseminated eczema?","options":["Eczematous drug eruption (e.g., due to calcium channel blockers)","Allergic contact dermatitis (ACD) to nickel","Mycosis fungoides","Eczema herpeticum (based on previous chapter knowledge, though not explicit in this excerpt, it fits the description of a widely disseminated infectious complication)"],"correctIndex":0,"explanation":"Conditions to be distinguished from disseminated eczema include atopic dermatitis, airborne contact dermatitis, contact dermatitis caused by constituents of textiles, photo-allergic dermatitis, and eczematous drug eruptions [17]. (Note: While the provided excerpts do not explicitly list all classic differential diagnoses, eczematous drug eruptions are listed as one of the differential diagnoses [17].)"},{"id":15,"chapterId":14,"question":"Nummular Dermatitis is characterized by lesions that are primarily described as:","options":["Polygonal papules","Coin-shaped (discoid) plaques","Serpiginous tracts","Linear streaks"],"correctIndex":1,"explanation":"Nummular dermatitis is characterized by its coin-shaped (discoid), disseminated, eczematous lesions [18], [19]."},{"id":16,"chapterId":14,"question":"In a study of Nummular Dermatitis patients undergoing patch testing, which allergen was most commonly associated with a positive reaction?","options":["Formaldehyde resins","Potassium dichromate","Neomycin","Nickel sulfate"],"correctIndex":3,"explanation":"In a study of nummular dermatitis patients who underwent patch testing, the most frequent positive patch test reactions were to nickel sulfate, potassium dichromate, and cobalt chloride [20]."},{"id":17,"chapterId":14,"question":"Stasis Dermatitis is strongly linked to chronic venous insufficiency and is primarily triggered by:","options":["Systemic hypercoagulability","Chronic venous hypertension","Allergic reaction to compression stockings","Lymphatic obstruction"],"correctIndex":1,"explanation":"Chronic venous hypertension *per se* is cited as the initial trigger for stasis dermatitis [21], [22]."},{"id":18,"chapterId":14,"question":"Which feature seen on a skin biopsy specimen is characteristic of Stasis Dermatitis, reflecting the underlying vascular pathology?","options":["Confluent parakeratosis with Munro microabscesses","Subepidermal bullae formation","Increased capillaries surrounded by fibrin cuffs and hemosiderin deposits","Psoriasiform epidermal hyperplasia without spongiosis"],"correctIndex":2,"explanation":"In stasis dermatitis, biopsy specimens display signs of venous hypertension, specifically an increased number of capillaries which are dilated and surrounded by cuffs of fibrin, along with hemosiderin deposits [23]."},{"id":19,"chapterId":14,"question":"Acute Lipodermatosclerosis, a stage of chronic venous insufficiency, may clinically mimic:","options":["Psoriasis","Cellulitis ('pseudoerysipelas')","Tinea pedis","Systemic sclerosis"],"correctIndex":1,"explanation":"Acute lipodermatosclerosis (LDS) involves inflammation that may mimic cellulitis, sometimes referred to as 'pseudoerysipelas' [24], [25]."},{"id":20,"chapterId":14,"question":"Dyshidrotic Eczema, also known as Pompholyx when large vesicles are present, is characterized by vesicles caused by:","options":["Trapped sweat within sweat ducts","A neutrophilic reaction (pustule formation)","Spongiosis within the epidermis","Dermal inflammation below the basement membrane"],"correctIndex":2,"explanation":"Dyshidrotic eczema is characterized by firm, pruritic vesicles and bullae. While the term may suggest sweat gland dysfunction, the vesicles are actually due to spongiosis within the epidermis [26]."},{"id":21,"chapterId":14,"question":"Dyshidrotic Eczema lesions, when small and clustered, are often clinically likened to the appearance of:","options":["Tapioca pudding","A dried riverbed","Petals of a flower","Asbestos-like scales"],"correctIndex":0,"explanation":"When smaller lesions of Dyshidrotic Eczema are clustered, they have been likened to tapioca pudding [27]."},{"id":22,"chapterId":14,"question":"Which metal ingestant, when chronically ingested, has been debated as a potential flare factor for dyshidrotic eczema in sensitized individuals?","options":["Lead","Cadmium","Aluminum","Nickel and cobalt"],"correctIndex":3,"explanation":"The role of ingestants, in particular nickel and cobalt, has been debated as a trigger for dyshidrotic eczema flares [27]. Improvement with a low-nickel diet in nickel-sensitive patients has been observed [27]."},{"id":23,"chapterId":14,"question":"Infective Dermatitis associated with Human T cell lymphotropic virus type I (HTLV-1) typically begins during which life stage?","options":["Adolescence","Early childhood","Late adulthood","In utero"],"correctIndex":1,"explanation":"Infective dermatitis typically appears only after protective maternal antibodies have disappeared, meaning the onset is during early childhood [28], [29]."},{"id":24,"chapterId":14,"question":"Which combination of sites is typically affected by the eczematous dermatosis in HTLV-associated Infective Dermatitis?","options":["Palms and soles only","Trunk and proximal extremities","Head and neck region, axillae, and groin","Antecubital and popliteal fossae"],"correctIndex":2,"explanation":"Infective dermatitis affects primarily the head and neck region, including the scalp, ears, eyelid margins, and paranasal skin, as well as the axillae and groin [30], [31]."},{"id":25,"chapterId":14,"question":"A key criterion for diagnosing HTLV-associated Infective Dermatitis is a rapid response to antibiotics followed by:","options":["Permanent cure","Recrudescence into ATLL (Adult T cell leukemia/lymphoma)","Prompt relapse after withdrawal","Development of strong pruritus"],"correctIndex":2,"explanation":"A major criterion for HTLV-associated infective dermatitis is a chronic relapsing dermatitis which responds quickly to antibiotics but relapses promptly after withdrawal [29], [32]."},{"id":26,"chapterId":14,"question":"Juvenile Plantar Dermatosis is strongly linked to an atopic diathesis and is primarily seen in which population?","options":["Infants (<1 year old)","Prepubertal children","Adolescents after puberty","Elderly, immunosuppressed adults"],"correctIndex":1,"explanation":"Juvenile plantar dermatosis occurs in prepubertal children, from the age of 3 years and upwards, and is a characteristic condition occurring primarily in children with an atopic diathesis [33]."},{"id":27,"chapterId":14,"question":"The clinical presentation of Juvenile Plantar Dermatosis usually spares which areas of the foot?","options":["The balls of the feet","The toe pads","The dorsa of the feet, the interdigital spaces, and the instep","The heels"],"correctIndex":2,"explanation":"Juvenile plantar dermatosis typically involves the balls of the feet and the toe pads, but the dorsa of the feet, the interdigital spaces, and the instep are usually spared [34]."},{"id":28,"chapterId":14,"question":"The pathogenesis of Irritant Diaper Dermatitis is increasingly blamed on which factor, facilitating skin barrier breakdown and secondary infection?","options":["Ammonia derived from urea","The alkaline pH resulting from fecal bacteria and ureases","Contact allergy to diaper elastics","Systemic zinc deficiency"],"correctIndex":1,"explanation":"While ammonia was previously blamed, the alkaline pH of the urine, enhanced by fecal bacteria and their urease products, increases the urinary pH, leading to horny layer barrier breakdown and facilitating secondary *C. albicans* infection [35], [36], [37]."},{"id":29,"chapterId":14,"question":"In the common irritant form of Diaper Dermatitis, which areas are typically spared, in contrast to secondary candidiasis?","options":["The convex surfaces of the buttocks","The lower abdomen and genitalia","The skin folds (creases)","The diaper margins"],"correctIndex":2,"explanation":"The common irritant form of diaper dermatitis typically spares the skin folds (creases) [38], whereas candidiasis favors the folds and genitalia [39]."},{"id":30,"chapterId":14,"question":"What is the hallmark histologic feature seen in acute, exudative eczematous eruptions, such as those found in the acute phases of Stasis Dermatitis or Dyshidrotic Eczema?","options":["Dermal fibrosis","Spongiosis (intraepithelial edema)","Acanthosis in a psoriasiform pattern","Confluent parakeratosis"],"correctIndex":1,"explanation":"In acute eczematous eruptions, intraepithelial edema (spongiosis) predominates, often leading to the formation of micro- or macrovesicles [40]."},{"id":1,"chapterId":15,"question":"Allergic Contact Dermatitis (ACD) accounts for approximately what percentage of all contact dermatitis cases?","options":["~80%","~50%","~20%","~5%"],"correctIndex":2,"explanation":"Irritant contact dermatitis (ICD) accounts for approximately 80% of all contact dermatitis, with allergic contact dermatitis (ACD) accounting for the remainder, meaning about 20% [1]."},{"id":2,"chapterId":15,"question":"Allergic Contact Dermatitis (ACD) is classified pathophysiologically as which type of immune reaction?","options":["Immediate-type hypersensitivity (Type I)","Cytotoxic hypersensitivity (Type II)","Immune complex reaction (Type III)","Delayed-type hypersensitivity (Type IV)"],"correctIndex":3,"explanation":"ACD is defined as a delayed-type hypersensitivity reaction that requires prior sensitization of the individual to the chemical in question [1, 2]."},{"id":3,"chapterId":15,"question":"Which diagnostic procedure remains the 'gold standard' for the accurate and consistent diagnosis of Allergic Contact Dermatitis (ACD), except when exposure is obvious (e.g., poison ivy)?","options":["Skin prick testing","Serological IgE measurement","Patch testing","Repeat Open Application Test (ROAT)"],"correctIndex":2,"explanation":"Patch testing remains the gold standard for accurate and consistent diagnosis of ACD [1, 3]."},{"id":4,"chapterId":15,"question":"Who is generally credited with describing the technique of patch testing over 100 years ago?","options":["Sulzberger and Wise","Jadassohn","Von Pirquet","Fisher"],"correctIndex":1,"explanation":"Jadassohn has been credited with describing the technique of patch testing over 100 years ago [4]."},{"id":5,"chapterId":15,"question":"The pathogenesis of ACD involves two main phases. The first phase, when the patient initially encounters the chemical that penetrates the skin and elicits a cascade of events, is known as:","options":["Elicitation phase","Challenge phase","Sensitization phase","Irritation phase"],"correctIndex":2,"explanation":"The pathogenesis of ACD involves an initial sensitization phase when the patient first comes in contact with the chemical, which penetrates the skin and then elicits a cascade of events that results in sensitization [2]."},{"id":6,"chapterId":15,"question":"Which two allergens are cited as prototypic reactions and are among the most common causes of ACD worldwide (Nickel) and in the US (Poison Ivy)?","options":["Formaldehyde and Bacitracin","Nickel and poison ivy","Gold and Neomycin","Chromate and Rubber mix"],"correctIndex":1,"explanation":"The prototypic reactions are ACD caused by nickel and poison ivy, and related plants [1]. Nickel (worldwide) and poison ivy (US) are among the most common etiologies of ACD [5]."},{"id":7,"chapterId":15,"question":"The classic clinical picture of acute Allergic Contact Dermatitis is characterized by lesions that are often:","options":["Deep-seated, urticarial plaques","Well-demarcated, erythematous, and vesicular plaques","Hypopigmented macules","Symmetric, non-scaly papules"],"correctIndex":1,"explanation":"The classic picture of contact dermatitis is a well-demarcated, erythematous, vesicular, and/or scaly patch or plaque with well-defined margins corresponding to the area of contact [3]."},{"id":8,"chapterId":15,"question":"Which morphological characteristic typically dominates in chronic ACD lesions?","options":["Blistering and weeping","Lichenified or scaly plaques","Urticarial wheals","Hemorrhagic crusting"],"correctIndex":1,"explanation":"The typical appearance of ACD may be chronic (lichenified or scaly plaques) [6]."},{"id":9,"chapterId":15,"question":"ACD lesions presenting with erythematous streaks and linear vesicles are often due to contact with:","options":["Jewelry","Gloves","A leaf or branch rubbed against the skin","Topical antibiotics"],"correctIndex":2,"explanation":"The distribution can be linear, when an object such as a leaf or branch is rubbed against the skin [3]."},{"id":10,"chapterId":15,"question":"Which morphological variant of ACD is described as symmetric erythema of the gluteal and inguinal area, often associated with systemic exposure to an allergen?","options":["Erythema multiforme","Lichenoid ACD","Baboon syndrome","Pigmented purpura"],"correctIndex":2,"explanation":"Baboon syndrome is an uncommon presentation of ACD defined by symmetric erythema of the gluteal and inguinal area in addition to other flexural sites, and it has clinical overlap with systemic contact dermatitis [7, 8]."},{"id":11,"chapterId":15,"question":"What is the recommended maximum equivalent daily oral dose of prednisone during patch testing to avoid reducing the individuals ability to elicit a reaction (false-negative test)?","options":["5 mg","10 mg","20 mg","40 mg"],"correctIndex":2,"explanation":"The daily oral AM dose of corticosteroids should not exceed the equivalent of 20 mg of prednisone during testing, as higher doses may result in a false-negative test [9]."},{"id":12,"chapterId":15,"question":"When performing patch testing, patches are typically removed at the second visit (Day 2 or 48 hours). When should the final reading for definitive interpretation be performed?","options":["Immediately upon removal (48 hours)","1 week after initial application (Day 7)","24 hours after removal (72 hours to 1 week)","Only if a positive reaction is noted at 48 hours"],"correctIndex":2,"explanation":"The patient returns at 48 hours for patch removal and initial scoring. The second reading is performed from 72 hours to 1 week after the initial application of patches [10, 11]."},{"id":13,"chapterId":15,"question":"Which of the following allergens commonly causes delayed patch test responses, necessitating a reading later than 48 hours?","options":["Nickel","Poison ivy (urushiol)","Neomycin","Methylisothiazolinone (MI)"],"correctIndex":2,"explanation":"The later reading is necessary as patch test responses to some allergens such as gold, neomycin, and corticosteroids may be delayed [11]."},{"id":14,"chapterId":15,"question":"According to the International Grading System for Patch Tests, a 'Strong, vesicular reaction with erythema, infiltration and papules' is scored as:","options":["+/","+","++","+++"],"correctIndex":2,"explanation":"A '++' reaction indicates a Strong, vesicular reaction with erythema, infiltration and papules [12]."},{"id":15,"chapterId":15,"question":"What is the most common site utilized for the application of patch tests?","options":["Volar forearm","Lateral neck","Upper back","Inner thigh"],"correctIndex":2,"explanation":"The most common site for patch testing is the upper back [9]."},{"id":16,"chapterId":15,"question":"The Repeat Open Application Test (ROAT), sometimes called the 'poor mans patch test', involves applying the product in question to a predetermined site (e.g., flexor forearm) how often for 12 weeks?","options":["Once daily","Twice daily","Once weekly","Only when pruritus occurs"],"correctIndex":1,"explanation":"In an open use test, the patient applies the product in question to the same predetermined location twice daily for 12 weeks [13]."},{"id":17,"chapterId":15,"question":"Acute Allergic Contact Dermatitis is histologically the prototype of spongiotic dermatitis, with severe reactions leading to:","options":["Subepidermal bullae","Intraepidermal vesiculation","Basal cell vacuolization","Dermal granuloma formation"],"correctIndex":1,"explanation":"In the acute stage of ACD, marked spongiosis results in intraepidermal vesiculation [14, 15]."},{"id":18,"chapterId":15,"question":"The histologic picture of chronic ACD typically includes:","options":["Necrosis and vasculitis","Marked spongiosis","Epidermal hyperplasia (often psoriasiform)","Lymphocytic infiltration of the basement membrane zone"],"correctIndex":2,"explanation":"In subacute to chronic stages, epidermal hyperplasia, often psoriasiform, develops [14, 15]."},{"id":19,"chapterId":15,"question":"According to the North American Contact Dermatitis Group (NACDG) 20172018 data, which specific allergen ranked as the most common positive reaction among patch test clinic patients?","options":["Methylisothiazolinone (MI)","Fragrance mix I","Nickel sulfate","Formaldehyde"],"correctIndex":2,"explanation":"Nickel sulfate ranked as the most common allergen tested by the NACDG in 20172018 [16]. In patch test clinics worldwide, nickel is the most common allergen [17]."},{"id":20,"chapterId":15,"question":"What test can be performed in the office setting to determine if a particular metal item (like a belt buckle or jewelry) releases nickel, resulting in a pink color indicator if positive?","options":["Dimethylglyoxime test","Potassium dichromate test","Cobalt spot test","Roxarsone test"],"correctIndex":0,"explanation":"A useful test to determine whether a particular item contains nickel is the dimethylglyoxime test, which identifies objects that release nickel using a pink color indicator [18, 19]."},{"id":21,"chapterId":15,"question":"Methylisothiazolinone (MI) became a leading allergen after 2005 when regulatory changes allowed its concentration in rinse-off products to increase to:","options":["3.75 ppm","20 ppm","100 ppm","500 ppm"],"correctIndex":2,"explanation":"In 2005, regulatory changes allowed MI concentration to increase to 100 ppm, followed by a current epidemic of sensitization [20]."},{"id":22,"chapterId":15,"question":"Fragrance Mix I contains how many different fragrance components, typically used at 1% concentration each?","options":["Four","Six","Eight","Ten"],"correctIndex":2,"explanation":"The current fragrance mix I contains eight different fragrance components (at 1% each) [21, 22]."},{"id":23,"chapterId":15,"question":"Patients allergic to fragrance must avoid products labeled 'unscented' because they may contain:","options":["High concentrations of alcohol","Formaldehyde releasers","Masking fragrances","Hydroperoxides of linalool only"],"correctIndex":2,"explanation":"Fragrances can be used to mask an unpleasant odor, resulting in products labeled 'unscented' that patients allergic to fragrance must still avoid [23]."},{"id":24,"chapterId":15,"question":"An individual with known formaldehyde sensitivity should generally avoid all the following substances, EXCEPT:","options":["Quaternium-15","Imidazolidinyl urea","DMDM hydantoin","Lanolin alcohol"],"correctIndex":3,"explanation":"Formaldehyde-sensitive individuals should generally avoid formaldehyde-releasing preservatives such as quaternium-15, imidazolidinyl urea, and DMDM hydantoin [24]."},{"id":25,"chapterId":15,"question":"Which topical antibiotic is reported to be the most common sensitizer among the topical antibiotics and is frequently combined with bacitracin and polymyxin B?","options":["Gentamicin","Mupirocin","Clindamycin","Neomycin"],"correctIndex":3,"explanation":"Neomycin is the most commonly used topical antibiotic and is the most common sensitizer among them. It is frequently used in conjunction with bacitracin and polymyxin B (e.g., Neosporin) [25]."},{"id":26,"chapterId":15,"question":"Which of the following classes of systemic exposure can cause systemic contact dermatitis in a patient previously sensitized topically?","options":["Vaccines (without thimerosal)","Oral quinolones","Statins","NSAIDs"],"correctIndex":1,"explanation":"Other causes of systemic contact dermatitis due to ingestion of allergens that have previously caused an ACD include antibiotics (e.g., quinolones) [26, 27]."},{"id":27,"chapterId":15,"question":"Which combination of screening agents is suggested to detect approximately 75% of allergic reactions to topical corticosteroids?","options":["Betamethasone-17-valerate and Clobetasol propionate","Hydrocortisone and Flucinonide","Tixocortol-21-pivalate and budesonide","Triamcinolone and Dexamethasone"],"correctIndex":2,"explanation":"The combination of tixocortol-21-pivalate and budesonide provides reasonable screening for corticosteroid allergy, detecting ~75% of reactions [28, 29]."},{"id":28,"chapterId":15,"question":"When an airborne allergen causes ACD, the dermatitis is predominantly located in exposed portions of the skin, with which site being especially common?","options":["The lower back","The abdomen (belt line)","The buttocks","The eyelids"],"correctIndex":3,"explanation":"Prolonged and repetitive exposure to airborne allergens generally produces an ACD that is predominantly located in the exposed portions of the skin: especially the eyelids, but also the face, V of the neck, arms, and legs [30]."},{"id":29,"chapterId":15,"question":"Which allergen, used in permanent hair colorants, has seen a resurgence in a new population due to its high concentration use in temporary tattoos?","options":["Toluene diamine sulphate (TDS)","p-Phenylenediamine (PPD)","Quaternium-15","Methyl methacrylate"],"correctIndex":1,"explanation":"*p-Phenylenediamine* (PPD) is the most commonly used permanent hair colorant. Since 1998, PPD has been found in temporary tattoos in higher concentrations than in hair color products, leading to a resurgence in sensitization [31]."},{"id":30,"chapterId":15,"question":"When treating ACD, even after identified allergens are completely avoided, approximately how long may it take to see complete and prolonged clearing of the dermatitis?","options":["2 days","1 week","2-4 weeks","6 weeks or more"],"correctIndex":3,"explanation":"It may take 6 weeks or more to see complete and prolonged clearing, even when allergens are being avoided [32]."},{"id":1,"chapterId":16,"question":"What is the primary pathophysiological mechanism of Irritant Contact Dermatitis (ICD)?","options":["Delayed-type hypersensitivity mediated by hapten-specific T cells","Immune complex deposition in the basement membrane zone","Activation of the innate immune system by direct cytotoxic effect","Immediate IgE-mediated mast cell degranulation"],"correctIndex":2,"explanation":"Irritant contact dermatitis (ICD) is a cutaneous inflammatory disorder resulting from activation of the innate immune system by the direct cytotoxic effect of a chemical or physical agent [1]."},{"id":2,"chapterId":16,"question":"Irritant Contact Dermatitis (ICD) is estimated to constitute what percentage of all occupational skin disorders?","options":["10% to 20%","30% to 50%","70% to 80%","90% or more"],"correctIndex":2,"explanation":"ICD is the most common form of occupational skin disease, estimated to constitute between 70% and 80% of all occupational skin disorders [2]."},{"id":3,"chapterId":16,"question":"Which term is used vernacularly to describe the severe presentation of ICD resulting from exposure to strong or absolute irritants like concentrated acids or alkalis, often leading to necrosis and ulceration?","options":["Eczema craquel","Chemical burn","Baboon syndrome","Degreasers flush"],"correctIndex":1,"explanation":"Strong or absolute irritants such as strong acids and alkalis, as well as oxidants, produce severe erythema, edema, vesicles, and in severe cases, necrosis and ulceration. The latter is vernacularly termed a 'chemical burn' [3]."},{"id":4,"chapterId":16,"question":"Which pre-existing condition increases an individual's risk of developing occupational dermatitis by 13.5 times?","options":["Ichthyosis vulgaris","Psoriasis","Atopic dermatitis","Seborrheic dermatitis"],"correctIndex":2,"explanation":"Patients with a history of atopic dermatitis have a 13.5 times greater risk of developing occupational dermatitis [4]."},{"id":5,"chapterId":16,"question":"What is the most commonly affected site in patients diagnosed with Irritant Contact Dermatitis?","options":["The face","The lower legs (shins)","The hands","The torso"],"correctIndex":2,"explanation":"The most commonly affected sites are exposed areas such as the hands and the face, with hand involvement seen in approximately 80% of patients [4]."},{"id":6,"chapterId":16,"question":"Which activity is considered one of the most important risk factors for developing irritant dermatitis, defined as immersion in water for >2 hours or hand washing >20 times/day?","options":["Exposure to organic solvents","Wet work","Repetitive frictional trauma","Exposure to strong alkalis"],"correctIndex":1,"explanation":"Excessive exposure to water, soaps and detergents, common causes of ICD, play a critical role given that wet work (immersion in water for >2 hours, occlusive protective gear, and/ or hand washing >20 times/day) represents one of the most important risk factors for developing irritant dermatitis [4]."},{"id":7,"chapterId":16,"question":"In the pathogenesis of Irritant Contact Dermatitis (ICD), which cellular component acts as a signal transducer and key immunoregulator, initiating the innate immune response?","options":["Dermal fibroblasts","Langerhans cells","Keratinocytes","Hapten-specific T cells"],"correctIndex":2,"explanation":"Increasing evidence suggests that activated keratinocytes act as signal transducers in the control of host homeostatic responses to exogenous stimuli and they serve as key immunoregulators [5]."},{"id":8,"chapterId":16,"question":"Which acute phase cytokine is listed as a major mediator in ICD, capable of inducing the production of other inflammatory molecules and contributing to leukocyte recruitment?","options":["Interleukin-4 (IL-4)","Tumor necrosis factor (TNF)","Interleukin-17 (IL-17)","Interleukin-31 (IL-31)"],"correctIndex":1,"explanation":"Tumor necrosis factor (TNF) and interleukin (IL-1) are the major mediators in the acute phase of ICD, capable of inducing production of other cytokines, chemokines, and adhesion molecules [6]."},{"id":9,"chapterId":16,"question":"What is the clinical term for the rapid healing of acute ICD lesions, which reach their peak quickly (minutes to hours) after exposure?","options":["Accommodation phenomenon","Decrescendo phenomenon","Koebner phenomenon","Hardening response"],"correctIndex":1,"explanation":"The acute reaction reaches its peak quickly, usually within minutes to hours after exposure, and then starts to heal. This is termed the decrescendo phenomenon [7]."},{"id":10,"chapterId":16,"question":"Acute delayed Irritant Contact Dermatitis, often seen with chemicals like benzalkonium chloride or anthralin, is typically characterized by which predominant symptom, aiding in differentiation from ACD?","options":["Pruritus","Burning and soreness","Urticaria","Fever"],"correctIndex":1,"explanation":"Acute delayed ICD may mimic allergic contact dermatitis; however, the associated symptom is more frequently burning rather than pruritus [8]."},{"id":11,"chapterId":16,"question":"Which type of chemical irritant causes tissue damage primarily through disruption of barrier lipids, protein denaturation, and fatty acid saponification, leading to cellular swelling and cytotoxicity?","options":["Inorganic acids","Organic solvents","Alkalis (bases)","Reducing agents"],"correctIndex":2,"explanation":"Alkalis disrupt barrier lipids and denature proteins with subsequent fatty acid saponification, thus subjecting the cell to edema and resultant cytotoxicity [9]."},{"id":12,"chapterId":16,"question":"Which strong acid is uniquely dangerous because its limited dissociation constant allows it to penetrate intact skin, causing intense pain and potential systemic toxicity, even at low concentrations?","options":["Sulfuric acid","Hydrochloric acid","Phosphoric acid","Hydrofluoric acid"],"correctIndex":3,"explanation":"Hydrofluoric acid causes severe burns, even at low concentrations, and significant absorption may lead to systemic toxicity. It penetrates intact skin due to its limited dissociation constant [10, 11]."},{"id":13,"chapterId":16,"question":"Exposure to wet cement can cause acute ulcerative damage because of the liberation of which strong alkaline compound?","options":["Sodium hydroxide","Calcium hydroxide","Potassium carbonate","Trisodium phosphate"],"correctIndex":1,"explanation":"Acute ulcerative damage from wet cement is a result of the high alkalinity due to liberation of calcium hydroxide [9, 12]."},{"id":14,"chapterId":16,"question":"Which category of irritant acts mainly by dissolving the intercellular lipid barrier of the epidermis, thereby substantially compromising barrier function?","options":["Detergents","Acids","Alcohols","Solvents"],"correctIndex":3,"explanation":"Solvents act mainly by dissolving the intercellular lipid barrier of the epidermis, thereby substantially compromising barrier function [13]."},{"id":15,"chapterId":16,"question":"Which anionic detergent is frequently used as a reference irritant in studies due to its consistent, non-allergic, and rapid toxic response?","options":["Cocamidopropyl betaine","Cocamide DEA","Sodium lauryl sulfate","Alkyl carboxylate salts (soap)"],"correctIndex":2,"explanation":"Sodium lauryl sulfate, an anionic detergent, is often used as a reference irritant in studies because of its consistent, non-allergic, rapid toxic response [14]."},{"id":16,"chapterId":16,"question":"Detergents and cleansers most commonly cause which form of ICD?","options":["Acute chemical burns","Folliculitis or acneiform lesions","Chronic forms of ICD","Airborne ICD"],"correctIndex":2,"explanation":"Detergents most commonly cause chronic forms of ICD and are present in skin cleansers, cosmetics, and household cleaning products [15]."},{"id":17,"chapterId":16,"question":"Which type of dermatitis develops from repeated low-grade frictional trauma, often involving the fingers of the dominant hand, such as from repetitive handling of paper or driving?","options":["Asteatotic dermatitis","Frictional Irritant Contact Dermatitis","Traumatic Irritant Contact Dermatitis","Airborne Irritant Contact Dermatitis"],"correctIndex":1,"explanation":"Frictional ICD is a distinct ICD subtype resulting from repeated low-grade frictional trauma. It often involves the fingers of the dominant hand [16]."},{"id":18,"chapterId":16,"question":"What is the key clinical feature that distinguishes the common irritant form of diaper dermatitis from secondary candidiasis?","options":["Presence of erosions and ulcerations","Sparing of the skin folds (creases)","Location on the convex surfaces of the buttocks","Associated intense pruritus"],"correctIndex":1,"explanation":"In babies, irritant diaper dermatitis is often characterized by glazed erythema of convex surfaces and at the diaper margins, with sparing of the skin folds [17]."},{"id":19,"chapterId":16,"question":"Chronic irritant dermatitis in the anogenital region of children or adults, caused by prolonged exposure to bodily fluids, can lead to papules and nodules referred to as:","options":["Erythema multiforme","Granuloma gluteale infantum","Keratolysis exfoliativa","Stasis dermatitis"],"correctIndex":1,"explanation":"In both children and adults, long-standing irritant dermatitis in the anogenital region can lead to papules and nodules (granuloma gluteale infantum [adultorum]; pseudoverrucous papules and nodules) [18]."},{"id":20,"chapterId":16,"question":"What is the primary mechanism of action by which alkalis cause severe cutaneous damage compared to most acids?","options":["Protein denaturation only","Solubilization of membrane lipids","Disruption of barrier lipids and fatty acid saponification","Strong oxidizing action"],"correctIndex":2,"explanation":"Alkalis disrupt barrier lipids and denature proteins with subsequent fatty acid saponification, thus subjecting the cell to edema and resultant cytotoxicity [9]."},{"id":21,"chapterId":16,"question":"Asteatotic Dermatitis, a special variant of ICD, is characterized by a pattern of superficially cracked skin resembling a 'dried riverbed' and is also referred to as:","options":["Irritant reaction","Eczema craquel","Toxic contact dermatitis","Baboon syndrome"],"correctIndex":1,"explanation":"Asteatotic dermatitis is also referred to as asteatotic eczema, eczema craquel, or exsiccation eczematid ICD [19]."},{"id":22,"chapterId":16,"question":"Which of the following is NOT typically a clinical sign of chronic ICD caused by repeated exposure to low-grade irritants?","options":["Lichenification","Excoriations","Fissures","Acute vesiculation and weeping"],"correctIndex":3,"explanation":"The clinical features of chronic ICD include erythema, lichenification, excoriations, scaling, and fissures [20]. Acute vesiculation and weeping are hallmarks of acute ICD [21]."},{"id":23,"chapterId":16,"question":"The development of pustular or acneiform ICD is typically associated with exposure to irritants such as:","options":["Strong organic acids","Bleaching agents and iodines","Oils, greases, and mineral oils","Inorganic acids"],"correctIndex":2,"explanation":"Pustular and acneiform ICD results from exposure to certain irritants, such as metals, croton oil, mineral oils, tars, greases, cutting and metal working fluids, and naphthalenes [22, 23]."},{"id":24,"chapterId":16,"question":"In the histopathology of acute Irritant Contact Dermatitis, what is the characteristic finding that differentiates it from other forms of eczema (though not specific to ICD)?","options":["Neutrophil-rich inflammatory infiltrate and necrotic keratinocytes","Perivascular lymphocytic infiltrate without spongiosis","Absence of inflammation","Epithelioid granulomas"],"correctIndex":0,"explanation":"The histopathologic features often include variable spongiosis, necrosis of keratinocytes, and an inflammatory infiltrate rich in neutrophils. The combination of a neutrophil-rich superficial perivascular infiltrate plus widely scattered necrotic keratinocytes is most typical [24]."},{"id":25,"chapterId":16,"question":"Exposure to which airborne substance is specifically noted to cause ICD predominantly located on exposed portions of the skin, especially the eyelids, philtrum, and submental regions?","options":["Latex powder","Fiberglass and floating dusts","Chromate dust","Nickel particles"],"correctIndex":1,"explanation":"Airborne ICD results from exposure to floating dusts, fibers (particularly fiberglass), fragrances, woods, and volatile solvents and sprays, affecting exposed areas like the face, periorbital regions (eyelids), philtrum, and submental regions [16, 25]."},{"id":26,"chapterId":16,"question":"What is the term for the process in which an individual develops spontaneous tolerance and resolution of ICD even with continuous exposure to the irritant?","options":["Systemic hyporeactivity","Accommodation or 'hardening'","Desensitization","T-cell anergy"],"correctIndex":1,"explanation":"In many individuals, ICD resolves spontaneously even with continuous exposure, a process referred to as 'accommodation' or 'hardening' [26]."},{"id":27,"chapterId":16,"question":"The worsening of ICD prognosis is related to all the following factors, EXCEPT:","options":["A previous history of atopy","Female sex","The presence of allergic contact dermatitis (as well as ICD)","Early diagnosis and patient education"],"correctIndex":3,"explanation":"Poor prognosis is related to a previous history of atopy, female sex, and the presence of allergic contact dermatitis (as well as ICD). Factors that can potentially improve prognosis are early diagnosis, treatment, and patient knowledge about the disease [27]."},{"id":28,"chapterId":16,"question":"In the management of chronic, hyperkeratotic palmoplantar ICD refractory to other treatments, systemic agents such as acitretin, alitretinoin, or methotrexate may be considered, similar to treatment for:","options":["Atopic dermatitis flares","Psoriasis","Dermatophytosis","Lupus erythematosus"],"correctIndex":1,"explanation":"Hyperkeratotic palmoplantar dermatitis, which may simulate psoriasis, may benefit from the adjunctive use of systemic retinoids such as acitretin and alitretinoin or systemic immunomodulators such as methotrexate [28]."},{"id":29,"chapterId":16,"question":"Which type of surfactant, often used in therapeutic formulations and personal care products, has the lowest irritation potential?","options":["Anionic detergents (e.g., sodium lauryl sulfate)","Cationic surfactants (e.g., benzalkonium chloride)","Non-ionic surfactants (e.g., cocamide DEA)","Amphoteric surfactants (e.g., cocamidopropyl betaine)"],"correctIndex":3,"explanation":"Amphoteric surfactants such as cocamidopropyl betaine... have the lowest irritation potential, [14]."},{"id":30,"chapterId":16,"question":"Which fruit contains the proteolytic enzyme bromelain (bromelin), which can lead to irritant contact dermatitis?","options":["Garlic","Apple","Pineapple","Lemon"],"correctIndex":2,"explanation":"Examples of foods that can lead to ICD include pineapples, which contain the proteolytic enzyme bromelain (bromelin), [29]."},{"id":1,"chapterId":17,"question":"In a UK household survey, what was the reported rate of occupational dermatosis per 10,000 individuals who had ever been employed?","options":["23%","5.1/10,000","15/10,000","45/10,000"],"correctIndex":2,"explanation":"In a UK household survey, a rate of occupational dermatosis of 15/10,000 for those who had ever been employed demonstrates the high frequency of affected individuals [1]."},{"id":2,"chapterId":17,"question":"Among the most common physical illnesses due to occupation, where do skin diseases rank in frequency?","options":["First (highest percentage)","Second (23%)","Third (10.5%)","Fourth (8%)"],"correctIndex":1,"explanation":"Of the most common physical illnesses due to occupation, skin diseases (23%) rank second, after musculoskeletal disorders (45%) [1]."},{"id":3,"chapterId":17,"question":"Which material is cited as the most common cause of occupational allergic contact dermatitis in an extensive surveillance report?","options":["Nickel","Epoxy and other resins","Rubber","Fragrances and cosmetics"],"correctIndex":2,"explanation":"The most common cause of occupational allergic contact dermatitis was rubber (23.4% of cases) [2]."},{"id":4,"chapterId":17,"question":"Which factor is the most frequently cited cause of occupational irritant contact dermatitis, accounting for 22% of cases?","options":["Cutting oils and coolants","Wet work","Soaps","Petroleum products"],"correctIndex":2,"explanation":"Soaps (22% of cases), wet work (20%), petroleum products (9%), solvents (8%), and cutting oils and coolants (8%) are the most frequently cited causes of occupational irritant dermatitis [3]."},{"id":5,"chapterId":17,"question":"What percentage of patients with occupational skin disease are estimated to have contact dermatitis, as reported by dermatologists?","options":["21%","71%","3%","95%"],"correctIndex":1,"explanation":"Contact dermatitis is reported by dermatologists in 71% of occupational skin disease cases [4]."},{"id":6,"chapterId":17,"question":"What is the most common site affected by occupational contact dermatitis?","options":["The face","The feet","The hands","The trunk"],"correctIndex":2,"explanation":"Contact dermatitis accounts for the majority of occupational skin disease that predominantly affects the hands [5]. In 90% of cases, the primary site of disease is the hands [6]."},{"id":7,"chapterId":17,"question":"Which condition associated with allergic contact dermatitis is characterized by symmetric erythema of the gluteal and inguinal area in addition to other flexural sites?","options":["Post-traumatic eczema","Baboon syndrome","Lichenification","Eczema craquel"],"correctIndex":1,"explanation":"Baboon syndrome is an uncommon presentation of ACD defined by symmetric erythema of the gluteal and inguinal area in addition to other flexural sites [7]."},{"id":8,"chapterId":17,"question":"What is the most important clue suggesting that a patient's dermatitis has an occupational cause?","options":["The presence of vesicles","Spread to distant sites (face and feet)","Improvement during periods away from work","Coexistence with psoriasis"],"correctIndex":2,"explanation":"Improvement of the dermatitis during periods away from work is an important clue to an occupational cause [8]."},{"id":9,"chapterId":17,"question":"Which type of personal protective equipment (PPE) is most frequently associated with causing occupational contact dermatitis?","options":["Face masks","Gloves","Safety glasses","Respirators"],"correctIndex":1,"explanation":"Hand dermatitis due to gloves is the most common PPE-related dermatitis [7]."},{"id":10,"chapterId":17,"question":"Which strong acid is unique because it causes liquefactive necrosis and can penetrate down to bone, continuing for several days after exposure?","options":["Sulfuric acid","Hydrochloric acid","Chromic acid","Hydrofluoric acid"],"correctIndex":3,"explanation":"Hydrofluoric acid differs from other strong acids in that it causes a liquefactive necrosis; penetration, even down to bone, can continue for several days after exposure. Pain, which can last several days, is typical [9]."},{"id":11,"chapterId":17,"question":"Why are chemical burns caused by strong alkalis generally more severe than those caused by most strong acids (apart from hydrofluoric acid)?","options":["Alkalis act primarily as oxidants.","Alkalis cause vasoconstriction leading to necrosis.","Alkalis aid penetration deeper into the skin by degrading lipids and saponifying fatty acids.","Alkalis are more easily absorbed systemically."],"correctIndex":2,"explanation":"Degradation of lipids and saponification of the resulting fatty acids form soaps which aid the penetration of alkalis deeper into the skin. As a consequence, damage is more severe than with most acids (apart from hydrofluoric acid) [9]."},{"id":12,"chapterId":17,"question":"Which underlying factor increases an employee's risk of developing occupational dermatitis, especially with hand involvement?","options":["Previous history of psoriasis","Previous atopic dermatitis","Male gender","Lack of sensitization to formaldehyde"],"correctIndex":1,"explanation":"Employees with previous atopic dermatitis, especially with hand involvement, are particularly at risk, as are those with mutations in the filaggrin gene [3]."},{"id":13,"chapterId":17,"question":"What is the primary mechanism of skin injury in Fiberglass dermatitis?","options":["IgE-mediated reaction to chemical coatings","Direct chemical toxicity leading to necrosis","Direct mechanical penetration of the glass fibers","Delayed-type hypersensitivity to fiber material"],"correctIndex":2,"explanation":"The mechanism of skin injury in fiberglass dermatitis is via direct penetration, which is directly proportional to the diameter (>3.5 microns) of the fiber and inversely proportional to its length [10]."},{"id":14,"chapterId":17,"question":"What physical finding may develop at sites of friction and repeated rubbing, often specific to a particular job?","options":["Vesicles","White fingers","Sclerodactyly","Callus or lichenification"],"correctIndex":3,"explanation":"Occupational marks are usually areas of lichenification or calluses and corns that develop at sites of friction and are specific to a particular job [11], [12]."},{"id":15,"chapterId":17,"question":"In the hierarchy of occupational disease prevention, which measure is categorized as 'Tertiary prevention'?","options":["Workforce education in skin care","Health surveillance","Treatment of active disease (medical management)","Chemical substitution"],"correctIndex":2,"explanation":"Tertiary prevention involves the Treatment of active disease and avoidance measures [13]."},{"id":16,"chapterId":17,"question":"What is the recommended guideline regarding wearing rings in the workplace to prevent contact dermatitis?","options":["Wear waterproof rings only.","Do not wear rings, as chemicals/water accumulate underneath.","Only wear rings with a cotton inner liner.","Rings should be worn only during wet work."],"correctIndex":1,"explanation":"A guideline aimed at preventing contact dermatitis is: Do not wear rings, because chemicals/water accumulate underneath [14]."},{"id":17,"chapterId":17,"question":"The phototoxic reaction known as 'tar/pitch smarts' is caused by exposure to coal tar and its products, resulting in what initial sensation after sun exposure?","options":["Intense pruritus","Burning or stinging sensation","Painless blanching","Immediate blistering"],"correctIndex":1,"explanation":"Coal tar and its products, including creosote, can cause a reaction known as tar/pitch smarts. A burning or stinging sensation develops after as little as 15 minutes of sun exposure [15]."},{"id":18,"chapterId":17,"question":"What percentage of cases of occupational skin cancer reported in the UK are attributed to solar UV exposure?","options":["~2%","~22%","~50%","~95%"],"correctIndex":3,"explanation":"Solar UV exposure has risen to account for ~95% of cases of occupational skin cancer reported in the UK [16]."},{"id":19,"chapterId":17,"question":"Which type of chemical carcinogen is historically associated with scrotal cancer in chimney sweeps, often preceded by 'soot warts'?","options":["Aromatic amines","Ionizing radiation","Inorganic arsenic","Polycyclic aromatic hydrocarbons (e.g., tars, pitches)"],"correctIndex":3,"explanation":"Sir Percivall Pott described the occurrence of scrotal cancer in chimney sweeps (associated with soot/tar/pitch exposure), often preceded by keratotic lesions known as soot warts [17]. Polycyclic aromatic hydrocarbons are listed as a major class of chemical carcinogens [18], [19]."},{"id":20,"chapterId":17,"question":"Which tumor type must arise in sun-exposed skin and is now recognized and compensated as an occupational disease in Germany for outdoor workers meeting specific exposure criteria?","options":["Basal cell carcinoma (BCC)","Squamous cell carcinoma (SCC)","Cutaneous melanoma","Angiosarcoma"],"correctIndex":1,"explanation":"Actinic keratoses (AKs) and cutaneous SCCs were recognized and compensated as occupational diseases in Germany, provided the SCCs arise in sun-exposed skin and the worker meets specific UV exposure requirements [16]."},{"id":21,"chapterId":17,"question":"Chloracne is a cutaneous sign of systemic exposure caused by which class of chemicals?","options":["Non-halogenated organic solvents","Polychlorinated dibenzodioxins (PCDDs) and dibenzofurans (PCDFs)","Inorganic arsenic compounds","Mineral oils and greases"],"correctIndex":1,"explanation":"Chloracne is caused by exposure to certain halogenated polycyclic hydrocarbons such as polychlorinated dibenzodioxins (PCDDs) and dibenzofurans (PCDFs) [20], [12]."},{"id":22,"chapterId":17,"question":"Chloracne is distinguished from ordinary acne vulgaris by the predominance of which type of lesion and specific location?","options":["Predominance of closed comedones in the T-zone","Predominance of open comedones, especially over the malar crescent and behind the ears","Deep, painful nodules on the trunk only","Microcomedones limited to the forehead"],"correctIndex":1,"explanation":"Chloracne is distinguished from ordinary acne vulgaris by the predominance of open (over closed) comedones and a concentration of lesions over the malar crescent and behind the ears [21]."},{"id":23,"chapterId":17,"question":"Acne mechanica is a form of inflammatory acne exacerbated by repeated:","options":["UV light exposure","Exposure to unhardened epoxy resin","Frictional trauma that occludes the follicle","Ingestion of iodides"],"correctIndex":2,"explanation":"Acne mechanica is a form of acne, usually inflammatory, that is exacerbated by repeated frictional trauma that occludes the follicle [22]."},{"id":24,"chapterId":17,"question":"Vibration White Finger is primarily associated with occupational exposure to vibrations within which frequency range?","options":["1 to 10 Hz","30 to 300 Hz","500 to 1000 Hz","Above 2000 Hz"],"correctIndex":1,"explanation":"Vibrations between 30 and 300 Hz are most strongly associated with development of this disorder [23]."},{"id":25,"chapterId":17,"question":"In the clinical presentation of Vibration White Finger, which characteristic distinguishes the blanching from that seen in Raynaud disease?","options":["It affects all ten fingers symmetrically.","The blanching is asymmetric and occurs only on the digits most exposed to vibration (thumbs are usually spared).","It is always triggered by work with the vibrating tool itself.","It results in permanent trophic changes immediately upon onset."],"correctIndex":1,"explanation":"In contrast to the symmetric distribution seen in Raynaud disease, in vibration white finger the blanching is asymmetric and occurs only on those digits most exposed to vibration; the thumbs are usually spared [24]."},{"id":26,"chapterId":17,"question":"Which mechanism mediates Immunologic Contact Urticaria (ICU)?","options":["T cell release of cytokines (Type IV)","Allergen-specific IgE binding to mast cells (Type I)","Prostaglandin release inhibited by NSAIDs","Cytotoxicity and necrosis"],"correctIndex":1,"explanation":"Immunologic contact urticaria is mediated by allergen-specific IgE. Binding of antigen, usually protein, to mast cells in a previously sensitized individual results in degranulation and release of mast cell mediators, including histamine [25]."},{"id":27,"chapterId":17,"question":"For latex-sensitive patients, hypersensitivity reactions to which group of foods may also occur due to similar antigens (cross-reaction)?","options":["Wheat, rye, and barley (grains)","Fish (salmon, swordfish, sole)","Shellfish (crab, prawn, lobster)","Bananas, avocados, and chestnuts"],"correctIndex":3,"explanation":"In a subgroup of latex-sensitive patients, hypersensitivity reactions to bananas, avocados, chestnuts, kiwis and other fruits may also occur [26], [27]."},{"id":28,"chapterId":17,"question":"Which occupation in Finland showed the highest relative risk for developing contact urticaria, based on occupational statistics?","options":["Nurses","Bakers","Butchers","Agricultural workers"],"correctIndex":1,"explanation":"The relative risk by occupation for developing contact urticaria showed bakers having the highest risk [28]."},{"id":29,"chapterId":17,"question":"Which occupational infection is caused by *Erysipelothrix rhusiopathiae* and typically affects individuals handling shellfish, fish, birds, or mammals (especially pigs)?","options":["Orf","Milkers nodule","Erysipeloid","Fish tank granuloma"],"correctIndex":2,"explanation":"Erysipeloid is caused by *Erysipelothrix rhusiopathiae (insidiosa)* and affects fishermen, abattoir workers, farmers, butchers, cooks, and veterinarians exposed to shellfish, fish, birds, and mammals (especially pigs) [29]."},{"id":30,"chapterId":17,"question":"In the assessment of suspected Type I latex allergy, if the specific IgE blood test is negative, what is the next definitive step advocated to confirm the diagnosis?","options":["Patch testing for chemical accelerators","Usage test (wearing the glove on a moistened hand)","Skin biopsy","Immediate change of occupation"],"correctIndex":1,"explanation":"If the specific IgE blood test is negative for latex allergy, the next step is to Confirm with usage test (wearing the suspect glove on a moistened hand) [30]."},{"id":1,"chapterId":18,"question":"The scientific name for common poison ivy was changed from the genus *Rhus* to which distinct genus?","options":["*Anacardiaceae*","*Toxicodendron*","*Magnoliophyta*","*Opuntia*"],"correctIndex":1,"explanation":"Research revealed that poison ivy, formerly known as *Rhus radicans* or *Rhus toxicodendron*, should be classified as a distinct genus, *Toxicodendron*, making the correct scientific name *Toxicodendron radicans* [1]."},{"id":2,"chapterId":18,"question":"In botanical nomenclature, the two names given to every plant entity consist of:","options":["The family name followed by the class name","The generic name followed by a specific epithet","The order name followed by the species name","The common name followed by the author's name"],"correctIndex":1,"explanation":"The nomenclatural scheme gives every entity two names: a generic name followed by a specific epithet (e.g., *Toxicodendron radicans*) [2]."},{"id":3,"chapterId":18,"question":"Which type of plant dermatosis is classified as a phototoxic reaction, requiring UVA light and a topical or oral photosensitizer?","options":["Toxin-mediated contact urticaria","Mechanical irritant dermatitis","Allergic contact dermatitis","Phytophotodermatitis"],"correctIndex":3,"explanation":"Phytophotodermatitis connotes phototoxic reactions consisting of erythema (with or without blistering) and delayed hyperpigmentation following exposure to plants. It is a non-immunologic reaction requiring UVA light plus topical or oral contact with a photosensitizer [3]."},{"id":4,"chapterId":18,"question":"Which plant family is responsible for causing more allergic contact dermatitis than all other plant families combined?","options":["Asteraceae (Daisy family)","Urticaceae (Nettle family)","Rutaceae (Citrus family)","Anacardiaceae (Sumac or Cashew family)"],"correctIndex":3,"explanation":"Members of the Anacardiaceae family cause more allergic contact dermatitis than all other plant families combined [4], [5]."},{"id":5,"chapterId":18,"question":"The primary allergen responsible for allergic contact dermatitis caused by plants in the Anacardiaceae family is:","options":["Tulipalin A","Glochids","Urushiol","Capsaicin"],"correctIndex":2,"explanation":"Two major plant allergens are **urushiol** (Anacardiaceae family) and **sesquiterpene lactones** (Asteraceae family) [6]. *Toxicodendron* oleoresin contains urushiol [7]."},{"id":6,"chapterId":18,"question":"The primary photosensitizing chemicals responsible for Phytophotodermatitis are:","options":["Calcium oxalates","Phorbol esters","Furocoumarins (psoralens and angelicins)","Sesquiterpene lactones (SQLs)"],"correctIndex":2,"explanation":"Furocoumarins (psoralens and angelicins) are the most common photosensitizers causing Phytophotodermatitis [3]."},{"id":7,"chapterId":18,"question":"Which combination of plants is cited as the most common cause of Phytophotodermatitis?","options":["Chrysanthemums, tulips, and garlic","Stinging nettles, daffodils, and prickly pear","Limes, celery, and rue (herb-of-grace)","Poinsettias, rhubarb, and common ivy"],"correctIndex":2,"explanation":"Limes, celery, and rue (herb-of-grace) are the most common causes of Phytophotodermatitis [3]."},{"id":8,"chapterId":18,"question":"In Phytophotodermatitis, the initial erythematous and bullous reaction typically appears after 24 hours and peaks at approximately:","options":["12 hours","24 hours","72 hours","1 week"],"correctIndex":2,"explanation":"Bizarre configurations of erythema, edema, and bullae appear after 24 hours and peak at 72 hours [8]."},{"id":9,"chapterId":18,"question":"Which plant is the most common cause of Toxin-Mediated (Non-immunologic) Contact Urticaria in the US?","options":["*Toxicodendron radicans*","*Urtica dioica* (Stinging nettle)","*Capsicum annuum* (Hot pepper)","*Opuntia spp.* (Prickly pear)"],"correctIndex":1,"explanation":"The most common culprit in the US causing toxin-mediated urticaria is the stinging nettle (*Urtica dioica*) [9], [10]."},{"id":10,"chapterId":18,"question":"The sharp hairs (trichomes) of stinging nettles release a chemical cocktail that includes:","options":["Furocoumarins and tulipalin A","Histamine, acetylcholine, and serotonin","Bromelain and capsaicin","Calcium oxalate and urushiol"],"correctIndex":1,"explanation":"Stinging nettle trichomes release an irritant chemical cocktail (histamine, acetylcholine, serotonin) [11], [12]."},{"id":11,"chapterId":18,"question":"Which type of plant dermatosis is defined by small fishhook-shaped spines embedding in the skin, commonly caused by prickly pears?","options":["Chemical irritant dermatitis","Mechanical irritant dermatitis","Toxin-mediated contact urticaria","Protein contact dermatitis"],"correctIndex":1,"explanation":"Mechanical irritant dermatitis involves small fishhook-shaped spines (glochids) that can embed in the skin, with prickly pears (*Opuntia spp.*) being a cause of glochid dermatitis [13], [14]."},{"id":12,"chapterId":18,"question":"In a controlled study, the most effective method for removing *Opuntia* glochids involved detaching larger clumps with tweezers and then applying:","options":["Ice packs and petroleum jelly","Acid wash followed by neutralizing cream","Glue and gauze to the affected area","High-pressure water jet"],"correctIndex":2,"explanation":"In a controlled study, *Opuntia* glochids were most effectively removed by first detaching the larger clumps with tweezers and then applying glue and gauze to the affected area [15]."},{"id":13,"chapterId":18,"question":"Which chemical irritant, found in daffodils and narcissus, is a major cause of plant-related irritant dermatitis in florists and horticulturalists ('daffodil itch')?","options":["Protoanemonin","Calcium oxalate","Thiocyanate","Primin"],"correctIndex":1,"explanation":"Daffodil sap contains **calcium oxalate** and causes 'daffodil itch,' probably the most common dermatitis in florists [16], [17]."},{"id":14,"chapterId":18,"question":"The active principle capsaicin in hot peppers (*Capsicum annuum*) causes 'chili burns' by:","options":["Causing massive intraepidermal vesiculation","Depolarizing cutaneous nerves","Saponifying skin lipids","Inducing IgE-mediated wheal formation"],"correctIndex":1,"explanation":"When applied to skin, the active principle, capsaicin, depolarizes nerves causing vasodilation, smooth muscle stimulation, glandular secretion, and sensory nerve activation. Because only nerves are affected, there is erythema but no vesicles or bullae [18]."},{"id":15,"chapterId":18,"question":"Which plant, common in homes and public places, contains water-insoluble calcium oxalate that can cause mucosal edema and hoarseness ('dumb cane') if chewed?","options":["*Narcissus spp.*","*Euphorbia pulcherrima*","*Dieffenbachia picta*","*Agave americana*"],"correctIndex":2,"explanation":"Calcium oxalate is found in *Dieffenbachia picta* ('dumb cane'), a plant that decorates millions of homes. When leaves are chewed, salivation, burning, mucosal edema, and blistering follow, causing hoarseness or aphonia [19], [20]."},{"id":16,"chapterId":18,"question":"Chronic dermatitis on the hands and fingertips (Protein Contact Dermatitis) is characterized by urticating within minutes of contact with the offending allergen and typically having negative results on which standard test?","options":["Prick tests","Scratch-chamber tests","Patch tests","Open application tests"],"correctIndex":2,"explanation":"The term 'protein contact dermatitis' describes a chronic dermatitis in which patch tests are typically negative but prick tests to large protein allergens are positive [21]."},{"id":17,"chapterId":18,"question":"The 'black-spot test' used to identify toxic Anacardiaceae relies on the plant enzyme laccase oxidizing urushiol to form an insoluble, black, plastic-like polymer. Within what time frame does the urushiol typically turn dark brown?","options":["Immediately upon crushing","Within 10 minutes","By 48 hours","After 1 week"],"correctIndex":1,"explanation":"Urushiol turns dark brown within 10 minutes and black by 24 hours, facilitated by the enzyme laccase, which oxidizes urushiol to form an insoluble, black, plastic-like polymer [7]."},{"id":18,"chapterId":18,"question":"Which characteristic finding helps distinguish Phytophotodermatitis lesions from those of poison ivy dermatitis in the initial bullous/erythematous phase?","options":["Phytophotodermatitis always causes severe pruritus.","PPD lesions occur only in sun-exposed areas.","PPD lesions are always delayed more than 1 week.","PPD lesions are characterized by non-pruritic wheals."],"correctIndex":1,"explanation":"To avoid misdiagnosis as poison ivy dermatitis, physicians must note that the initial erythematous and bullous reaction in Phytophotodermatitis only occurs in sun-exposed areas. These reactions are typically painful and non-pruritic [8]."},{"id":19,"chapterId":18,"question":"Which characteristic feature is associated with common poison ivy (*Toxicodendron radicans*) identification?","options":["Leaves with five leaflets and fruit arising terminally.","Flowers or fruit arising from an axillary position and climbing by hairy aerial rootlets.","Thorns on woody stems and brightly colored fruit.","Finely serrated leaves and flowers in simple umbels."],"correctIndex":1,"explanation":"Poison ivy identification features include: compound leaves with three leaflets, flowers or fruit arising from the axillary position, and climbing as a vine with hairy aerial roots [22], [5]."},{"id":20,"chapterId":18,"question":"Which common fruit tree, popular in tropical and subtropical America, contains sensitizing resorcinols in its leaves, bark, stems, and fruit skin?","options":["Sweet orange (*Citrus sinensis*)","Fig tree (*Ficus carica*)","Cashew nut tree (*Anacardium occidentale*)","Mango (*Mangifera indica*)"],"correctIndex":3,"explanation":"Mango (*Mangifera indica*) is the most popular fruit tree in tropical and subtropical America. The leaves, bark, stems, and fruit skin contain sensitizing resorcinols [23]."},{"id":21,"chapterId":18,"question":"What is the recommended maximum duration for oral prednisone tapering courses used to treat severe poison ivy dermatitis?","options":["6 days","1 week","23 weeks","4 weeks or more"],"correctIndex":2,"explanation":"Oral prednisone should be dosed at 12 mg/kg/day based upon ideal weight and gradually tapered over 23 weeks, as shorter courses (e.g., 6-day tapering courses) are often too low dose and lead to rebound inflammation [24]."},{"id":22,"chapterId":18,"question":"What is the key mechanism responsible for the severe bullous reactions caused by phototoxic furocoumarins in the skin within 2 hours of UVA exposure?","options":["Covalent interstrand DNA cross-links","Activation of IgE-mediated mast cell degranulation","Formation of reactive oxygen species inducing cytoplasmic vacuolization and membrane rupture of keratinocytes","Destruction of melanocytes leading to vitiligo"],"correctIndex":2,"explanation":"In the presence of UVA, psoralens interact with molecular oxygen and form reactive oxygen species that induce cytoplasmic vacuolization and membrane rupture of keratinocytes, leading to blister formation within 2 hours of UVA exposure [25]."},{"id":23,"chapterId":18,"question":"Which chemical found in Ranunculaceae (e.g., buttercups), causes severe, linear vesiculation but does not lead to subsequent hyperpigmentation, aiding in the differentiation from early phytophotodermatitis?","options":["Protoanemonin","5-methoxypsoralen (5-MOP)","Allicin","Tulipalin B"],"correctIndex":0,"explanation":"Buttercups contain the glycoside ranunculin, which is converted to **protoanemonin** after plant injury. Protoanemonin causes severe, linear vesiculation that may resemble early phytophotodermatitis, but no hyperpigmentation ensues [18]."},{"id":24,"chapterId":18,"question":"In the management of weepy, acute plant-induced dermatitis (e.g., poison ivy), which treatment method is recommended to cool and dry the lesions?","options":["Topical antihistamines","Topical calcineurin inhibitors","Wet-to-dry soaks or open wet dressings with Burows solution (aluminum acetate)","Continuous application of petrolatum"],"correctIndex":2,"explanation":"Weepy lesions are best treated with tepid baths, wet-to-dry soaks, or bland shake lotions (calamine). An astringent such as Burows solution (aluminum acetate) works well to cool and dry lesions when applied as a wet-to-dry dressing or open wet dressing [26]."},{"id":25,"chapterId":18,"question":"Which infectious microorganism has been associated with cutaneous inoculation injuries from cactus spines in the setting of mechanical irritant dermatitis?","options":["*Clostridium tetani*","*Sporothrix schenckii*","*Mycobacterium marinum*","*Staphylococcus aureus*"],"correctIndex":2,"explanation":"Spine and thorn injuries can be complicated by cutaneous inoculation of microorganisms. Atypical mycobacteria such as *Mycobacterium marinum* (from cactus spines) have added infectious insult to mechanical injury [27]."},{"id":26,"chapterId":18,"question":"The most common cause of allergic contact dermatitis among home gardeners is:","options":["Tulip bulbs (*Tulipa spp.*)","Peruvian lilies (*Alstroemeria spp.*)","Chrysanthemums (*X Dendranthema cultivars*)","Primulas (*Primula obconica*)"],"correctIndex":2,"explanation":"Chrysanthemums probably cause more allergic contact dermatitis than any other home garden plant, especially among florists who engage in 'dead-heading' [28]."},{"id":27,"chapterId":18,"question":"Allergic Contact Dermatitis caused by *Parthenium hysterophorus* (congress grass) in India most commonly presents with which pattern?","options":["Erythema multiforme","Chronic actinic dermatitis (CAD) only","Airborne contact pattern (ABCD)","Hyperkeratosis and fissures of the fingertips"],"correctIndex":2,"explanation":"*Parthenium hysterophorus* allergic contact dermatitis most commonly presents with an Airborne Contact Dermatitis (ABCD) pattern (45% of patients in one study) [29]."},{"id":28,"chapterId":18,"question":"To detect approximately 96% of individuals with Sesquiterpene Lactone (SQL) allergy, the recommended patch testing approach involves a combination of three compounds, including the SQL mix, Compositae II mix, and:","options":["Urushiol","Primin","Parthenolide","Neroli oil"],"correctIndex":2,"explanation":"A combination of three commercially available patch tests  SQL mix, Compositae II mix, and parthenolide (also contained in Compositae II mix)  detects 96% of known SQL allergic individuals [30]."},{"id":29,"chapterId":18,"question":"Which plant, highly prevalent in the Pacific Northwest, causes 'woodcutters eczema' via rainwater-dispersed sesquiterpene lactones (SQLs)?","options":["Poison sumac (*Toxicodendron vernix*)","Ginkgo tree (*Ginkgo biloba*)","Liverworts (*Frullania spp.*)","Tea tree (*Melaleuca alternifolia*)"],"correctIndex":2,"explanation":"Forestry workers in the American and Canadian Pacific Northwest may develop 'woodcutters eczema', an allergic contact dermatitis caused by airborne or rainwater-dispersed SQLs from liverworts (*Frullania spp.*) growing on trees and rocks [31]."},{"id":30,"chapterId":18,"question":"Immunologic Contact Urticaria is considered rather uncommon, with approximately 95% of cases being related to:","options":["Recreational activities (hiking)","Exposure to raw vegetables and fruits","Work-related activities (occupational exposure)","Systemic ingestion of allergens"],"correctIndex":2,"explanation":"Immunologic contact urticaria is rather uncommon. Approximately 95% of cases are work-related, with long-time food handlers with underlying dermatitis being at greatest risk [32]."},{"id":1,"chapterId":19,"question":"By definition, individual lesions known as wheals typically resolve within which time frame?","options":["4 hours","12 hours","24 hours","72 hours"],"correctIndex":2,"explanation":"Wheals are pruritic, pink or pale swellings of the superficial dermis. By definition, individual lesions come and go rapidly, generally within 24 hours [1]."},{"id":2,"chapterId":19,"question":"Which characteristic is typical of angioedema swellings, in contrast to superficial wheals?","options":["Pruritic and pale center","Occur only in the oropharynx","Often painful, larger, less well-defined, and may last 2 to 3 days","Resolve within 1 hour"],"correctIndex":2,"explanation":"Angioedema swellings occur deeper in the dermis and in the subcutaneous or submucosal tissue. They are often painful, less well-defined, and typically last for 2 to 3 days [2], [3]."},{"id":3,"chapterId":19,"question":"What is the overall lifetime prevalence rate reported for chronic urticaria in a recent meta-analysis?","options":["0.7%","1.4%","8%","22%"],"correctIndex":1,"explanation":"In a recent meta-analysis, chronic urticaria had an overall lifetime prevalence rate of 1.4% [2]."},{"id":4,"chapterId":19,"question":"What is the typical female-to-male ratio observed for Chronic Spontaneous Urticaria (CSU)?","options":["1:1","1:2","2:1","4:1"],"correctIndex":2,"explanation":"Overall, urticaria is more common in women, with a female : male ratio of approximately 2 : 1 for Chronic Spontaneous Urticaria (CSU) [4]."},{"id":5,"chapterId":19,"question":"Mast cells located in the bowel mucosa, alveolar wall, and nasal mucosa primarily contain which neutral protease?","options":["Chymase only (MCT)","Tryptase only (MCT)","Tryptase and Chymase (MCTC)","Elastase"],"correctIndex":1,"explanation":"Mast cells in the bowel mucosa, alveolar wall, and nasal mucosa contain only tryptase (MCT), whereas those in the skin and intestinal submucosa contain tryptase and chymase (MCTC) [5]."},{"id":6,"chapterId":19,"question":"Which cell is recognized as the primary effector cell in the pathogenesis of urticaria?","options":["Keratinocyte","B cell","Mast cell","Eosinophil"],"correctIndex":2,"explanation":"The mast cell is the primary effector cell of urticaria [5]."},{"id":7,"chapterId":19,"question":"Which finding is crucial for clinically distinguishing urticarial vasculitis from Chronic Spontaneous Urticaria (CSU)?","options":["Presence of angioedema","Duration of individual wheals lasting more than 24 hours","Coexistence with autoimmune thyroid disease","Presence of IgE autoantibodies"],"correctIndex":1,"explanation":"Urticarial vasculitis is a systemic disease defined by damage to small blood vessels. It must be excluded in patients with chronic urticaria, requiring confirmation that individual wheals last more than 24 hours (by serial examination of marked lesions) and a lesional skin biopsy [6], [7], [8]."},{"id":8,"chapterId":19,"question":"Isolated angioedema without wheals is of special significance because some patients may have a deficiency of C1 esterase inhibitor (C1 inh), resulting in edema formation mediated by:","options":["Histamine release from mast cells","Bradykinin formation","IgE-dependent allergic reactions","Complement component C5a"],"correctIndex":1,"explanation":"Isolated angioedema (without wheals) is significant because some patients will have a deficiency of C1 esterase inhibitor (C1 inh), which is due to bradykinin formation rather than release of mast cell mediators [6], [9]."},{"id":9,"chapterId":19,"question":"Which factor is explicitly listed as a stimulus that can lead to mast cell degranulation independent of FcRI activation?","options":["Allergen cross-linking IgE","IgG anti-IgE antibodies","Substance P","IgM anti-FcRI antibodies"],"correctIndex":2,"explanation":"Stimuli that can lead to mast cell degranulation independent of FcRI activation include C5a, stem cell factor, and agents that bind MRGPRX2 (MAS-related G-protein coupled receptor X2); the latter includes substance P and drugs such as opioids [10], [11]."},{"id":10,"chapterId":19,"question":"What is considered the most important preformed mediator of inflammation released from mast cell granules upon degranulation?","options":["Tryptase","Histamine","Leukotrienes C4, D4, E4","GM-CSF"],"correctIndex":1,"explanation":"Mast cell granules contain preformed mediators of inflammation, the most important of which is histamine [12], [13]."},{"id":11,"chapterId":19,"question":"Which group of newly synthesized mediators released from mast cells are collectively known as the slow releasing substance of anaphylaxis?","options":["Tryptase and Heparin","Prostaglandin D2 and Cytokines","Leukotrienes C4, D4, and E4","Histamine and Platelet-activating factor"],"correctIndex":2,"explanation":"Newly synthesized mediators include Prostaglandin D2 and the leukotrienes (LT) C4, D4, and E4, which are known as the slow releasing substance of anaphylaxis [13]."},{"id":12,"chapterId":19,"question":"Based upon *in vitro* assays, what percentage of patients with Chronic Spontaneous Urticaria (CSU) have functional IgG autoantibodies that release histamine?","options":["10%20%","30%50%","60%70%","80%90%"],"correctIndex":1,"explanation":"Functional IgG autoantibodies that release histamine (and other mediators) from mast cells and basophils have been detected in the serum of 30%50% of patients with CSU [14]."},{"id":13,"chapterId":19,"question":"The majority of functional autoantibodies in Chronic Spontaneous Urticaria (CSU) bind which specific part of the FcRI receptor?","options":["The intracellular beta subunit","The extracellular alpha subunit","The gamma chain dimer","The Fc portion of IgE"],"correctIndex":1,"explanation":"The majority of these autoantibodies bind the extracellular  subunit of FcRI [14]. Those directed against the terminal  1 domain are non-competitive [15]."},{"id":14,"chapterId":19,"question":"How do peripheral blood basophils from CSU patients who are non-responders to anti-IgE antibodies typically behave *in vitro*?","options":["They show increased responsiveness due to sensitization.","They are reduced in number and less responsive, possibly due to desensitization.","They show increased expression of SHIP (src homology 2-containing inositol phosphatase).","They show normal histamine release levels."],"correctIndex":1,"explanation":"In general, blood basophils from CSU patients are less responsive *in vitro* to anti-IgE antibodies as an immunologic stimulus, possibly through desensitization, and these cells are reduced in number [16]."},{"id":15,"chapterId":19,"question":"Eosinophils may contribute to the persistence of wheals in CSU by generating LTC4, LTD4, and LTE4 and by releasing which toxic granule protein, which can trigger mast cells via MRGPRX2?","options":["Tryptase","Heparin","Major basic protein (MBP)","Tissue factor"],"correctIndex":2,"explanation":"Eosinophils can contribute to the persistence of wheals by generating LTC4, LTD4, and LTE4 and by releasing toxic granule proteins, including major basic protein (MBP); the latter can trigger mast cells via MRGPRX2 [17]."},{"id":16,"chapterId":19,"question":"Chronic Spontaneous Urticaria (CSU) has been strongly associated with which autoimmune condition?","options":["Systemic lupus erythematosus","Rheumatoid arthritis","Autoimmune thyroid disease","Pernicious anemia"],"correctIndex":2,"explanation":"Chronic spontaneous urticaria has been associated with autoimmune thyroid disease and other autoimmune conditions, including vitiligo, insulin-dependent diabetes, rheumatoid arthritis, and pernicious anemia [18]."},{"id":17,"chapterId":19,"question":"Based on one survey of acute urticaria cases presenting to emergency dermatology clinics, what was the most frequent identified cause?","options":["Foods (1%)","Upper respiratory tract infections (40%)","Drugs (9%)","Idiopathic (50%)"],"correctIndex":1,"explanation":"In one survey of acute urticaria causes, upper respiratory tract infections accounted for 40% of cases [19], [20]."},{"id":18,"chapterId":19,"question":"What percentage of chronic urticaria cases are classified as Spontaneous (non-physical, non-vasculitic)?","options":["25%","45%","75%","95%"],"correctIndex":2,"explanation":"75% of chronic urticaria cases are classified as Spontaneous (non-physical, non-vasculitic) [21]."},{"id":19,"chapterId":19,"question":"Urticaria is generally classified as chronic if it persists for which duration?","options":["More than 24 hours","More than 1 week","More than 6 weeks","More than 6 months"],"correctIndex":2,"explanation":"Urticarias become chronic after a period of time that is usually defined as 6 weeks or more [22]."},{"id":20,"chapterId":19,"question":"Which statement accurately describes Simple immediate dermographism?","options":["It is the most common physical urticaria and is pruritic.","It is an exaggerated physiologic response, typically not pruritic.","It is delayed, appearing 30 minutes after stroking.","It is synonymous with white dermographism."],"correctIndex":1,"explanation":"Simple immediate dermographism occurs in at least 5% of the normal population in response to moderate stroking of the skin and may be regarded as an exaggerated physiologic response and is typically not pruritic [23]."},{"id":21,"chapterId":19,"question":"Delayed Pressure Urticaria (DPU) is characterized by swellings that develop after a delay of:","options":["Less than 10 minutes, lasting 30 minutes","15 minutes, lasting 4 hours","30 minutes to 12 hours, sometimes persisting for several days","24 hours, resolving within 48 hours"],"correctIndex":2,"explanation":"Delayed pressure urticaria (DPU) is characterized by the development of deep erythematous swellings at sites of sustained pressure, after a delay of 30 minutes to 12 hours, and may persist for several days [24]."},{"id":22,"chapterId":19,"question":"Cholinergic urticaria develops in response to stimulation of which structures by cholinergic sympathetic innervation?","options":["Arrector pili muscles","Adrenergic receptors on mast cells","Sweat glands","Postcapillary venules"],"correctIndex":2,"explanation":"Cholinergic urticaria develops in response to stimulation of cholinergic sympathetic innervation of the sweat glands. Release of acetylcholine from nerve endings leads to mast cell activation and histamine release [25]."},{"id":23,"chapterId":19,"question":"Vibratory angioedema is a rare form of urticaria where a vibratory stimulus induces localized swelling and erythema, typically lasting for:","options":["30 minutes","4 hours","24 hours","72 hours"],"correctIndex":0,"explanation":"Vibratory angioedema is a very rare form of urticaria, where a vibratory stimulus induces localized swelling and erythema within minutes, lasting 30 minutes [26]."},{"id":24,"chapterId":19,"question":"Non-immunologic Contact Urticaria caused by substances like benzoic acid may be mediated by which inflammatory compounds, allowing it to be suppressed by NSAIDs?","options":["Bradykinin","Prostaglandins (PGD2)","Histamine and Serotonin","IgG autoantibodies"],"correctIndex":1,"explanation":"Non-immunologic (i.e., non-allergic) contact urticaria, such as from exposure to sorbic acid and benzoic acid, may be mediated by PGD2 and can be inhibited by NSAIDs [27], [28]."},{"id":25,"chapterId":19,"question":"Angiotensin-converting enzyme (ACE) inhibitor-induced angioedema results from the inhibition of endogenous kininase II, leading to increased production of:","options":["Histamine","Leukotrienes","C1 esterase inhibitor","Bradykinin"],"correctIndex":3,"explanation":"ACE inhibitor-induced urticaria is believed to result from the inhibition of endogenous kininase II (also known as ACE), which leads to increased production of bradykinin via inhibition of its metabolism [29], [30]."},{"id":26,"chapterId":19,"question":"Regarding H1 antihistamines in the management of chronic urticaria, what is the EAACI/GA2LEN/EDF/WAO consensus guideline recommendation for sedating H1 antihistamines?","options":["Strongly recommended as monotherapy","Strongly recommended against using as monotherapy","Recommended as first-line treatment for all patients","Used only during pregnancy and breastfeeding"],"correctIndex":1,"explanation":"The EAACI/GA2LEN/EDF/WAO consensus guidelines on chronic urticaria strongly recommend against using sedating H1 antihistamines as monotherapy [31]."},{"id":27,"chapterId":19,"question":"For chronic spontaneous urticaria (CSU) that shows little or no response to licensed doses of second-generation H1 antihistamines (First line), the next step recommended by guidelines is:","options":["Discontinue all antihistamines and start cyclosporine.","Increase the daily dose of the second-generation H1 antihistamine up to fourfold.","Start systemic corticosteroids immediately.","Add an H2 antagonist as monotherapy."],"correctIndex":1,"explanation":"If there is little or no response to licensed doses of second-generation H1 antihistamines, guidelines recommend increasing the daily dose of the H1 antihistamine up to fourfold (though this is an unlicensed dosage) [32], [33]."},{"id":28,"chapterId":19,"question":"Systemic corticosteroids (e.g., prednisone/prednisolone) are generally avoided for regular long-term treatment of chronic urticaria primarily due to:","options":["Lack of efficacy after 6 weeks of use.","Risk of rebound flares and unacceptable long-term side effects.","High cost compared to immunomodulatory agents.","Contradiction with all H1 antihistamines."],"correctIndex":1,"explanation":"Regular treatment with oral corticosteroids should be avoided because of the usually prolonged duration of chronic urticaria and because of their predictable long-term side effects (e.g., hypertension, weight gain, osteoporosis). Rebound is also a common problem [34], [35]."},{"id":29,"chapterId":19,"question":"What is the treatment of choice for anaphylactic shock or severe anaphylactoid reactions, including severe acute allergic urticaria of the throat?","options":["Prednisolone 50 mg daily","Subcutaneous or intramuscular epinephrine (adrenaline)","High-dose second-generation H1 antihistamines","Intravenous C1 esterase inhibitor concentrate"],"correctIndex":1,"explanation":"Epinephrine (adrenaline) by subcutaneous or intramuscular injection is the treatment of choice for anaphylactic shock or severe anaphylactoid reactions [36]."},{"id":30,"chapterId":19,"question":"Which drug is specifically ineffective for the management of acute attacks in patients with C1 esterase inhibitor (C1 inh) deficiency?","options":["Intravenous C1 inh concentrate","Subcutaneous icatibant","Epinephrine","Subcutaneous ecallantide"],"correctIndex":2,"explanation":"Intravenous C1 inh concentrate or recombinant C1 inh, subcutaneous icatibant (a specific bradykinin B2 receptor antagonist), or subcutaneous ecallantide (a kallikrein inhibitor) should be given in an emergency. Antihistamines, corticosteroids, and epinephrine are not effective in patients with C1 inh deficiency [37]."},{"id":1,"chapterId":20,"question":"Erythema, defined as a change in skin color due to blood vessel dilation, is characterized by which physical property?","options":["Fixed brown hyperpigmentation","Non-blanchable purpura","Blanchable color (pink to dark red to violaceous)","Central necrosis"],"correctIndex":2,"explanation":"Erythema represents a change in the color of the skin due to the dilation of blood vessels, especially those in the papillary and reticular dermis. The color, which is blanchable, can vary from pink to dark red to violaceous [1]."},{"id":2,"chapterId":20,"question":"Which term was originally used by Colcott-Fox in 1881 to describe persistent, ring-shaped lesions with pruritus, later considered a variant of Erythema Annulare Centrifugum (EAC)?","options":["Erythema perstans","Erythema marginatum","Erythema gyratum perstans","Superficial gyrate erythema"],"correctIndex":2,"explanation":"In 1881, Colcott-Fox described persistent, ring-shaped lesions with pruritus, naming the entity 'erythema gyratum perstans'. This term is now thought to refer to a clinical variant of EAC [2]."},{"id":3,"chapterId":20,"question":"Erythema Annulare Centrifugum (EAC) typically shows a peak incidence in which decade of life?","options":["First decade (Childhood)","Third decade","Fifth decade","Eighth decade"],"correctIndex":2,"explanation":"Although EAC can appear in any age group, its peak incidence is in the fifth decade of life [3]."},{"id":4,"chapterId":20,"question":"The classic distinguishing feature of the superficial form of Erythema Annulare Centrifugum (EAC) lesions is:","options":["A dense central crusting","Non-blanchable petechiae","Trailing scale at the inner margin of the advancing edge","Palpable subcutaneous nodules"],"correctIndex":2,"explanation":"In the superficial form of EAC, the lesions are minimally elevated, and there is desquamation at the inner margin, referred to as trailing scale [4], [5], [6], [7]."},{"id":5,"chapterId":20,"question":"Histologically, the superficial form of EAC is characterized by which finding, sometimes referred to as the 'coat sleeve' appearance?","options":["Leukocytoclastic vasculitis","Sarcoidal granulomas","A tight perivascular aggregate of lymphohistiocytic inflammatory cells","Subepidermal bullae formation"],"correctIndex":2,"explanation":"The inflammatory cells in superficial EAC lesions form a fairly tight aggregate around vessels, referred to as the 'coat sleeve' appearance [8], [7]."},{"id":6,"chapterId":20,"question":"Which key clinical feature differentiates deep EAC lesions from superficial EAC lesions?","options":["Deep lesions are more pruritic.","Deep lesions are typically less elevated and less indurated.","Deep lesions generally lack trailing scale and are more indurated.","Deep lesions frequently involve the palms and soles."],"correctIndex":2,"explanation":"The deep gyrate erythemas have a more infiltrated border [5], and deep lesions of EAC are generally elevated and more indurated than the superficial form, and they do not have trailing scale or pruritus [9], [10]."},{"id":7,"chapterId":20,"question":"Erythema Annulare Centrifugum (EAC) has been anecdotally associated with several infectious agents. Which category of infectious agent is explicitly mentioned in the sources as associated with EAC?","options":["Spirochetes (*Borrelia* spp.)","Dermatophytes and other fungi (*Candida, Penicillium*)","Prions","Rickettsial agents"],"correctIndex":1,"explanation":"EAC has been associated with infectious agents, particularly dermatophytes, but also with other fungi (e.g., *Candida*, *Penicillium* in blue cheese), viruses, bacteria, parasites, and ectoparasites [3]."},{"id":8,"chapterId":20,"question":"Regarding the clinical course of EAC, what percentage of patients typically have an identifiable underlying disorder or antigen?","options":["Nearly 100%","Approximately one-third of patients","Approximately two-thirds of patients","Less than 5%"],"correctIndex":1,"explanation":"In one series, an associated disease was identified in only one-third of patients [3]. Most patients with EAC do not have an identifiable underlying disorder [11]."},{"id":9,"chapterId":20,"question":"Which common dermatologic treatment is often applied to the advancing border of EAC lesions when management is required?","options":["Systemic cyclosporine","Topical calcineurin inhibitors","Topical corticosteroids","Oral metronidazole"],"correctIndex":2,"explanation":"Topical corticosteroids applied to the advancing border of the lesions may be of benefit [12]."},{"id":10,"chapterId":20,"question":"The primary cause of Erythema Marginatum (EM) is an abnormal immunologic response to a preceding infection with:","options":["Group B -hemolytic streptococci","Group A -hemolytic streptococci","*Borrelia burgdorferi*","*Staphylococcus aureus*"],"correctIndex":1,"explanation":"Rheumatic fever (RF) is characterized by an abnormal immunologic response to a preceding infection with group A -hemolytic streptococci [13]. Erythema marginatum is a cutaneous manifestation of acute rheumatic fever [14]."},{"id":11,"chapterId":20,"question":"Erythema Marginatum (EM) is characterized by lesions that are described as:","options":["Painful, fixed plaques that last several weeks","Annular, polycyclic, and rapidly migrating patches/plaques","Pustular lesions with peripheral scale","Deep, indurated plaques without central clearing"],"correctIndex":1,"explanation":"Erythema marginatum is a migratory, annular and polycyclic, erythematous eruption [14]. The lesions are usually asymptomatic, and, over a period of 12 hours, they can migrate from 2 to 12 mm [15]."},{"id":12,"chapterId":20,"question":"In the context of Acute Rheumatic Fever, what is the typical latency period between the initial streptococcal pharyngitis and the development of Erythema Marginatum?","options":["13 days","25 weeks","612 weeks","More than 6 months"],"correctIndex":1,"explanation":"Following the initial episode of streptococcal pharyngitis, there is usually a latency period of 25 weeks before the development of the erythematous macules that spread peripherally and become patches or plaques [15]."},{"id":13,"chapterId":20,"question":"The most common locations for Erythema Marginatum lesions are:","options":["Palms, soles, and face","Trunk, axillae, and proximal extremities, sparing the face","Distal lower legs and ankles","Scalp and mucous membranes"],"correctIndex":1,"explanation":"The most common locations for erythema marginatum are the trunk, axillae, and proximal extremities, with sparing of the face [16]."},{"id":14,"chapterId":20,"question":"Histologically, Erythema Marginatum typically shows an interstitial and perivascular infiltrate composed predominantly of:","options":["Neutrophils without vasculitis","Lymphocytes and plasma cells with mucin deposits","Eosinophils and flame figures","Palisading granulomas"],"correctIndex":0,"explanation":"An interstitial and perivascular infiltrate composed predominantly of neutrophils without vasculitis is observed in Erythema Marginatum [17]. Leukocytoclastic vasculitis is typically absent [18]."},{"id":15,"chapterId":20,"question":"What is the specific treatment recommended for the cutaneous lesions of Erythema Marginatum?","options":["High-potency topical corticosteroids","Systemic antibiotics for the skin lesions","Systemic corticosteroids tapered over 3 weeks","No specific therapy, as lesions resolve spontaneously"],"correctIndex":3,"explanation":"There is no specific therapy for this dermatosis. In general, its clinical course is unaltered by treatment of the underlying acute RF; however, symptoms are usually mild and lesions resolve spontaneously [19]."},{"id":16,"chapterId":20,"question":"Erythema Migrans (EMi) is the initial cutaneous manifestation of Lyme disease, which is an infection caused by:","options":["*Rickettsia rickettsii*","*Mycobacterium marinum*","*Borrelia burgdorferi* spirochetes","*Bartonella henselae*"],"correctIndex":2,"explanation":"Lyme disease (LD) is an infection due to *Borrelia burgdorferi* spirochetes that are transmitted by bites from several species of *Ixodes* ticks [20], [21]."},{"id":17,"chapterId":20,"question":"What is the median time range between tick detachment and the appearance of the primary Erythema Migrans lesion?","options":["Within 24 hours","715 days","35 weeks","612 months"],"correctIndex":1,"explanation":"Typically, 715 days (range, 330 days) after tick detachment, an erythematous, expanding, circular or annular plaque appears [22]."},{"id":18,"chapterId":20,"question":"A single primary lesion of Erythema Migrans must reach at least what diameter to meet the criterion for the CDC case definition?","options":["1 cm","3 cm","5 cm","10 cm"],"correctIndex":2,"explanation":"A single primary lesion must reach  5 cm in diameter for the definition of Erythema Migrans according to the abridged 2022 CDC Lyme Disease Surveillance Case Definition [23]."},{"id":19,"chapterId":20,"question":"Which clinical feature of Erythema Migrans suggests early disseminated disease (Stage 2)?","options":["The primary lesion persisting for less than 24 hours.","Development of subcutaneous nodules.","Multiple secondary lesions that may be smaller in size.","Arthritis only involving the knee 1 year later."],"correctIndex":2,"explanation":"In 20%25% of patients, multiple lesions can appear due to multiple tick bites or as a result of disseminated disease secondary to spirochetemia. Disseminated lesions tend to be smaller in size and less pronounced [22]."},{"id":20,"chapterId":20,"question":"What percentage of patients with Erythema Migrans during the acute phase (without dissemination) typically have positive results on standard serologic testing?","options":["0%10%","25%40%","50%65%","75%90%"],"correctIndex":1,"explanation":"Serologic testing has a low sensitivity in the acute phase, with only 25%40% of patients with erythema migrans during the acute phase (but without evidence of dissemination) having positive test results [24]."},{"id":21,"chapterId":20,"question":"Which antibiotic is the preferred oral treatment for Erythema Migrans, providing good CNS penetration and also treating human granulocytic anaplasmosis?","options":["Azithromycin","Amoxicillin","Cefuroxime axetil","Doxycycline"],"correctIndex":3,"explanation":"Doxycycline is listed as an effective treatment for Erythema Migrans, provides good CNS penetration, and also treats human granulocytic anaplasmosis [25]."},{"id":22,"chapterId":20,"question":"A JarischHerxheimer-like reaction, characterized by an increase in systemic symptoms and inflammation of the EM lesion, occurs in approximately what percentage of patients within 24 hours of initiating antimicrobial therapy?","options":["~5%","~15%","~30%","~50%"],"correctIndex":1,"explanation":"A JarischHerxheimer-like reaction with an increase in systemic symptoms and in the size or intensity of the inflammation of the erythema migrans lesion occurs in ~15% of patients within 24 hours after the initiation of antimicrobial therapy."},{"id":23,"chapterId":20,"question":"Erythema Gyratum Repens (EGR) is recognized primarily as a paraneoplastic figurate erythema, most commonly associated with which underlying neoplasm?","options":["Melanoma","Carcinoma of the lung","Prostate cancer","Non-Hodgkin lymphoma"],"correctIndex":1,"explanation":"In the vast majority of patients, erythema gyratum repens (EGR) represents a paraneoplastic figurate erythema [27]. The most common underlying neoplasm is carcinoma of the lung [27], [28]."},{"id":24,"chapterId":20,"question":"The speed of peripheral spread for lesions of Erythema Gyratum Repens (EGR) is typically estimated at up to:","options":["1 mm per day","1 cm per day","6 cm per week","1 meter per month"],"correctIndex":1,"explanation":"Patients usually have multiple, annular or polycyclic, erythematous lesions that... advance at a rapid rate (up to 1 cm per day) [29]. This rate of peripheral spread is significantly faster than that of EAC [29]."},{"id":25,"chapterId":20,"question":"The characteristic clinical appearance of Erythema Gyratum Repens (EGR) is described as:","options":["Targetoid lesions with central dusky necrosis","Concentric rings with a 'wood-grain' or zebra-like pattern","Fixed, scaling plaques resembling psoriasis","Deep, painful nodules along bony prominences"],"correctIndex":1,"explanation":"Lesions have a wood-grain or zebra-like pattern, due to the development of 'rings within rings' [29]. EGR is migratory and composed of concentric rings with a wood-grain appearance [27]."},{"id":26,"chapterId":20,"question":"When Erythema Gyratum Repens (EGR) is associated with an underlying neoplasm, how are the cutaneous lesions typically affected upon successful treatment of the malignancy?","options":["The skin lesions persist indefinitely.","The lesions become fixed and lichenified.","The cutaneous lesions resolve.","The lesions evolve into urticarial vasculitis."],"correctIndex":2,"explanation":"EGR resolves when the associated neoplasm is successfully treated. Recurrence of cutaneous lesions may occur in association with metastases or local recurrences of the malignancy [27], [30]."},{"id":27,"chapterId":20,"question":"Which figurate erythema or related condition is listed in the differential diagnosis as transient (typically lasting <24 hours) and often associated with a recent viral or bacterial infection, absence of mucosal crusts, and often featuring central ecchymosis?","options":["Erythema annulare centrifugum (EAC)","Urticaria multiforme","Granuloma annulare","LE tumidus"],"correctIndex":1,"explanation":"Urticaria multiforme (a variant of annular urticaria) is characterized by annular and polycyclic wheals, often with central ecchymosis, absence of mucous membrane erosions or crusts, and recent viral or bacterial infection. Individual lesions are transient, typically lasting <24 hours [31], [32]."},{"id":28,"chapterId":20,"question":"What is the characteristic histological finding associated with Urticarial Vasculitis, a condition where individual urticarial plaques may last longer than 24 hours?","options":["Perivascular plasma cells","Leukocytoclastic vasculitis","Palisading granulomas","Marked spongiosis"],"correctIndex":1,"explanation":"Urticarial vasculitis, characterized by urticarial plaques lasting >24 hours, is histologically identified by leukocytoclastic vasculitis [33]."},{"id":29,"chapterId":20,"question":"A disorder that presents with transient gyrate or circinate erythematous patches that usually fade/migrate within a few hours, along with fixed figurate hyperkeratotic plaques, is called:","options":["Annular erythema of infancy","Erythrokeratodermia variabilis et progressiva","Allergic urticarial eruption","Annular LE"],"correctIndex":1,"explanation":"*Erythrokeratodermia variabilis et progressiva* is defined by transient gyrate or circinate erythematous patches (usually fade/migrate within a few hours) and fixed figurate hyperkeratotic plaques [34]."},{"id":30,"chapterId":20,"question":"Which neutrophilic dermatosis, associated with autoimmune or autoinflammatory disorders, shows overlapping histologic features with Erythema Marginatum, sometimes exhibiting purpura and vesicles in adults?","options":["Neutrophilic sebaceous adenitis","Eosinophilic pustular folliculitis","Neutrophilic figurate erythema of infancy (variant)","Pustular psoriasis"],"correctIndex":2,"explanation":"The histologic findings of Erythema Marginatum (predominantly neutrophils) may overlap with the neutrophilic variant of annular erythema of infancy (neutrophilic figurate erythema of infancy), which can also affect adults and be accompanied by vesicles and purpura [17], [35], [36]."},{"id":1,"chapterId":21,"question":"Erythema Multiforme (EM) major is defined as EM associated with severe mucosal involvement and systemic symptoms, but specifically excludes which disorder, based on recent clinical evidence?","options":["Erythema multiforme minor (von Hebra's disease)","Mycoplasma pneumoniae-induced rash and mucositis (MIRM)","StevensJohnson syndrome (SJS)","Urticaria multiforme"],"correctIndex":2,"explanation":"Recent investigations have clarified the situation by providing strong evidence that the term 'EM major' should be used for EM associated with mucosal lesions and systemic symptoms, but not for describing SJS, because SJS and EM major are distinct clinical disorders [1], [2]."},{"id":2,"chapterId":21,"question":"What is the primary characteristic feature of a 'typical' target lesion in Erythema Multiforme (EM)?","options":["Non-blanchable purpuric center","At least three distinct zones of color change","A poorly defined border with only two zones","Central zone showing intact, normal skin"],"correctIndex":1,"explanation":"The characteristic elementary skin lesion of EM is the typical target lesion, which consists of at least three distinct zones of color change surrounding a central circular zone that has evidence of damage to the epidermis in the form of bulla formation or crust [3], [4]."},{"id":3,"chapterId":21,"question":"Which infectious agent is clearly the most commonly associated precipitating factor for Erythema Multiforme (EM)?","options":["*Mycoplasma pneumoniae*","Varicella zoster virus","Herpes simplex virus (HSV)","Cytomegalovirus"],"correctIndex":2,"explanation":"HSV is clearly the most commonly associated infectious agent in EM [5], [6], [7], [8]."},{"id":4,"chapterId":21,"question":"In patients with HSV-associated Erythema Multiforme, preceding *herpes labialis* most commonly appears how many days before the onset of the cutaneous target lesions?","options":["12 days","314 days","35 weeks","23 months"],"correctIndex":1,"explanation":"Most commonly, herpes labialis precedes target lesions of EM by 314 days [6]."},{"id":5,"chapterId":21,"question":"Which locations do the target lesions of Erythema Multiforme typically favor?","options":["Trunk and proximal abdomen","Acrofacial sites (extremities and face)","Palms and soles exclusively","Genitalia and mucous membranes only"],"correctIndex":1,"explanation":"Target lesions favor acrofacial sites [7]. In general, lesions of EM develop preferentially on the extremities and the face; target lesions favor the upper extremities [9]."},{"id":6,"chapterId":21,"question":"In the majority of patients with Erythema Multiforme (EM), the vast majority of lesions appear within which time frame from onset?","options":["12 hours","24 hours","1 week","3 weeks"],"correctIndex":1,"explanation":"Erythema multiforme is characterized by the abrupt onset of papular 'target' lesions, with the vast majority of lesions appearing within 24 hours [3], [10]. Full development has usually occurred by 72 hours [11]."},{"id":7,"chapterId":21,"question":"By daily observation of individual lesions, Erythema Multiforme (EM) papules are described as 'fixed' at the same site for at least how many days?","options":["Less than 24 hours (transient)","48 hours","7 days","14 days"],"correctIndex":2,"explanation":"EM papules are 'fixed' at the same skin site for at least 7 days, which helps distinguish them from urticarial lesions, which last less than 24 hours [11], [12]."},{"id":8,"chapterId":21,"question":"Which HLA allele has been found in association with the development of Erythema Multiforme?","options":["HLA-B*15:02","HLA-DQw3 (specifically DQB1*301 split)","HLA-B*58:01","HLA-A*31:01"],"correctIndex":1,"explanation":"Several small studies of HLA alleles in EM have found associations with HLA-DQw3 (specifically the DQB1*301 split), DRw53, and Aw33 [6], [13], [14]."},{"id":9,"chapterId":21,"question":"In the pathogenesis of HSV-associated Erythema Multiforme, T helper type 1 (Th1) cells produce which cytokine in response to viral antigens within the skin?","options":["Interleukin-4 (IL-4)","Interferon- (IFN-)","Interleukin-10 (IL-10)","Fas ligand (FasL)"],"correctIndex":1,"explanation":"Development of cutaneous lesions in HSV-associated EM is initiated by the expression of HSV DNA sequences within the skin, followed by the recruitment of virus-specific T helper type 1 (Th1) cells that produce interferon- in response to viral antigens within the skin [15], [8]."},{"id":10,"chapterId":21,"question":"The Koebner phenomenon, involving target lesions appearing within areas of cutaneous injury (e.g., scratches), occurs only if the injury precedes which event?","options":["Mucosal involvement","Systemic symptoms","Onset of the EM eruption","Resolution of the primary HSV lesion"],"correctIndex":2,"explanation":"The Koebner phenomenon may be observed, with target lesions appearing within areas of cutaneous injury; however, the injury must precede the onset of the EM eruption because the Koebner phenomenon does not occur once the EM lesions have appeared [16]."},{"id":11,"chapterId":21,"question":"Which finding is the hallmark of the early stages of StevensJohnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) at a tissue level, leading to subsequent epidermal necrolysis?","options":["Lymphocytic vasculitis","Massive keratinocyte cell death via apoptosis","Neutrophil-rich subcorneal pustules","Subepidermal deposition of IgA"],"correctIndex":1,"explanation":"The tissue damage described as epidermal necrolysis is a reflection of massive keratinocyte cell death via apoptosis. Apoptosis of individual keratinocytes is a hallmark of the early stages of SJS and TEN [17]."},{"id":12,"chapterId":21,"question":"StevensJohnson Syndrome (SJS) is defined by epidermal detachment covering what percentage of the Body Surface Area (BSA)?","options":["Less than 10%","10% to 30%","More than 30%","More than 50%"],"correctIndex":0,"explanation":"SJS is characterized by <10% BSA detachment. SJS/TEN overlap involves 10%30% BSA detachment, and TEN involves >30% [18], [19], [20]."},{"id":13,"chapterId":21,"question":"Toxic Epidermal Necrolysis (TEN) is defined by epidermal detachment covering what percentage of the Body Surface Area (BSA)?","options":["Less than 10%","10% to 30%","More than 30%","More than 50%"],"correctIndex":2,"explanation":"TEN is defined by >30% BSA detachment [21], [19], [20]."},{"id":14,"chapterId":21,"question":"What is the typical time frame between the initiation of the causative drug (first exposure) and the onset of StevensJohnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN)?","options":["Within 48 hours","7 to 21 days","2 to 6 months","More than 1 year"],"correctIndex":1,"explanation":"TEN and SJS usually occur 721 days after initiation of the responsible drug if it is the first exposure [19], [22], [23]."},{"id":15,"chapterId":21,"question":"Which prognostic scoring system, consisting of seven parameters, is specifically used for predicting the clinical outcome and mortality risk of Toxic Epidermal Necrolysis (TEN)?","options":["EASI (Eczema Area and Severity Index)","SCORTEN","ABCD-10 score","TBSA (Total Body Surface Area) score"],"correctIndex":1,"explanation":"Mortality risk can be calculated by applying a severity-of-illness score specifically developed for predicting the clinical outcome of TEN (SCORTEN) [24], [25], [26]."},{"id":16,"chapterId":21,"question":"What is the primary cause of mortality in patients with Toxic Epidermal Necrolysis (TEN)?","options":["Massive cardiac arrest","Respiratory failure and multiple organ failure","Intracranial hemorrhage","Infections (*S. aureus* and *P. aeruginosa*)"],"correctIndex":3,"explanation":"On average, death occurs in every third patient with TEN, and it is mainly due to infections (*S. aureus* and *Pseudomonas aeruginosa*) [27]."},{"id":17,"chapterId":21,"question":"The high incidence of keratinocyte apoptosis in SJS/TEN is mediated by the cytotoxic secretory protein granulysin, which is produced by which cell types?","options":["Basophils and macrophages","Mast cells and B cells","CTLs, NK cells, and NKT cells","Fibroblasts and endothelial cells"],"correctIndex":2,"explanation":"High concentrations of granulysin, a secreted, cationic, cytolytic protein produced by cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, and natural killer T (NKT) cells, were found in blister fluid from patients with SJS/TEN [28], [29]."},{"id":18,"chapterId":21,"question":"In the context of SJS/TEN, which HLA allele is strongly associated with carbamazepine-induced severe cutaneous adverse reactions (SCARs) in Asian and East Indian populations?","options":["HLA-B*58:01","HLA-A*31:01","HLA-B*15:02","HLA-DQB1*06:01"],"correctIndex":2,"explanation":"HLA-B*15:02 is associated with Asians and East Indians who are exposed to carbamazepine [30], [31], [32]."},{"id":19,"chapterId":21,"question":"Which clinical finding, when induced by slight tangential mechanical pressure, is characteristic of impending or overt epidermal detachment in SJS/TEN?","options":["Nikolsky sign","Darier sign","Koebner phenomenon","AsboeHansen sign"],"correctIndex":0,"explanation":"The Nikolsky sign is elicited by exerting tangential mechanical pressure on erythematous zones; cleavage is induced, which is a sign of impending full-blown epidermal necrolysis [33]."},{"id":20,"chapterId":21,"question":"In the management of SJS/TEN, the immediate and prompt withdrawal of the offending drug is crucial because it is estimated to reduce the risk of death by what percentage per day?","options":["1%","10%","30%","50%"],"correctIndex":2,"explanation":"Late withdrawal of the causative drug is associated with a less favorable outcome. It has been estimated that prompt withdrawal of the offending drug reduces the risk of death by 30% per day [25]."},{"id":21,"chapterId":21,"question":"Healing of detached epidermis in SJS/TEN occurs through re-epithelialization by keratinocytes migrating from 'reservoir' sites, thus eliminating the need for:","options":["Systemic antibiotics","Intensive care unit admission","Skin grafting","Pain control"],"correctIndex":2,"explanation":"Healing of areas of detached epidermis usually starts within days, and is complete within 3 weeks. Due to this conserved capacity for re-epithelialization, skin grafting is not required in SJS or TEN [34]."},{"id":22,"chapterId":21,"question":"Which long-term sequela is reported to affect up to 35% of Toxic Epidermal Necrolysis (TEN) survivors?","options":["Permanent alopecia","Chronic renal failure","Ocular symptoms (e.g., sicca syndrome, blindness)","Systemic lupus erythematosus"],"correctIndex":2,"explanation":"Up to 35% of survivors of TEN can have ocular symptoms ranging from sicca syndrome to blindness [35]."},{"id":23,"chapterId":21,"question":"Which histopathologic finding differentiates SJS/TEN from Staphylococcal Scalded Skin Syndrome (SSSS)?","options":["Dense perivascular lymphocytic infiltrate","Subcorneal split with a normal underlying epidermis (SSSS)","Coagulation necrosis of keratinocytes","Epidermal hyperplasia"],"correctIndex":1,"explanation":"Histopathologic examination is useful for confirming the diagnosis of SJS and TEN, as the morphologic findings are distinct from those observed in SSSS (subcorneal blister with cleavage located in the granular layer of the epidermis and a normal underlying epidermis) [36], [37]."},{"id":24,"chapterId":21,"question":"Which cytotoxic mechanism, mediated by the interaction of Fas (CD95) and Fas ligand (FasL), contributes to keratinocyte apoptosis in SJS/TEN?","options":["Complement activation cascade","Death receptor-mediated pathway","Necroptosis via annexin A1-FPR1 interaction","T-cell receptor cross-linking (p-i concept)"],"correctIndex":1,"explanation":"Fas ligand (FasL), binding to its specific receptor Fas, triggers cellular destruction by apoptosis, which is one of the proposed death receptor-mediated apoptotic pathways in SJS/TEN [38], [39]."},{"id":25,"chapterId":21,"question":"Which drug class is listed among the most frequently implicated drugs associated with StevensJohnson Syndrome and Toxic Epidermal Necrolysis?","options":["ACE inhibitors","Calcium channel blockers","Aromatic anticonvulsants","HMG-CoA reductase inhibitors (statins)"],"correctIndex":2,"explanation":"The most frequently implicated drugs consist primarily of allopurinol, antibiotics, nonsteroidal anti-inflammatory drugs, and aromatic anticonvulsants [22], [40]."},{"id":26,"chapterId":21,"question":"What is the recommended first-line supportive care setting for a patient with SJS or TEN involving 10%20% or more of BSA?","options":["General medical ward","ICU or burn unit","Dermatology day care unit","Outpatient management with daily dressings"],"correctIndex":1,"explanation":"Supportive care is similar to that performed for severe thermal burns, and it is preferably done in an intensive care unit (ICU) or burn unit if there is epidermal detachment involving 10%20% (or more) of BSA [35], [41]."},{"id":27,"chapterId":21,"question":"The use of systemic corticosteroids for severe acute EM is controversial; however, if considered, the recommended dosing regimen is generally short-term and high-dose, such as:","options":["Prednisone 5 mg/day for 6 months","Pulse methylprednisolone 20 mg/kg/day for 3 days","Dexamethasone 10 mg weekly","Hydrocortisone 100 mg daily indefinitely"],"correctIndex":1,"explanation":"In severe EM with functional impairment, early therapy with systemic corticosteroids (e.g., prednisone [0.51 mg/kg/day for 35 days] or pulse methylprednisolone [20 mg/kg/day for 3 days]) should be considered [42]."},{"id":28,"chapterId":21,"question":"Which prophylactic antiviral therapy, demonstrated effective in a double-blind, placebo-controlled study, should be considered for at least 6 months in individuals with frequent recurrences of HSV-associated EM?","options":["Valganciclovir","Acyclovir","Oseltamivir","Ribavirin"],"correctIndex":1,"explanation":"In individuals with HSV-associated EM with frequent recurrences, prophylaxis for at least 6 months with oral valacyclovir, famciclovir, or acyclovir should be considered. A double-blind, placebo-controlled study in young adults demonstrated the efficacy of acyclovir prophylaxis [43], [44]."},{"id":29,"chapterId":21,"question":"Mycoplasma pneumoniae-induced rash and mucositis (MIRM) or Reactive Infectious Mucocutaneous Eruption (RIME) is often distinguished from SJS/TEN by which key feature?","options":["Severe systemic symptoms including hepatitis and nephritis","Absent or sparse cutaneous involvement (<10% BSA) with predominance of severe mucositis","High mortality rate (15%25%)","Lesions characterized by dusky macules with confluence"],"correctIndex":1,"explanation":"MIRM/RIME is characterized by a predominance of severe mucosal involvement (typically  2 mucosal sites) and absent or sparse polymorphic cutaneous involvement (<10% BSA detachment) [45], [46]."},{"id":30,"chapterId":21,"question":"For recurrent EM that is resistant to prophylactic antiviral therapy, which immunosuppressive agent has been described as a successful therapeutic approach, although not validated by controlled trials?","options":["Sirolimus","Cyclosporine","Infliximab","Interferon "],"correctIndex":1,"explanation":"In patients with recurrent EM that is resistant to prophylactic antiviral therapy, especially severe cases, several therapeutic approaches have been described, including thalidomide, dapsone, cyclosporine, mycophenolate mofetil, and PUVA [47], [48], [49]."},{"id":1,"chapterId":22,"question":"Adverse cutaneous reactions (CARs) to drugs occur in up to what percentage of hospitalized patients?","options":["1%","4%","8%","15%"],"correctIndex":2,"explanation":"Cutaneous Adverse Reactions (CARs) to drugs occur in up to 8% of hospitalized patients, and represent approximately 5% of admissions to an inpatient dermatology service [1]."},{"id":2,"chapterId":22,"question":"Which two forms represent the most common types of cutaneous drug reactions?","options":["Fixed drug eruption and lichenoid reaction","Pustular reaction and vasculitis","Exanthematous (morbilliform) eruption and urticaria","Bullous reaction and StevensJohnson syndrome"],"correctIndex":2,"explanation":"Exanthematous (morbilliform) eruptions and urticaria are the two most common forms of cutaneous drug reactions [2]."},{"id":3,"chapterId":22,"question":"The incidence of fatalities due to drug reactions (systemic and cutaneous) among hospitalized inpatients is estimated to be between:","options":["0.01% and 0.03%","0.1% and 0.3%","1% and 3%","5% and 10%"],"correctIndex":1,"explanation":"The incidence of fatalities due to drug reactions (systemic and cutaneous) among inpatients is between 0.1% and 0.3% [1]."},{"id":4,"chapterId":22,"question":"In which high-risk population is there a 10- to 50-fold greater risk of developing an exanthematous eruption to sulfamethoxazole?","options":["Patients with chronic renal failure","Patients with autoimmune thyroid disease","Patients infected with HIV","Patients with severe cardiovascular disease"],"correctIndex":2,"explanation":"Immunosuppression, such as in HIV-infected individuals, poses a risk factor for adverse drug reactions, where these patients have a 10- to 50-fold greater risk of developing an exanthematous eruption to sulfamethoxazole [1]."},{"id":5,"chapterId":22,"question":"Which of the following is considered a Severe Cutaneous Adverse Reaction (SCAR) to drugs?","options":["Pityriasis rosea-like eruption","Acute generalized exanthematous pustulosis (AGEP)","Acneiform reaction","Hyperpigmentation"],"correctIndex":1,"explanation":"Severe cutaneous adverse reactions (SCARs) include Anaphylaxis, Anticoagulant-induced skin necrosis, Acute generalized exanthematous pustulosis (AGEP), DRESS/DIHS, Generalized bullous fixed drug eruption, and StevensJohnson syndrome and toxic epidermal necrolysis [3]."},{"id":6,"chapterId":22,"question":"In the GellCoombs classification, IgE-dependent drug reactions such as urticaria and anaphylaxis correspond to which type of immunologically mediated reaction?","options":["Type I","Type II","Type III","Type IV"],"correctIndex":0,"explanation":"IgE-dependent drug reactions (formerly type I, GellCoombs classification) include urticaria, angioedema, and anaphylaxis [4]."},{"id":7,"chapterId":22,"question":"Delayed-type, cell-mediated drug reactions (formerly type IV) are responsible for which major category of cutaneous adverse reactions?","options":["Urticaria and anaphylaxis","Serum sickness and vasculitis","Exanthematous, fixed, and lichenoid drug eruptions, SJS/TEN","Petechiae secondary to drug-induced thrombocytopenia"],"correctIndex":2,"explanation":"Delayed-type, cell-mediated drug reactions (formerly type IV) are responsible for exanthematous, fixed, and lichenoid drug eruptions, as well as StevensJohnson syndrome (SJS) and TEN [4]."},{"id":8,"chapterId":22,"question":"The concept where drugs induce the formation of HLAdrug complexes that directly activate T cell immune responses without the need for a specific peptide ligand is known as:","options":["The hapten/pro-hapten concept","The pharmacoimmune reaction (p-i concept)","The Th2 immune reaction (IVb)","Delayed toxicity mechanism"],"correctIndex":1,"explanation":"The pharmacoimmune reaction ('p-i concept') describes how drugs induce the formation of HLAdrug complexes that can directly activate T cell immune responses without the need for a specific peptide ligand [5]."},{"id":9,"chapterId":22,"question":"Drug reactions mediated by a non-immunologic mechanism are sometimes predictable because they relate to the drug's dose and/or:","options":["HLA allele association","Patient age (>75 years)","Pharmacologic properties","Prior sensitization"],"correctIndex":2,"explanation":"Non-immunologic drug reactions are sometimes predictable given their relationship to the dose and/or the pharmacologic properties of the drug [6], [7]."},{"id":10,"chapterId":22,"question":"Which HLA allele is strongly associated with an increased risk of StevensJohnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) in Han Chinese and other Asian populations exposed to carbamazepine?","options":["HLA-B*57:01","HLA-B*58:01","HLA-B*15:02","HLA-A*31:01"],"correctIndex":2,"explanation":"HLA-B*15:02 is strongly associated with SJS/TEN in Han Chinese and other Asian populations exposed to carbamazepine [8], [9]."},{"id":11,"chapterId":22,"question":"Allopurinol-induced SJS/TEN in Asian populations (Han Chinese) is strongly associated with which HLA allele?","options":["HLA-B*15:02","HLA-B*57:01","HLA-B*58:01","HLA-A*31:01"],"correctIndex":2,"explanation":"HLA-B*58:01 is associated with SJS/TEN in Asians (Han Chinese) who take allopurinol [8], [10]."},{"id":12,"chapterId":22,"question":"Methotrexate toxicity leading to epidermal necrosis, particularly in patients with reduced renal function or dosing errors, is an example of which non-immunologic mechanism?","options":["Photosensitivity","Overdose","Delayed toxicity","Drug-drug interaction"],"correctIndex":1,"explanation":"The clinical manifestations of a drug overdose, such as methotrexate toxicity leading to epidermal necrosis, are predictable and represent an exaggeration of the medications pharmacologic actions, often due to altered metabolism or excretion [11]."},{"id":13,"chapterId":22,"question":"Accumulation of minocycline within the skin, leading to cutaneous discoloration, is classified as which type of non-immunologic adverse reaction?","options":["Pharmacologic side effect","Cumulative toxicity","Exacerbation of disease","Alteration in metabolism"],"correctIndex":1,"explanation":"Prolonged exposure to a medication or its metabolites may lead to cumulative toxicity, such as accumulation of minocycline leading to cutaneous discoloration [12]."},{"id":14,"chapterId":22,"question":"How long after initial drug administration does a morbilliform (exanthematous) eruption classically begin?","options":["Minutes to hours","4 to 14 days","15 to 40 days","2 to 6 months"],"correctIndex":1,"explanation":"A morbilliform eruption classically begins 4 to 14 days after the initial drug administration [13], [14]."},{"id":15,"chapterId":22,"question":"The mortality rate associated with an uncomplicated exanthematous (morbilliform) drug eruption is typically:","options":["0%","1% to 2%","5% to 10%","More than 30%"],"correctIndex":0,"explanation":"Exanthematous (morbilliform) eruptions have a reported mortality of 0% [13]."},{"id":16,"chapterId":22,"question":"Which clinical feature appearing in an exanthematous eruption strongly suggests the possibility of a Severe Cutaneous Adverse Reaction (SCAR)?","options":["Low-grade fever","Pruritus","Edema of the face","Resolution within 7 days"],"correctIndex":2,"explanation":"Signs and symptoms that point to the possibility of a more severe drug-induced eruption (SCAR) include skin pain, edema of the face, pustules, vesicles, purpuric macules, skin fragility (Nikolsky sign), mucous membrane involvement, and/or marked peripheral blood eosinophilia [15], [16]."},{"id":17,"chapterId":22,"question":"Approximately what percentage of all cases of urticaria are thought to be caused by drugs?","options":["<10%","20%","50%","80%"],"correctIndex":0,"explanation":"Although drugs are thought to be responsible for <10% of all cases of urticaria, they are more often associated with acute rather than chronic urticaria [17], [13]."},{"id":18,"chapterId":22,"question":"IgE-mediated drug-induced urticaria typically occurs within which time frame after drug administration?","options":["Minutes to less than an hour","4 to 14 days","7 to 21 days","30 minutes to 12 hours"],"correctIndex":0,"explanation":"In IgE-mediated urticaria, lesions typically appear within minutes to less than an hour after drug administration, especially when there has been prior sensitization [17], [13]."},{"id":19,"chapterId":22,"question":"The majority of cases of Angiotensin-converting enzyme (ACE) inhibitor-induced angioedema appear within which time frame after starting the drug?","options":["Within 1 day","Within the first year","1 to 3 years","More than 5 years"],"correctIndex":1,"explanation":"In the case of ACE inhibitor-induced angioedema, lesions may appear from 1 day to several years after starting the drug, but most appear within the first year [18]."},{"id":20,"chapterId":22,"question":"What is the primary treatment for life-threatening angioedema and anaphylaxis?","options":["High-dose systemic corticosteroids","Intravenous C1 esterase inhibitor concentrate","Subcutaneous or intramuscular epinephrine (adrenaline)","High-dose H1 antihistamines"],"correctIndex":2,"explanation":"Subcutaneous epinephrine (adrenaline) is the primary treatment for life-threatening angioedema and anaphylaxis [19]."},{"id":21,"chapterId":22,"question":"In a Fixed Drug Eruption (FDE), how quickly do lesions usually appear upon re-exposure to the causative drug?","options":["1 to 2 weeks","Less than 48 hours, usually within 24 hours","7 to 21 days","2 to 8 weeks"],"correctIndex":1,"explanation":"In FDE, upon subsequent exposures, lesions usually appear within 24 hours, but less than 48 hours [13], [20]."},{"id":22,"chapterId":22,"question":"Which highly characteristic clinical feature is seen in Fixed Drug Eruption (FDE) upon readministration of the causative drug?","options":["Generalized urticarial eruption","Recurrence of lesions in exactly the same sites","Development of new target lesions on the extremities","Rapid epidermal detachment (>30% BSA)"],"correctIndex":1,"explanation":"Upon readministration of the causative drug, FDE lesions recur in exactly the same sites [21]."},{"id":23,"chapterId":22,"question":"DRESS (Drug Reaction With Eosinophilia and Systemic Symptoms) typically develops how long after the initial drug initiation?","options":["1 to 3 days","7 to 14 days","7 to 21 days","2 to 8 weeks"],"correctIndex":3,"explanation":"Clinically, DRESS develops 2 to 8 weeks after drug initiation, which is later than most other immunologically mediated skin reactions [22], [23]."},{"id":24,"chapterId":22,"question":"What are the two major internal organ manifestations most commonly seen in patients with DRESS?","options":["Renal failure and myocarditis","Hepatitis and lymphadenopathy","Interstitial pneumonitis and thyroiditis","Pancreatitis and central nervous system involvement"],"correctIndex":1,"explanation":"The major internal manifestations in DRESS include lymphadenopathy and hepatitis, seen in approximately 80% of patients [24]."},{"id":25,"chapterId":22,"question":"Systemic corticosteroids used to treat moderate-to-severe DRESS typically require a slow taper over what time frame to prevent relapse?","options":["1 week","1 month","3 to 6 months","More than 1 year"],"correctIndex":2,"explanation":"Although guidelines for DRESS treatment are still lacking, systemic corticosteroids are typically first-line therapy, and a slow taper over a period of 3 to 6 months is required because relapse can occur when the dosage is reduced [25]."},{"id":26,"chapterId":22,"question":"Acute Generalized Exanthematous Pustulosis (AGEP) typically occurs within how many days after drug administration?","options":["Less than 4 days","7 to 14 days","15 to 40 days","2 to 8 weeks"],"correctIndex":0,"explanation":"AGEP is characterized by a short interval (<4 days) between drug administration and the onset of the eruption [22], [26]."},{"id":27,"chapterId":22,"question":"The primary cutaneous feature of Acute Generalized Exanthematous Pustulosis (AGEP) is:","options":["Target lesions with epidermal bullae","Palpable purpura on the lower legs","Numerous small, non-follicular, sterile pustules within edematous erythema","Large, violaceous fixed plaques"],"correctIndex":2,"explanation":"AGEP is characterized by numerous small (<5 mm), primarily non-follicular, sterile pustules arising within large areas of edematous erythema [26], [27]."},{"id":28,"chapterId":22,"question":"Drug-induced cutaneous small vessel vasculitis (CSVV) usually presents clinically as:","options":["Erythematous macules on the trunk","Urticarial wheals lasting less than 24 hours","Purpuric papules, primarily on the lower extremities","Fixed, targetoid lesions on acral sites"],"correctIndex":2,"explanation":"Drug-induced CSVV usually presents as purpuric papules, primarily on the lower extremities [28]."},{"id":29,"chapterId":22,"question":"Neutrophilic Eccrine Hidradenitis (NEH) is most frequently seen 714 days after initiating chemotherapy, particularly the combination of cytarabine plus:","options":["Taxanes","Anthracyclines","Tyrosine kinase inhibitors","Alkylating agents"],"correctIndex":1,"explanation":"NEH is most frequently seen 714 days after initiating chemotherapy, in particular cytarabine plus an anthracycline (e.g. idarubicin, mitoxantrone) [29]."},{"id":30,"chapterId":22,"question":"Which clinical criteria is essential for the diagnosis of Symmetrical Drug-Related Intertriginous and Flexural Exanthema (SDRIFE)?","options":["Fixed, purpuric plaques on sun-exposed sites","Sharply demarcated, symmetrical erythema of the anogenital and at least one other flexural area","Absence of fever, leukocytosis, or lymphadenopathy","Onset within 48 hours of re-exposure"],"correctIndex":1,"explanation":"SDRIFE requires sharply demarcated, symmetrical erythema of the gluteal/perianal area and/or V-shaped erythema of the inguinal/perigenital area, and involvement of at least one other intertriginous site/flexural fold [30]."},{"id":1,"chapterId":23,"question":"What is the definition of purpura addressed in the sources?","options":["Visible inflammation without hemorrhage","Visible hemorrhage within the skin or mucous membranes","Hemorrhage secondary only to trauma or scratching","Blanchable erythema of the superficial dermis"],"correctIndex":1,"explanation":"Purpura is defined as visible hemorrhage within the skin or mucous membranes [1]."},{"id":2,"chapterId":23,"question":"The diagnostic approach to purpura is initially based on identifying one of three broad categories of pathomechanism. Which category is NOT one of these three?","options":["Simple hemorrhage (vascular breach)","Inflammatory hemorrhage (vessel-directed inflammation)","Microvascular occlusion/ischemia","Platelet hyperaggregation (thrombocytosis)"],"correctIndex":3,"explanation":"The initial goal is to identify the most plausible of three broad categories: simple hemorrhage (vascular breach), inflammatory hemorrhage (vessel-directed inflammation), or microvascular occlusion/ischemia [2]."},{"id":3,"chapterId":23,"question":"Which size criteria define macular petechiae?","options":[" 4 mm in diameter","59 mm in diameter"," 1 cm in diameter"," 5 mm in diameter and palpable"],"correctIndex":0,"explanation":"The macular group consists of petechiae, defined as  4 mm in diameter."},{"id":4,"chapterId":23,"question":"Purpuric lesions appearing in a generalized pattern composed only of petechiae most often suggest exclusion of severe thrombocytopenia or:","options":["Hypergammaglobulinemic purpura of Waldenstrm","Thrombotic thrombocytopenic purpura","Viral or drug eruption","Calciphylaxis"],"correctIndex":2,"explanation":"Petechiae appearing in a generalized pattern... are most often due to a viral or drug eruption. If only petechiae are present, severe thrombocytopenia should also be excluded [5], [6]."},{"id":5,"chapterId":23,"question":"Widespread, generalized retiform purpura in a severely ill patient with multi-organ disease suggests which diagnosis?","options":["Hypergammaglobulinemic purpura","Erythema multiforme","Fulminant microvascular disease (e.g., catastrophic antiphospholipid syndrome or sepsis/DIC)","Warfarin-induced skin necrosis"],"correctIndex":2,"explanation":"Generalized retiform purpura in the setting of multi-organ disease suggests fulminant microvascular disease (e.g. catastrophic antiphospholipid syndrome) or sepsis-associated disseminated intravascular coagulation (DIC) with purpura fulminans [7], [8]."},{"id":6,"chapterId":23,"question":"A Pauci-random distribution pattern of purpura is typical for which group of disorders?","options":["Pigmented purpuric eruptions","ANCA-associated vasculitides","Cryoglobulinemia (cold-induced)","Severe thrombocytopenia"],"correctIndex":1,"explanation":"A pauci-random distribution pattern is typical of ANCA-associated vasculitides, various microvascular occlusive diseases, or lymphomatoid papulosis [8]."},{"id":7,"chapterId":23,"question":"Retiform purpura is generally used to denote a frequent marker of which primary pathomechanism?","options":["Simple hemorrhage","Thrombotic or occlusive microvascular disease","IgE-mediated mast cell degranulation","Immunosuppression"],"correctIndex":1,"explanation":"Retiform purpura is generally used to denote a frequent marker of thrombotic or occlusive microvascular disease [3]."},{"id":8,"chapterId":23,"question":"Retiform purpura results from involvement of the same dermal vessels that produce which classic non-purpuric pattern?","options":["Erythema annulare centrifugum","Acanthosis nigricans","Livedo reticularis","Urticarial wheals"],"correctIndex":2,"explanation":"Retiform purpura morphology results from involvement of the same vessels that produce the livedo reticularis pattern [9]."},{"id":9,"chapterId":23,"question":"Palpable purpura is classically described as inflammatory purpura with prominent early erythema, often due to:","options":["Poor dermal support of vessels","Leukocytoclastic vasculitis due to immune complex disease","Drug overdose leading to systemic toxicity","Fixed increased venous pressure"],"correctIndex":1,"explanation":"Palpable purpura is defined as inflammatory purpura with prominent early erythema, such as leukocytoclastic vasculitis due to immune complex disease [10]."},{"id":10,"chapterId":23,"question":"Histologically, a biopsy of a late lesion of microvascular occlusion, characterized by necrosis and a wound healing response, may sometimes resemble a lesion of:","options":["Psoriasis","Erythema multiforme","Leukocytoclastic vasculitis","Angioedema"],"correctIndex":2,"explanation":"A late lesion of occlusion with some resulting dermal necrosis may on histologic examination show features characteristic of leukocytoclastic vasculitis (LCV) [11]. The wound response in occlusive lesions may also lead to secondary vasculitis [12]."},{"id":11,"chapterId":23,"question":"Purpuric lesions in the macular group (non-palpable) are categorized on the basis of size and typically develop via which pathomechanism?","options":["Inflammatory hemorrhage","Simple hemorrhage","Vessel-invasive organisms","Antiphospholipid antibody syndrome"],"correctIndex":1,"explanation":"The three subsets of macular (non-palpable) purpura typically develop via simple hemorrhage, with extravasated red blood cells and minimal inflammation observed in biopsy specimens [3], [13]."},{"id":12,"chapterId":23,"question":"Petechial hemorrhage occurs when platelet counts fall below which threshold, due to inadequate support of endothelial cell junctions?","options":["10,00020,000 mm","<50,000 mm","<100,000 mm","<500,000 mm"],"correctIndex":0,"explanation":"When counts fall below 10,00020,000 mm, inadequate platelet support leads to degradation of junction function, increased permeability, and hemorrhage, resulting in petechiae [14], [15]."},{"id":13,"chapterId":23,"question":"The intrinsic (contact activation) coagulation pathway is assessed by which laboratory test?","options":["Prothrombin time (PT)","Activated partial thromboplastin time (aPTT)","Bleeding time","D-dimer level"],"correctIndex":1,"explanation":"The intrinsic (contact activation) pathway is assessed by the activated partial thromboplastin time (aPTT) [16]."},{"id":14,"chapterId":23,"question":"The extrinsic coagulation pathway is monitored by which laboratory test and is primarily triggered by what?","options":["aPTT; Factor XII activation","PT; Tissue factor released from endothelial cells","PT; Factor IXa","aPTT; Thrombin binding to thrombomodulin"],"correctIndex":1,"explanation":"The extrinsic pathway is monitored by the prothrombin time (PT). It is triggered by tissue factor released from endothelial and other cells [16]."},{"id":15,"chapterId":23,"question":"Which molecule greatly enhances the ability of Antithrombin III (ATIII) to neutralize activated clotting factors?","options":["Protein C","Heparan sulfate or heparin","Tissue Factor Pathway Inhibitor (TFPI)","Factor V Leiden"],"correctIndex":1,"explanation":"The ability of ATIII to neutralize thrombin as well as factors IXa, Xa, and XIIa is greatly enhanced by heparan sulfate or heparin binding to ATIII [17]."},{"id":16,"chapterId":23,"question":"The thrombomodulin/Protein C/Protein S system is considered critical for the normal function of which vascular system?","options":["Large arteries (e.g., aorta)","Medium-sized muscular arteries (e.g., polyarteritis nodosa)","Microvasculature (small vessels)","Deep venous system (DVT)"],"correctIndex":2,"explanation":"While both ATIII and protein C pathways are important in large vessels, the protein C system seems to be critical for normal function of the microvasculature [18], [19]."},{"id":17,"chapterId":23,"question":"Which condition is classified as a non-inflammatory retiform purpura primarily due to occlusion related to cold-related precipitation?","options":["Warfarin-induced skin necrosis","Disseminated Strongyloidiasis","Cryoglobulinemia, primarily type I","Levamisole-adulterated cocaine toxicity"],"correctIndex":2,"explanation":"Non-inflammatory retiform purpura due to cold-related precipitation includes Cryoglobulinemia, usually monoclonal (primarily type I) [6], [20]."},{"id":18,"chapterId":23,"question":"A prolonged PT and a prolonged aPTT suggest a combined deficiency of multiple procoagulant factors, which can be caused by:","options":["Heparin administration","Factor VII deficiency","Severe vitamin K deficiency","Thrombocytosis secondary to myeloproliferative disorders"],"correctIndex":2,"explanation":"A prolonged PT and prolonged aPTT suggests a combined deficiency of multiple procoagulant factors, such as severe vitamin K deficiency or high-dose oral anticoagulant [21]."},{"id":19,"chapterId":23,"question":"Which syndrome, a variant of pigmented purpuric dermatosis, is characterized by a solitary patch whose color varies from golden to rust to purplebrown, often over a perforator vein?","options":["Schamberg disease","Purpura annularis telangiectodes of Majocchi","Lichen aureus","Eczematid-like purpura of Doucas and Kapetanakis"],"correctIndex":2,"explanation":"Lichen aureus is a rare variant characterized by a solitary patch whose color varies from golden to rust to purplebrown, usually on the lower extremity, often over a perforator vein [22], [23]."},{"id":20,"chapterId":23,"question":"The presence of pinpoint petechiae within yellowbrown patches, often likened to 'cayenne pepper,' is characteristic of which pigmented purpuric dermatosis variant?","options":["Purpura annularis telangiectodes of Majocchi","Lichen aureus","Schamberg disease","Linear pigmented purpura"],"correctIndex":2,"explanation":"Schamberg disease is characterized by yellowbrown patches with pinpoint petechiae within them, likened to 'cayenne pepper' [24]."},{"id":21,"chapterId":23,"question":"Histopathologic features of pigmented purpuric dermatoses (capillaritis) include red cell extravasation, endothelial cell swelling, and:","options":["A tight perivascular infiltrate resembling a 'coat sleeve'","A perivascular lymphocytic infiltrate and hemosiderin-containing macrophages","Leukocytoclastic vasculitis and fibrinoid necrosis","Subcorneal pustules"],"correctIndex":1,"explanation":"Histopathologic features include red cell extravasation, endothelial cell swelling, a perivascular lymphocytic infiltrate, and hemosiderin-containing macrophages [25], [26]."},{"id":22,"chapterId":23,"question":"The clinical presentation of pigmented purpuric eruptions needs to be distinguished from dermal hemorrhage secondary to venous hypertension (stasis purpura), which presents with:","options":["Discrete yellowbrown patches (Schamberg-like)","Petechiae superimposed on diffuse hemosiderosis","Annular plaques with central telangiectasias","Linear array of purpura"],"correctIndex":1,"explanation":"Pigmented purpuric eruptions on the legs must be differentiated from dermal hemorrhage secondary to venous hypertension, which presents with petechiae superimposed on diffuse hemosiderosis (referred to as 'stasis purpura') [27], [28]."},{"id":23,"chapterId":23,"question":"Benign Hypergammaglobulinemic Purpura of Waldenstrm is often associated with which autoimmune connective tissue disease (AI-CTD)?","options":["Systemic lupus erythematosus (LE)","Rheumatoid arthritis (RA)","Sjgren syndrome","Systemic sclerosis"],"correctIndex":2,"explanation":"Hypergammaglobulinemic purpura of Waldenstrm is often associated with an autoimmune connective tissue disease (AI-CTD), especially Sjgren syndrome [29], [30]."},{"id":24,"chapterId":23,"question":"In Hypergammaglobulinemic Purpura of Waldenstrm, lesions on the lower extremities are most commonly characterized as:","options":["Painful, deep nodules","Fixed, ulcerating purpuric plaques","Recurrent crops of petechiae and larger purpuric macules","Non-pruritic urticarial wheals"],"correctIndex":2,"explanation":"The purpura is often preceded by a slight itch, mild tingling or burning. Macular hemorrhage (e.g. petechiae or larger purpuric macules) on the lower extremities represents the most common presentation [31], [28]."},{"id":25,"chapterId":23,"question":"What is the primary distinguishing feature of the lesions in GardnerDiamond Syndrome?","options":["Fixed, painless purpuric macules","Painful, swollen ecchymoses occurring spontaneously or at trauma sites","Retiform purpura associated with cold exposure","Annular lesions with trailing scale"],"correctIndex":1,"explanation":"GardnerDiamond syndrome is characterized by painful, swollen ecchymoses occurring spontaneously or at trauma sites [32], [33]."},{"id":26,"chapterId":23,"question":"Paroxysmal Finger Hematoma (Achenbach syndrome) is characterized by recurrent acute episodes of painful ecchymoses on which specific site?","options":["The dorsum of the hand","The palmar surface of one or more fingers","The tips of the toes","The ears and nose"],"correctIndex":1,"explanation":"Paroxysmal Finger Hematoma is characterized by recurrent acute episodes of painful ecchymoses on the palmar surface of one or more fingers [33], [34]."},{"id":27,"chapterId":23,"question":"Mondor disease is characterized by superficial thrombophlebitis of subcutaneous veins, most specifically affecting which anatomical wall?","options":["The anterior abdominal wall","The lateral thoracic, thoracoepigastric, and superior epigastric veins (anterolateral thoracoabdominal wall)","The saphenous vein in the thigh","The antecubital fossa veins"],"correctIndex":1,"explanation":"Mondor disease is characterized by superficial thrombophlebitis of subcutaneous veins within the anterolateral thoracoabdominal wall (e.g., lateral thoracic, thoracoepigastric, and superior epigastric veins) [34]."},{"id":28,"chapterId":23,"question":"Up to 10% of patients diagnosed with Mondor syndrome affecting the chest wall have an underlying association with:","options":["Systemic lupus erythematosus","Breast carcinoma","A congenital heart defect","Chronic venous insufficiency"],"correctIndex":1,"explanation":"Common pathogenic factors include trauma and surgery, and up to 10% of patients with Mondor syndrome have an underlying breast carcinoma [35]."},{"id":29,"chapterId":23,"question":"Recurrent superficial thrombophlebitis (migratory thrombophlebitis or Trousseau syndrome), a differential diagnosis for Mondor disease, is frequently associated with an underlying malignancy, most often:","options":["Carcinoma of the lung or pancreas","Basal cell carcinoma","Thyroid carcinoma","Chronic myelogenous leukemia"],"correctIndex":0,"explanation":"Recurrent superficial thrombophlebitis (migratory thrombophlebitis) is frequently associated with an underlying malignancy (Trousseau syndrome; most often pancreatic or lung carcinoma) [36]."},{"id":30,"chapterId":23,"question":"Onyalai, a disease often presenting with hemorrhagic blisters in the mouth, results from the consumption of sorghum grains contaminated with which organism?","options":["Candida albicans","Epicoccum sorghinum (fungus)","Plasmodium falciparum","Staphylococcus aureus"],"correctIndex":1,"explanation":"Onyalai results from the consumption of sorghum grains contaminated with the fungus *Epicoccum sorghinum*, which produces compounds that inhibit platelet aggregation and angiogenesis [37], [15]."},{"id":1,"chapterId":24,"question":"Heparin-Induced Thrombocytopenia (HIT) syndrome typically presents cutaneous lesions in which morphology?","options":["Widespread, non-blanchable petechiae","Non-necrotic hemorrhagic bullae","Retiform purpura or non-inflammatory necrosis","Palpable purpuric papules limited to the injection site"],"correctIndex":2,"explanation":"Heparin-induced skin necrosis typically presents as retiform purpura or non-inflammatory necrosis [1]. The cutaneous lesions are usually tender, sharply demarcated, non-inflammatory, and purpuric or necrotic [2]. Non-necrotic hemorrhage and bullae are unrelated to HIT [3, 4]."},{"id":2,"chapterId":24,"question":"The pathologic pathway underlying Heparin-Induced Thrombocytopenia (HIT) involves the formation of ultralarge complexes (ULCs) composed of heparin bound to:","options":["Protein C","Antithrombin III","Platelet factor 4 (PF4)","Tissue factor"],"correctIndex":2,"explanation":"HIT involves the binding of platelet factor 4 (PF4) to a polyanion, usually unfractionated heparin, to form ultralarge complexes (ULCs) [5]."},{"id":3,"chapterId":24,"question":"Consideration of HIT syndrome should be prompted by a decrease in the platelet count of more than 50% from the most recent highest value, occurring approximately how many days after heparin exposure?","options":["12 days","510 days","1520 days","4060 days"],"correctIndex":1,"explanation":"HIT usually occurs between days 5 and 10 of heparin therapy [6]. A decline in the platelet count of >50% from the most recent highest value prior to the administration of heparin should prompt consideration of HIT [1, 2]."},{"id":4,"chapterId":24,"question":"The risk of developing HIT is highest with which type of heparin?","options":["Low-molecular-weight heparin (LMWH)","Unfractionated heparin (UFH)","Synthetic pentasaccharide fondaparinux","Oral Factor Xa inhibitors"],"correctIndex":1,"explanation":"The risk of developing HIT is highest with unfractionated heparin, lower with low-molecular-weight heparin, and negligible with the synthetic pentasaccharide fondaparinux [7]."},{"id":5,"chapterId":24,"question":"What is the FDA-approved first-line therapeutic anticoagulation agent for acute HIT?","options":["Warfarin","Low-dose aspirin","Argatroban (a direct thrombin inhibitor)","Recombinant C1 esterase inhibitor"],"correctIndex":2,"explanation":"Treatment requires cessation of heparin therapy and initiation of therapeutic anticoagulation. Argatroban and bivalirudin, direct thrombin inhibitors, are FDA-approved for the treatment of HIT [8]."},{"id":6,"chapterId":24,"question":"Vitamin K antagonists (e.g., warfarin) are contraindicated during the acute phase of HIT because of an increased risk of developing:","options":["Systemic lupus erythematosus","Venous limb gangrene secondary to decreased protein C levels","Severe bleeding due to thrombocytopenia","Delayed-onset allergic contact dermatitis"],"correctIndex":1,"explanation":"Vitamin K antagonists (e.g. warfarin) are contraindicated during the acute phase because of an increased risk of developing venous limb gangrene secondary to decreased protein C levels [9]."},{"id":7,"chapterId":24,"question":"In the differential diagnosis of microvascular syndromes, the finding of retiform purpura or non-inflammatory (bland) necrosis strongly suggests which type of injury?","options":["Inflammatory injury (vasculitis)","Simple hemorrhage (vascular breach)","Non-inflammatory occlusive injury to vessels","IgE-mediated degranulation"],"correctIndex":2,"explanation":"The diagnosis of occlusive syndromes in the skin is greatly facilitated by recognizing the telltale lesions of retiform purpura or non-inflammatory (bland) necrosis [10]."},{"id":8,"chapterId":24,"question":"Approximately 90%95% of patients with Polycythemia Vera (PV) harbor a somatic phenotypic driver mutation in which gene?","options":["BCR-ABL","PIG-A","ADAMTS13","JAK2 (V617F)"],"correctIndex":3,"explanation":"The Philadelphia chromosome-negative MPNs are clonal disorders driven by mutations in JAK2, CALR, or MPL [11]. A single mutation, JAK2 V617F, is present in 90%95% of PV patients and 50%70% of those with Essential Thrombocythemia (ET) and Primary Myelofibrosis (PMF) [12]."},{"id":9,"chapterId":24,"question":"Erythromelalgia secondary to thrombocythemic Essential Thrombocythemia (ET) characteristically responds dramatically to which medication?","options":["Low-dose aspirin","High-dose systemic corticosteroids","Ruxolitinib","Warfarin"],"correctIndex":0,"explanation":"This version of secondary erythromelalgia (most closely associated with ET) typically responds dramatically to aspirin administration [13, 14]."},{"id":10,"chapterId":24,"question":"In patients with myeloproliferative neoplasms (MPNs), at what extreme platelet count range does bleeding typically predominate over thrombosis?","options":["4001000 times 10^9/L","10002000 times 10^9/L",">2000 times 10^9/ L","Within the normal range"],"correctIndex":2,"explanation":"Bleeding predominates when the platelet count is  >2000 times 10^9L in MPNs."},{"id":11,"chapterId":24,"question":"Paroxysmal Nocturnal Hemoglobinuria (PNH) is caused by a somatic mutation in the *PIG-A* gene, which prevents the proper anchoring of which class of proteins required for protection against complement-mediated injury?","options":["GPI-anchored proteins","HLA Class I molecules","Platelet Factor 4","CD40 ligand"],"correctIndex":0,"explanation":"PNH is due to a somatic mutation in *PIG-A* (phosphatidyl inositol glycan class A), which encodes a glycosylphosphatidylinositol (GPI)-anchored protein that is required for the cell membrane attachment of several important membrane proteins [16]."},{"id":12,"chapterId":24,"question":"The therapeutic agents eculizumab and ravulizumab for PNH function by inhibiting which phase of the complement cascade?","options":["C1 activation","C3 tickover (Factors B and D)","Terminal phase at the C5 stage","MAC formation via CD59 stabilization"],"correctIndex":2,"explanation":"Patients can receive life-long IV therapy with eculizumab or ravulizumab which inhibit the terminal phase of the complement cascade at the C5 stage [17]."},{"id":13,"chapterId":24,"question":"Thrombotic Microangiopathy (TMA) is a syndrome characterized by the simultaneous presence of microangiopathic hemolytic anemia and:","options":["Leukocytosis","Thrombocytopenia","Hyperfibrinogenemia","Severe neutropenia"],"correctIndex":1,"explanation":"TMA is a syndrome characterized by microangiopathic hemolytic anemia and thrombocytopenia [18, 19]."},{"id":14,"chapterId":24,"question":"Hereditary Thrombotic Thrombocytopenic Purpura (TTP) is due to biallelic mutations in *ADAMTS13*. This enzyme is responsible for cleaving ultra-large multimers of:","options":["Fibrinogen","Tissue factor","Protein C","von Willebrand factor (vWF)"],"correctIndex":3,"explanation":"Hereditary TTP (UpshawSchulman syndrome) is due to biallelic mutations of *ADAMTS13*. Its protein product is an enzyme responsible for cleaving ultra-large multimers of von Willebrand factor (vWF) [20]."},{"id":15,"chapterId":24,"question":"What is the first-line therapy for acquired (immune-related) TTP, which can lead to a reduction in mortality of up to 90%?","options":["Plasma exchange","High-dose intravenous corticosteroids","Eculizumab","Rituximab"],"correctIndex":0,"explanation":"Since TTP is usually due to acquired antibodies to ADAMTS13, total plasma exchange represents first-line therapy, leading to a reduction in mortality of up to 90% [21]."},{"id":16,"chapterId":24,"question":"The cardinal clinical sign of cold occlusion, including that due to cryoglobulinemia (Type I), is typically found in which location?","options":["The trunk and proximal extremities","Acral sites (hands, feet, nose, ears) upon cold exposure","The palms and soles independent of temperature","Pressure areas (buttocks, sacrum)"],"correctIndex":1,"explanation":"The cardinal sign of cold occlusion, including that due to cryoglobulinemia, is purpuric or necrotic lesions, often retiform, at sites of cold exposure that are typically acral [22]."},{"id":17,"chapterId":24,"question":"Type I cryoglobulinemia, characterized by a monoclonal antibody, primarily causes disease via which mechanism?","options":["Immune complex-mediated vasculitis (LCV)","Induction of hyperviscosity or precipitation in the cold","Complement-mediated T-cell activation","Angioinvasion by opportunistic pathogens"],"correctIndex":1,"explanation":"Type I cryoglobulin is a monoclonal antibody. Because type I cryoglobulins are not part of an immune complex, they typically affect vessels via induction of hyperviscosity or precipitation in the cold [23]. Simple occlusion with minimal early inflammation and often retiform purpura/necrosis develops when cryoproteins precipitate upon cold exposure [24]."},{"id":18,"chapterId":24,"question":"Cold agglutinins cause vascular occlusion in cold-exposed sites primarily through:","options":["IgG precipitation and hyperviscosity","Fibrinogen consumption","Red cell agglutination and sludging","Direct endothelial cell toxicity"],"correctIndex":2,"explanation":"Cold agglutinins bind to red cells in the cold, leading to occlusion. Pentameric IgM antibodies more readily agglutinate these cells, leading to occlusion [25, 26]."},{"id":19,"chapterId":24,"question":"Ecthyma Gangrenosum is a syndrome of occlusion by organisms proliferating in the adventitia of subcutaneous blood vessels. The classic causative organism is:","options":["*Staphylococcus aureus*","*Pseudomonas aeruginosa*","*Candida albicans*","*Strongyloides stercoralis*"],"correctIndex":1,"explanation":"The classic organism is *Pseudomonas aeruginosa*, but ecthyma gangrenosum-like skin lesions have also been described with other organisms [27]."},{"id":20,"chapterId":24,"question":"Poorly controlled diabetes mellitus is a specific risk factor for which angioinvasive fungal infection that may present with cutaneous necrosis, presumably originating from a sinus cavity infection?","options":["*Aspergillus* spp.","*Fusarium* spp.","Mucormycosis (e.g., *Rhizopus, Mucor* spp.)","*Candida* spp."],"correctIndex":2,"explanation":"In diabetic patients, mucormycosis may present in the central face with cutaneous necrosis, presumably originating from a sinus cavity infection [28]. Poorly controlled diabetes mellitus is listed as a risk factor for vessel-invasive opportunistic fungi [29]."},{"id":21,"chapterId":24,"question":"The Lucio phenomenon in Hansen disease (leprosy) is typically distinguished from Erythema Nodosum Leprosum by the absence of:","options":["Purpuric lesions","Ulceration","Fever, leukocytosis, and tenderness","Endothelial swelling and thrombus formation"],"correctIndex":2,"explanation":"The associated thrombotic lesions of Lucio phenomenon are distinguished from erythema nodosum leprosum by an absence of fever, leukocytosis, and tenderness [30]."},{"id":22,"chapterId":24,"question":"Which clinical setting is considered a major trigger for Cholesterol Embolus syndrome?","options":["Initiation of intravenous heparin","Arterial or coronary catheterization","Short-term prophylactic anticoagulation","Severe Vitamin K deficiency"],"correctIndex":1,"explanation":"The first clinical setting known to prompt embolization is arterial or coronary catheterization, which may disrupt a plaque, leading to emboli within hours to days of catheterization [31]."},{"id":23,"chapterId":24,"question":"The characteristic histologic finding used to diagnose Cholesterol Embolus in a skin biopsy specimen is:","options":["Fibrin thrombi within the vessel lumen without crystals","Leukocytoclastic vasculitis","Elongated clefts within the lumina of small vessels at the dermalsubcutaneous junction","Dense perivascular plasma cell infiltrate"],"correctIndex":2,"explanation":"Histologically, cholesterol emboli produce elongated clefts within lumina of small vessels [32] (Fig. 23.5E). The affected arteriole is usually at the dermalsubcutaneous junction [32]."},{"id":24,"chapterId":24,"question":"What finding distinguishes oxalate embolus from calciphylaxis in a skin biopsy specimen, despite both often occurring in renal failure?","options":["Presence of cholesterol clefts","Presence of birefringent rectangular or radial crystals that stain with alizarin red S","Extensive subepidermal bullae","Leukocytoclastic vasculitis"],"correctIndex":1,"explanation":"Skin biopsy specimens demonstrate yellowbrown, birefringent crystals in a rectangular or radial pattern within and around vessels [33]. Although clinical lesions may mimic those of cutaneous calciphylaxis, calcium deposition in vessels is not a characteristic finding in cutaneous oxalate emboli [33]."},{"id":25,"chapterId":24,"question":"Neonatal purpura fulminans is caused by severe congenital deficiency or dysfunction of which proteins?","options":["Antithrombin III only","Factor V Leiden","Protein C or Protein S","ADAMTS13"],"correctIndex":2,"explanation":"Homozygous (or compound heterozygous) deficiency or severe dysfunction of either protein C or protein S leads to neonatal purpura fulminans within a few hours to 5 days after birth [34]."},{"id":26,"chapterId":24,"question":"Warfarin necrosis usually develops within which time frame after initiating warfarin therapy, particularly if loading doses are used?","options":["6 to 12 months","2 to 8 weeks","2 to 5 days","More than 1 year"],"correctIndex":2,"explanation":"Warfarin necrosis usually develops within 25 days of warfarin initiation in the absence of heparin, and it is much more likely to occur if loading doses of warfarin are used [35]."},{"id":27,"chapterId":24,"question":"The development of Purpura Fulminans in a septic patient with Disseminated Intravascular Coagulation (DIC) is believed to be caused by an inability of which pathway to prevent clot propagation?","options":["Intrinsic coagulation pathway","Extrinsic coagulation pathway","Protein Cthrombomodulin pathway","Plasminogen activator inhibitor system"],"correctIndex":2,"explanation":"Development of retiform purpura can be the first sign of microvascular thrombosis, possibly due to an inability of the protein Cthrombomodulin pathway to prevent propagation of clot [36]."},{"id":28,"chapterId":24,"question":"A definite diagnosis of Antiphospholipid Antibody Syndrome (APS) requires at least one clinical criterion and one laboratory criterion, with laboratory criteria needing to be present on two or more occasions at least how many weeks apart?","options":["4 weeks","8 weeks","12 weeks","24 weeks"],"correctIndex":2,"explanation":"The definite diagnosis of antiphospholipid antibody syndrome requires at least one clinical and one laboratory criterion [37]. Laboratory criteria must be present on two or more occasions at least 12 weeks apart [38]."},{"id":29,"chapterId":24,"question":"The combination of persistent livedo reticularis/racemosa and recurrent neurologic symptoms due to cerebrovascular disease in a young woman characterizes which disorder?","options":["Livedoid vasculopathy","Sneddon syndrome","Erythema annulare centrifugum","Cutaneous calciphylaxis"],"correctIndex":1,"explanation":"Sneddon syndrome is characterized by the association of persistent livedo reticularis or livedo racemosa with an increased risk of transient ischemic attacks (TIAs) and cerebrovascular accidents (CVAs). It usually affects young women [39, 40]."},{"id":30,"chapterId":24,"question":"The resolution of the painful, punched-out ulcers characteristic of Livedoid Vasculopathy typically results in which distinctive skin finding?","options":["Hyperpigmentation (Schamberg-like)","Annular, erythematous rings (EAC-like)","White, round, or stellate scars with peripheral telangiectasias (atrophie blanche)","Hyperkeratotic, fissured plaques"],"correctIndex":2,"explanation":"Resolution of Livedoid Vasculopathy ulcers classically results in small atrophic white macules with surrounding telangiectasias, referred to as atrophie blanche [41]."},{"id":1,"chapterId":25,"question":"Vasculitis is fundamentally defined as inflammation and destruction of blood vessels leading to:","options":["Angiogenesis and collateral formation","Resultant downstream ischemic tissue damage","Generalized lymphadenopathy","Pauci-immune complex deposition"],"correctIndex":1,"explanation":"Vasculitis is defined as inflammation and destruction of blood vessels with resultant downstream ischemic tissue damage [1]."},{"id":2,"chapterId":25,"question":"The widely accepted classification scheme for vasculitis, including cutaneous forms, is based primarily upon the predominant size of the affected:","options":["Infiltrating immune cells","Involved blood vessels","Extravasated erythrocytes","Fibrinoid deposits"],"correctIndex":1,"explanation":"The classification scheme employed in the sources is based upon the predominant size of the involved blood vessels, as this helps predict the clinical presentation and corresponding histopathologic findings [2]."},{"id":3,"chapterId":25,"question":"In the skin, which structures are categorized as small vessels involved in vasculitis?","options":["Aorta and named arteries","Small arteries and veins of the deep dermis","Arterioles, capillaries, and postcapillary venules","Arteries within the subcutaneous fat"],"correctIndex":2,"explanation":"Small vessels include arterioles, capillaries, and postcapillary venules, which are found in the superficial and mid dermis of the skin [3]."},{"id":4,"chapterId":25,"question":"Which term is strictly a histologic designation referring to transmural infiltration of vessel walls by neutrophils undergoing karyorrhexis?","options":["Cutaneous small vessel vasculitis (CSVV)","Cutaneous vasculitis","Leukocytoclastic vasculitis (LCV)","Acute hemorrhagic edema of infancy (AHEI)"],"correctIndex":2,"explanation":"Leukocytoclastic vasculitis (LCV) is a histologic designation, defined by transmural infiltration of vessel walls (primarily postcapillary venules) by neutrophils undergoing karyorrhexis and fibrinoid necrosis [4], [5]."},{"id":5,"chapterId":25,"question":"Which is the most common type of vasculitis observed in children?","options":["Polyarteritis nodosa (PAN)","Urticarial vasculitis","IgA vasculitis (HenochSchnlein purpura)","Granulomatosis with polyangiitis (GPA)"],"correctIndex":2,"explanation":"The most common type of vasculitis in children is IgA vasculitis (HenochSchnlein purpura) [6], [7]."},{"id":6,"chapterId":25,"question":"Cutaneous small vessel vasculitis (CSVV) resulting from immune complex deposition most commonly presents clinically as:","options":["Fixed subcutaneous nodules","Digital necrosis","Palpable purpura","Ulceration with overlying eschar"],"correctIndex":2,"explanation":"The most common clinical manifestation of CSVV is palpable purpura [8], [9]."},{"id":7,"chapterId":25,"question":"The skin lesions of Cutaneous Small Vessel Vasculitis (CSVV) usually appear how long after the inciting event?","options":["Within hours","710 days","1 month","6 months"],"correctIndex":1,"explanation":"The skin lesions of CSVV usually appear 710 days after the inciting event [10]."},{"id":8,"chapterId":25,"question":"The pathogenesis of ANCA-associated vasculitis is distinguished from immune complex-mediated vasculitis by which feature?","options":["It primarily involves large vessels.","Vessel damage is directly mediated by neutrophils, resulting in \\"pauci-immune\\" disease.","It requires activation of the classic complement pathway.","It is defined by deposition of IgA in the vessel walls."],"correctIndex":1,"explanation":"In ANCA-associated vasculitis, vessel wall damage is directly mediated by neutrophils rather than by immune complex deposition, hence the term pauci-immune vasculitis [11], [12]."},{"id":9,"chapterId":25,"question":"Which cytokine is involved in ANCA-mediated vasculitis by priming neutrophils and endothelial cells to express adhesion molecules?","options":["Interleukin-4 (IL-4)","Tumor necrosis factor (TNF)","Transforming growth factor beta (TGF-)","Interleukin-10 (IL-10)"],"correctIndex":1,"explanation":"In ANCA-mediated vasculitis, following primary activation by cytokines such as tumor necrosis factor (TNF), intracellular proteins from neutrophils... become expressed on the cell surface [12]."},{"id":10,"chapterId":25,"question":"Which clinical finding most strongly suggests involvement of medium-sized vessels in cutaneous vasculitis?","options":["Palpable purpura limited to the ankles","Macular petechiae that are non-blanching","Livedo racemosa, retiform purpura, or ulcers","Transient urticarial papules that resolve within 24 hours"],"correctIndex":2,"explanation":"In medium-sized vessel vasculitis, the affected blood vessels reside within the reticular dermis or subcutis... it typically presents with livedo racemosa, retiform purpura, ulcers, subcutaneous nodules, and/or digital necrosis [13]."},{"id":11,"chapterId":25,"question":"A skin biopsy for Direct Immunofluorescence (DIF) is ideally obtained from lesions of small vessel vasculitis within which time frame to maximize detection of immunoreactants?","options":["Within 4 hours of onset","Within the first 24 to 48 hours of appearance","After 72 hours but before 1 week","Only after systemic symptoms have begun"],"correctIndex":1,"explanation":"For routine processing and DIF, lesions should be biopsied within the first 24 to 48 hours of appearance. Immunoglobulin deposition is highest (up to 100%) in skin lesions present for  48 hours."},{"id":12,"chapterId":25,"question":"Which systemic manifestation is characteristic of small vessel disease, rather than medium-sized vessel vasculitis?","options":["Renal artery aneurysms","Renovascular hypertension","Glomerulonephritis","Digital necrosis"],"correctIndex":2,"explanation":"Systemic manifestations tend to correlate with the size of the affected blood vessels; for example, glomerulonephritis is a manifestation of small vessel disease, while renal artery aneurysms and renovascular hypertension are features of medium-sized vessel vasculitis [16]."},{"id":13,"chapterId":25,"question":"In ANCA-associated vasculitis, the skin biopsy for Direct Immunofluorescence (DIF) is typically:","options":["Positive for IgA deposition","Positive for C3 and IgM","Negative (pauci-immune)","Diagnostic for IgE complexes"],"correctIndex":2,"explanation":"In patients with ANCA-associated vasculitis, the DIF of lesional skin is usually negative [15]."},{"id":14,"chapterId":25,"question":"IgA vasculitis (HenochSchnlein purpura) is defined by which key pathologic feature?","options":["IgM and IgG immune complex deposition","IgA-dominant immune deposits in the small vessel walls","ANCA-mediated pauci-immune infiltration","Granulomatous inflammation of the vessel wall"],"correctIndex":1,"explanation":"IgA vasculitis (IgAV), also referred to as HenochSchnlein purpura (HSP), is a type of vasculitis affecting small blood vessels in which vascular IgA deposition is a key diagnostic and pathophysiologic feature [7]."},{"id":15,"chapterId":25,"question":"The development of nephritis in IgA vasculitis typically occurs within which time frame after the appearance of cutaneous lesions?","options":["Within 1 week","Within the first month of diagnosis (85%)","After 6 months","1 year later"],"correctIndex":1,"explanation":"Renal involvement usually appears within the first month of diagnosis (85%) and develops within six months in > 95% of patients."},{"id":16,"chapterId":25,"question":"Which factor in children with IgA vasculitis is identified as a risk factor for the development of nephritis?","options":["Age <2 years at onset","Female sex","Severe gastrointestinal symptoms","Isolated palpable purpura"],"correctIndex":2,"explanation":"In pediatric patients, risk factors for the development of nephritis include male sex, age > 10 years at onset, severe gastrointestinal symptoms, arthritis/arthralgia, persistent or recurrent purpura, and several laboratory abnormalities [17]."},{"id":17,"chapterId":25,"question":"Which medication is NOT effective in preventing renal disease due to IgA vasculitis and is therefore not recommended for this specific purpose?","options":["Prednisone (systemic corticosteroids)","ACE inhibitor","Angiotensin receptor blocker (ARB)","Dapsone"],"correctIndex":0,"explanation":"Corticosteroids have not been shown to be effective in preventing renal disease due to IgAV and are therefore not recommended [18]."},{"id":18,"chapterId":25,"question":"Acute Hemorrhagic Edema of Infancy (AHEI) most commonly affects children within which age range?","options":["Birth to 4 months","4 to 24 months","2 to 5 years","5 to 10 years"],"correctIndex":1,"explanation":"Acute hemorrhagic edema of infancy (AHEI) is an unusual form of small vessel vasculitis that usually affects children 4 to 24 months of age [19]."},{"id":19,"chapterId":25,"question":"The hallmark clinical features distinguishing Acute Hemorrhagic Edema of Infancy (AHEI) from IgA Vasculitis include:","options":["Chronic renal failure and severe abdominal pain","Tender, non-pitting edema of acral sites and targetoid purpuric plaques","Persistent purpura lasting months and frank arthritis","Fever, leukocytosis, and profound illness"],"correctIndex":1,"explanation":"AHEI key features include annular, circular, or targetoid purpuric plaques on the face and extremities, and tender, non-pitting edema of acral sites [20]. Children typically do not appear ill [21]."},{"id":20,"chapterId":25,"question":"Urticarial vasculitis is clinically distinguished from typical chronic urticaria by the persistence of individual wheal-like lesions for:","options":["Less than 12 hours","Less than 24 hours","More than 24 hours","Exactly 7 days"],"correctIndex":2,"explanation":"Urticarial vasculitis is distinguished from chronic urticaria by the persistence of individual lesions beyond 24 hours [22]."},{"id":21,"chapterId":25,"question":"The hypocomplementemic form of urticarial vasculitis (HUVS) is strongly associated with which autoimmune connective tissue disease?","options":["Psoriatic arthritis","Rheumatoid arthritis (RA)","Systemic lupus erythematosus (SLE)","Systemic sclerosis"],"correctIndex":2,"explanation":"The hypocomplementemic urticarial vasculitis syndrome (HUVS) is typically a more severe syndrome... and is associated with autoimmune connective tissue disease, especially systemic lupus erythematosus (SLE) [23], [24]."},{"id":22,"chapterId":25,"question":"Which clinical feature is characteristic of Erythema Elevatum Diutinum (EED)?","options":["Transient target lesions on the trunk","Symmetric, violaceous plaques favoring the extensor surfaces of joints","Painful vesicles and bullae on the face and oral mucosa","Non-blanchable petechiae that are strongly pruritic"],"correctIndex":1,"explanation":"The typical cutaneous lesions of EED are violaceous, redbrown or yellowish papules, plaques, or nodules that are symmetrically distributed. They favor acral and periarticular sites, in particular the extensor surfaces of the elbows, knees, ankles, hands, and fingers [25]."},{"id":23,"chapterId":25,"question":"The histopathology of late-stage Erythema Elevatum Diutinum (EED) is characterized by a fibrosing leukocytoclastic vasculitis with prominent:","options":["Epidermal bulla formation","Transmural eosinophilic infiltration","Granulation tissue and perivascular/concentric fibrosis","Sarcoidal granulomas"],"correctIndex":2,"explanation":"Older lesions [of EED] are characterized by the presence of granulation tissue and perivascular, concentric, or storiform fibrosis plus mixed inflammation [26]."},{"id":24,"chapterId":25,"question":"Erythema Elevatum Diutinum (EED) is strongly associated with which specific hematologic disorder?","options":["Chronic lymphocytic leukemia (CLL)","IgA monoclonal gammopathy","Essential thrombocythemia","Acute myeloid leukemia"],"correctIndex":1,"explanation":"EED has been described in association with... hematologic disorders, especially IgA monoclonal gammopathy [27]."},{"id":25,"chapterId":25,"question":"Cryoglobulinemic vasculitis involving small and medium-sized vessels (Types II and III) is most commonly secondary to infection with:","options":["Hepatitis B virus (HBV)","Hepatitis C virus (HCV)","Human immunodeficiency virus (HIV)","EpsteinBarr virus (EBV)"],"correctIndex":1,"explanation":"While 40%60% of patients with HCV infection have cryoglobulinemia, overt cryoglobulinemic vasculitis develops in 5%  30% of these individuals."},{"id":26,"chapterId":25,"question":"In Granulomatosis with Polyangiitis (GPA), the most commonly detected ANCA pattern and antigen specificity are:","options":["p-ANCA, anti-MPO","c-ANCA, anti-PR3","p-ANCA, anti-elastase","ANCA-negative"],"correctIndex":1,"explanation":"Patients with GPA most frequently have circulating c-ANCAs and anti-PR3 antibodies [29], [30]."},{"id":27,"chapterId":25,"question":"Which feature is classically present in Granulomatosis with Polyangiitis (GPA) but absent in Microscopic Polyangiitis (MPA)?","options":["Pauci-immune glomerulonephritis","Constitutional symptoms (fever, malaise)","Necrotizing granulomatous inflammation of the respiratory tracts","Purpuric macules and papules"],"correctIndex":2,"explanation":"GPA is classically described as the triad of **granulomatous inflammation** of the upper and lower respiratory tracts, systemic necrotizing vasculitis, and pauci-immune glomerulonephritis [30]. Granulomatous inflammation is absent in MPA [31]."},{"id":28,"chapterId":25,"question":"Microscopic Polyangiitis (MPA) is most frequently associated with which ANCA pattern and antigen specificity?","options":["p-ANCA, anti-MPO","c-ANCA, anti-PR3","ANCA-negative","p-ANCA, anti-lactoferrin"],"correctIndex":0,"explanation":"Anti-MPO antibodies (55%65% of patients) are detected more often than anti-PR3 antibodies (20%30%) in MPA (p-ANCA) [31]."},{"id":29,"chapterId":25,"question":"Eosinophilic Granulomatosis with Polyangiitis (EGPA) is distinguished by a prodromal phase characterized by:","options":["Severe renal failure and hematuria","Recurrent episodes of mononeuritis multiplex","Asthma and allergic rhinitis","Necrotizing vasculitis of the upper respiratory tract"],"correctIndex":2,"explanation":"EGPA is distinguished by an association with asthma and eosinophilia. The prodromal phase involves symptoms of allergic rhinitis, nasal polyps, and asthma [32], [33]."},{"id":30,"chapterId":25,"question":"The characteristic histologic feature of Polyarteritis Nodosa (PAN) in the skin involves segmental necrotizing vasculitis of which specific vessel size?","options":["Capillaries and postcapillary venules (small vessels)","Medium-sized muscular arteries in the deep dermis/subcutis","Aorta and named large arteries","Arterioles in the papillary dermis"],"correctIndex":1,"explanation":"The histology of PAN is characterized by segmental necrotizing vasculitis of medium-sized muscular arteries [34]. In the skin, affected medium-sized vessels are located within the deep dermis and subcutaneous fat [34]."},{"id":1,"chapterId":26,"question":"Histologically, neutrophilic dermatoses are characterized by perivascular and diffuse dermal or subcutaneous neutrophilic infiltrates without the presence of:","options":["Identifiable infectious agents","Leukocytoclasia","Fibrinoid necrosis","Associated edema"],"correctIndex":0,"explanation":"Histologically, these disorders are characterized by perivascular and diffuse dermal or subcutaneous neutrophilic infiltrates without identifiable infectious agents."},{"id":2,"chapterId":26,"question":"Granulocyte colony-stimulating factor (G-CSF) plays a critical role in regulating the development of which cell type?","options":["Eosinophils","Basophils","Neutrophils","Monocytes"],"correctIndex":2,"explanation":"Granulocyte colony-stimulating factor (G-CSF) plays a critical role in regulation of neutrophil development."},{"id":3,"chapterId":26,"question":"Which term refers to the process where neutrophils set extracellular traps composed of histones and antimicrobial granular proteins?","options":["Apoptosis","NETosis","Phagocytosis","Diapedesis"],"correctIndex":1,"explanation":"NETosis also occurs, representing the process of setting neutrophil extracellular traps; these traps are composed of histones and antimicrobial granular and cytoplasmic proteins."},{"id":4,"chapterId":26,"question":"The contents of primary (azurophilic) granules, which are acquired at the promyelocyte stage of neutrophil maturation, include:","options":["Myeloperoxidase, lysozyme, and defensins","Lactoferrin and neutrophil collagenase","Gelatinase B (MMP9)","Vascular cell adhesion molecule (VCAM)"],"correctIndex":0,"explanation":"Primary (azurophilic) granules  acquired at the promyelocyte stage and their contents include myeloperoxidase, lysozyme, neutrophil elastase, defensins, proteinase 3, cathepsin 3, and bactericidal/permeability-increasing protein."},{"id":5,"chapterId":26,"question":"Which proinflammatory cytokine plays a key role in neutrophilic inflammation by upregulating G-CSF activity and enhancing production of IL-8?","options":["IL-1","TNF","IL-17","IL-23"],"correctIndex":2,"explanation":"Proinflammatory cytokines that play a key role in neutrophilic inflammation include IL-1, TNF, and IL-17. The latter [IL-17] upregulates G-CSF activity, which is important for neutrophil differentiation and release, and it enhances production of IL-8."},{"id":6,"chapterId":26,"question":"Sweet syndrome is defined as Acute Febrile Neutrophilic Dermatosis. Which systemic sign is common (50%) in this condition?","options":["Fever and Leukocytosis","Aseptic meningitis","Mesangial glomerulonephritis","Sensorineural hearing loss"],"correctIndex":0,"explanation":"Common (50%) systemic manifestations of Sweet syndrome include Fever and Leukocytosis."},{"id":7,"chapterId":26,"question":"Sweet syndrome disproportionately affects women, with a reported female to male predominance of:","options":["4 to 1","2 to 1","1 to 1","1 to 3"],"correctIndex":0,"explanation":"The average age of onset is 3060 years... there is a female predominance of 4 to 1."},{"id":8,"chapterId":26,"question":"Histologically, the characteristic presentation of Sweet syndrome is a dense, diffuse dermal infiltrate predominantly composed of neutrophils without definitive evidence of:","options":["Leukocytoclasia","Dermal edema","A dense perivascular infiltrate","Vasculitis"],"correctIndex":3,"explanation":"The characteristic histologic presentation is a dense, diffuse dermal nodular and perivascular neutrophilic infiltrate without evidence of vasculitis, although occasionally leukocytoclastic vasculitis (LCV) can be observed."},{"id":9,"chapterId":26,"question":"Which malignancy category is the most frequent associated disorder with Sweet syndrome (15%30% of cases)?","options":["Hematologic malignancies (e.g., AML)","Solid organ carcinomas (e.g., lung)","Cutaneous T-cell lymphoma","Melanoma"],"correctIndex":0,"explanation":"At least half of patients have an identifiable associated disorder or trigger: 15%30% have an internal malignancy (hematologic >> solid organ)."},{"id":10,"chapterId":26,"question":"Which severe clinical manifestation is a recognized variant of Sweet syndrome that may mimic necrotizing fasciitis?","options":["Subcutaneous Sweet syndrome","Targetoid variant","Necrotizing neutrophilic dermatosis","Pseudovesicular appearance"],"correctIndex":2,"explanation":"A subset of patients, often with systemic involvement, can develop lesions that mimic necrotizing fasciitis, referred to as necrotizing neutrophilic dermatosis."},{"id":11,"chapterId":26,"question":"Which drug class is listed among the most common triggers for drug-induced Sweet syndrome?","options":["Colony stimulating factors (e.g., G-CSF)","NSAIDs (e.g., celecoxib)","Antibiotics (e.g., minocycline)","TNF inhibitors (e.g., adalimumab)"],"correctIndex":0,"explanation":"The most common associated drugs are Colony stimulating factors (e.g. G-CSF, GM-CSF, pegfilgrastim) and All-trans-retinoic acid (ATRA) > other retinoids."},{"id":12,"chapterId":26,"question":"A relapsing localized variant of Sweet syndrome has been described to occur within areas of lymphedema or at sites of:","options":["Prior exposure to ultraviolet light","Orthopedic implants","Deep vein thrombosis","Previous arthropod bites"],"correctIndex":1,"explanation":"A relapsing localized variant can develop within areas of lymphedema or at sites of orthopedic implants."},{"id":13,"chapterId":26,"question":"Which of the following is NOT a major criterion for the diagnosis of Sweet syndrome, according to the widely accepted criteria?","options":["Abrupt onset of typical cutaneous lesions","Histopathology consistent with Sweet syndrome","Excellent response to systemic corticosteroids","Both major criteria are required"],"correctIndex":2,"explanation":"The major criteria are: 1. Abrupt onset of typical cutaneous lesions and 2. Histopathology consistent with Sweet syndrome. Excellent response to systemic corticosteroids is a minor criterion."},{"id":14,"chapterId":26,"question":"The histiocytoid variant of Sweet syndrome is characterized by cells that represent immature myeloid cells and stain positively for:","options":["Factor VIII","CD30","Myeloperoxidase (MPO)","S100"],"correctIndex":2,"explanation":"The histiocytoid variant is characterized by a dermal... infiltrate composed of histiocyte-like immature myeloid cells. These cells have myeloperoxidase activity."},{"id":15,"chapterId":26,"question":"What is the most effective first-line systemic therapy for Sweet syndrome, typically initiated at a dose of 0.51.0 mg/kg/day?","options":["Dapsone","Oral prednisone","Colchicine","Potassium iodide"],"correctIndex":1,"explanation":"The most effective therapy for Sweet syndrome is oral prednisone (0.51.0 mg/kg/day) for 26 weeks."},{"id":16,"chapterId":26,"question":"The characteristic lesion of Pyoderma Gangrenosum (PG) is an expanding ulcer with an irregular, necrotic undermined border, and a base that may be:","options":["Hyperkeratotic and fissured","Purulent or vegetative","Fixed and hemorrhagic","Dusky and non-inflammatory"],"correctIndex":1,"explanation":"Characteristic lesion is an expanding ulcer with a necrotic undermined border; the base may be purulent or vegetative."},{"id":17,"chapterId":26,"question":"Nearly half of patients with Pyoderma Gangrenosum have an underlying systemic disease, most commonly involving:","options":["Autoimmune thyroiditis","Sarcoidosis","Systemic lupus erythematosus","Inflammatory bowel disease, arthritis, or a hematologic disorder"],"correctIndex":3,"explanation":"Nearly half of the patients have an underlying systemic disease, most commonly inflammatory bowel disease, arthritis, or a hematologic disorder."},{"id":18,"chapterId":26,"question":"The bullous variant of PG (atypical PG) frequently favors the face and upper extremities and occurs most commonly in the setting of:","options":["Rheumatoid arthritis","Acute myelogenous leukemia and myelodysplasia","Crohn disease","Hepatitis C virus infection"],"correctIndex":1,"explanation":"The bullous variant... occurs most commonly in the setting of acute myelogenous leukemia, myelodysplasia, IgA monoclonal gammopathy, and myeloproliferative disorders."},{"id":19,"chapterId":26,"question":"The phenomenon where new lesions develop in PG following minor trauma, such as needle sticks, is known as:","options":["Pathergy","Koebner phenomenon","Nikolsky sign","Darier sign"],"correctIndex":0,"explanation":"Pathergy is seen in 20%30% of patients with PG and not only does this phenomenon lead to new cutaneous lesions but it can also aggravate them."},{"id":20,"chapterId":26,"question":"In patients with typical (classic) Pyoderma Gangrenosum, the ulcers most frequently occur on which body site?","options":["The face and neck","The trunk and axillae","The palms and soles","The lower extremities, especially the pretibial area"],"correctIndex":3,"explanation":"Cutaneous lesions are painful and most frequently occur on the lower extremities in patients with typical (classic) PG, especially the pretibial area."},{"id":21,"chapterId":26,"question":"Healing of Pyoderma Gangrenosum ulcers typically results in which distinctive skin finding?","options":["Hypertrophic scars and keloids","Atrophic cribriform pigmented scars","Pustular plaques with surrounding edema","Annular, non-scarring erythema"],"correctIndex":1,"explanation":"Re-epithelialization occurs from the margins and the ulcers heal with atrophic cribriform pigmented scars."},{"id":22,"chapterId":26,"question":"Which medication, alongside systemic corticosteroids, is considered a first-line therapeutic option for severe Pyoderma Gangrenosum, based upon an evidence-based review?","options":["Cyclosporine","Methotrexate","Dapsone","Colchicine"],"correctIndex":0,"explanation":"The standard medical treatment of PG is local or combined local and systemic corticosteroid therapy, with or without adjunctive systemic therapy; based upon an evidence-based review, cyclosporine is also considered first-line therapy."},{"id":23,"chapterId":26,"question":"In the Delphi Consensus Criteria for PG diagnosis, which feature is listed as a major criterion?","options":["Cribriform or wrinkled paper scars at healed ulcer sites","Progressive course","Absence of relevant differential diagnoses","Amelioration due to immunosuppressant"],"correctIndex":2,"explanation":"Major criterion [Delphi Consensus]: Absence of relevant differential diagnoses."},{"id":24,"chapterId":26,"question":"Behet disease is geographically most prevalent in regions along which ancient trade route?","options":["The Amber Road","The Silk Route","The Spice Route","The Trans-Saharan Trade Route"],"correctIndex":1,"explanation":"Most patients are from regions along the ancient Silk Route, which stretched from the Korean peninsula and Japan to the Mediterranean Sea."},{"id":25,"chapterId":26,"question":"Which clinical manifestation is listed as the major criterion required for the diagnosis of Behet disease, according to the International Study Group criteria?","options":["Recurrent genital ulceration","Ocular lesions (e.g., uveitis)","Positive pathergy test","Recurrent oral ulceration (aphthous stomatitis)"],"correctIndex":3,"explanation":"The major criterion required is Recurrent oral ulceration: Aphthous (idiopathic) oral ulceration observed by physician or patient, recurring at least three times in a 12-month period."},{"id":26,"chapterId":26,"question":"In Behet disease, which ocular finding is described as the most characteristic, often leading to severe morbidity and potential blindness?","options":["Conjunctivitis","Posterior uveitis","Scleritis","Anterior uveitis"],"correctIndex":1,"explanation":"Posterior uveitis (most characteristic ocular finding) [is seen in Behet disease]."},{"id":27,"chapterId":26,"question":"Bowel-associated dermatosisarthritis syndrome (BADAS) is thought to be mediated by resultant immune complexes containing:","options":["Bacterial antigens","Immunoglobulin A (IgA)","Neutrophil elastase","Fibrinogen"],"correctIndex":0,"explanation":"It is postulated that resultant immune complexes containing bacterial antigens are then deposited within the skin and synovium."},{"id":28,"chapterId":26,"question":"The characteristic skin lesions of BADAS (erythematous macules progressing to papules and purpuric vesiculopustules) typically appear within how long after constitutional symptoms begin?","options":["12 hours","48 hours","7 to 10 days","4 to 6 weeks"],"correctIndex":1,"explanation":"The characteristic skin lesions are erythematous macules which progress to papules and purpuric vesiculopustules within 48 hours and last for 24 weeks."},{"id":29,"chapterId":26,"question":"The acronym SAPHO syndrome stands for Synovitis, Acne, Pustulosis, Hyperostosis, and:","options":["Ophthalmopathy","Osteomyelitis","Otorrhea","Osteitis"],"correctIndex":3,"explanation":"The acronym SAPHO (synovitis, acne, pustulosis, hyperostosis and osteitis) syndrome was coined to describe this clinicoradiologic entity that involves skin, bone, and joints."},{"id":30,"chapterId":26,"question":"Erosive Pustular Dermatosis (EPD) most commonly develops within which specific location on older adults?","options":["The feet and ankles (stasis dermatitis area)","Photodamaged, atrophic skin of the midline scalp","The intertriginous folds (axillae and groin)","The dorsal hands (similar to neutrophilic dermatosis of the dorsal hands)"],"correctIndex":1,"explanation":"The most common site of involvement is the photodamaged skin of the midline scalp in an elderly adult."},{"id":1,"chapterId":27,"question":"What is the typical size and nuclear structure of an eosinophil leukocyte?","options":["~58 microns with a polysegmented nucleus","~1016 microns with a segmented (usually bi-lobed) nucleus","~2025 microns with an unsegmented, large nucleus","~1016 microns with a ring-shaped nucleus"],"correctIndex":1,"explanation":"The eosinophil is a leukocyte approximately 1016 microns in diameter that possesses a segmented (usually bi-lobed) nucleus [1]."},{"id":2,"chapterId":27,"question":"Under normal conditions, the circulating eosinophil count in human blood ranges from:","options":["0 to 50 cells/mcl","0 to 500 cells/mcl","500 to 1500 cells/mcl","1500 to 5000 cells/mcl"],"correctIndex":1,"explanation":"Under normal conditions, circulating eosinophil counts range from 0 to 500 cells/mcl of human blood [1]."},{"id":3,"chapterId":27,"question":"Which cytokine is the most potent activator of eosinophils, followed by IL-3 and IL-5, in order of potency?","options":["IL-4","Granulocyte-macrophage colony-stimulating factor (GM-CSF)","Interleukin-10 (IL-10)","Tumor necrosis factor (TNF)"],"correctIndex":1,"explanation":"Eosinophils are activated by GM-CSF, followed by IL-3, IL-5, TNF, and IL-4, in order of potency [2]."},{"id":4,"chapterId":27,"question":"Glucocorticoids help treat eosinophil-driven conditions, in part by inducing which process in eosinophils?","options":["Chemotaxis","Prolonged survival","Apoptosis","Granulocyte colony-stimulating factor (G-CSF) release"],"correctIndex":2,"explanation":"Glucocorticoids can counteract the prolonged survival induced by IL-3, IL-5, and GM-CSF, which may in part explain their therapeutic efficacy in most eosinophil-driven conditions, as they induce apoptosis [2]."},{"id":5,"chapterId":27,"question":"Which surface receptors, expressed on eosinophils and mast cells, mediate apoptosis?","options":["VLA-4 and VCAM-1","Toll-like receptors (TLR) 7 and 9","Siglec-8 and Siglec-10","CCR-3"],"correctIndex":2,"explanation":"The surface receptors sialic acid-binding immunoglobulin-like lectins (Siglec)-8 and -10, which are expressed on eosinophils and mast cells, have been shown to mediate apoptosis [2]."},{"id":6,"chapterId":27,"question":"Eotaxins (CCL11, 2, and 3) are crucial chemotactic factors for eosinophils and signal primarily through which receptor?","options":["VLA-4","CCR-3","FcRIII (Fc gamma Receptor III)","P2X4"],"correctIndex":1,"explanation":"Eotaxins 1, 2, and 3 signal primarily through C-C chemokine receptor (CCR)-3, which is highly expressed on eosinophils [3, 4]."},{"id":7,"chapterId":27,"question":"Eosinophil Major Basic Protein 1 (eMBP1), the constituent of the granules' crystalline cores, performs which specific function?","options":["Cleaving ultra-large von Willebrand factor multimers","Inducing basophil histamine release","Inhibiting complement activation at C5","Neutralizing histamine and serotonin"],"correctIndex":1,"explanation":"eMBP1 directly damages helminths and mammalian cells [5]. In addition, eMBP1, but none of the other eosinophil granule proteins, induces basophil histamine release [5]."},{"id":8,"chapterId":27,"question":"Eosinophil peroxidase (EPO) kills microorganisms in the presence of hydrogen peroxide and halides. This combination of products also initiates secretion from which cell type?","options":["Keratinocytes","T lymphocytes","Mast cells","Fibroblasts"],"correctIndex":2,"explanation":"Eosinophil peroxidase (EPO) kills numerous microorganisms in the presence of hydrogen peroxide... and halides [6]. This combination of products also initiates mast cell secretion [6]."},{"id":9,"chapterId":27,"question":"Cytolytic degranulation, which occurs in hypereosinophilic syndromes (HES) and atopic dermatitis, is characterized by extensive deposition of eosinophil granule products and:","options":["Fusion of mast cells and basophils","Organelle rupture and loss of morphologic integrity of the eosinophil nucleus","Increased surface expression of VCAM-1","Conversion of arachidonic acid to leukotriene B4"],"correctIndex":1,"explanation":"Cytolytic degranulation is characterized by organelle rupture, chromatolysis of nuclei with loss of morphologic integrity, and extensive deposition of eosinophil granules and granule products within tissue [7, 8]."},{"id":10,"chapterId":27,"question":"Which adhesion molecule is constitutively expressed by eosinophils to facilitate their transmigration across blood vessels by adhering to endothelial VCAM-1?","options":["Very late antigen (VLA)-4","P-selectin","ICAM-1","CharcotLeyden crystal protein"],"correctIndex":0,"explanation":"Eosinophils constitutively express very late antigen (VLA)-4, the ligand for vascular cell adhesion molecule (VCAM)-1, which is important for transmigration [3]."},{"id":11,"chapterId":27,"question":"Mucocutaneous lesions occur in over 50% of patients with Hypereosinophilic Syndromes (HES), most commonly presenting as:","options":["Fixed brown hyperpigmentation and alopecia","Pruritic erythematous papules or nodules, urticaria, and angioedema","Palpable purpura limited to the lower extremities","Subcorneal pustules without pruritus"],"correctIndex":1,"explanation":"Mucocutaneous lesions occur in over 50% of patients with hypereosinophilic syndromes (HESs), most commonly presenting as pruritic erythematous papules or nodules, urticaria, angioedema, and/or mucosal ulcers [9, 10]."},{"id":12,"chapterId":27,"question":"Histologically, the hallmark finding of Wells syndrome (Eosinophilic cellulitis) is the presence of:","options":["Dense, diffuse dermal nodular neutrophilic infiltrates","Extensive subepidermal bullae due to basement membrane antibodies","Foci of amorphous/granular material termed 'flame figures'","Segmental necrotizing vasculitis of medium-sized arteries"],"correctIndex":2,"explanation":"Histologically, a diffuse dermal infiltrate composed of eosinophils and histiocytes is seen as are foci of amorphous/granular material, termed flame figures, which reflect localized degranulation of eosinophils [11]. The classic histopathologic findings consist of a diffuse dermal infiltrate of eosinophils plus characteristic flame figures [12]."},{"id":13,"chapterId":27,"question":"In Wells syndrome, the markedly edematous plaques most frequently affect which body sites?","options":["The face and neck","The trunk only","The extremities","The palms and soles"],"correctIndex":2,"explanation":"The extremities are most frequently affected, but involvement of the trunk can also be seen [13]."},{"id":14,"chapterId":27,"question":"Patients presenting with Wells syndrome are often misdiagnosed clinically as having:","options":["Chronic spontaneous urticaria","Livedoid vasculopathy","Erysipelas or acute cellulitis","Granuloma annulare"],"correctIndex":2,"explanation":"Patients are often misdiagnosed as having erysipelas or acute cellulitis [13]. Early on, bacterial cellulitis and erysipelas are the most common clinical mimics [14]."},{"id":15,"chapterId":27,"question":"Flame figures, seen in Wells syndrome and other eosinophil-rich dermatoses, histologically consist of:","options":["Apoptotic keratinocytes forming membrane-bound vesicles","Eosinophil granule proteins coating collagen fibers","Deposits of C3 and C4 complement components","Microthrombi composed of fibrin and platelets"],"correctIndex":1,"explanation":"The characteristic brightly eosinophilic flame figures consist of collagen fibers coated with eosinophil granule proteins [15]. Extracellular eMBP1 from eosinophil granules has been localized to flame figures [15, 16]."},{"id":16,"chapterId":27,"question":"Eosinophilic annular erythema (EAE) is considered by many authors to be a subset of which specific eosinophil-associated dermatosis?","options":["Urticaria multiforme","Hypereosinophilic syndrome (HES)","Wells syndrome","Atopic dermatitis"],"correctIndex":2,"explanation":"Eosinophilic annular erythema (EAE) is also in the differential diagnosis [of Wells syndrome], but this entity is considered by many to be a subset of Wells syndrome [17]."},{"id":17,"chapterId":27,"question":"What is the typical first-line treatment for Wells syndrome, known for producing dramatic improvement within a few days?","options":["Topical calcineurin inhibitors","Oral prednisone","Dapsone","Anti-IL-5 monoclonal antibodies (e.g., Mepolizumab)"],"correctIndex":1,"explanation":"Initial therapy with prednisone 1080 mg daily results in dramatic improvement within a few days in most patients [18]. Dramatic improvement after administration of systemic corticosteroids is a key feature [12]."},{"id":18,"chapterId":27,"question":"Primary (neoplastic) Hypereosinophilic Syndrome (HES), including eosinophilic leukemia, is frequently caused by a fusion gene involving:","options":["BCR-ABL","FIP1L1-PDGFRA","JAK2 V617F","HLA-B*15:02"],"correctIndex":1,"explanation":"The *FIP1L1-PDGFRA* fusion gene, due to a chromosomal translocation, leads to a constitutively activated tyrosine kinase and is present in patients with primary (neoplastic) HES [19-23]."},{"id":19,"chapterId":27,"question":"The *FIP1L1-PDGFRA* fusion protein, a constitutively activated tyrosine kinase, is specifically targeted by which medication?","options":["Cyclosporine","Imatinib mesylate","Benralizumab","Interferon-"],"correctIndex":1,"explanation":"The protein product of the *FIP1L1-PDGFRA* fusion gene is a constitutively activated tyrosine kinase that is 100 times more sensitive to inhibition by imatinib [20]. If *FIP1L1-PDGFRA* or other genetic abnormalities involving *PDGFRA* or *PDGFRB* are present, imatinib therapy is warranted [24]."},{"id":20,"chapterId":27,"question":"The lymphocytic (lymphoid) subtype of secondary (reactive) HES is characterized by hypereosinophilia driven by clonal T cells producing an excess of which cytokines?","options":["Th2 cytokines, particularly IL-5","Th1 cytokines, particularly IFN-","GM-CSF and IL-1","TGF- and TNF"],"correctIndex":0,"explanation":"The lymphocytic (lymphoid) subtype of secondary (reactive) HES is characterized by a clonal proliferation of T cells with increased production of Th2 cytokines, particularly IL-5 [20, 25]."},{"id":21,"chapterId":27,"question":"Peripheral blood hypereosinophilia, a diagnostic criterion for HES, is defined as a count greater than:","options":["500 times 10^9/L on one occasion","1.0 times 10^9/L on one occasion","1.5 times 10^9/L on two examinations at an interval of one month or greater","5.0 times 10^9/L on any occasion"],"correctIndex":2,"explanation":"Peripheral blood hypereosinophilia is defined as > 1.5 eosinophils times 10^9 L blood >1500 eosinophils/mcl) on two examinations at an interval of one month or greater."},{"id":22,"chapterId":27,"question":"Which complication due to sustained tissue eosinophilia is described as a life-threatening form of end-organ damage in HES?","options":["Bullous pemphigoid","Endomyocardial fibrosis and/or thrombosis","Severe acne conglobata","Myasthenia gravis"],"correctIndex":1,"explanation":"End-organ damage may occur from sustained tissue eosinophilia, including life-threatening endomyocardial fibrosis and/or thrombosis [20]."},{"id":23,"chapterId":27,"question":"Eosinophils elaborate several inflammatory and regulatory cytokines, including which transforming growth factor that is associated with tissue remodeling and fibrosis?","options":["IL-4","TGF- and TGF- 1","IL-12","IL-10"],"correctIndex":1,"explanation":"Eosinophils themselves elaborate important inflammatory and regulatory cytokines, including... TGF- and TGF- 1 . Eosinophil infiltration is associated with tissue remodeling and fibrosis [28]."},{"id":24,"chapterId":27,"question":"In patients receiving imatinib therapy for HES, which cardiac biomarker should be routinely monitored due to the risk of endomyocardial disease worsening during the first several weeks of treatment?","options":["Troponin I","N-terminal pro-brain natriuretic peptide (NT-proBNP)","Creatine kinase (CK-MB)","D-dimer"],"correctIndex":1,"explanation":"Because endomyocardial disease may worsen during the first several weeks of imatinib therapy, N-terminal pro-brain natriuretic peptide (NT-proBNP) should be monitored [24, 29]."},{"id":25,"chapterId":27,"question":"A key characteristic finding in the histopathology of affected organs in IgG4-related disease (IgG4-RD) is the presence of dense infiltrates of lymphocytes and plasma cells, where IgG4+ to IgG+ plasma cells exceed:","options":["10%","40%","75%","90%"],"correctIndex":1,"explanation":"Histopathology of affected organ(s)/tissue(s) in IgG4-RD shows IgG4+ to IgG+ plasma cells >40% and >10 IgG4+ plasma cells/hpf."},{"id":26,"chapterId":27,"question":"Which cutaneous disorder is proposed as a potential cutaneous manifestation of IgG4-related disease (IgG4-RD)?","options":["Bullous Pemphigoid","Granuloma faciale","Erythema toxicum neonatorum","Scabies"],"correctIndex":1,"explanation":"Proposed cutaneous manifestations [of IgG4-RD] are granuloma faciale and lesions that resemble angiolymphoid hyperplasia with eosinophilia [31]."},{"id":27,"chapterId":27,"question":"Which cutaneous presentation in patients with Hypereosinophilic Syndromes (HES) occurs almost exclusively in the primary (neoplastic) HES variant and suggests thrombosis?","options":["Annular erythema centrifugum-like lesions","Livedo reticularis, retiform purpura, or superficial thrombophlebitis","Pruritic papules on the face and upper trunk","Urticaria limited to the trunk"],"correctIndex":1,"explanation":"Other cutaneous manifestations include erythema annulare centrifugum-like lesions, livedo reticularis, retiform purpura, and superficial thrombophlebitis, with the thrombotic entities occurring almost exclusively in primary HES [10]. Signs of cutaneous thromboses (e.g., retiform purpura) are noted in Myeloid HES [21]."},{"id":28,"chapterId":27,"question":"Eosinophilic dermatosis associated with hematologic malignancy is most common in patients with:","options":["Acute myelogenous leukemia (AML)","Chronic lymphocytic leukemia (CLL)","Multiple myeloma","Myelodysplastic syndrome (MDS)"],"correctIndex":1,"explanation":"Eosinophilic dermatosis associated with hematological disorders is most common in patients with CLL, but reported in patients with other hematologic malignancies [32, 33]."},{"id":29,"chapterId":27,"question":"Papuloerythroderma of Ofuji is characterized clinically by widespread, pruritic, redbrown papules with which distinctive feature?","options":["Palpable purpura on the lower legs","Recurrent subcutaneous masses of the head and neck","Characteristic sparing of the skin folds ('deck-chair' sign)","Fixed, painful ulcers with undermined borders"],"correctIndex":2,"explanation":"Papuloerythroderma of Ofuji is characterized by widespread, pruritic, redbrown papules that may become more confluent with characteristic sparing of the skin folds ('deck-chair' sign) [34]."},{"id":30,"chapterId":27,"question":"Which severe eosinophil-associated vasculitis is characterized by prominent IgG4 and IgE responses, peripheral blood eosinophilia, and a history of asthma or allergic rhinitis?","options":["Polyarteritis nodosa (PAN)","Eosinophilic Granulomatosis with Polyangiitis (EGPA) (ChurgStrauss syndrome)","IgA vasculitis","Erythema Elevatum Diutinum (EED)"],"correctIndex":1,"explanation":"Eosinophilic granulomatosis with polyangiitis (EGPA; ChurgStrauss syndrome) presents with peripheral blood eosinophilia; pulmonary (e.g. asthma), neurologic (e.g. mononeuritis multiplex), and cardiac involvement; prominent IgG4 and IgE responses [35, 36]. EGPA is listed as an eosinophil-associated dermatosis [37]."},{"id":1,"chapterId":28,"question":"The IgG1 autoantibodies in Gestational Pemphigoid are directed against which transmembrane hemidesmosomal protein?","options":["BP230","BP180; BPAG2; collagen XVII","Laminin 5","Type VII collagen"],"correctIndex":1,"explanation":"IgG1 autoantibodies in Gestational Pemphigoid are directed against a 180 kDa transmembrane hemidesmosomal protein (BP180; BPAG2; collagen XVII) [1, 2]."},{"id":2,"chapterId":28,"question":"What is the essential immunofluorescence finding for the diagnosis of gestational pemphigoid, seen in 100% of patients?","options":["Linear IgG along the basement membrane zone (BMZ)","Granular IgA in the dermis","Linear C3 deposition along the BMZ","Granular C3 in the superficial dermis"],"correctIndex":2,"explanation":"The essential component for the diagnosis of gestational pemphigoid is a linear deposition of C3 along the BMZ of perilesional skin by direct IF microscopy, which is observed in 100% of patients [3-5]."},{"id":3,"chapterId":28,"question":"Gestational Pemphigoid classically presents during late pregnancy with abrupt onset of cutaneous lesions typically within or immediately adjacent to which site?","options":["The flexural extremities","The soles and palms","The umbilicus","The face"],"correctIndex":2,"explanation":"Gestational pemphigoid classically presents during late pregnancy with an abrupt onset of cutaneous lesions on the trunk, in particular the abdomen and often within or immediately adjacent to the umbilicus [5, 6]."},{"id":4,"chapterId":28,"question":"In what percentage of patients with Gestational Pemphigoid does a flare occur at the time of delivery?","options":["10%","25%","50%","75%"],"correctIndex":3,"explanation":"Spontaneous improvement during late gestation is common, but this is followed by a flare at the time of delivery in 75% of patients [6]."},{"id":5,"chapterId":28,"question":"Gestational Pemphigoid is associated with an increased risk of prematurity and small-for-gestational age neonates. This risk correlates with what specific factor?","options":["Maternal age > 35 years","Disease severity (blistering and early onset)","The presence of anti-HLA antibodies","Simultaneous presence of HLA DR3 and DR4"],"correctIndex":1,"explanation":"There seems to be an increased risk of prematurity and small-for-gestational age neonates, and this risk correlates with disease severity, i.e., occurrence of blistering and early onset [1, 7, 8]."},{"id":6,"chapterId":28,"question":"Which term did Milton first use in 1872 for the condition now known as Gestational Pemphigoid?","options":["Pemphigoid gestationis","Herpes gestationis","Toxaemic rash of pregnancy","Papular dermatitis of pregnancy"],"correctIndex":1,"explanation":"Milton first coined the term 'herpes gestationis' in 1872 [9]."},{"id":7,"chapterId":28,"question":"Histologically, the most constant feature of gestational pemphigoid, even in the absence of a subepidermal vesicle, is the presence of a variable number of:","options":["Plasma cells","Neutrophils","Eosinophils","Giant cells"],"correctIndex":2,"explanation":"The presence of eosinophils is the most constant histologic feature of gestational pemphigoid [3]."},{"id":8,"chapterId":28,"question":"The most effective systemic therapy for Gestational Pemphigoid is oral prednisolone, usually started at 0.5 mg/kg daily. Why is prednisolone preferred over other systemic corticosteroids?","options":["It has a lower risk of fetal adrenal suppression.","It is largely inactivated in the placenta (mother:fetus = 10:1).","It does not cause oral clefts in the first trimester.","It is not excreted in breast milk."],"correctIndex":1,"explanation":"Prednisolone is the systemic corticosteroid of choice for dermatologic indications as it is largely inactivated in the placenta (mother : fetus = 10 : 1) [10, 11]."},{"id":9,"chapterId":28,"question":"Polymorphic Eruption of Pregnancy (PEP) is a common gestational dermatosis formerly known by which acronym, which describes its initial clinical findings?","options":["AEP","ICP","PUPPP","HUVS"],"correctIndex":2,"explanation":"Polymorphic eruption of pregnancy (PEP), formerly known as PUPPP (Pruritic urticarial papules and plaques of pregnancy), is a common gestational dermatosis [12, 13]."},{"id":10,"chapterId":28,"question":"The initial lesions of PEP, which typically appear within the abdominal striae, are usually:","options":["Tense bullae","Purpuric papules","Urticarial papules and plaques","Widespread eczematous plaques"],"correctIndex":2,"explanation":"While pruritic urticarial papules are the initial lesions in almost all patients [14, 15], PEP is characterized by urticarial papules and plaques that usually first appear within striae distensae [12]."},{"id":11,"chapterId":28,"question":"Polymorphic Eruption of Pregnancy onset is most often during which time period?","options":["First trimester","Second trimester","Latter part of the third trimester or immediate postpartum period","More than 6 months postpartum"],"correctIndex":2,"explanation":"Onset is most often during the latter part of the third trimester (85%) or in the immediate postpartum period (15%) [14]."},{"id":12,"chapterId":28,"question":"Which characteristic typically distinguishes PEP lesions from Gestational Pemphigoid lesions on the abdomen?","options":["Involvement of the umbilicus","Periumbilical sparing","The presence of urticarial papules","The presence of vesicles"],"correctIndex":1,"explanation":"Pruritic erythematous and edematous papules and plaques usually first appear within the abdominal striae, typically with periumbilical sparing (Fig. 27.4) [14, 15]."},{"id":13,"chapterId":28,"question":"PEP has been suggested to be caused by damage to connective tissue in stretched abdominal skin. Which related factor is suggested to prevent recurrence in subsequent pregnancies?","options":["Increased progesterone levels","Fetal DNA deposition (peripheral chimerism)","Immune tolerance","Increased maternal weight gain"],"correctIndex":2,"explanation":"Immune tolerance during subsequent pregnancies might prevent recurrence [16]."},{"id":14,"chapterId":28,"question":"Intrahepatic Cholestasis of Pregnancy (ICP) is the most important diagnosis to exclude in a pregnant patient with pruritus because it is associated with significant fetal risk, specifically increased risk of:","options":["Congenital heart defects and neural tube defects","Intrapartum fetal distress and stillbirths","Neonatal lupus and permanent skin scarring","Severe anemia and thrombocytopenia"],"correctIndex":1,"explanation":"ICP is associated with significant fetal risk, in particular an increase in premature labor (20%60%), intrapartal fetal distress (20%30%), and stillbirths (1%2%) [17-20]."},{"id":15,"chapterId":28,"question":"What is the key clinical characteristic of Intrahepatic Cholestasis of Pregnancy (ICP) upon presentation?","options":["Tense bullae on the umbilical area","Eczematous lesions on flexural surfaces","Pruritus without primary skin lesions","Purulent folliculitis of the trunk"],"correctIndex":2,"explanation":"ICP is characterized by pruritus without primary skin lesions, with an onset during the third trimester [17, 21]."},{"id":16,"chapterId":28,"question":"Pruritus in ICP typically starts on which specific sites?","options":["The palms and soles","The abdominal striae","The back and buttocks","The face and scalp"],"correctIndex":0,"explanation":"Patients typically present during their last trimester with a sudden onset of intense, generalized pruritus that often starts on the palms and soles [21]."},{"id":17,"chapterId":28,"question":"In ICP, fetal risk correlates with serum bile acid levels. Prompt diagnosis and treatment are essential, especially when levels exceed which threshold?","options":["Normal non-pregnant range (0-6 mol/l","11 mol/l","40 mol/l","100 mol/l"],"correctIndex":2,"explanation":"Fetal risk correlates with the elevation in serum bile acid levels, especially when levels exceed 40 mol/l."},{"id":18,"chapterId":28,"question":"Which medication is the only successful oral agent to date for treating ICP, though its use is off-label?","options":["Dexamethasone","Oral ursodeoxycholic acid (UDCA)","Prednisolone","Cholestyramine"],"correctIndex":1,"explanation":"To date, the only successful agent has been oral ursodeoxycholic acid (UDCA) [22, 23]."},{"id":19,"chapterId":28,"question":"Why is Cholestyramine contraindicated in the treatment of ICP?","options":["It causes severe hypertension.","It exacerbates pruritus.","It can further reduce vitamin K absorption and increase bleeding risk.","It is highly teratogenic."],"correctIndex":2,"explanation":"Cholestyramine is contraindicated as it can further reduce vitamin K absorption and increase the risk of bleeding [23]."},{"id":20,"chapterId":28,"question":"Atopic Eruption of Pregnancy (AEP) is the most common pruritic disorder during gestation and typically appears earlier than the other pregnancy-related dermatoses, with 75% of patients presenting before the:","options":["End of the first trimester","Second trimester","Third trimester","Immediate postpartum period"],"correctIndex":2,"explanation":"AEP generally appears earlier than the other pregnancy-related dermatoses (75% before the third trimester) [24-26]."},{"id":21,"chapterId":28,"question":"The pathogenesis of AEP is thought to be favored by the physiologic shift during pregnancy towards a dominant immune response driven by:","options":["Th1 cytokines (IL-12, IFN-","Th2 cytokines (IL-4, IL-10)","T regulatory cells","Neutrophil extracellular traps (NETs)"],"correctIndex":1,"explanation":"This natural switch towards a dominant Th2 response, which worsens the imbalance already present in most atopic patients, is thought to favor the development of AEP [27]."},{"id":22,"chapterId":28,"question":"In AEP, the eczematous lesions (seen in two-thirds of patients) often involve which typical 'atopic sites'?","options":["The face, neck, and flexural aspects of the extremities","The umbilicus and abdominal striae","The palms and soles","The lower legs (pretibial area)"],"correctIndex":0,"explanation":"Two-thirds of patients present with eczematous lesions... often involving 'atopic sites' such as the face, neck, and flexural aspects of the extremities [25]."},{"id":23,"chapterId":28,"question":"What is the maternal and fetal prognosis for Atopic Eruption of Pregnancy?","options":["High risk of prematurity and fetal distress","High risk of recurrence but excellent prognosis","Low risk of recurrence but risk of fetal growth restriction","Associated with autoimmune disease in the mother"],"correctIndex":1,"explanation":"Fetal and maternal prognoses are excellent and recurrences in subsequent pregnancies are common [20, 25]."},{"id":24,"chapterId":28,"question":"Which former diagnosis of pregnancy dermatosis is now generally recognized as pustular psoriasis, perhaps induced by relative hypocalcemia of pregnancy?","options":["Prurigo gestationis","Impetigo herpetiformis","Toxaemic rash of pregnancy","Papular dermatitis of pregnancy"],"correctIndex":1,"explanation":"Impetigo herpetiformis is now generally recognized as pustular psoriasis, perhaps induced by the relative hypocalcemia of pregnancy [28]."},{"id":25,"chapterId":28,"question":"Which pre-existing dermatosis commonly improves during pregnancy but flares within 612 weeks following delivery due to the down-regulation of the Th1 immune response?","options":["Atopic dermatitis","Psoriasis","Acne","Rosacea"],"correctIndex":1,"explanation":"Psoriasis commonly improves during pregnancy, then flares within 612 weeks following delivery. This is explained by the down-regulation of the Th1 immune response during a normal pregnancy [29]."},{"id":26,"chapterId":28,"question":"Which non-sedating systemic antihistamine is recommended as the first choice during pregnancy, based on safety data?","options":["Diphenhydramine","Loratadine","Cetirizine","Hydroxyzine"],"correctIndex":1,"explanation":"If a non-sedating agent is requested, loratadine is the first choice and cetirizine the second choice; both are considered safe throughout pregnancy [30, 31]."},{"id":27,"chapterId":28,"question":"Which of the following physiologic changes during pregnancy results from distention, instability, and new vessel formation, and is most pronounced during the third trimester?","options":["Melasma","Linea nigra","Pyogenic granulomas and spider angiomas","Postpartum telogen effluvium"],"correctIndex":2,"explanation":"Vascular changes, including spider angiomas, palmar erythema, and pyogenic granulomas, result from distention, instability, and new vessel formation. Clinically obvious changes are most pronounced during the third trimester [32]."},{"id":28,"chapterId":28,"question":"Which highly teratogenic systemic dermatologic agent is strictly contraindicated in pregnancy, requiring the iPLEDGE Program for risk management?","options":["Dapsone","Cyclosporine","Methotrexate (for non-neoplastic disease)","Azathioprine"],"correctIndex":2,"explanation":"Methotrexate is contraindicated in pregnancy for non-neoplastic diseases; embryo-fetal toxicity warning. Use effective contraception during and 6 months after the final dose [33, 34]."},{"id":29,"chapterId":28,"question":"Which topical retinoid is classified as Category X (Contraindicated in pregnancy) due to teratogenicity in animal studies and potential for embryo-fetal toxicity?","options":["Tretinoin","Adapalene","Tazarotene","Azelaic acid"],"correctIndex":2,"explanation":"Tazarotene is contraindicated in pregnancy; embryo-fetal toxicity warning. It is classified as former FDA Category X [35, 36]."},{"id":30,"chapterId":28,"question":"The use of potent topical corticosteroids during pregnancy should be limited, especially due to a reported risk of fetal growth restriction with extensive use, particularly exceeding what amount during pregnancy?","options":["30 g","100 g","300 g","500 g"],"correctIndex":2,"explanation":"Because fetal growth restriction has been reported with extensive use of potent corticosteroids, particularly > 300 g during the pregnancy, mild to moderate CS are recommended over potent CS [10]."},{"id":1,"chapterId":29,"question":"The epidermal basement membrane (BM) is a highly specialized structure. Which of the following is NOT one of the four distinct ultrastructural subregions identified via transmission electron microscopy?","options":["Lamina lucida","Lamina reticularis","Lamina densa","Sublamina densa region"],"correctIndex":1,"explanation":"The four distinct subregions of the epidermal basement membrane are: basal keratinocytes, the lamina lucida, the lamina densa, and the sublamina densa region [1-4]."},{"id":2,"chapterId":29,"question":"Which layer of the epidermal basement membrane is described as an electron-lucent region that contains delicate anchoring filaments, connecting hemidesmosomes to the underlying lamina densa?","options":["Basal keratinocyte membrane","Lamina lucida","Lamina densa","Sublamina densa region"],"correctIndex":1,"explanation":"The lamina lucida is an electron-lucent region containing delicate anchoring filaments; the latter connect hemidesmosomes in basal keratinocytes to the underlying lamina densa [2, 3, 5]."},{"id":3,"chapterId":29,"question":"Specialized studies of cryopreserved skin suggest that the lamina lucida may represent an artifact of which laboratory process?","options":["Immunofluorescent staining","Tissue dehydration (fixation artifact)","Transmission electron microscopy preparation","Cryopreservation itself"],"correctIndex":1,"explanation":"Specialized transmission electron microscopy studies of cryopreserved skin have suggested that the lamina lucida may actually represent an artifact of tissue dehydration [2]."},{"id":4,"chapterId":29,"question":"Which function is common to virtually all basement membranes?","options":["Synthesizing laminin 511 (laminin 10)","Providing a template for tissue repair","Mediating muscular contraction","Regulating neurotransmitter release"],"correctIndex":1,"explanation":"Functions common to virtually all basement membranes include serving as: (1) a substrate for cell attachment; (2) a template for tissue repair; (3) a matrix for cell migration; (4) a foundation for infrastructure influencing epithelial differentiation, morphogenesis, and apoptosis; and (5) a permeability barrier [1, 3, 6]."},{"id":5,"chapterId":29,"question":"The epidermal basement membrane is comprised of proteins derived from basal keratinocytes (ectodermal origin) and which other cell type (mesodermal origin)?","options":["Melanocytes","Langerhans cells","Dermal fibroblasts","Schwann cells"],"correctIndex":2,"explanation":"The epidermal basement membrane is comprised of proteins derived from both keratinocytes of ectodermal origin and dermal fibroblasts of mesodermal origin [7]."},{"id":6,"chapterId":29,"question":"Which structural element primarily tethers the lamina densa and the overlying epidermis to the papillary dermis in the 'laminated' model?","options":["Anchoring filaments","Hemidesmosomes","Anchoring fibrils","Integrin  6 4"],"correctIndex":2,"explanation":"The lamina densa is tethered to the dermis by anchoring fibrils that begin and end on the underside of the lamina densa, forming ultrastructural loops [8, 9]."},{"id":7,"chapterId":29,"question":"Which collagen type is the major component of anchoring fibrils localized to the sublamina densa region?","options":["Type I collagen","Type III collagen","Type IV collagen","Type VII collagen"],"correctIndex":3,"explanation":"Type VII collagen is the major component of anchoring fibrils and is restricted to the basement membrane of stratified squamous epithelia, where it localizes to the sublamina densa region [7, 10-12]."},{"id":8,"chapterId":29,"question":"Plectin, BPAG1e, desmoplakin, and envoplakin are all members of which protein family, known for connecting cytoskeletal networks to each other and to adhesive junctions?","options":["Integrin family","Tetraspan superfamily","Plakin family","Fibrillin family"],"correctIndex":2,"explanation":"Plectin, like BPAG1, desmoplakin, periplakin, and envoplakin, is a member of the plakin family. Plakins are large, multidomain cytolinkers [13]."},{"id":9,"chapterId":29,"question":"Bullous Pemphigoid Antigen 2 (BPAG2), a transmembrane collagen associated with hemidesmosome-anchoring filament complexes, is also known by which synonym?","options":["BP230","Dystonin","Type XVII collagen","Epiligrin"],"correctIndex":2,"explanation":"Bullous Pemphigoid Antigen 2 is synonymous with BP180 and type XVII collagen [13, 14]."},{"id":10,"chapterId":29,"question":"Bullous Pemphigoid Antigen 1 (BPAG1e or BP230) is localized to which specific structure within basal keratinocytes?","options":["The extracellular domain (lamina lucida)","The cytoplasmic plaque of hemidesmosomes","Anchoring fibrils (sublamina densa)","The lamina densa"],"correctIndex":1,"explanation":"BPAG1e is a 230 kDa plakin protein localized to the cytoplasmic plaque of hemidesmosomes (HDs) [15, 16]."},{"id":11,"chapterId":29,"question":"Proteolytic processing (shedding) of the extracellular domain of BPAG2 is mediated by 'sheddases' belonging to which family?","options":["Matrix metalloproteinases (MMPs)","A disintegrin and metalloproteinase (ADAM) family","Caspases","Cathepsins"],"correctIndex":1,"explanation":"Proteolytic processing of BPAG2 is mediated by 'sheddases' of the a disintegrin and metalloproteinase (ADAM) family, in particular ADAM metallopeptidase domain 17 (ADAM17) [17]."},{"id":12,"chapterId":29,"question":"BPAG1 knockout mice show signs of epithelial fragility and unexpected neurologic impairment (dystonia and ataxia) due to the concomitant inactivation of which type of BPAG1 isoforms?","options":["Endothelial isoforms","Neuronal isoforms (BPAG1n)","Vascular isoforms","Dermal isoforms"],"correctIndex":1,"explanation":"BPAG1 knockout mice show neurologic impairment (dystonia and ataxia), which results from concomitant inactivation of neuronal isoforms of BPAG1 (BPAG1n) [18]."},{"id":13,"chapterId":29,"question":"Which integrin heterodimer is concentrated within hemidesmosomes (HDs) of epithelial cells?","options":["Integrin  2 1","Integrin  3 1","Integrin  6 4","Integrin  5 3"],"correctIndex":2,"explanation":"The cytoplasmic domains and associations of integrin  6 4 are concentrated within HDs of epithelial cells [19, 20]. Basal keratinocytes produce integrin subunits  6 and  4 for HDs [7]."},{"id":14,"chapterId":29,"question":"Which integrin subunit has a cytoplasmic domain that is unusually large ( 1000 amino acid residues), in contrast to most subunits with  50 residues?","options":["Integrin subunit  6","Integrin subunit  1","Integrin subunit  4","Integrin subunit  3"],"correctIndex":2,"explanation":"Integrin subunit  4 has a larger cytoplasmic domain of >1000 amino acid residues."},{"id":15,"chapterId":29,"question":"Mutations in *FERMT1*, the gene encoding kindlin-1, are responsible for which specific type of Epidermolysis Bullosa (EB)?","options":["Dystrophic EB","Junctional EB","EB simplex with muscular dystrophy","Kindler EB (Kindler syndrome)"],"correctIndex":3,"explanation":"Mutations in *FERMT1*, which encodes kindlin-1, are responsible for Kindler EB (Kindler syndrome) [22]."},{"id":16,"chapterId":29,"question":"Which non-hemidesmosomal integrin is found along the lateral and apical aspects of basal keratinocytes and is used in culture to mediate initial adhesion to the extracellular matrix via interaction with laminin 332?","options":["Integrin  6 4","Integrin  3 1","Integrin  5 1","Integrin  2 1"],"correctIndex":1,"explanation":"Keratinocytes in culture utilize integrin  3 1 to mediate initial adhesion to extracellular matrix via interaction with laminin 332 [23, 24]."},{"id":17,"chapterId":29,"question":"The predominant laminin isoforms in the epidermal basement membrane are 332, 311, and 511. Which previous numerical name corresponds to Laminin 332?","options":["Laminin 1","Laminin 5","Laminin 6","Laminin 10"],"correctIndex":1,"explanation":"Laminin 332 ( 3 3 2) is formerly known as laminin 5, epiligrin, kalinin, nicein, GB3 antigen, or BM600 [13, 25-27]."},{"id":18,"chapterId":29,"question":"Inherited disruptions in the genes encoding the subunits of laminin 332 (*LAMA3, LAMB3, LAMC2*) lead to subtypes of which inherited blistering disease?","options":["Epidermolysis Bullosa Simplex (EBS)","Recessive Dystrophic EB (RDEB)","Junctional EB (JEB)","Kindler EB"],"correctIndex":2,"explanation":"Inherited disruptions in the genes that encode laminin 332 subunits (*LAMA3, LAMB3, LAMC2*), lead to subtypes of junctional EB characterized by subepidermal blister formation [28, 29]."},{"id":19,"chapterId":29,"question":"Unlike classic fibrillar collagens, the structure of Type IV collagen is unique because it links in which configuration, forming a two-dimensional lattice?","options":["Head-to-head (non-parallel)","Side-to-side only","In parallel (fibrillar)","Helix-to-helix via disulfide bonds"],"correctIndex":0,"explanation":"Type IV collagen links head-to-head rather than in parallel, forming a type IV collagen lattice (two-dimensional network) that serves as a key matrix within the lamina densa [30, 31]."},{"id":20,"chapterId":29,"question":"Goodpasture disease, a lethal autoimmune disorder, is caused by anti-basement membrane antibodies directed against the NC1 domain of which Type IV collagen -chain subunit?","options":[" 1 (IV)"," 2 (IV)"," 3 (IV)"," 6 (IV)"],"correctIndex":2,"explanation":"Goodpasture disease is caused by anti-basement membrane antibodies directed against the NC1 domain of  3(IV) and  5(IV)."},{"id":21,"chapterId":29,"question":"Which dumbbell-shaped 150 kDa glycoprotein localized to the lamina densa binds both laminin isoforms (containing  1) and Type IV collagen, stabilizing macromolecules within the lamina densa?","options":["Perlecan","Nidogen","Fibulin 2","Elastin"],"correctIndex":1,"explanation":"Nidogen is a dumbbell-shaped 150 kDa glycoprotein localized to the lamina densa. Nidogen binds laminin isoforms containing the  1-subunit with high affinity and the G2 domain binds with high affinity to type IV collagen, thus thought to stabilize macromolecules [33]."},{"id":22,"chapterId":29,"question":"Which proteoglycan is thought to have a more important role than nidogen in connecting laminin- and collagen IV-containing networks (spot welding) in the epidermal basement membrane?","options":["Dermatopontin","Heparan sulfate proteoglycan (HSPG) / Perlecan","Aggrecan","Syndecan"],"correctIndex":1,"explanation":"More recent studies have found that perlecan (a heparan sulfate proteoglycan) may have a more important role in linking Type IV collagen and laminin networks together [11, 33, 34]."},{"id":23,"chapterId":29,"question":"Anchoring fibrils are formed by Type VII collagen dimers aggregating laterally into bundles. How does the initial assembly of these dimers begin?","options":["NC1 domains bind to hemidesmosomes.","NC2 'tails' align in an antiparallel fashion and unite via disulfide bonds.","The central rod portion coils around laminin 332.","They are cross-linked by fibulins."],"correctIndex":1,"explanation":"The assembly of anchoring fibrils initiates when NC2 'tails' of individual type VII collagen molecules align in an antiparallel fashion and unite via disulfide bonds [12]."},{"id":24,"chapterId":29,"question":"The phenotype of patients with severe recessive dystrophic EB is often characterized by premature termination codons in *COL7A1*, resulting in what outcome?","options":["Abnormal-appearing Type VII collagen","A complete lack of detectable Type VII collagen and anchoring fibrils","Increased production of Type VII collagen","Blistering limited to acral sites"],"correctIndex":1,"explanation":"Patients with severe recessive dystrophic EB typically have mutations that lead to premature termination codons and nonsense-mediated mRNA decay, resulting in no detectable type VII collagen and no anchoring fibrils [35]."},{"id":25,"chapterId":29,"question":"In Dominant Dystrophic EB, missense mutations in one *COL7A1* allele disrupt the function of the protein derived from the normal allele. This mechanism is classified as:","options":["Loss-of-function","Haploinsufficiency","Dominant-negative effect","Mosaicism"],"correctIndex":2,"explanation":"Patients with dominant dystrophic EB usually have a missense mutation in one *COL7A1* allele that creates a dominant-negative effect on protein derived from their other, normal *COL7A1* allele [35]."},{"id":26,"chapterId":29,"question":"Epidermolysis Bullosa Acquisita (EBA) and the Bullous Eruption of Systemic Lupus Erythematosus (SLE) are autoimmune diseases that target which specific structural protein?","options":["BPAG1e (BP230)","Laminin 332","Integrin  6  4","Type VII collagen"],"correctIndex":3,"explanation":"The antigen targeted in EBA is type VII collagen, and the bullous eruption of SLE is also caused by IgG autoantibodies directed against immunodominant epitopes in type VII collagen [36-38]."},{"id":27,"chapterId":29,"question":"Which component of the epidermal basement membrane is targeted by autoantibodies in Gestational Pemphigoid (PG)?","options":["Plectin","BPAG2 (Type XVII collagen)","Type VII collagen","Laminin 332"],"correctIndex":1,"explanation":"The autoantigen in Pemphigoid Gestationis (PG) is BPAG2 (180 kDa) localized to the hemidesmosome-anchoring filament complexes [16, 38]."},{"id":28,"chapterId":29,"question":"In an indirect immunofluorescence (IF) study using 1 M NaCl salt-split skin, where do IgG autoantibodies from patients with classic Bullous Pemphigoid (BP) typically bind?","options":["The epidermal side of the split","The dermal side of the split","Only the lamina densa","The subcutaneous fat"],"correctIndex":0,"explanation":"Patients with classic BP can be distinguished by their IgG anti-basement membrane autoantibodies binding the epidermal side of salt-split skin [39-41]."},{"id":29,"chapterId":29,"question":"In the direct immunofluorescence (DIF) microscopy technique utilizing 1 M NaCl salt-split skin, the cleavage plane occurs within which specific ultrastructural region?","options":["The basal keratinocyte cytoplasm","The lower portion of the lamina lucida","The middle of the lamina densa","The sublamina densa region"],"correctIndex":1,"explanation":"One example of these techniques is the use of 1 M NaCl salt-split skin, cleaved within the lamina lucida [39]. The cleavage plane in 1 M NaCl salt-split skin is in the lower portion of the lamina lucida [40]."},{"id":30,"chapterId":29,"question":"CD151, a tetraspan cell surface protein concentrated in hemidesmosomes (HDs), is considered a component of pre-HDs whose recruitment is regulated by which integrin heterodimer?","options":["Integrin  3  1","Integrin  6  4","Integrin  2  1","Integrin  5  1"],"correctIndex":1,"explanation":"CD151 is therefore considered to be a component of pre-HDs wh,ose recruitment is regulated by integrin  6  4."},{"id":1,"chapterId":30,"question":"Pemphigus describes a group of chronic blistering skin diseases where autoantibodies are directed against the cell surface of keratinocytes, resulting in the loss of cellcell adhesion known as:","options":["Cytolysis","Acantholysis","Spongiosis","Keratinocyte necrosis"],"correctIndex":1,"explanation":"The term pemphigus describes a group of chronic blistering skin diseases in which autoantibodies are directed against the cell surface of keratinocytes, resulting in the loss of cellcell adhesion of keratinocytes through a process called acantholysis [1]."},{"id":2,"chapterId":30,"question":"What finding, made by Beutner and Jordon in 1964, formed the basis of understanding pemphigus as a tissue-specific autoimmune disease?","options":["The identification of the Dsg3 antigen","The discovery of circulating antibodies directed against the cell surface of keratinocytes","The confirmation of T cell-mediated cytotoxicity","The use of plasma exchange to reduce autoantibody titers"],"correctIndex":1,"explanation":"The modern history of pemphigus began with the discovery by Beutner and Jordon in 1964 of circulating antibodies directed against the cell surface of keratinocytes in the sera of pemphigus vulgaris patients [2]."},{"id":3,"chapterId":30,"question":"In Pemphigus vulgaris, intraepidermal blisters typically develop at which specific location?","options":["Within the stratum corneum","Just above the basal cell layer (suprabasilar)","Between the epidermis and dermis (subepidermal)","In the superficial portion, mostly at the granular layer"],"correctIndex":1,"explanation":"The blisters of pemphigus vulgaris develop within the deeper portion of the epidermis, just above the basal cell layer [3, 4]."},{"id":4,"chapterId":30,"question":"Pemphigus foliaceus is clinically defined by cutaneous involvement without mucosal lesions, and the splits typically occur in which layer of the epidermis?","options":["Basal layer","Stratum spinosum","Superficial portion, mostly at the granular layer","Sublamina densa region"],"correctIndex":2,"explanation":"Patients with pemphigus foliaceus only have cutaneous involvement without mucosal lesions, and the splits occur in the superficial portion of the epidermis, mostly at the granular layer [3]."},{"id":5,"chapterId":30,"question":"Which specific desmoglein is the primary target antigen for IgG autoantibodies in patients with Pemphigus vulgaris?","options":["Desmoglein 1 (Dsg1)","Desmoglein 2 (Dsg2)","Desmoglein 3 (Dsg3)","Desmocollin 1 (Dsc1)"],"correctIndex":2,"explanation":"Patients with pemphigus vulgaris and pemphigus foliaceus have IgG autoantibodies against desmoglein 3 and desmoglein 1, respectively [5]."},{"id":6,"chapterId":30,"question":"The mucosal-dominant type of Pemphigus vulgaris is characterized by IgG autoantibodies directed against:","options":["Only Desmoglein 1 (Dsg1)","Only Desmoglein 3 (Dsg3)","Both Dsg1 and Dsg3","Plectin and Envoplakin"],"correctIndex":1,"explanation":"While patients with pemphigus foliaceus have only anti-Dsg1 IgG autoantibodies, individuals with the mucosal-dominant type of pemphigus vulgaris have only anti-Dsg3 IgG autoantibodies [6]."},{"id":7,"chapterId":30,"question":"According to the desmoglein compensation theory, why do sera containing only anti-Dsg3 IgG cause mucosal erosions but only limited or no cutaneous blisters?","options":["Dsg3 is only expressed in mucosa.","Dsg1 expression in the skin compensates for the impaired Dsg3 function.","Anti-Dsg3 IgG is unable to penetrate the skin epidermis.","Mucosa is a Th1 environment, unlike skin."],"correctIndex":1,"explanation":"When sera contain only anti-Dsg3 IgG, they are inefficient in producing cutaneous blisters because coexpressed Dsg1 compensates for the impaired function of Dsg3, resulting in no, or only limited, skin lesions [7]."},{"id":8,"chapterId":30,"question":"What is the primary mechanism by which pemphigus autoantibodies are thought to directly inhibit the adhesive function of desmogleins?","options":["Activation of complement components","Steric hindrance, interfering with adhesive interaction","Internalization of plakoglobin","Activation of Matrix Metalloproteinases (MMPs)"],"correctIndex":1,"explanation":"The direct inhibition is mediated by steric hindrance, i.e. the binding of autoantibodies to desmogleins spatially interferes with the adhesive interaction of desmogleins between cells [8]."},{"id":9,"chapterId":30,"question":"The incidence of pemphigus is notably higher (16 to 32 cases per million per year) in individuals of which specific ancestry?","options":["Japanese","Finnish","Ashkenazi Jews","Brazilian Pardo"],"correctIndex":2,"explanation":"The incidence is much higher (16 to 32 cases per million per year) in those of Jewish ancestry, particularly Ashkenazi Jews [9]."},{"id":10,"chapterId":30,"question":"The endemic variant of pemphigus foliaceus, known as Fogo selvagem, is strongly associated with which environmental factor in rural Brazil?","options":["Consumption of contaminated grain","Exposure to black flies (*Simulium spp.*)","Exposure to asbestos","Use of specific pesticides"],"correctIndex":1,"explanation":"The majority of patients [with fogo selvagem] live close to rivers and within the 1015 km flying range of black flies (*Simulium spp.*), which may be the vector that precipitates the disease [10]."},{"id":11,"chapterId":30,"question":"The presence of flaccid blisters and widespread cutaneous erosions in addition to mucosal involvement defines which subtype of Pemphigus vulgaris?","options":["Mucosal-dominant type","Pemphigus vegetans (Neumann type)","Mucocutaneous type","Herpetiform pemphigus"],"correctIndex":2,"explanation":"Pemphigus vulgaris is divided into two subgroups: (1) the mucosal-dominant type with mucosal erosions but minimal skin involvement; and (2) the mucocutaneous type with extensive skin blisters and erosions in addition to mucosal involvement [11]."},{"id":12,"chapterId":30,"question":"Which clinical sign in active pemphigus is demonstrated by applying gentle pressure to an intact bulla, causing the fluid to spread laterally under the skin?","options":["Nikolsky sign","Darier sign","AsboeHansen sign","Koebner phenomenon"],"correctIndex":2,"explanation":"The lack of cohesion of the skin may also be demonstrated with the bulla-spread phenomenon  gentle pressure on an intact bulla forces the fluid to spread under the skin away from the site of pressure (AsboeHansen sign, also referred to as the 'indirect Nikolsky' or 'Nikolsky II' sign) [12]."},{"id":13,"chapterId":30,"question":"A rare vegetative variant of Pemphigus vulgaris characterized by fungoid vegetations, particularly in intertriginous areas, is known as:","options":["Pemphigus erythematosus","Pemphigus vegetans","Herpetiform pemphigus","Fogo selvagem"],"correctIndex":1,"explanation":"Pemphigus vegetans is a rare vegetative variant of pemphigus vulgaris, characterized by flaccid blisters that become erosions and then form fungoid vegetations or papillomatous proliferations, especially in intertriginous areas [13]."},{"id":14,"chapterId":30,"question":"Drug-induced pemphigus foliaceus is seen more commonly than pemphigus vulgaris in patients taking which drug class?","options":["Penicillamine and ACE inhibitors","Immune checkpoint inhibitors","Methotrexate","Beta-lactam antibiotics"],"correctIndex":0,"explanation":"There are sporadic cases of pemphigus associated with the use of drugs, in particular penicillamine and captopril [14]. In patients receiving penicillamine, pemphigus foliaceus is seen more commonly than pemphigus vulgaris, with a ratio of approximately 4:1 [14]."},{"id":15,"chapterId":30,"question":"Paraneoplastic Pemphigus is distinct from classic forms of pemphigus as it involves autoantibodies directed against desmogleins as well as multiple members of which specific protein family?","options":["Cadherin family (classic cadherins)","Integrin family","Plakin family","Laminin family"],"correctIndex":2,"explanation":"Patients with paraneoplastic pemphigus develop characteristic IgG autoantibodies against multiple antigens [15], including Dsg3 and/or Dsg1 [16], multiple members of the plakin family (plectin, epiplakin, desmoplakins I and II, bullous pemphigoid antigen 1, envoplakin, and periplakin) [15]."},{"id":16,"chapterId":30,"question":"The most commonly associated neoplasms with Paraneoplastic Pemphigus (accounting for two-thirds of patients) are:","options":["Adenocarcinomas of the breast or colon","Squamous cell carcinomas and basal cell carcinomas","Non-Hodgkin lymphoma and chronic lymphocytic leukemia","Melanoma and sarcomas"],"correctIndex":2,"explanation":"The most commonly associated neoplasms are non-Hodgkin lymphoma and chronic lymphocytic leukemia, followed by Castleman disease, malignant and benign thymomas, sarcomas, and Waldenstrm macroglobulinemia [17]. Non-Hodgkin lymphoma and chronic lymphocytic leukemia together account for two-thirds of patients [17]."},{"id":17,"chapterId":30,"question":"Which severe complication of Paraneoplastic Pemphigus involves the lung and can be fatal due to respiratory failure?","options":["Pulmonary hypertension","Bronchiolitis obliterans","Eosinophilic pneumonia","Diffuse alveolar hemorrhage"],"correctIndex":1,"explanation":"Some patients with paraneoplastic pemphigus develop bronchiolitis obliterans, which can be fatal as a result of respiratory failure [18, 19]."},{"id":18,"chapterId":30,"question":"The occurrence of blisters and erythema multiforme-like lesions on the palms and soles is often used to differentiate Paraneoplastic Pemphigus from Pemphigus vulgaris because in PV, lesions on the palms and soles are:","options":["More common and severe","Rare and highly unusual","Typically targetoid","Subcorneal"],"correctIndex":1,"explanation":"The occurrence of blisters and erythema multiforme-like lesions on the palms and soles is often used to differentiate paraneoplastic pemphigus from pemphigus vulgaris, in which lesions on the palms and soles are unusual [18]."},{"id":19,"chapterId":30,"question":"IgA Pemphigus is a group of intraepidermal blistering diseases characterized by autoantibodies of the IgA class directed against the keratinocyte cell surface, with the two major subtypes being intraepidermal neutrophilic (IEN) type and:","options":["Mucosal-dominant type","Pemphigus erythematosus","Subcorneal pustular dermatosis (SPD) type","Herpetiform type"],"correctIndex":2,"explanation":"IgA pemphigus... is divided into two major subtypes: intraepidermal neutrophilic (IEN) type and subcorneal pustular dermatosis (SPD) type [20, 21]."},{"id":20,"chapterId":30,"question":"The characteristic configuration of pustules in the intraepidermal neutrophilic (IEN) type of IgA Pemphigus is often described as:","options":["Annular or circinate pattern","Linear configuration","Sunflower-like configuration","Reticular pattern"],"correctIndex":2,"explanation":"The pustules tend to coalesce to form an annular or circinate pattern with crusts in the center of the lesion... although a sunflower-like configuration of pustules is a characteristic sign of the intraepidermal neutrophilic type [19, 22]."},{"id":21,"chapterId":30,"question":"Which desmosomal protein is recognized by IgA autoantibodies in the subcorneal pustular dermatosis (SPD) type of IgA Pemphigus?","options":["Desmoglein 3","Desmocollin 1","Plakoglobin","BPAG1"],"correctIndex":1,"explanation":"IgA autoantibodies in the subcorneal pustular dermatosis type were shown to recognize desmocollin 1 [23, 24]."},{"id":22,"chapterId":30,"question":"For routine histology in pemphigus, the biopsy specimen should ideally include:","options":["Nearby normal skin only","The oldest, crusted lesion","The edge of a fresh vesicle or bulla plus the inflammatory rim","A large area of denuded erosion only"],"correctIndex":2,"explanation":"For routine histology... the biopsy specimen should include the edge of a fresh vesicle or bulla plus the inflammatory rim [25]."},{"id":23,"chapterId":30,"question":"Histologically, Pemphigus vulgaris is characterized by suprabasilar acantholysis, with basal cells maintaining attachment to the basement membrane, creating the appearance of:","options":["Dilapidated brick wall","Row of tombstones","Interface dermatitis","Eosinophilic spongiosis"],"correctIndex":1,"explanation":"Although the basal cells lose lateral desmosomal contact with their neighbors, they maintain their attachment to the basement membrane via hemidesmosomes, thus giving the appearance of a 'row of tombstones' [4]."},{"id":24,"chapterId":30,"question":"In Pemphigus foliaceus, the detached, superficial roof of the fragile blister is often difficult to obtain, resulting in scale-crusts sometimes likened to:","options":["Cigarette paper","Cornflakes","Cayenne pepper","Wet tissue paper"],"correctIndex":1,"explanation":"The scales [of pemphigus foliaceus] have been likened to cornflakes [26, 27]."},{"id":25,"chapterId":30,"question":"What is the gold standard diagnostic test for pemphigus, demonstrating in vivo bound IgG deposition on the keratinocyte cell surfaces?","options":["Tzanck smear cytology","Indirect Immunofluorescence (IIF) on monkey esophagus","Direct Immunofluorescence (DIF) microscopy of perilesional skin","Enzyme-Linked Immunosorbent Assay (ELISA) targeting BP230"],"correctIndex":2,"explanation":"DIF examines patients skin or mucous membranes in order to demonstrate in vivo bound IgG deposition on the keratinocyte cell surfaces [28, 29]. DIF is the most reliable and sensitive diagnostic test for all forms of pemphigus [28]."},{"id":26,"chapterId":30,"question":"In a patient with Pemphigus vulgaris, the detection of circulating autoantibodies by Indirect Immunofluorescence (IIF) traditionally recommends the use of which substrate to optimize sensitivity for anti-Dsg3 IgG?","options":["Human skin, salt-split","Rat bladder","Monkey esophagus","Guinea pig esophagus"],"correctIndex":2,"explanation":"For Pemphigus vulgaris, the recommended substrate for Indirect Immunofluorescence is monkey esophagus (to detect anti-Dsg3) [30, 31]."},{"id":27,"chapterId":30,"question":"Which laboratory assay can serologically distinguish between the subtypes of Pemphigus vulgaris (mucosal-dominant, mucocutaneous) and Pemphigus foliaceus?","options":["Direct Immunofluorescence (DIF)","Tzanck smear","Enzyme-linked immunosorbent assay (ELISA)","Routine histology"],"correctIndex":2,"explanation":"ELISA is increasingly being used to detect antigen-specific autoantibodies for the diagnosis of pemphigus [32]. This assay has enabled investigators to serologically distinguish subtypes of pemphigus vulgaris and foliaceus [32]."},{"id":28,"chapterId":30,"question":"What is considered the mainstay of systemic therapy for Pemphigus vulgaris, typically started at 1 mg/kg/day due to its rapid clinical response?","options":["Cyclophosphamide","Azathioprine","Oral prednisone","Dapsone"],"correctIndex":2,"explanation":"Systemic corticosteroids are a mainstay of therapy in pemphigus vulgaris, given the rapidity of clinical response [20]. Systemic corticosteroid therapy, usually in the form of oral prednisone, is standard treatment [33]. Prednisone at 1 mg/kg/day (usually 60 mg/day) is a typical initial dosage [33]."},{"id":29,"chapterId":30,"question":"Which therapeutic agent, a potent B cell-depleting chimeric anti-CD20 monoclonal antibody, is an FDA-approved first-line option for moderate-to-severe pemphigus?","options":["IVIg","Rituximab","Cyclosporine","Methotrexate"],"correctIndex":1,"explanation":"Rituximab represents a first-line, FDA-approved therapeutic option for moderate-to-severe pemphigus [1]. Rituximab is a potent B cell-depleting chimeric anti-CD20 monoclonal antibody [34]."},{"id":30,"chapterId":30,"question":"What is the drug of choice for most patients with IgA Pemphigus, leading to clinical response typically within 2448 hours?","options":["Systemic corticosteroids","Dapsone","Mycophenolate mofetil","Rituximab"],"correctIndex":1,"explanation":"Dapsone is the drug of choice for most patients with IgA pemphigus [35]. A clinical response usually occurs within 2448 hours [35]."}]`);function Im(){const{chapterId:r}=vh(),c=as(),l=Number(r),u=xm.filter(B=>B.chapterId===l),[m,h]=b.useState(0),[v,k]=b.useState(null),[w,T]=b.useState(!1),[q,C]=b.useState(0),R=u[m];if(!R)return E.jsx("div",{className:"min-h-screen bg-gray-900 flex items-center justify-center text-gray-400",children:"No questions available for this chapter."});const V=()=>{v===R.correctIndex&&C(B=>B+1),T(!0)},U=()=>{if(m+1===u.length){c("/Result",{state:{totalQuestions:u.length,correctAnswers:q+(v===R.correctIndex?1:0)}});return}k(null),T(!1),h(z=>z+1)};return E.jsx("main",{className:"min-h-screen bg-gray-900 px-6 py-12",children:E.jsxs("div",{className:"mx-auto max-w-3xl",children:[E.jsxs("div",{className:"mb-6 text-gray-400 text-sm",children:["Question ",m+1," of ",u.length]}),E.jsxs("div",{className:"rounded-lg border border-white/10 bg-gray-800 p-6",children:[E.jsx("h2",{className:"text-xl font-semibold text-white",children:R.question}),E.jsx("div",{className:"mt-6 space-y-3",children:R.options.map((B,z)=>{let G="w-full text-left rounded-md px-4 py-3 border transition";return w?z===R.correctIndex?G+=" bg-green-600/20 border-green-500 text-white":z===v?G+=" bg-red-600/20 border-red-500 text-white":G+=" border-white/10 text-gray-300":G+=v===z?" bg-indigo-500/20 border-indigo-400 text-white":" border-white/10 text-gray-300 hover:bg-gray-700",E.jsx("button",{disabled:w,onClick:()=>k(z),className:G,children:B},z)})}),w&&E.jsxs("div",{className:"mt-6 rounded-md bg-gray-900 p-4 text-sm text-gray-300",children:[E.jsx("strong",{className:"text-white",children:"Explanation:"})," ",R.explanation]}),E.jsx("div",{className:"mt-6 flex justify-between",children:w?E.jsx("button",{onClick:U,className:"rounded-md bg-indigo-500 px-4 py-2 text-sm font-semibold text-white hover:bg-indigo-400",children:"Next Question "}):E.jsx("button",{disabled:v===null,onClick:V,className:"rounded-md bg-indigo-500 px-4 py-2 text-sm font-semibold text-white hover:bg-indigo-400 disabled:opacity-40",children:"Submit Answer"})})]})]})})}function wm(){const r=ei(),c=as(),{totalQuestions:l,correctAnswers:u}=r.state||{};if(l===void 0||u===void 0)return E.jsx("div",{className:"min-h-screen bg-gray-900 flex items-center justify-center text-gray-400",children:"No result data available."});const m=Math.round(u/l*100),h=m>=60;return E.jsx("main",{className:"min-h-screen bg-gray-900 px-6 py-12 flex items-center justify-center",children:E.jsxs("div",{className:"w-full max-w-xl rounded-lg border border-white/10 bg-gray-800 p-8 text-center",children:[E.jsx("h1",{className:"text-3xl font-bold text-white",children:"Quiz Completed"}),E.jsx("p",{className:"mt-2 text-gray-400",children:"Heres how you performed"}),E.jsxs("div",{className:"mt-8",children:[E.jsxs("div",{className:"text-6xl font-bold text-white",children:[m,"%"]}),E.jsxs("p",{className:"mt-2 text-gray-300",children:[u," / ",l," correct"]})]}),E.jsx("div",{className:`mt-6 rounded-md px-4 py-2 text-sm font-semibold ${h?"bg-green-600/20 text-green-400":"bg-red-600/20 text-red-400"}`,children:h?"Passed":"Needs Improvement"}),E.jsxs("div",{className:"mt-8 flex flex-col gap-4 sm:flex-row sm:justify-center",children:[E.jsx("button",{onClick:()=>c(-1),className:"rounded-md bg-indigo-500 px-5 py-2 text-sm font-semibold text-white hover:bg-indigo-400",children:"Retry Quiz"}),E.jsx("button",{onClick:()=>c("/BologniaQuizChapters"),className:"rounded-md border border-white/10 px-5 py-2 text-sm font-semibold text-gray-300 hover:bg-gray-700",children:"Back to Chapters"})]})]})})}function bm(){return E.jsxs("div",{children:[E.jsx(hm,{}),E.jsxs(zh,{children:[E.jsx(Fi,{path:"/",element:E.jsx(mm,{})}),E.jsx(Fi,{path:"/QuizList",element:E.jsx(ym,{})}),E.jsx(Fi,{path:"/BologniaQuizChapters",element:E.jsx(vm,{})}),E.jsx(Fi,{path:"/QuizTest/:chapterId",element:E.jsx(Im,{})}),E.jsx(Fi,{path:"/Result",element:E.jsx(wm,{})})]})]})}Hp.createRoot(document.getElementById("root")).render(E.jsx(b.StrictMode,{children:E.jsx(im,{basename:"/React-Derma-Quiz",children:E.jsx(bm,{})})}));
